Spectra Optia®

Apheresis System

Operator’s Manual
Spectra Optia® Apheresis System

Operator’s Manual

Part No. 1000004965

Reorder No. 703261003
2021-01
©2021 Terumo BCT, Inc.
Terumo BCT is a registered trademark of Terumo Corporation.
Seal Safe is a trademark of Terumo BCT, Inc.
Spectra Optia is a registered trademark of Terumo BCT, Inc.
This product may be covered by one or more patents or pending patent applications. See TERUMOBCT.COM/patents
for details.

Terumo BCT, Inc.

10811 W. Collins Avenue
Lakewood, Colorado 80215
USA
USA Phone: +1.877.339.4228
Phone: +1.303.231.4357
USA Fax: +1.866.715.6768
Fax: +1.303.542.5215

Terumo BCT Europe N.V.

Ikaroslaan 41
1930 Zaventem, Belgium
Phone: +32.2.715.05.90
Fax: +32.2.721.07.70

TERUMOBCT.COM
 Contents

Chapter 1: Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
About This Operator’s Manual . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Conventions Used in this Manual . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Numbered Steps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Touch screen buttons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2
Bullets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Warnings, Cautions, and Notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Spectra Optia Apheresis System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Intended Use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Contraindications for Use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Warnings and Cautions for Use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Warnings for Use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
System warnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3
Service warnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4
Electrical warnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4
General procedural warnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4
Exchange procedure warnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7
Collection and depletion procedure warnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7
General tubing set warnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8
Accessory set warnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8
Fluid warnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8
Seal Safe system warnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8
Cautions for Use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
System cautions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9
Service cautions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10
General procedural cautions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11
Collection and depletion procedure cautions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11
General tubing set cautions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .12
Exchange Set cautions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13
Collection Set cautions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13
IDL Set cautions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13
Fluid cautions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .14
Seal Safe system cautions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .14
Service Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Special Use of Additional Equipment and Devices During Apheresis Procedures . . . . . . . . . . . . . . . . . . . . . . . 15
Fluids Administered During Apheresis Procedures. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Saline Solution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Anticoagulant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
ACD-A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .16
Hydroxyethyl Starch (HES) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .16

Spectra Optia Apheresis System Operator’s Manual i

Contents

Replacement Fluids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Adverse Events of Apheresis Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Reactions to Blood Products Transfused During Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Disposal of Infectious and Non-Infectious Waste . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Return of Used Product . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18

Chapter 2: Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Spectra Optia System Description . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Spectra Optia System Components . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
Front Panel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Pumps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Valves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Sensors and detectors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Return line air detector . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Centrifuge Chamber . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Filler . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
AIM System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Operating Modes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Automatic Mode . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Semi-Automatic Mode . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Procedure States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Packing Factor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Operation Status Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Caution Status . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
Fluid Balance Limits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Spectra Optia System Touch Screen. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Navigating the Procedure Screens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Entering and changing numerical data using the data entry pad . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Screen Colors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
Screen Buttons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
Buttons, Icons, and Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36

Chapter 3: Installing and Transporting the Spectra Optia System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

Installing the Spectra Optia System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Setting Up the Spectra Optia System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Turning the Spectra Optia System On and Off . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Transporting the Spectra Optia System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Preparing the Spectra Optia System for Transport . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Transporting the Spectra Optia System in a Vehicle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
Loading the system into the vehicle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
Securing the system inside the vehicle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
Storing the Spectra Optia System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46

Chapter 4: Configuring the Spectra Optia System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47

Configuring the Spectra Optia System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
Configuring Procedure-Independent Operating Parameters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
Configuring Procedure-Specific Operating Parameters. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
Therapeutic Plasma Exchange (TPE) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
Therapeutic Plasma Exchange With A Secondary Plasma Device (TPE-SPD) . . . . . . . . . . . . . . . . . . . . . 52

ii Spectra Optia Apheresis System Operator’s Manual

 Contents

Red Blood Cell Exchange (RBCX) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53

Mononuclear Cell (MNC) Collection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
Continuous Mononuclear Cell Collection (CMNC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
Granulocyte (PMN) Collection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
White Blood Cell Depletion (WBCD) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
Platelet Depletion (PLTD) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
Bone Marrow Processing (BMP) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
Configuring the Use of a Blood Warmer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59

Chapter 5: Preparing to Perform a Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61

Supplies Required to Perform a Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
Selecting the Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
Installing the Filler . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
Removing the Filler . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
Re-Installing the Filler . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
Loading the Tubing Set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
Unpacking the Lines and the Bags . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
Exchange Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
Collection Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
IDL Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
Snapping the Cassette into the Cassette Tray . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
Loading the Channel into the Centrifuge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
Loading the Lower and Upper Bearings and the Upper Collar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
Priming the Tubing Set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71

Chapter 6: Selecting Procedure Options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73

Selecting Procedure Options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
Selecting Rinseback . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
Selecting and Performing a Custom Prime . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
Selecting the custom prime option . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
Accepting a custom prime recommendation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
Entering data for the custom prime . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
Starting the custom prime . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
Ending the custom prime before it is complete . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
Extending the custom prime . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
Indicating the Use of HES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
Selecting and Performing a Saline Rinse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
Selecting the saline rinse option . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
Starting the saline rinse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
Repeating a saline rinse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
Selecting and Confirming the Single-Needle Option . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
Indicating Plasma Collection (BMP) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
Indicating the Use of a Blood Warmer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
Exchange procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
Collection and depletion procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
Indicating the Timing of Plasma Collection (CMNC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81

Chapter 7: Therapeutic Plasma Exchange (TPE) Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83

Functional Description of a Therapeutic Plasma Exchange (TPE) Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . 84
TPE Procedures Using a Single Needle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
Preparing to Perform a Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
Supplies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84

Spectra Optia Apheresis System Operator’s Manual iii

Contents

Selecting the Procedure and Loading the Tubing Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84

Navigating the TPE Procedure Screens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
Menu Buttons and Tabs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
Descriptions of Buttons, Icons, and Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
Entering and Changing Data During the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
Entering and Confirming Patient and Procedure Data. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
Entering Patient Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
Entering Fluid Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
Selecting the type of replacement fluid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
Entering the fluid balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
Reviewing and Confirming the Run Values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
Converting the Access to a Single Needle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
Selecting and Confirming the Single-Needle Option . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
Connecting the Single-Needle Connector . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
Priming the Inlet Line, the Return Line, and the Replace Line. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
Connecting the Patient and Starting the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
Monitoring the Run. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
Main Run Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
Algorithm control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
Exchange Status Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
Replacement fluid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
Monitoring the Patient. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
Managing Citrate Toxicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
Giving a Fluid Bolus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
Bolus volume and reported fluid balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
Optimizing the Run. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
Prediction for Removing a Substance From the Patient’s Plasma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
Handling Turbulence or Platelet Swirling in the Connector . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
Decreasing the Run Time After Converting the Access to a Single Needle . . . . . . . . . . . . . . . . . . . . . . . . 96

Chapter 8: Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures . . . . 97
Functional Description of a Therapeutic Plasma Exchange With a
Secondary Plasma Device (TPE-SPD) Procedure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
Preparing to Perform a Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
Supplies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
Selecting the Procedure and Loading the Tubing Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
Navigating the TPE-SPD Procedure Screens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
Menu Buttons and Tabs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
Descriptions of Buttons, Icons, and Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
Entering and Changing Data During the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
Entering and Confirming Patient and Procedure Data. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Entering Patient Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Reviewing and Confirming the Plasma Device Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Reviewing and Confirming the Run Values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
Connecting the Plasma Device Using an Extension Tubing Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
Setting Up and Priming the Extension Tubing Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
Connecting the Treated Plasma Bag . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
Saline prime: Yes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
Saline prime: No . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
Priming the Inlet Line and the Return Line . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
Connecting the Patient and Starting the Run. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
Filling the Treated Plasma Bag . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107

iv Spectra Optia Apheresis System Operator’s Manual

 Contents

Monitoring the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108

Main Run Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
Treatment Status Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
Monitoring the Patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
Managing Citrate Toxicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
Giving a Fluid Bolus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
Bolus volume and reported fluid balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
Optimizing the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
Adjusting the Volume of Treated Plasma in the Treated Plasma Bag . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
Adjusting the volume currently in the treated plasma bag . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
Adjusting the volume maintained in the treated plasma bag . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
Managing a Positive Fluid Balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
Returning the Contents of the Treated Plasma Bag to the Patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
Rinsing the Plasma Device and Performing Rinseback . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
Managing a Prime Divert When the Patient Has a Low TBV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
Manually Priming the Plasma Device with Albumin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
Performing a Manual Prime Divert . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112

Chapter 9: Red Blood Cell Exchange (RBCX) Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115

RBCX Procedure Types . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
Functional Description of a Red Blood Cell Exchange (RBCX) Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
Preparing to Perform a Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
Supplies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
Selecting the Procedure and Loading the Tubing Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
Navigating the RBCX Procedure Screens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
Menu Buttons and Tabs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
Descriptions of Buttons, Icons, and Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
Entering and Changing Data During the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
Entering and Confirming Patient and Procedure Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
Entering Patient Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
Selecting the Exchange Type and Entering the Fluid Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
Selecting the exchange type . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
Entering the replacement fluid data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
Entering the fluid balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
Entering and Confirming Run Values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
Exchange procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
Depletion/Exchange procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
Depletion procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
Priming the Inlet Line, the Return Line, and the Replace Line . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
Connecting the Patient and Starting the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
Monitoring the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
Main Run Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
Exchange Status Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
Replacement fluid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
Patient Hct . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
Monitoring the Patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
Managing Citrate Toxicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
Giving a Fluid Bolus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
Bolus volume and reported fluid balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
Optimizing the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
Impact of Patient Data and Procedure Data on the Procedure Outcome . . . . . . . . . . . . . . . . . . . . . . . . . 128
Updating the Entered Patient Hct . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128

Spectra Optia Apheresis System Operator’s Manual v

Contents

Chapter 10: Mononuclear Cell (MNC) Collection Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131

Functional Description of a Mononuclear Cell (MNC) Collection Procedure . . . . . . . . . . . . . . . . . . . . . . . . 132
Accumulation phase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
Collection phase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
Preparing to Perform a Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
Supplies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
Selecting the Procedure and Loading the Tubing Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
Navigating the MNC Collection Procedure Screens. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
Menu Buttons and Tabs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
Descriptions of Buttons, Icons, and Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
Entering and Changing Data During the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
Entering and Confirming Patient and Procedure Data. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
Entering Patient Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
Reviewing and Confirming Run Values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
Priming the Inlet Line and the Return Line . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
Connecting the Patient and Starting the Run. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
Monitoring the Run. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
Main Run Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
Collection Status Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
Collection preference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
Graph of inlet volume processed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
Advanced Control Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
Flush chamber . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
Clumping in connector . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
Collection phase control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
Chamber . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
Monitoring the Patient. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
Managing Citrate Toxicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
Optimizing the Run. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
Optimizing the Collection Preference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
Minimizing Buffy Coat Accumulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
Decreasing the Run Time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
Transferring Plasma from the Plasma Bag into the Collection Bag . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
Transferring plasma when a collection phase is ready to start . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
Handling the Contents of a Partially Full Chamber . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
Resuming the Current Accumulation Phase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
Collecting the Contents During Rinseback . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
Recovering the Contents in the Chamber After Disconnecting the Patient . . . . . . . . . . . . . . . . . . . . . . . 146
Recovering the contents in the chamber during rinseback. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
Removing the chamber . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146

Chapter 11: Continuous Mononuclear Cell Collection (CMNC) Procedures . . . . . . . . . . . . . . . . . . . . . . . . 147

Functional Description of a Continuous Mononuclear Cell Collection (CMNC) Procedure . . . . . . . . . . . . 148
Preparing to Perform a Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
Supplies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
Selecting the Procedure and Loading the Tubing Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
Navigating the CMNC Procedure Screens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
Menu Buttons and Tabs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
Descriptions of Buttons, Icons, and Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
Entering and Changing Data During the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
Entering and Confirming Patient and Procedure Data. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153
Entering Patient Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153

vi Spectra Optia Apheresis System Operator’s Manual

 Contents

Reviewing and Confirming the Run Values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153

Collecting plasma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
Priming the Inlet Line and the Return Line . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
Connecting the Patient and Starting the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
Monitoring the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 156
Main Run Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 156
Collection Status Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 156
Collection preference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 156
Return to patient and collect into bag buttons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 156
Monitoring the Patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
Managing Citrate Toxicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
Optimizing the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
Optimizing the Collection Preference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
Monitoring the contents in the collect line and adjusting the color . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
Minimizing Buffy Coat Accumulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
Collecting a Target Volume . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
Decreasing the Run Time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
Addressing Clumping in the Connector . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159

Chapter 12: Granulocyte (PMN) Collection Procedures. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161

Functional Description of a Granulocyte (PMN) Collection Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
Preparing to Perform a Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
Supplies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
Anticoagulant Solutions for PMN Collection Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
Using HES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
Using ACD-A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
Selecting the Procedure and Loading the Tubing Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
Navigating the PMN Collection Procedure Screens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
Menu Buttons and Tabs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
Descriptions of Buttons, Icons, and Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
Entering and Changing Data During the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 165
Entering and Confirming Patient and Procedure Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
Entering Patient Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
Reviewing and Confirming the Run Values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
Collecting plasma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 169
Priming the Inlet Line and the Return Line . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170
Connecting the Patient and Starting the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170
Monitoring the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
Main Run Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
Collection Status Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
Collection preference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
Return to patient and collect into bag buttons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
Monitoring the Patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 172
Managing Citrate Toxicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 172
Optimizing the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
Optimizing a PMN Collection Procedure When Using ACD-A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
Optimizing the Collection Preference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
Monitoring the contents in the collect line and adjusting the color . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
Minimizing Buffy Coat Accumulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
Targeting a Lower Collect Volume . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
Decreasing the Run Time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
Addressing Clumping in the Connector . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175

Spectra Optia Apheresis System Operator’s Manual vii

Contents

Chapter 13: White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures . . . . . . . . . . 177
Functional Description of a White Blood Cell Depletion (WBCD) or a
Platelet Depletion (PLTD) Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
Preparing to Perform a Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
Supplies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
Anticoagulant Solutions for WBCD Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
Using ACD-A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
Using HES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
Selecting the Procedure and Loading the Tubing Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
Navigating the WBCD and PLTD Procedure Screens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180
Menu Buttons and Tabs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180
Descriptions of Buttons, Icons, and Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180
Entering and Changing Data During the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181
Entering and Confirming Patient and Procedure Data. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
Entering Patient Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
Reviewing and Confirming the Run Values and the Fluid Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
Entering and changing the fluid data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185
Priming the Inlet Line and the Return Line . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187
Positioning the IV Pole and the Replacement Fluid Container . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187
Connecting the Patient and Starting the Run. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187
Monitoring the Run. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188
Main Run Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188
Collection Status Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188
Collection preference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188
Return to patient and collect into bag buttons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188
Monitoring the Patient. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189
Managing Citrate Toxicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189
Optimizing the Run. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190
Facilitating the Flow of Replacement Fluid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190
Improving the flow of replacement fluid contained in bottles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190
Optimizing the Collection Preference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190
Monitoring the contents in the collect line and adjusting the color . . . . . . . . . . . . . . . . . . . . . . . . . . 191
Minimizing Buffy Coat Accumulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191
Targeting a Lower Collect Volume . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191
Addressing Clumping in the Connector . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 192

Chapter 14: Bone Marrow Processing (BMP) Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193

Functional Description of a Bone Marrow Processing (BMP) Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
Preparing to Perform a Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
Supplies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
Filtering the Bone Marrow . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
Adding ACD-A to the Bone Marrow . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
Transferring the Bone Marrow Into the BMP Accessory Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195
Selecting the Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 196
Preparing the Tubing Set for Plasma Collection When Using an IDL Set
With Catalog Number 10300 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 196
Spiking the plasma bag on the replace line . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 196
Using a sterile tubing welder to connect the plasma bag to the replace line . . . . . . . . . . . . . . . . . . . . 196
Loading and Priming the Tubing Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 196
Navigating the BMP Procedure Screens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
Menu Buttons and Tabs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
Descriptions of Buttons, Icons, and Images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197

viii Spectra Optia Apheresis System Operator’s Manual

 Contents

Entering and Changing Data During the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 198

Entering and Confirming Bone Marrow (BM) and Procedure Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200
Entering BM Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200
Reviewing and Confirming the Run Values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200
Preparing to Start the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
Connecting the BMP Bag to the Tubing Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
Priming the Inlet Line . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
Starting the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
Mixing the Contents of the BMP Bag During the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
Monitoring the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202
Main Run Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202
Collection Status Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202
Collection preference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202
Return to BMP bag and collect into bag buttons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203
Optimizing the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 204
Optimizing the Collection Preference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 204
Monitoring the contents in the collect line and adjusting the color . . . . . . . . . . . . . . . . . . . . . . . . . . . 204
Addressing Clumping in the Connector . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 204
Reducing the Concentration of Platelets in the Collection Bag . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 204
Changing the Target Plasma Volume . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 205
Concentrating the RBC in the BMP Bag . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 205

Chapter 15: Ending the Run and Completing the Procedure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 207
Ending the Run Before a Run Target is Attained . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 208
Ending the Run After a Run Target is Attained. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 208
Ending the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 208
Extending the Run . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 209
Completing the Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210
Disconnecting the Patient and Sealing the Lines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210
Sealing the lines using the Seal Safe System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210
Reviewing the Data on the Procedure Summary Screens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 212
Starting a New Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 213
Removing the Tubing Set . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 214

Chapter 16: Troubleshooting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 215

Troubleshooting Alarms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 216
Navigating the Alarm Screens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 216
Troubleshooting Multiple Alarms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 218
Viewing Alarm History . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 218
Muting the Alarm Tone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 218
Using Semi-Automatic Mode . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219
Entering Semi-Automatic Mode With the AIM System Enabled . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219
Entering Semi-Automatic Mode With the AIM System Disabled . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219
Resuming the Procedure in Semi-Automatic Mode . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 220
Exchange procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 220
MNC collection procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 220
CMNC, PMN collection, and depletion procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 220
Managing Anticoagulation of the Extracorporeal Circuit. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 221
Handling Fluid Leaks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 221
Resuming a Procedure After a System Reset . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 222
Performing a Manual Rinseback . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223
Clamping and Sealing the Lines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223

Spectra Optia Apheresis System Operator’s Manual ix

Contents

Draining the Channel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223

Returning the Fluid to the Patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
Manual Method for Opening the Centrifuge Door and Raising the Cassette . . . . . . . . . . . . . . . . . . . . . . . . . 226
Manually Opening the Centrifuge Door . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 226
Manually Raising the Cassette . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 226

Chapter 17: Maintaining the Spectra Optia System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 229

Cleaning and Disinfecting the Spectra Optia System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 230
Compatible Cleaning Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 230
Compatible Disinfecting Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 230
Application of Cleaning and Disinfecting Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231
Frequency of Cleaning and Disinfecting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231
Cleaning and Disinfecting the System Components. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
Surface of the System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
Exterior surfaces . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
Touch screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
Components on the Front Panel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
Sensors and detectors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
Valves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
Pump housings and pump rotors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 233
Components in the Centrifuge Chamber . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 233
Fluid leak detector . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 233
Covers on the AIM system lights . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 234
Filler . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 234
Seal Safe System: Jaw Cavity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 234
Seal Safe System: Sealer Head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 235
Disassembling of the sealer head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 235
Cleaning the sealer head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 236
Reassembling the sealer head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 237
Attaching a new splash guard . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 238
Cleaning Schedule for the Spectra Optia System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 239
Performing Preventive Maintenance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 240

Chapter 18: Spectra Optia System Specifications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 241

Spectra Optia System Specifications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 242
General System Specifications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 242
Electrical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 242
Environmental . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 242
Physical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 243
Sound pressure level . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 244
System Components . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 245
Centrifuge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 245
Pumps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 245
Sensors and detectors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 246
Monitor and touch screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 247
System Software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 248
Safety system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 248
Alarms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 248
Extracorporeal Volume (ECV) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250
Tubing Set and Accessory Set Components . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250

x Spectra Optia Apheresis System Operator’s Manual

 Contents

Electromagnetic Compatibility (EMC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252

60601-1-2 (4th Ed.) EMC information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252
60601-1-2 (3rd Ed.) EMC information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 255
Symbols and Certifications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 261

Appendix A: Supplementary Information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 265

Formula for Calculating Total Blood Volume (TBV) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 266
TPE Procedures: Plasma and Platelet Removal Efficiency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 266
Exchange Procedures: Using a Blood Warmer on the Replace Line . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 267
Tubing Sets: Using the Needleless Injection Ports. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 268
Collection Set and IDL Set: Additional Instructions for Use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 269
Using the Needle Protector on the Inlet Needle of the Collection Set and the IDL Set . . . . . . . . . . . . . . 269
Inserting the inlet needle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 269
Removing the inlet needle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 269
Using the Diversion Bag to Collect a Sample From a Venipuncture . . . . . . . . . . . . . . . . . . . . . . . . . . . . 269
Adding Anticoagulant to the Collection Bag . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 270
Using the Sample Bulbs to Obtain a Product Sample . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 271
Obtaining a Product Sample . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 271
Removing a Product Sample From the Sample Bulb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 271
Calculating the Volume of the Collected Product . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 273
Determining the Weight of the Collected Product . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 273
Preparing a tare bag and establishing a tare weight . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 273
Determining the weight of the collected product . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 273
Calculating the Volume of the Collected Product . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 273
Printing Procedure Data Reports. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 274
Connecting a Printer to the Spectra Optia System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 274
Connecting a Computer to the System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 275
Printing a Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 275

Appendix B: Glossary of Terms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 277

Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 287

Spectra Optia Apheresis System Operator’s Manual xi

Contents

xii Spectra Optia Apheresis System Operator’s Manual

 1
Preface

Spectra Optia Apheresis System Operator’s Manual 1

Preface

About This Operator’s Manual

This manual contains information and instructions on how to safely operate, transport, troubleshoot, and maintain
the Spectra Optia® Apheresis system. You should read and understand the information in this manual before
using the system.

Conventions Used in this Manual

This manual uses certain conventions to help you identify the tasks that you must perform. The conventions are
described below.

Numbered Steps
All step-by-step instructions are numbered and the numbers appear in bold, as shown in the following example:
1 Unpack the system from the shipping container.
When steps are numbered, the sequence in which they are performed is important. Always perform the steps in the
order presented.

Touch screen buttons

Many of the steps instruct you to touch a button on the screen. The text on the button appears in bold, as shown in
the following example:
1 Touch Confirm.

Bullets
Bullets (•) are used to indicate items in a list.

Warnings, Cautions, and Notes

The following examples show how warnings, cautions, and notes appear in this document:
Warning: Warnings alert the operator of serious hazards, consequences, or conditions that are likely to result in
a harmful reaction, trauma, or death to the patient or operator.

Caution: Cautions alert the operator to the possibility of a problem with the device associated with its use or
misuse. This includes device malfunction, failure, and damage to the device or other property.

Note: Notes emphasize important details.

2 Spectra Optia Apheresis System Operator’s Manual

 Preface

Spectra Optia Apheresis System

Intended Use 1
The Spectra Optia Apheresis System, a blood component separator, may be used to perform the following
therapeutic apheresis, cell collection, and cell processing procedures*:
• Therapeutic plasma exchange
• Therapeutic plasma exchange with a secondary plasma device
• Red blood cell exchange, depletion, and depletion/exchange
• Mononuclear cell collection from the peripheral blood
• Granulocyte collection from the peripheral blood
• White blood cell depletion
• Platelet depletion
• Processing of harvested bone marrow
*Procedure availability varies by country.

Contraindications for Use

Leukocytapheresis is contraindicated in AML FAB M3 (APL) because of the accompanying disseminated
intravascular coagulation. (Vahdat L, et al., “Early mortality and the retinoic acid syndrome in acute promyelocytic
leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform and CD13 expression in
patients treated with all-trans retinoic acid.” Blood 1994; 84: 3843-3849. Daver, et al., “Clinical characteristics and
outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis.” British Journal of Haematology
2015, 168, 646-653.)
Other contraindications for the use of the Spectra Optia system are limited to those associated with the infusion of
solutions and replacement fluids as required by the apheresis procedure, and those associated with all types of
automated apheresis systems.

Warnings and Cautions for Use

Below is a complete listing of warnings and cautions that apply to the use of the Spectra Optia system and the Seal
Safe system. Although the information may also appear in other sections of this manual, the operator should read
and understand the information in these lists before using the system.
Some of the warnings or cautions may instruct you to contact Terumo BCT. Customers in the U.S. should contact
Terumo BCT Customer Support. Customers outside the U.S. should contact their local Terumo BCT
representative.

Warnings for Use

System warnings
1 DANGER: Do not use the Spectra Optia system in an explosive atmosphere.
2 To avoid possible patient injury or loss of life, use only operating procedures published by Terumo BCT.
3 Terumo BCT will not be responsible for patient safety if the procedures to operate the Spectra Optia system
are other than those specified by Terumo BCT. Individuals performing the procedures must be appropriately
trained and qualified.

Spectra Optia Apheresis System Operator’s Manual 3

Preface

4 Use only the filler and the tubing sets that Terumo BCT manufactures for the Spectra Optia system.
5 The manufacturer, assembler, installer, or importer regards itself as responsible for effects on the safety,
reliability, and performance of the device, only if the device is employed in accordance with the instructions
for use.
6 The Spectra Optia system can interfere with EKG monitoring when a patient is simultaneously undergoing
apheresis and EKG monitoring.
7 The Spectra Optia system alarms are inactive when the system is turned off.

Service warnings
8 To avoid possible patient injury or loss of life, use only maintenance procedures published by Terumo BCT.
9 Terumo BCT will not be responsible for patient safety if the procedures to maintain and calibrate the
Spectra Optia system are other than those specified by Terumo BCT. Individuals performing the procedures
must be appropriately trained and qualified.
10 Only a qualified service representative should perform equipment modifications. Any modifications must be
approved in writing by Terumo BCT.
11 Turn off the system before cleaning or disinfecting to prevent possible electrical shock or damage to the
equipment.
12 The power cord should be unplugged from the wall to isolate the device from the power supply before
servicing. Do not position the device to make it difficult to unplug the power cord.
13 Only a qualified service representative should service or repair the Spectra Optia system.
14 When cleaning and disinfecting equipment surfaces that might have been exposed to blood, take adequate
precautions to prevent possible exposure to and transmission of infectious diseases.

Electrical warnings
15 All electrical installations must comply with all applicable local electrical codes and Terumo BCT’s
specifications.
16 To avoid the risk of electric shock, plug the system into a properly installed, three-wire, grounded electrical
receptacle that is protected by an approved branch circuit overcurrent protection and disconnection device.
The branch circuit protection and disconnection device must be located away from, but close enough to, the
system so that the system can be easily disconnected from the main power supply if the centrifuge
malfunctions.
17 Non-medical electrical equipment connected to the Ethernet connection should not be located within the
patient environment. The definition of “patient environment” can be found in the IEC standard
60601-1 Edition 3.1, definition 3.79.
18 Accessory equipment connected to the analog and digital interfaces must be certified according to the
respective IEC standards (e.g., IEC 60950 for data processing equipment and IEC 60601-1 for medical
equipment). The installer of accessory equipment is responsible for the integrated medical system
compliance with requirements of IEC 60601-1 Edition 3.1. If you are in doubt, contact your Terumo BCT
service representative.

General procedural warnings

19 Do not connect the patient before the system instructs you to do so.
20 Rigorous attention should be paid to proper venipuncture site selection and decontamination.

4 Spectra Optia Apheresis System Operator’s Manual

 Preface

21 It is advisable to obtain the patient’s detailed drug history before each apheresis procedure. For those drugs
potentially affected by apheresis procedures, the physician should either adjust the doses or give the

22
medications immediately after the procedure.
To avoid potential side effects and complications during apheresis, patients taking angiotensin-converting
enzyme (ACE) inhibitors should discontinue these medications before the procedure. The patient’s
1
attending physician should prescribe and supervise this and any medication change before apheresis.
23 The operator must verify the correct input of information relevant to the safety of each apheresis procedure.
24 When preparing to perform a procedure, ensure that the lines are connected to the correct fluids, and that
fluid is flowing into the drip chambers:
• AC line (orange) to the anticoagulant container
• Saline line (green) to the saline (0.9%) container
25 Check that the tubing is correctly loaded in all pumps before starting a procedure. Visually inspect each
pump to ensure that tubing does not protrude.
26 Before starting a procedure, inspect all lines, especially those in the centrifuge and on the front panel, to
ensure that they are not obstructed. Tubing that is occluded or mechanically constrained can lead to
malfunction or fluid imbalance. Inlet and return lines perform without difficulty as long as the interior
diameter of the tubing is larger than the interior diameter of the patient’s inlet and return access.
27 Residual ethylene oxide (EO) found within a Spectra Optia system tubing set may cause allergic, including
anaphylactoid and anaphylactic, reactions. The Spectra Optia system allows you to rinse the tubing set with
saline solution when you are concerned about hypersensitivity reactions associated with the residual EO,
which is a result of sterilization. This option is available to select before you connect the patient. Refer to
‘‘Selecting and Performing a Custom Prime’’ on page 79 for instructions on performing a saline rinse.
28 Only blood or blood products should be processed in the centrifuge.
29 If you are using a blood warmer on the return line, ensure that you completely prime the blood warmer
tubing set to remove all the air in the set before you connect the patient.
30 When connecting a blood warmer tubing set to the return line, ensure that the tubing connection is tight.
Put the luer connection no higher than 20 in (50 cm) above the return access to prevent the possibility of air
entering the tubing.
31 Before connecting the patient, check the inlet and return lines for air. If air is present in the lines, remove the
air before connecting the patient.
32 Monitor the return line for air. If you see air in the line, go to the operation status screen, touch Remove Air
From Return Line, and follow the instructions on the screen.
33 Before connecting the patient, ensure that the AC line contains anticoagulant at the inlet manifold.
34 The inlet and return pressure sensors are not intended to detect infiltrations of the vein. Monitor the patient
for infiltrations.
35 Tubing sets may occasionally fail, which could result in the loss of blood, blood products, or the
introduction of air into the tubing set. It is very important that the operator watch for leaks in the cassette,
all tubing and welds, and in the channel while the set is in use. Operators should take adequate precautions
in handling blood and blood products in accordance with their facility’s standard operating procedures.
36 When handling extracorporeal blood circuits, take adequate precautions to prevent the possible exposure to
and transmission of infectious diseases.
37 You must completely close the inlet saline line when the system instructs you to do so. If the line is left open,
the additional saline will dilute the blood in the channel, which could result in an ineffective procedure.

Spectra Optia Apheresis System Operator’s Manual 5

Preface

38 To avoid potential side effects and complications for patients that have a low blood volume (LBV) or a low
hematocrit (Hct), the Spectra Optia Apheresis System recommends performing a custom prime of the
tubing set for patients whose extracorporeal volume (ECV) is greater than 10% or 15% of their total blood
volume (TBV), or if their extracorporeal red blood cell volume (ERCV) is greater than 10% or 15% of their
red blood cell volume (RCV). The attending physician should prescribe the appropriate procedural settings
for the patient.
39 When performing a custom prime using red blood cells (RBC), ensure the unit contains a sufficient number
of RBC or RBC volume (RCV) to adequately fill the extracorporeal circuit of the tubing set. An insufficient
RCV may lead to an unintended decrease in patient hematocrit. The system will calculate the necessary
extracorporeal RCV based on the patient data entered (TBV and Hct), the tubing set and filler used, if a
blood/fluid warmer is used, and the type of procedure being performed.
40 Terumo BCT does not recommend the use of a diluted RBC unit to perform a custom prime. A diluted unit
may not contain a sufficient number of RBC or RBC volume (RCV) to compensate the patient for the RCV
required to adequately fill the extracorporeal circuit of the tubing set. If a diluted unit is used, the patient
may experience a decrease in hematocrit and may be unable to tolerate the procedure. The attending
physician should assess the patient’s condition and determine the appropriate RCV of the unit used.
41 The following can cause fluid imbalance:
• Administration of replacement fluid that is not at room temperature during a procedure
• Use of improperly vented fluid containers
• Equipment malfunction
• Improperly clamped or closed lines, or improperly loaded valves
• Use of inadequately primed or clotted filters on the replace line of the Exchange Set
• Tubing that is incorrectly loaded in the pumps
42 The alarm system is inactive during a manual rinseback. If you must perform a manual rinseback, watch for
air in the return line. If you see air, immediately discontinue the rinseback.
43 Do not apply excess pressure to the vent bag when pushing fluid from the reservoir to the patient during a
manual rinseback or you could damage the red blood cells that you are returning to the patient.
44 Do not continue to squeeze the vent bag after the fluid in the reservoir reaches the level of the reservoir filter
during a manual rinseback. If you continue to squeeze the bag, you could deliver air to the patient.
45 Do not touch Unload to unload the tubing from the pumps or remove the tubing set when a patient is
connected to the Spectra Optia system, or the patient may receive surplus fluids through the inlet and return
lines.
46 All used disposable materials should be considered hazardous, and should be handled and disposed of at the
end of the procedure in accordance with all applicable regulations.
47 Turn off the system before cleaning to prevent possible electrical shock or damage to the equipment.

6 Spectra Optia Apheresis System Operator’s Manual

 Preface

Exchange procedure warnings

48 Platelets are removed with red blood cells during a red blood cell exchange (RBCX) procedure. The
approximate percentage of platelets removed depends on the number of total blood volumes (TBV)
processed, as shown in the table below. It is the physician’s responsibility to determine the appropriate
treatment for the patient.
1
TBV Processed Percentage Platelets Removed
(Approximate)

0.5 39

1.0 63

1.5 78

2.0 86

49 Terumo BCT does not recommend performing rinseback during RBCX procedures. The data that the
system uses to predict the run targets does not include rinseback volume. If rinseback is performed, the run
targets may not be accurate.
50 Before performing a therapeutic plasma exchange procedure with a secondary plasma device (TPE-SPD
procedure), carefully review the instructions for use provided by the manufacturer of the secondary plasma
device.
51 Some secondary plasma devices can leach small amounts of potentially toxic substances to patients and must
be flushed before use. Flush the device according to the manufacturer’s instructions to ensure patient safety.
52 Some secondary plasma devices can remove significant quantities of plasma-circulating proteins, including
important clotting factors and albumin. The attending physician should evaluate each patient and prescribe
replacement proteins, if appropriate.
53 If a TPE-SPD procedure is being performed on a patient who has a TBV of 1 liter or less, Terumo BCT
recommends that the treated plasma bag and the AC container be weighed throughout the TPE-SPD
procedure to assess and manage the fluid balance.

Collection and depletion procedure warnings

54 Platelets are collected with target cells during continuous mononuclear cell collection (CMNC) procedures,
granulocyte (PMN) collection procedures, and white blood cell depletion (WBCD) procedures. If the initial
platelet count is low and the patient is not properly managed, excessive platelet depletion can occur.
55 Red blood cells (RBC) are collected with target cells during granulocyte (PMN) collection procedures, white
blood cell depletion (WBCD) procedures, and platelet depletion (PLTD) procedures. If the procedure is not
properly monitored, excessive RBC depletion may occur. To monitor excessive RBC depletion, consider
testing the patient’s hematocrit throughout the run.
56 Do not use a blood warmer on the replace line during a white blood cell depletion (WBCD) procedure or a
platelet depletion (PLTD) procedure. Using a blood warmer on the replace line slows the flow of
replacement fluid into the reservoir, affecting the system’s management of the fluid balance.
57 During collection and depletion procedures, the operator must monitor the plasma line for hemolysis. The
RBC detector is not used to monitor the plasma line during these procedures. If hemolysis occurs that is not
related to the patient’s condition, the operator should consider consulting the physician to determine
whether or not to continue the procedure and perform rinseback.
58 Before using a granulocyte-colony stimulating factor (G-CSF) or other agents to prepare the patient for a
procedure performed on the Spectra Optia system, consult the manufacturer’s package insert for potential
contraindications and adverse events.

Spectra Optia Apheresis System Operator’s Manual 7

Preface

General tubing set warnings

59 Do Not Reuse/Not for Reuse: Terumo BCT, Inc.(Terumo BCT Ltd) products bearing the “Do Not Reuse”
symbol are intended for single use only and are not intended to be reused or re-sterilized in any manner.
Terumo BCT cannot ensure the functionality or sterility of the product if it is reused or re-sterilized.
Reuse of a single-use product could result in:
• Product performance issues due to a loss of product integrity, including but not limited to the following:
– Fluid leaks
– Parts that are warped or deformed
– Plastics that are brittle and discolored
– Filters that have reduced filtration capabilities
• Exposure to excessive ethylene oxide (EO) residuals
• Viral infections such as hepatitis or human immunodeficiency virus (HIV)
• Bacterial infections
• Cross-contamination
Any of these risks could result in serious injury or death. These risks are shared by product users, donors,
patients, and recipients of end products of the device.
60 Terumo BCT, Inc. (Terumo BCT Ltd.) products bearing the DEHP symbol contain phthalates (DEHP).
Whole blood donors are not exposed to DEHP; the potential health risk to apheresis donors is low, because
the time-averaged DEHP dose exposure is very low. Patient groups that include pregnant or nursing women
and children are considered to be the most at risk to potential harmful effects of exposure to DEHP.
However, regulatory bodies have noted that the benefit of doing a needed procedure is far greater than the
risk associated with exposure to DEHP. It is the responsibility of the treating physician to balance this risk
for the patient.

Accessory set warnings

61 Use only the Spectra Optia BMP Accessory Set when performing a BMP procedure on the Spectra Optia
system. The system’s performance has not been validated using other accessories.

Fluid warnings
62 When using biologically-derived replacement fluids, closely monitor the patient for reactions.
63 Use only the fluids specified in this manual when performing procedures on the Spectra Optia system. Using
a fluid with a different composition or concentration could cause hemolysis.
64 Before using hydroxyethyl starch (HES) for a procedure performed on the Spectra Optia system, consult the
manufacturer’s package insert for potential contraindications and adverse events.

Seal Safe system warnings

65 Use only the sealer head and radio frequency (RF) cable provided by Terumo BCT with the Seal Safe system.
The Seal Safe system does not function correctly with components from other tubing sealers.
66 Do not seal the tubing within 8 cm (3 in) of the needle, or you may cause a burn at the needle entry point.
67 Do not place your fingers within 2.5 cm (1 in) of the Seal Safe system’s sealing jaw, or you may receive a
radio frequency (RF) burn.
68 Do not release the lever of the sealer head until after the indication light goes out. Releasing the lever sooner
could result in an inadequate seal.

8 Spectra Optia Apheresis System Operator’s Manual

 Preface

69 Ensure that the sealer head and the tubing are free of moisture and debris before using the Seal Safe system.
70 Moisture on the surface of the tubing or the sealer head may cause an electrical arc to occur between the jaws
when the power is applied, terminating the sealing process. If an arc occurs, carefully inspect the seal to
ensure it is satisfactory. 1
71 Ensure that there is no tension on the tubing when operating the Seal Safe system. Stretching the hot tubing
could cause a leak.
72 Do not submerge the Seal Safe system in liquid or you may receive an electric shock.
73 Disconnect the sealer head from the RF cable before cleaning to avoid receiving a serious radio frequency
(RF) burn during the cleaning process.
74 The jaw on the sealer head contains an indentation where the spring rests. If you do not properly seat the
spring in the indentation after cleaning, you may damage the spring, which could cause inadequate tubing
seals.
75 Do not open the sealer head to service the device or you may receive an electric shock. Contact a qualified
service representative to service the device.

Cautions for Use

System cautions
1 Federal law (USA) restricts this device to sale by or on the order of a physician.
2 Each operator should be thoroughly familiar with the Spectra Optia system’s operating instructions before
using the system. All procedures should be performed by qualified medical personnel under the supervision
of a physician.
3 The Spectra Optia system and the Seal Safe system comply with all relevant international standards
concerning electromagnetic emissions and compatibility. Before undergoing apheresis, patients with active
implantable medical devices should review the implant manufacturer’s instructions for any cautions or
contraindications concerning the use of and/or proximity to devices that emit electromagnetic energy.
Examples of active implantable devices include cardiac pacemakers and cardioverter defibrillators, cochlear
implants, vagus nerve stimulators, and devices that stimulate the peripheral or central nervous systems. This
caution also extends to other devices that may be connected to the patient such as ECG equipment and
infusion systems. Care should be taken to prevent the Seal Safe system from touching the patient or any
cables of the devices that may be connected to the patient.
4 Do not use the Spectra Optia system under any of the following conditions:
• Power cords, plugs, or receptacles are damaged or worn.
• Switches are loose.
• System has received a physical shock, or liquid has spilled on the electronics housed under the cover.
• Anyone has received an electrical shock while using the system.
• System appears to be overheating.
5 Keep hair, fingers, clothing, and other articles away from pumps and valves to avoid entanglement.
6 Do not put open containers containing fluid on the device. Fluid spills can contribute to electrical and
mechanical hazards.
7 To avoid damage to the Spectra Optia system, do not operate the centrifuge without a filler installed or
before loading the channel.

Spectra Optia Apheresis System Operator’s Manual 9

Preface

8 Before installing a filler or loading a tubing set, inspect the filler and visible interior of the centrifuge
chamber for fluid spills or structural damage. Ensure the metal band around the perimeter of the filler is
centered and secure.
9 To avoid damage to the centrifuge and the filler, do not operate the centrifuge if the filler latch is not
lowered and locked in place. Ensure that the filler cannot be pulled off the gear train without unlocking and
raising the filler latch.
10 To avoid personal injury or damage to the system, use proper lifting techniques when lifting the
Spectra Optia system.
11 Ensure that the wheel pedal is pressed to the right side (locked position) and the rear wheel brake levers are
locked during procedures, so that the Spectra Optia system does not move.
12 When the wheel pedal is not in the locked position (pressed to the right side) and the rear wheel brake levers
are released, ensure at least one person is in continuous contact with and controls the movement of the
Spectra Optia system.
13 Only perform procedures when the system is on a smooth, dry, level surface.
14 Do not leave the device unattended in a traffic area.
15 In the event of a prolonged power interruption, the use of an uninterruptible power supply (UPS) may allow
the operator to discontinue the procedure and perform rinseback. However, a UPS does not ensure that the
operator can complete the procedure as intended.
16 When using the Spectra Optia system with another device, consult the device manufacturer’s instructions for
use for any precautions or contraindications for using the device in proximity to equipment that emits
electromagnetic energy.
17 The use of cables other than those specified by Terumo BCT could result in improper function of the
Spectra Optia system.
18 Portable RF communications equipment including peripherals, such as antenna cables and external
antennas, should be located no closer than 30 cm (12 in) from any part of the Spectra Optia system
including cords, or the system may not perform properly.

Service cautions
19 Clean the Spectra Optia system using a mild, non-abrasive cleaning solution or a mild detergent. Industry
standard practice defines mild cleaning solution and mild detergent as a solution or detergent that is safe on
skin and on washable surfaces, such as dishwashing liquid. Use of a solution that is not compatible with the
materials on the system may damage the material or operating characteristics of the system.
20 Disinfect the Spectra Optia system using a disinfecting solution that is compatible for use on the system.
Use of a disinfecting solution that is not compatible could damage the material or operating characteristics
of the system.
21 Use only a gauze pad, a lint-free cloth, or a wipe when cleaning or disinfecting the touch screen, the covers
on the AIM system lights in the centrifuge, and the aperture plate on the filler. Use of an abrasive brush,
scrub material, or a sharp object can damage the surface of the components.
22 To avoid damaging the touch screen, do not douse the touch screen with fluid or leave fluid on the screen
after cleaning or disinfecting the screen. Always dry the screen with a gauze pad or a clean cloth after
exposing it to fluid.
23 Terumo BCT has validated the methods described in this manual for cleaning and decontaminating the
Spectra Optia system. Before using an alternative method, verify that it will not damage the system.
24 Do not lubricate pumps or pump rotors for any reason.

10 Spectra Optia Apheresis System Operator’s Manual

 Preface

General procedural cautions

25 The Spectra Optia system has many safety features. However, a patient reaction can occur rapidly. Therefore,

26
it is imperative that the operator monitor the patient and the system throughout the procedure.
The physiological condition of patients may affect the outcomes of procedures performed on the
1
Spectra Optia system.
27 Patients with impaired or abnormal citrate metabolism (for example, if the patient has liver or renal disease)
may present an increased risk of citrate sensitivity. Attending physicians should assess the appropriateness of
such patients for apheresis procedures and prescribe how they should be monitored during procedures.
28 Use aseptic technique throughout all procedures to ensure patient safety or product quality.
29 Terumo BCT has validated the system's performance when the extracorporeal circuit is properly
anticoagulated using ACD-A, and recommends using ACD-A to anticoagulate the circuit.
30 The higher the inlet:AC ratio used during the procedure, the greater the risk is for platelet aggregates and
clots to form in the tubing set.
31 For patient comfort and optimal system operation, ensure that the fluids used during the procedure are at
room temperature before connecting them to the tubing set.
32 Before loading the tubing set, confirm that the filler that is installed is the correct filler for the procedure.
Using the incorrect filler will compromise the performance of the system and the outcome of the procedure.
33 Do not connect the fluids to the tubing set before the system instructs you to do so.
34 To avoid a failed test of the tubing set, do not raise and lower the cassette after there is fluid in the set.
35 Handling and transfusion of blood products should be conducted in accordance with applicable standards
and regulations, and performed under the direction of a licensed physician.
36 If you leave the roller clamp on the saline line completely open when the patient is connected, you will
quickly infuse a large volume of saline to the patient.
37 Before using the injection port on the inlet line to infuse medication to the patient during a procedure, you
must pause the system or the medication will be pumped into the extracorporeal circuit instead of to the
patient.
38 If you use the injection port on the return line to infuse fluid or medication, monitor the patient for
hypervolemia. The Spectra Optia system cannot account for the additional volume of fluid infused through
the injection port.

Collection and depletion procedure cautions

39 When transferring plasma from the plasma bag to the collection bag during an MNC collection procedure,
you must put the collection bag lower than the plasma bag as indicated in the instructions on the screen.
Otherwise, cells in the collection bag can flow into the plasma bag.
40 Confirm that the bone marrow has been filtered to remove clots, bone chips, and debris before transferring it
into the BMP bag of the BMP Accessory Set. The bone marrow must be adequately filtered before
processing to reduce the risk of obstructing the tubing set.
41 Ensure that the bone marrow is adequately anticoagulated before processing. Inadequate anticoagulation
causes clumping and can result in decreased cell recovery.
42 Ensure that the bone marrow is at room temperature before processing. If the bone marrow is cold, it will
not adequately separate in the tubing set channel, and the system performance may be compromised.
43 If you leave the roller clamp on the saline line completely open when the BMP bag is connected, you will
quickly infuse a large volume of saline into the bag.

Spectra Optia Apheresis System Operator’s Manual 11

Preface

44 When performing a collection procedure using the Collection Set or the IDL Set, seal the collect line above
the T-shaped connector to the plasma line as shown in the illustration below. If you seal the collect line
below the connector, the cells in the collection bag could flow back into the tubing set when the system
raises the cassette.

45 When using hydroxyethyl starch (HES) during a procedure, you must add 46.7% trisodium citrate solution
to the HES for anticoagulation. Failure to use the correct solution can result in inadequate anticoagulation
of the extracorporeal circuit, ineffective sedimentation and collection of cells, and adverse patient reactions.
46 If hydroxyethyl starch (HES) is not used during a PMN collection procedure, the collection efficiency will
be lower.
47 If you use a low inlet pump flow rate during a CMNC procedure, it will take the system longer to process
the required volume to establish the interface and to collect the target cells. Be aware of how this is relevant
to a patient with a small total blood volume. Also, try to avoid conditions that will cause a delay in
establishing the interface, such as pump pauses.

General tubing set cautions

48 The blood and fluid pathways of the tubing set are sterilized with ethylene oxide and are nonpyrogenic. Do
not use the set if any of the following conditions are true:
• Severe kinks in the tubing are apparent, such that the interior diameter of the tubing is smaller than the
interior diameter of the patient’s inlet or return access.
• Tubing set appears to be incorrectly assembled.
• Tubing set is damaged.
• Any clamps are closed on the lines.
• End caps on the lines of the tubing set are missing when you open the package.
49 You may load the tubing set up to 24 hours before the procedure as long as you do not lower the cassette or
prime the set. Once you lower the cassette or prime the set, you must use the set during the same work shift.
50 Do not stretch the tubing when folding the channel to install it in the centrifuge to avoid damaging the
tubing set.
51 Use only your fingers to load the channel into the filler. To avoid puncturing the channel, never use a
sharp object.
52 Do not seal the inlet line of the four-lumen tubing. Sealing the line could cause the tubing set to fail when
you raise the cassette to unload the set.
53 Ensure all luer connections are secure.
54 To prevent port damage, do not use a needle or a blunt cannula to access the needleless injection port.
55 Use only standard luer connection devices to access the needleless injection ports; non-standard syringes or
connectors can damage the needleless injection port. A standard luer connector must conform to the
harmonized standards ISO 594-1 or ISO 594-2. Syringes and male luer connectors have a large variety of
configurations and can vary significantly in design and dimensions.

12 Spectra Optia Apheresis System Operator’s Manual

 Preface

56 To prevent damage to the needleless injection port housing, do not overtighten the connector. Do not use
any instruments to tighten the connection.

Exchange Set cautions

57 Do not remove the cap on the unused luer on the second remove line on the remove bag to prevent fluid
1
leakage. Ensure the cap fits tightly.

Collection Set cautions

58 The Collection Set is no longer considered functionally closed if any of the following conditions are true:
• Inlet needle is not connected.
• First attempt to insert the inlet needle fails (unless you attach a new needle using a connection device that
maintains the sterility of the tubing set).
• Inlet needle is disconnected during the procedure.
• If using the diversion bag to collect a blood sample, the sample is taken before the line to the bag is
sealed.
• Injection port on the inlet line is accessed.
• Product bag or the diversion bag is disconnected before the line to the bag is sealed.
• Product sample is removed from the sample bulb before you permanently seal the line.
• Sterile barrier filters are damaged.
• Integrity of the tubing set is compromised for any reason.
59 To correctly lock the needle protector over the inlet needle, you must hold it in place while you pull the
tubing to remove the needle. It will not lock if you use the wings of the needle or the body of the needle
protector to remove the needle. After use, visually confirm that the needle protector is locked over the needle
and that the wings are secured behind the locked prongs.

IDL Set cautions

60 The IDL Set is no longer considered functionally closed if any of the following conditions are true:
• Inlet needle is not connected.
• First attempt to insert the inlet needle fails (unless you attach a new needle using a connection device that
maintains the sterility of the tubing set).
• Inlet needle is disconnected during the procedure.
• If using the diversion bag to collect a blood sample, the sample is taken before the line to the bag is
sealed.
• Injection port on the inlet line is accessed.
• Frangible connector on the replace line is broken for any reason.
• Product bag or the diversion bag is disconnected before the line to the bag is sealed.
• Product sample is removed from the sample bulb before you permanently seal the line.
• Sterile barrier filters are damaged.
• Integrity of the tubing set is compromised for any reason.

Spectra Optia Apheresis System Operator’s Manual 13

Preface

61 To correctly lock the needle protector over the inlet needle, you must hold it in place while you pull the
tubing to remove the needle. The needle protector will not lock if you use the wings of the needle or the
body of the needle protector to remove the needle. After use, visually confirm that the needle protector is
locked over the needle and that the wings are secured behind the locked prongs.

Fluid cautions
62 Hydroxyethyl starch (HES) is not approved or available for use in some countries for apheresis procedures.
Check your country regulations before you consider using HES for a procedure on the Spectra Optia
system.

Seal Safe system cautions

63 The Spectra Optia system and the Seal Safe system comply with all relevant international standards
concerning electromagnetic emissions and compatibility. Before undergoing apheresis, patients with active
implantable medical devices should review the implant manufacturer’s instructions for any cautions or
contraindications concerning the use of and/or proximity to devices that emit electromagnetic energy.
Examples of active implantable devices include cardiac pacemakers and cardioverter defibrillators, cochlear
implants, vagus nerve stimulators, and devices that stimulate the peripheral or central nervous systems. This
caution also extends to other devices that may be connected to the patient such as ECG equipment and
infusion systems. Care should be taken to prevent the Seal Safe system from touching the patient or any
cables of the devices that may be connected to the patient.
64 Use the Seal Safe system only on tubing distributed by Terumo BCT. The Seal Safe system may not perform
as expected on other tubing.
65 To avoid possible damage to the Seal Safe system, always disconnect the sealer head and the RF cable before
transporting the Spectra Optia system.

14 Spectra Optia Apheresis System Operator’s Manual

 Preface

Service Information
Terumo BCT or its subsidiaries will not be responsible for the safety, reliability, or performance of this equipment
unless:
• Operational procedures, calibration, and repairs are carried out by appropriately qualified persons.
1
• All equipment modifications are authorized in writing by Terumo BCT and performed by appropriately
qualified persons.
• The electrical installation of the relevant room complies with all applicable local electrical codes and IEC
requirements.
• The equipment is used in accordance with the published instructions for use.
Detailed service information for this equipment, including schematic diagrams and recommended service
procedures, is available from your Terumo BCT representative.

Special Use of Additional Equipment and Devices During Apheresis

Procedures
You may require one or more of the following items to complete an apheresis procedure using the Spectra Optia
system:
• Blood/fluid warmer (used for patient comfort but has no impact on the performance of the device)
• Fluids such as saline solution, anticoagulant solution, and replacement fluid
For instructions on how to safely use the additional items with the Spectra Optia system, refer to the guidelines
provided by the device or fluid manufacturer.

Spectra Optia Apheresis System Operator’s Manual 15

Preface

Fluids Administered During Apheresis Procedures

This section includes descriptions of fluids that may be used during apheresis procedures on the Spectra Optia
system. Before use, verify that the fluid has not expired by checking the expiration date printed on the package. Do
not use the item if the current date is past the expiration date.

Saline Solution
Use sterile 0.9% sodium chloride injection to prime the tubing set and to perform the procedure.

Anticoagulant
ACD-A
Each 100 mL of ACD-A contains 2.2 g sodium citrate hydrous, 730 mg citric acid anhydrous, and 2.45 g dextrose
hydrous.

Citrate toxicity
ACD-A can cause citrate toxicity in certain patients. Mild forms of this condition are generally recognized by
peripheral paresthesia, tingling sensations in the extremities, and/or restlessness. Severe forms of this condition can
result in significant cardiac dysfunction. Terumo BCT recommends that you frequently assess the condition of the
patient throughout the apheresis procedure.

Hydroxyethyl Starch (HES)

HES is a sedimenting agent that causes RBC to separate more efficiently from granulocytes during a collection
procedure. When using HES, you must add trisodium citrate to the HES for anticoagulation.

Replacement Fluids
Careful selection and use of appropriate replacement fluids contributes to the maintenance of the patient’s plasma
oncotic pressure and blood pressure. During TPE and depletion procedures, the patient response to decreasing
blood viscosity and plasma protein levels may vary and be difficult to predict. In addition, non-target cells may be
depleted and may require replacement. Therefore, the physician should prescribe the type and volume of
replacement fluid used. The prescription should consider the patient’s fluid status, protein balance, and other
pertinent factors that the physician believes could affect the patient’s condition.

16 Spectra Optia Apheresis System Operator’s Manual

 Preface

Adverse Events of Apheresis Procedures

Be aware of possible patient reactions to apheresis procedures, and be prepared to take appropriate action should
any reactions occur. Some previously reported reactions are: 1
• Anxiety
• Headache
• Light-headedness
• Digital and/or facial paresthesia
• Fever
• Chills
• Hematoma
• Hyperventilation
• Nausea and vomiting
• Syncope (fainting)
• Urticaria
• Hypotension
• Allergic reactions
• Infection
• Hemolysis
• Thrombosis in patient and device
• Hypocalcemia
• Hypokalemia
• Thrombocytopenia
• Hypoalbuminemia
• Anemia
• Coagulopathy
• Fatigue
• Hypomagnesemia
• Hypogammaglobulinemia
• Adverse tissue reaction
• Device failure/disposable failure
• Air embolism
• Blood loss/anemia
• Electrical shock hazard
• Fluid imbalance
• Inadequate separation of blood components

Spectra Optia Apheresis System Operator’s Manual 17

Preface

Reactions to Blood Products Transfused During Procedures

Reactions to transfused blood products can include fever, circulatory overload, shock, allergic reactions,
alloimmunization, transfusion-related acute lung injury (TRALI), and graft-versus-host disease (GVHD), as well as
transmission of infectious diseases and bacteria. (Sources: Circular of Information for the Use of Human Blood and
Blood Components, AABB, et al, ed., April, 2006; Guide to the preparation, use and quality assurance of blood
components, 10th Edition, Council of Europe Publishing; Blood. Toy P et al., “Transfusion-Related Acute Lung
Injury: Incidence and Risk Factors.” Blood, 2012; 119: 1757-1767.)

Disposal of Infectious and Non-Infectious Waste

Follow your local regulations for disposing of material that may be contaminated with biohazardous products.

Return of Used Product

If for any reason this product must be returned to Terumo BCT, Inc., a returned goods authorization (an RGA
number) is required from Terumo BCT prior to shipping.
Instructions for cleaning and materials, including appropriate shipping containers, proper labeling, and an RGA
number, may be obtained from the Terumo BCT Quality Assurance Department.
IT IS THE RESPONSIBILITY OF THE HEALTH CARE INSTITUTION TO ADEQUATELY PREPARE
AND IDENTIFY THE PRODUCT FOR RETURN SHIPMENT.
Please contact your local representative for information regarding returned goods and product complaints.

18 Spectra Optia Apheresis System Operator’s Manual

 2
Introduction

Spectra Optia Apheresis System Operator’s Manual 19

Introduction

Spectra Optia System Description

The Spectra Optia Apheresis System is a transportable, automatic blood component separator that uses
centrifugation and optical detection (Automated Interface Management system or AIM system) to perform
therapeutic apheresis and cell collection procedures.
The Spectra Optia system’s touch screen interface enables the operator to communicate with the system. The
operator follows the instructions on the screen to enter patient data and procedure data, load and prime the tubing
set, and perform and troubleshoot procedures. The system displays detailed information about the procedure, so
that the operator can adjust the run values to achieve a specific outcome or troubleshoot a condition. After the
procedure is complete, the system provides a report of procedure data for the patient record.
Table 2-1 lists the procedures that are available on the system and the procedure abbreviations that appear on the
bottom of the screens. The abbreviation appears after you select the procedure.
Table 2-1: Spectra Optia system procedures and procedure abbreviations

Procedure Procedure Abbreviation

Therapeutic plasma exchange TPE

Therapeutic plasma exchange with a secondary plasma device SPD

Red blood cell exchange RBCX

Mononuclear cell collection MNC

Continuous mononuclear cell collection CMNC

Granulocyte collection PMN

White blood cell depletion WBCD

Platelet depletion PLTD

Bone marrow processing BMP

20 Spectra Optia Apheresis System Operator’s Manual

 Introduction

Spectra Optia System Components

1 2
13 13
3
5 4
6 7 15
14
8

16

17

11 18
12 19
10
12
Figure 2-1: Spectra Optia Apheresis System front and back views

Table 2-2: Spectra Optia system components

Component Function

1 Monitor with touch screen Allows you to communicate with the system.

2 Dual IV pole Has hooks for hanging bags and containers. You can adjust the height of the pole for
transporting the device, or to hang and remove bags.

3 Accessory bracket Can be used to hold an additional device used during an apheresis procedure, such
as a blood warmer or an infusion pump.

4 Seal Safe system Used to seal the lines of the tubing set. The system generates a radio frequency (RF)
electromagnetic field between the jaws of the sealer head to seal the tubing.

5 Front panel Holds the pumps, valves, sensors, and detectors.

6 Cassette tray Holds the tubing set cassette in place.

7 Power switch Allows you to turn power to the system on and off.

8 View port Allows you to look through the centrifuge door to see the interface in the channel.

9 Centrifuge door Allows access to the centrifuge chamber.

Spectra Optia Apheresis System Operator’s Manual 21

Introduction

Table 2-2: Spectra Optia system components (continued)

Component Function

10 Wheels Allow you to move and transport the system.

11 Wheel pedal Allows you to secure the front wheels in a forward position to facilitate control when
moving the device. Also allows you to lock the wheels in place so that the system
does not roll.

12 Rear wheel brake levers Allow you to lock the rear wheels in place to prevent the machine from moving.

13 Handle wheels Help to move the system when it is in a horizontal position.

14 System serial number Unique number used to identify the system.

15 IV pole release button Allows you to raise and lower the IV pole by pressing the button.

16 Power cord Connects the system to a power source.

17 Power cord holder Secures the power cord during transport and storage.

18 Circuit breaker Protects the device from electrical damage by monitoring the current and shutting of
the flow of power if the current gets too high.

19 Ethernet port Allows you to connect the system to an external device to export data or to print a
procedure report.

Note: Spectra Optia system operators are allowed to remove the system components listed below. All other
components must be removed by a qualified service representative.
• Pump rotors
• Tubing set
• Filler
• Seal Safe system sealer head and RF cable
• Accessory bracket
• Power cord and power cord clamp
• Ethernet cable, if used

22 Spectra Optia Apheresis System Operator’s Manual

 Introduction

Front Panel
The front panel of the Spectra Optia system holds the pumps, sensors, and valves that are used to perform an
apheresis procedure. The components of the front panel are shown in Figure 2-2, and are described in Tables 2-3
through 2-5.

18 19
2
5
17 6 7 8

11
12
1 10 16
9 14 4
13 15

2 3

Figure 2-2: Front panel components (cassette tray shown in the lowered position)

Pumps
Table 2-3: Pumps

Pump Function

1 AC (anticoagulant) pump Pumps anticoagulant from the AC container into the inlet line.

2 Inlet pump Pumps anticoagulated blood from the patient into the channel.

3 Plasma pump Pumps plasma out of the channel.

4 • Replace pump (exchange) • Exchange procedures: Pumps replacement fluid out of the fluid container and into
• Collect pump (collection, the reservoir.
depletion) • Collection and depletion procedures: Pumps the targeted component out of the
(Pump has a black dot on the channel or the chamber and into the collection bag or the reservoir.
pump rotor.)

5 Return pump Pumps the contents of the reservoir to the patient.

Spectra Optia Apheresis System Operator’s Manual 23

Introduction

Valves
Table 2-4: Valves

Valve Function

6 RBC valve Directs the flow of red blood cells from the channel.

7 Plasma valve Directs the flow of plasma from the channel.

8 • Remove valve (exchange) Directs the flow of the separated blood components pumped from the channel.
• Collect valve (collection,
depletion)

Sensors and detectors

Table 2-5: Sensors and detectors

Sensor/Detector Function

9 Inlet pressure sensor Monitors negative pressure in the inlet line to ensure that adequate inlet pressure is
maintained.

10 Low-level reservoir sensor Monitors the volume of fluid in the reservoir, and ensures that air does not enter the
return line.

11 Return pressure sensor Monitors positive pressure in the return line to ensure that the correct level of return
pressure is not exceeded.

12 High-level reservoir sensor Monitors the volume of fluid in the reservoir to help control the volume of fluid in the
tubing set.

13 Centrifuge pressure sensor Monitors pressure in the channel and lines in the centrifuge to ensure that the
correct level of pressure is not exceeded.

14 Barcode reader Reads the tubing set identification number on the cassette to ensure that the correct
tubing set is loaded for the procedure selected.

15 RBC detector • Exchange procedures: Detects red blood cells in the plasma line.
• MNC collection procedures: Detects red blood cells in the collect line.

16 • Plasma pressure sensor • TPE with a secondary plasma device (SPD) procedures: Monitors pressure in the
(exchange) plasma line.
• Collect pressure sensor • Collection and depletion procedures: Monitors pressure in the collect line.
(collection, depletion)

17 Return line air detector Monitors air in the return line. Signals the system if the patient has excess air in
(Detector is a component of the circulation.
return pump.)

18 AC fluid detector Detects fluid in the anticoagulant (AC) line. Signals the system if the line contains air
instead of fluid.

19 Replacement fluid detector Exchange and depletion procedures: Detects fluid in the replace line. Signals the
system if the line contains air instead of fluid.

Return line air detector

The return line air detector is an ultrasonic detector located in the return pump that detects air in the return line. If
the volume of air detected exceeds what is safe for the patient to have in circulation, the return line air detector

24 Spectra Optia Apheresis System Operator’s Manual

 Introduction

signals the system and an alarm occurs. Follow the instructions on the alarm screens to perform an air removal to
remove the air from the line.
During an air removal the system pumps 18 mL of saline into the return line to flush the fluid in the line into the
reservoir and the air into the vent bag. The total volume of saline delivered to the patient for the air removals
performed is displayed on the operation status screen during the run and on the procedure summary screen after
the procedure has been completed.

Warning: Monitor the return line for air. If you see air in the line, go to the operation status screen, touch
Remove Air From Return Line, and follow the instructions on the screen.
2

Spectra Optia Apheresis System Operator’s Manual 25

Introduction

Centrifuge Chamber
The Spectra Optia system centrifuge spins to create a centrifugal force that separates the blood into cellular
components. The centrifuge chamber houses the centrifuge and the system components, as shown in Figures 2-3
and 2-4, and described in Table 2-6.

4
3 5

2
7

4
6
9

8 10
5

Figure 2-3: Centrifuge chamber components Figure 2-4: AIM system light behind the gear shroud

Table 2-6: Centrifuge chamber components

Component Function
1 Upper collar holder Secures the upper collar at the entrance to the centrifuge chamber.

2 Centrifuge arm Holds the upper bearing holder. Lowers the filler latch if the latch is left in the raised
position when the centrifuge spins.

3 Upper bearing holder Secures the upper bearing to the tip of the centrifuge arm.

4 AIM system lights (2) Illuminate the filler and the connector to allow the AIM system to determine the position
One light is located on the of the interface. Each light is protected by a clear plastic cover.
ceiling of the centrifuge
chamber, and one light is
located on the floor of the
chamber behind the gear
shroud (Figure 2-4).

5 Strobe lights (2) Provide illumination for viewing different areas of the channel through the view port.

6 Fluid leak detector Detects moisture in the centrifuge chamber.

7 Filler (standard filler is shown) Secures the tubing set channel, the connector, and the lines that are attached to the
connector to the centrifuge.

8 Lower bearing holder Secures the lower bearing at the entrance to the loading port.

9 Gear shroud Covers the centrifuge gear train.

10 Loading port Allows access to the filler for loading the tubing set.

26 Spectra Optia Apheresis System Operator’s Manual

 Introduction

Filler
The filler secures the tubing set channel, the connector, and the lines that are attached to the connector to the
centrifuge. The Spectra Optia system has two fillers: the standard filler and the IDL filler. Confirm that you are
using the correct filler for the procedure before you load the tubing set. See Table 5-1 on page 62 for instructions
on the correct filler to use for each procedure.
The fillers and components are shown in Figures 2-5 and 2-6. The components are described in Table 2-7.
2
1 1

2 2

3 3
6

4 4

5 5

Figure 2-5: Standard filler Figure 2-6: IDL filler

Table 2-7: Filler components

Component Function
1 Centrifuge collar holder Secures the lower collar of the tubing set at the opening to the centrifuge loading port.

2 Filler latch Locks the filler onto the centrifuge.

3 Groove Secures the channel and the connector in the filler.

4 Aperture plate Plastic component that is attached to the underside of the filler directly beneath the
opening for the connector (Figure 2-7). Ensures uniform lighting to the appropriate
areas of the connector. Helps the AIM system control the concentration of cells that flow
through the collect port during a collection or depletion procedure.

5 Optical reference Black corner piece that provides a reference point for the AIM system to use to
determine the position of the interface during a procedure (Figures 2-8 and 2-9).

6 Chamber bracket (standard Secures the chamber onto the standard filler if a Collection Set is used.
filler only)

Spectra Optia Apheresis System Operator’s Manual 27

Introduction

Figure 2-7: Aperture plate

Figure 2-8: Optical reference Figure 2-9: Optical reference (shown with the connector
loaded)

28 Spectra Optia Apheresis System Operator’s Manual

 Introduction

AIM System
The AIM system is an optical detection system that is composed of hardware and software, and that interprets the
interface position in the tubing set connector during procedures on the Spectra Optia system. To accurately
interpret the interface position, the AIM system focuses on the optical reference on the filler, which is illuminated
by the AIM system lights in the centrifuge chamber.
The AIM system has three main functions:
• Monitor the interface position.
2
• Interpret the interface position and measure the intensity of the light passing through the connector.
• Adjust the plasma pump flow rate to maintain the optimal interface position so that the target blood
components can be collected or removed.
For additional information about how the AIM system functions during each procedure, see the procedure
functional descriptions in Chapters 7 through 14.

Operating Modes
The Spectra Optia system has two modes of operation: Automatic mode and Semi-Automatic mode. Below are
descriptions of the two modes.

Automatic Mode
During Automatic mode, the system uses the configuration parameters and the procedure data entered to
determine and control the pump flow rates, centrifuge speed, packing factor, run targets, and to establish the
interface position. The AIM system monitors the interface position, so that the desired blood components can be
collected or removed, and the fluid remaining in the channel can be returned to the patient.

Semi-Automatic Mode
During Semi-Automatic mode, the AIM system does not control the position of the interface. The software
controls the interface position using the entered hematocrit and other procedure values during TPE procedures.
During collection procedures, the operator can use the up and down arrows on the collection status screen to adjust
the interface position. For information about the reasons for entering Semi-Automatic mode and instructions for
using Semi-Automatic mode, see “Using Semi-Automatic Mode” on page 219.

Spectra Optia Apheresis System Operator’s Manual 29

Introduction

Procedure States
Table 2-8 describes the Spectra Optia system’s procedure states. Both Automatic mode and Semi-Automatic mode
include these states.
Table 2-8: Procedure states

State Description
Load Operator selects the procedure and loads the appropriate tubing set.

Tubing set test System verifies that the correct tubing set is loaded, and confirms the function of the pumps,
valves, and sensors.

Prime System primes the tubing set to remove air from the set, to perform volumetric tests, and to
balance the pumps prior to the start of the run. The system also verifies that the correct filler is
installed.

Run Operator connects the patient and the system performs apheresis according to the selected
procedure.

Rinseback System returns the blood remaining in the tubing set to the patient after the run is complete to
reduce the patient’s RBC loss. The operator may choose to perform or skip rinseback.

Disconnect test System verifies that the lines to the patient are clamped. During a collection procedure, the
system also verifies that the collect line to the collection bag is sealed.

Unload System raises the cassette and unloads the tubing from the pumps.

Procedure summary System displays the final procedure values.

Next procedure System prepares for the next procedure.

Packing Factor
The packing factor represents the relationship between the inlet pump flow rate and the centrifuge speed during the
run. It indicates how tightly the cells are packed in the channel. When the inlet pump flow rate is increased or
decreased, the centrifuge speed increases or decreases accordingly. The packing factor is displayed on the main run
screen.
Using the optimal (default) packing factor ensures that more of the target cells or components are collected or
removed and that more of the non-target cells or components are returned to the patient. See Chapters 7
through 14 for the default packing factor for each procedure. If the inlet pump flow rate used is high or very low, it
may not be possible for the system to achieve the optimal packing factor because the centrifuge has already reached
its maximum or minimum speed. The centrifuge cannot spin any faster or slower to accommodate the change to
the inlet pump flow rate.
If you are performing a CMNC, a PMN collection, or a WBCD procedure and conditions require that you use a
packing factor that is not the default, be aware that an excess number of platelets could be collected. The system
displays a warning screen with instructions for monitoring the patient for platelet depletion and for resuming the
procedure in Caution status.

30 Spectra Optia Apheresis System Operator’s Manual

 Introduction

Operation Status Screen

The operation status screen allows you to monitor and respond to certain conditions that could occur during the
run. Table 2-9 describes the messages and parameters that can appear on the operation status screen during a
procedure.
Table 2-9: Operation status screen

Message or Parameter Procedures Description 2

• AIM system: enabled All procedures Indicates whether the AIM system was disabled in response to an
• AIM system: disabled alarm condition or is currently operational.

• Proceed to Semi-Automatic mode • TPE Allows you to change the mode of operation in response to an
• Proceed to Automatic mode • SPD alarm condition or to troubleshoot certain procedure conditions.
• MNC
• CMNC
• PMN
• WBCD
• PLTD
• BMP

• Disable RBC detector • TPE Allows you to disable or enable the RBC detector in response to an
• Enable RBC detector • SPD alarm condition or to troubleshoot certain procedure conditions.
• RBCX • MNC collection procedures: If the RBC detector is disabled, the
• MNC collection phase control automatically changes to Operator.

• Disable RBC too soon alarm MNC Allows you to change the frequency of the alarm that occurs when
• Enable RBC too soon alarm RBC are detected in the collect line before the chamber is full. To
prevent the alarm from occurring each time cells are detected,
disable the alarm. If you decide you want the alarm to continue to
recur, you can re-enable it.

Remove air from return line All procedures Allows you to initiate an air removal if you see air in the return line
and an alarm has not occurred.

Total saline to patient: volume mL All procedures Displays the total volume of saline that was delivered to the
patient as a result of the air removals performed during the
current procedure.

Caution status: Reason for Caution All procedures Explains the reason for Caution status. See “Caution Status” on
status page 32 for details about conditions that cause the system to
enter Caution status.

Spectra Optia Apheresis System Operator’s Manual 31

Introduction

Caution Status
Caution status alerts you that the system is operating outside of certain established limits. When the system is
operating in Caution status, a yellow line appears on the bottom of the screen. The yellow line disappears if the
system operation changes and Caution status no longer applies. To view the reason why the system is operating in
Caution status, touch the Operation Status tab. The reason is shown in yellow text on the operation status screen.
Certain conditions that cause the system to enter Caution status are procedure-specific. Table 2-10 describes the
conditions that cause the system to enter Caution status during each procedure.
Table 2-10: Conditions for Caution status

Procedure Condition
All procedures Target or actual AC infusion rate exceeds 1.2 mL/min/L of the patient’s TBV.

TPE Patient data or procedure data that was entered caused the predicted fluid balance to be less than 90%
or greater than 110% of the patient’s TBV.

SPD Patient data or procedure data that was entered caused the target or actual fluid balance to be less
than 85% or greater than 140% of the patient’s TBV.

RBCX Patient data or procedure data that was entered caused the predicted fluid balance to be less than 95%
or greater than 105% of the patient’s TBV.

MNC • Patient data or procedure data that was entered caused the target or actual fluid balance to be less
than 85% or greater than 140% of the patient’s TBV.
• Control selected for the collection phase is Operator.

CMNC • Patient data or procedure data that was entered caused the target or actual fluid balance to be less
than 85% or greater than 140% of the patient’s TBV.
• Return to Patient button on the collection status screen was touched. Cells are not being collected.
• Packing factor that was entered exceeds the default. An excess number of platelets may be collected.
• Procedure data that was entered caused the packing factor to exceed the default. An excess number
of platelets may be collected.

PMN • Patient data or procedure data that was entered caused the target or actual fluid balance to be less
than 85% or greater than 115% of the patient’s TBV.
• Return to Patient button on the collection status screen was touched. Cells are not being collected.
• Packing factor that was entered exceeds the default. An excess number of platelets may be collected.
• Procedure data that was entered caused the packing factor to exceed the default. An excess number
of platelets may be collected.
• Target or actual collect volume exceeds 15% of the patient’s TBV. An excess number of RBC may be
collected.

WBCD • Patient data or procedure data that was entered caused the target or actual fluid balance to be less
than 85% or greater than 115% of the patient’s TBV.
• Return to Patient button on the collection status screen was touched. Cells are not being collected.
• Packing factor entered exceeds the default. An excess number of platelets may be collected.
• Procedure data that was entered caused the packing factor to exceed the default. An excess number
of platelets may be collected.

PLTD • Patient data or procedure data that was entered caused the target or actual fluid balance to be less
than 85% or greater than 115% of the patient’s TBV.
• Return to Patient button on the collection status screen was touched. Cells are not being collected.

BMP Return to BMP Bag button on the collection status screen was touched. Cells are not being collected.

32 Spectra Optia Apheresis System Operator’s Manual

 Introduction

Fluid Balance Limits

Table 2-11 shows the hypovolemia and hypervolemia limits the system enforces for each patient procedure. The
limits are a percentage of the patient’s TBV.
Table 2-11: Fluid balance limits

Procedure
Fluid Balance Limits (% TBV)
Hypovolemia Hypervolemia
2
TPE 75 125

SPD 75 220

RBCX 75 125

MNC 75 N/A

CMNC 75 N/A

PMN 75 125

WBCD 70 125

PLTD 70 125

Spectra Optia Apheresis System Operator’s Manual 33

Introduction

Spectra Optia System Touch Screen

Navigating the Procedure Screens

The Spectra Optia system’s touch screen allows you to perform, adjust, and monitor procedures. A procedure screen
is divided into several areas, as shown in Figure 2-10 and described in Table 2-12.

1
2
3

Figure 2-10: Example of a Spectra Optia system screen

Table 2-12: Description of a procedure screen

Area Description
1 Menu bar Contains menu buttons that you touch to show or hide menu tabs.

2 Menu tabs • Associated with a specific menu button.

• Appear when the menu button is touched.
• Provide access to screens that allow you to view information or modify the procedure.

3 Message bar Displays information about the status of the procedure or instructions to enter data.

4 Activity area Displays tasks to complete and buttons that allow you to do the following:
• Navigate to another screen.
• Change the operating mode.
• Change values or information about the procedure.

5 Action bar Contains buttons that you touch to perform the action stated on the button or to
navigate to a different screen.

Entering and changing numerical data using the data entry pad
To enter numerical data or to change a numerical value for certain operating parameters during the procedure,
touch the button for the parameter and use the data entry pad that the system displays on the screen. See
Chapters 7 through 14 for more information about entering and changing data during the run.

34 Spectra Optia Apheresis System Operator’s Manual

 Introduction

Screen Colors
The Spectra Optia system uses a color scheme to indicate the different procedure states, allowing you to quickly
determine the progress of the procedure. Table 2-13 describes the color that corresponds to each procedure state.
Table 2-13: Color schemes for procedure states

Procedure State Color

Load, prepare procedure, tubing set test, prime (patient is not connected) Teal 2
Run, rinseback, disconnect test (patient is connected) Blue

Unload, procedure summary, next procedure (patient has been disconnected) Burgundy

Screen Buttons
The screen displays active and inactive buttons, as shown in the following examples:

• Active button:
Active buttons are colored according to the procedure state and appear as if they are raised. Touch an active
button to enter, change, or save data, or to proceed to the next activity or action.
• Inactive button:
Inactive buttons are gray. They indicate that the action or the information is not available.

Spectra Optia Apheresis System Operator’s Manual 35

Introduction

Buttons, Icons, and Images

The buttons, icons, and images described in Table 2-14 can appear on the monitor or on the screens. They allow
you to operate and adjust the Spectra Optia system during a procedure, or they communicate important
information about the procedure.
Table 2-14: Buttons, icons, and images

Graphic Description Location Function

Go back button • Bottom right side of screens Returns you to a previous screen or to
• Top left side of the report the main run screen. The button is active
summary screen and the only when it is safe to return to a
report detail screen previous screen.
On some screens you must confirm any
data you change before you touch the go
back button, or the data will not be
saved.

Alarm mute button (Icon on the Bottom left side of alarm Allows you to mute the alarm tone during
button depends on the screens an alarm condition. The tone is
software version in use.) automatically restored if another alarm
occurs.

(muted)

(muted)

Stop button Bottom left corner of the Stops the centrifuge and pauses the
monitor pumps.

Pause button Bottom right corner of the Pauses the pumps.

monitor

Active alarm Bottom left side of the screen Indicates an active alarm. Takes you to
button during an alarm condition an active alarm screen or to a list of
active alarms, if more than one alarm is
active.

Clock button • Run time graph on the main Allows you to view clock time or elapsed
run screen time for the run.
• Exchange procedures: Run
time graph on the exchange
status screen

Up and down scroll buttons • Active alarm screens Allows you to view additional information
• Alarm history screen on the screen.
• Procedure selection screen

36 Spectra Optia Apheresis System Operator’s Manual

 Introduction

Table 2-14: Buttons, icons, and images (continued)

Graphic Description Location Function

Left and right arrow buttons Strobe screen • Allows you to adjust the timing of the
strobe.
• Allows you to view different areas of

Left and right scroll buttons • Alarm action screens

• Report summary screen
the channel.

• Allows you to scroll through alarm

action screens.
2
• Report detail screen • Allows you to scroll through pages of
the report summary screen and the
report detail screen.

Check mark icon • Procedure preparation screen Appears on buttons. Indicates that the
• Patient data screen required task is complete or the
selection is confirmed.

Do not connect Bottom right side of the screens Safety feature that reminds you that the
patient icon before the patient is connected patient should not be connected during
the current operating state.

Semi-Automatic mode icon Bottom right side of the run Indicates that the system is operating in
screens Semi-Automatic mode.

Interface graphic TPE procedures: Main run Displays a representation of the current
screen interface and the thickness of the buffy
coat in the connector.

Collect port image Collection and depletion Shows a real-time image of cells flowing
procedures: Main run screen, through the collect port.
collection status screen

Algorithm control icon TPE procedures: Main run Indicates that the AIM system is not
screen controlling the interface position. The
system is using certain procedure data
to control the position instead.

Blood drop icon RBCX procedures: Allows you to enter the values for
• Run values screen defective RBC instead of the fraction of
• Run targets screen cells remaining (FCR) for an exchange or
Appears on a button on the data a depletion/exchange procedure.
entry pad. Touch FCR to toggle
to  .

Single-needle icon TPE procedures: Main run Indicates that the single-needle option
screen was selected and confirmed.

Spectra Optia Apheresis System Operator’s Manual 37

Introduction

Table 2-14: Buttons, icons, and images (continued)

Graphic Description Location Function

Blood warmer icon TPE procedures: Screens that Shows the blood warmer on the return
instruct the user to prime the line and connection of the blood warmer
blood warmer tubing and tubing to the single-needle connector.
connect it to the single-needle
connector.

Hash mark icon • Run values screen Allows you to enter the number of
• Run targets screen collection phases instead of the target
Appears on a button on the data collect volume.
entry pad. Touch mL to toggle
to #.

Test tube icon MNC collection procedures: Graph on the collection status screen
Collection status screen only. Indicates that the control selected
for the collection phase is Inlet.

Inlet volume processed icon MNC collection procedures: • Indicates the inlet volume processed
• Main run screen (mL) during the current accumulation
• Collection status screen phase.
• Run targets screen • Indicates the inlet volume processed
(mL) during the current and previous
accumulation phases.

RBC detected icon MNC collection procedures: Graph on the collection status screen.
Collection status screen Indicates the inlet volume that was
processed before the RBC detector
detected cells in the collect line.

Operator override icon • TBV (total blood volume) • Indicates that the operator entered the
button on the patient data patient’s TBV instead of using the
screen volume the system calculated.

• MNC collection procedures: • Indicates that the control selected for

Collection status screen the collection phase is Operator.

Not equal icon MNC collection procedures: Indicates that the current volume in the
• Run values screen bag may be different from the displayed
• Run targets screen volume because plasma was transferred
• Procedure summary screen from the plasma bag into the collection
bag.

Up and down arrow buttons TPE-SPD procedures: Data Allows you to adjust the volume in the
entry pad that appears if you treated plasma bag.
touch Replace on the main
run screen

38 Spectra Optia Apheresis System Operator’s Manual

 Introduction

Table 2-14: Buttons, icons, and images (continued)

Graphic Description Location Function

Up and down arrow buttons Collection and depletion • Automatic mode: Used to increase or
procedures: Collection status decrease the collection preference.
screen • Semi-Automatic mode: Used to
increase or decrease the concentration
of cells flowing through the collect
port.
2
Collection preference graphic Collection and depletion Represents a buffy coat.
procedures: Collection status
screen

Spectra Optia Apheresis System Operator’s Manual 39

Introduction

40 Spectra Optia Apheresis System Operator’s Manual

 3
Installing and Transporting the
Spectra Optia System

Spectra Optia Apheresis System Operator’s Manual 41

Installing and Transporting the Spectra Optia System

Installing the Spectra Optia System

Installation information is included in the shipping container of each Spectra Optia system. An authorized service
representative uses this information to install the system in your facility. The service representative also tests the
system to confirm it is functioning properly before you begin using it.

Setting Up the Spectra Optia System

Perform the following steps to set up the Spectra Optia system:
1 Unpack the system from the shipping container.
2 Put the system in the desired location and press the wheel pedal to the right side and press the rear wheel
brake levers to lock the system in place.
3 Establish a safety boundary of at least 30 cm (11.8 in) around the perimeter of the system from all points
within which hazardous material is not permitted. When the centrifuge is spinning, limit access inside the
boundary to necessary individuals.
4 Raise the monitor until it is fully upright.
5 Press the IV pole release button located on the left side of the front panel and raise the IV pole.
6 Attach one end of the RF cable of the Seal Safe system to the connector on the Spectra Optia system, and
the other end of the cable to the connector on the sealer head. Turn the ends of the cable clockwise on the
connectors to lock them in place.
7 Put the sealer head into the holder.
8 Plug the system into a properly installed, three-wire, grounded electrical receptacle that is protected by an
approved branch circuit overcurrent protection and disconnection device. The branch circuit protection and
disconnection device must be located away from but close enough to the system so that the system can be
easily disconnected from the main power supply if the centrifuge malfunctions.

42 Spectra Optia Apheresis System Operator’s Manual

 Installing and Transporting the Spectra Optia System

Turning the Spectra Optia System On and Off

1 Confirm that the proper power cord is attached to the system and plugged into an appropriate electrical
receptacle.
2 Press the power switch on the upper-right side of the system to the ON position. The system performs a
series of self-diagnostic tests to validate the functionality of the hardware and software before you begin the
procedure. Once the tests are complete, the buttons on the screen become active and you may begin the
procedure.
3 To turn off the system, press the power switch to the OFF position.
Caution: When the wheel pedal is not in the locked position (pressed to the right side) and the rear wheel brake levers
are released, ensure at least one person is in continuous contact with and controls the movement of the Spectra Optia
system.
3
Caution: Ensure that the wheel pedal is pressed to the right side (locked position) and the rear wheel brake levers are
locked during procedures, so that the Spectra Optia system does not move.

Caution: Only perform procedures when the system is on a smooth, dry, level surface.

Caution: Do not leave the device unattended in a traffic area.

Spectra Optia Apheresis System Operator’s Manual 43

Installing and Transporting the Spectra Optia System

Transporting the Spectra Optia System

The Spectra Optia system can be transported manually or in a vehicle. It is not necessary to recalibrate the system
after transport; the system is ready for use.

Preparing the Spectra Optia System for Transport

1 Unplug the Spectra Optia system and secure the power cord in the power cord holder.
2 Press the IV pole release button located on the left side of the front panel and lower the IV pole.
3 Lower the monitor and lay it over the front panel (Figure 3-1).

Figure 3-1: Monitor lowered over the front panel

4 Open the centrifuge door and confirm that the filler latch on the filler is lowered and locked. Close the
centrifuge door.
5 Remove the following components and transport them separately to avoid damage to the system and the
components:
• Blood warmer and accessory bracket, if used.
• Seal Safe system sealer head and cable.

Caution: To avoid possible damage to the Seal Safe system, always disconnect the sealer head and the
RF cable before transporting the Spectra Optia system.

6 If you are transporting the system in a vehicle, cover the system with a heavy-duty cover or a shipping
blanket to protect the system.

44 Spectra Optia Apheresis System Operator’s Manual

 Installing and Transporting the Spectra Optia System

7 Press the wheel pedal to the appropriate position:

• To lock the front wheels in a forward position for moving in corridors, press the wheel pedal to the left
side.
• To allow free movement of all wheels, press the wheel pedal to the horizontal position.
• To lock the front wheels in position, press the wheel pedal to the right side (Figure 3-2).

Figure 3-2: Front wheels in the locked position

8 To lock the rear wheels in place, press down on each of the rear wheel brake levers (Figure 3-3).

Figure 3-3: Rear wheel brake levers in the locked position

Transporting the Spectra Optia System in a Vehicle

Perform steps 1 through 6 of “Preparing the Spectra Optia System for Transport” on page 44. Then follow the
instructions in this section to load the system into the vehicle and secure the system for transport.

Loading the system into the vehicle

1 If the vehicle has a liftgate, perform steps a. through e. to load the system in a vertical position into the vehicle.
If the vehicle does not have a liftgate, proceed to step 2.
a. Completely lower the liftgate of the vehicle.
b. Roll the system onto the liftgate with the handle facing the vehicle.
c. Press the wheel pedal to the right to lock the front wheels.
d. Raise the liftgate. To prevent the system from falling, use one hand to steady the system while the liftgate is
in operation.
e. Press the wheel pedal to the horizontal position to unlock the front wheels, and then roll the system into
the vehicle.

Spectra Optia Apheresis System Operator’s Manual 45

Installing and Transporting the Spectra Optia System

2 If the vehicle does not have a liftgate, perform steps a. through c. to load the system in a horizontal position
into the vehicle.

Note: Before transporting the system in a horizontal position, consider removing the filler from the
centrifuge chamber and transporting it separately. This helps to minimize wear on the centrifuge and reduce
the risk of damage to components inside the centrifuge chamber.

a. Tip the system backward so that the front wheels are off the ground.
b. Use the specially-designed lift handles, if installed, or the metal frame of the device to lift the system into
the vehicle. Do not use the bumpers or the blue side panels for lifting, or you may damage the system.
Always use proper lifting technique when lifting the system.
c. Lay the system in the vehicle so that it rests on the rear wheels and the two wheels on the handle of the
system.

Securing the system inside the vehicle

1 Use a cargo strap to secure the system inside the vehicle so that the system remains stable during transport. Do
not put any weight or objects on the monitor or on the centrifuge cover during transport.
2 Ensure that any other equipment in the vehicle is secured to prevent damage to the system.

Storing the Spectra Optia System

Cover the Spectra Optia system and store it in a clean environment, according to the specifications stated in
Table 18-2 on page 242.

46 Spectra Optia Apheresis System Operator’s Manual

 4
Configuring the Spectra Optia System

Spectra Optia Apheresis System Operator’s Manual 47

Configuring the Spectra Optia System

Configuring the Spectra Optia System

The Spectra Optia system allows you to configure procedure-independent and procedure-specific operating
parameters to meet your facility’s requirements. Configuration settings for the procedure-independent parameters
apply to all procedures. Configuration settings for procedure-specific parameters apply to only the specified
procedure. Several parameters have a default setting. The system uses the default setting unless you enter a different
setting. You must touch Confirm after you finish configuring the parameters to save the settings.
You can configure most procedure-independent operating parameters after you turn on the system and before you
connect the patient except for the language setting, and the inlet pressure and return pressure alarm limits, which
are described in Table 4-2.
You can configure procedure-specific operating parameters after you select the procedure and before you enter and
confirm the patient data.
To configure the parameters, perform the following steps:
1 Touch the Config menu button. The configuration tabs appear.
2 Touch the tab for the parameters that you want to configure. The corresponding configuration screen
appears.
3 Touch the button for the parameter that you want to configure:
• For parameters with only two settings, toggle between the settings until the setting that you prefer appears
on the button.
• For parameters with more than two settings, a list appears to enable you to select a setting.
• For parameters that require a numeric setting, a data entry pad appears to enable you to enter a number.
The range of acceptable values appears on the data entry pad.
4 Repeat step 3 until you finish configuring the parameters.
5 Touch Confirm.

48 Spectra Optia Apheresis System Operator’s Manual

 Configuring the Spectra Optia System

Configuring Procedure-Independent Operating Parameters

Tables 4-1 through 4-3 show the configuration parameters and setting options for the operating parameters that
apply to all procedures.

System
Table 4-1 shows the operating parameters to configure for the system.

Table 4-1: System configuration parameters and setting options

Tab Parameter Description Setting Options

System Language Language that appears on the screen. Multiple languages
A language must be configured before a procedure can available

Time format
be selected. The language cannot be changed after the
procedure is selected.

Format used to display the time. • hh:mm (24-hour)

4
• hh:mm (12-hour, a.m./
p.m.)

Decimal Punctuation used to represent a decimal point. • 0,00 (comma)

• 0.00 (point)

Current time Current time. • hh:mm (24-hour)

• hh:mm (12-hour, a.m./
p.m.)

Alarm volume Audible volume of the alarm tone. • Low

• High

Date format Format used to display the date. • mm-dd-yyyy

• dd-mm-yyyy

Software Software version and verification value for each type of Not configurable
procedure.
This information is used to confirm that the system
software version and the verification value for a
particular procedure type have not changed after
software for a new procedure type was installed.

Current date Current date. • mm-dd-yyyy

• dd-mm-yyyy

Spectra Optia Apheresis System Operator’s Manual 49

Configuring the Spectra Optia System

Procedure
Table 4-2 shows the operating parameters to configure for procedures.

Table 4-2: Procedure configuration parameters and setting options

Tab Parameter Description Setting Options

Procedure Height units Unit of measure for the patient’s height. • ft, in (feet, inches)
• cm (centimeters)

Weight units Unit of measure for the patient’s weight. • lb (pounds)

• kg (kilograms)

Pressure alarm limit: Limit at which an inlet pressure alarm occurs. −250 to −100
Inlet (mmHg) (Default: −250)

Pressure alarm limit: Limit at which a return pressure alarm occurs. 200 to 400
Return (mmHg) Default: 400

Custom prime Percentage of the patient’s total blood volume (TBV) or • 10

recommendation (% TBV) RBC volume in the tubing set at which the system • 15
displays a screen recommending a custom prime. Default: 10

AC container: Notification Indication of whether the system will display a • Yes

notification when the AC container is nearly empty. • No
Default: Yes

AC container: Volume (mL) Volume of AC in the AC container used during the 250 to 1000
procedure. Default: 1000

50 Spectra Optia Apheresis System Operator’s Manual

 Configuring the Spectra Optia System

Report
Table 4-3 shows the operating parameters to configure for the report.

Table 4-3: Report configuration parameters and setting options

Tab Parameter Description Setting Options

Report Device Device that is used to deliver a copy of the report. • No Device
If you select “Printer,” you must also select a paper size. • Printer
• Computer
Default: No Device

Paper Size of paper that is used to print the report if “Printer” • Letter
is the device selected. • A4
Default: Letter

IP address IP address for the device that is used to print the report. Device-specific
The format for the address is XXX.XX.XXX.XXX. The first
five digits must be 172.21 to match the system’s
4
address.

Port Port number for the device that is used to print the 100 to 9999
report. The format for the number is XXXX. It is Default: 9100
recommended that you use the default number.

Connection Test that is used to verify that a device for printing a Not configurable
report is connected to the system.
Touch Test to verify the connection. If the system can
verify the connection, “Passed” appears on the button.
If the system cannot verify the connection, “Failed”
appears.

Report Type of procedure report that you want to view or print. • Summary
There are two types of reports: • Detail
• Summary: Single-page report including the system Default: Summary
serial number, the date of the procedure, the patient
data, the fluid balance, and the initial and final run
values)
• Detail: Summary report plus additional procedure
details, which are reported according to time
configured for the report update interval.

Report update Interval at which procedure information appears on the 10 to 60

interval (min) report. Default: 15

Spectra Optia Apheresis System Operator’s Manual 51

Configuring the Spectra Optia System

Configuring Procedure-Specific Operating Parameters

Tables 4-4 through 4-15 show the configuration parameters and setting options for the operating parameters that
apply to specific procedures.

Therapeutic Plasma Exchange (TPE)

Table 4-4 shows the operating parameters to configure for a TPE procedure.

Table 4-4: Parameters and setting options to configure for a TPE procedure

Tab Parameter Description Setting Options

TPE AC infusion Rate at which anticoagulant (AC) is infused to the 0.8 to 1.2
rate (mL/min/L TBV) patient. Default: 0.8
The configured rate represents the maximum rate at the
start of the run.

Inlet:AC ratio (__:1) Ratio of the inlet pump flow rate to the AC pump flow 6 to 15
rate. The configured ratio represents the ratio at the Default:10
start of the run.

Plasma volumes Run target. Number of the patient’s plasma volumes to 0.5 to 4
exchanged be exchanged, accounting for the amount of AC in the Default: 1
plasma removed.
The configured number represents the number the
system uses to calculate the initial run values.

Custom replacement Percentage of citrate in the custom replacement fluid. 0 to 25

fluid (%) Default: 0

Therapeutic Plasma Exchange With A Secondary Plasma Device (TPE-SPD)

Tables 4-5 and 4-6 show the operating parameters to configure for a TPE-SPD procedure.

Table 4-5: Parameters and setting options to configure for a TPE-SPD procedure

Tab Parameter Description Setting Options

SPD AC infusion Rate at which anticoagulant (AC) is infused to the 0.8 to 1.2
rate (mL/min/L TBV) patient. Default: 0.8
The rate configured represents the maximum rate at the
start of the run.

Inlet:AC ratio (__:1) Ratio of the inlet pump flow rate to the AC pump flow 6 to 15
rate. The ratio configured represents the ratio at the Default:10
start of the run.

Plasma volumes treated Run target. Number of the patient’s plasma volumes to 0.5 to 4
be treated, accounting for the amount of AC in the Default: 1
plasma removed.
The number configured represents the number the
system uses to calculate the initial run values.

52 Spectra Optia Apheresis System Operator’s Manual

 Configuring the Spectra Optia System

Table 4-6: Parameters and setting options to configure for a secondary plasma device

Tab Parameter Description Setting Options

Plasma Prime divert volume (mL) Volume of plasma pumped into the plasma device to 0 to 500
Device displace the fluid that was used to prime the plasma Default: 0
device into the waste bag. This is typically the volume of
the plasma device.

Saline prime Indication that a saline prime of the plasma device will • Yes
be performed. • No
Default: No

Replace pump balance (%) Percentage change in the replace pump flow rate that is 50 to 150
required to balance the flow rates of the replace pump Default: 100
and the plasma pump so that the desired volume of
treated plasma is maintained in the treated plasma bag.

Maximum plasma flow

rate (mL/min)
Maximum flow rate of the plasma pump during the run. 2 to 142
Default: 100
4
Plasma pressure alarm Limit at which the operator is notified of elevated 50 to configured alarm limit
limit: Notification (mmHg) pressure in the plasma line. for maximum plasma
pressure
Default: 200

Plasma pressure alarm Limit at which the operator is notified that the pressure 50 to 1350
limit: Maximum (mmHg) in the plasma line is too high. Default: 250

Red Blood Cell Exchange (RBCX)

Table 4-7 shows the operating parameters to configure for an RBCX procedure.

Table 4-7: Parameters and setting options to configure for an RBCX procedure

Tab Parameter Description Setting Options

RBCX AC infusion Rate at which anticoagulant (AC) is infused to the 0.8 to 1.2
rate (mL/min/L TBV) patient. The configured rate represents the maximum Default: 0.8
rate at the start of the run.

Inlet:AC ratio (__:1) Ratio of the inlet pump flow rate to the AC pump flow 6 to 15
rate. The configured ratio represents the ratio at the Default: 13
start of the run.

Custom replacement Percentage of citrate in the custom replacement fluid. 0 to 25

fluid (%) Default: 0

Spectra Optia Apheresis System Operator’s Manual 53

Configuring the Spectra Optia System

Mononuclear Cell (MNC) Collection

Tables 4-8 and 4-9 show the operating parameters to configure for an MNC collection procedure.

Table 4-8: Parameters and setting options to configure for an MNC collection procedure

Tab Parameter Description Setting Options

MNC Run target: Whole blood Amount of the patient’s blood to be processed. Does not 100 to 50000
processed (mL) include AC. Default: 0
If you enter a value for this parameter, the system
automatically sets the targets for the run time and the
TBV processed to zero.

Run target: Run time (min) Time required to complete the run. 40 to 480
The run starts when the patient is connected and ends Default: 0
when the run targets have been attained. When you
enter a value for this parameter, the system
automatically sets the targets for the whole blood
processed and the TBV processed to zero.

Run target: TBV processed Number of the patient’s total blood volumes to be pro- 1 to 10
cessed. Default: 2
If you enter a value for this parameter, the system
automatically sets the targets for the whole blood
processed and the run time to zero.

Plasma: Plasma bag (mL) Volume of plasma to be collected into the plasma bag. 0 to 500
Default: 0

Plasma: Collection Volume of plasma to be collected into the collection bag. 0 to 500
bag (mL) Default: 0

Chamber flush (mL) Volume of plasma the system uses to flush cells from 6 to 100
the chamber into the collection bag during the collection Default: 16
phase.

Chamber chase (mL) Volume of plasma the system uses to rinse any cells 0 to 100
remaining in the collect line between the chamber and Default: 2
the collect valve into the collection bag.
The chamber chase occurs after the chamber flush and
before the collect valve moves into the return position.

54 Spectra Optia Apheresis System Operator’s Manual

 Configuring the Spectra Optia System

Table 4-9: Parameters and setting options to configure for the use of AC during an MNC collection procedure

Tab Parameter Description Setting Options

AC AC infusion Rate at which AC is infused to the patient. The 0.8 to 1.2
rate (mL/min/L TBV) configured rate represents the maximum rate at the Default: 0.9
start of the run.

Inlet:AC ratio (__:1) Ratio of the inlet pump flow rate to the AC pump flow 6 to 15
rate. The configured ratio represents either the target Default: 12
ratio if inlet:AC ratio ramping is indicated, or the ratio at
the start of the run.

Inlet:AC ratio ramping Indication that the system will ramp the inlet:AC ratio at • Yes
the start of the run. • No
The system processes the first 100 mL of inlet volume Default: Yes
at a ratio of 8.0:1. While processing the next 100 mL,
the system ramps the ratio to the target ratio. Ramping
is automatically disabled if you choose to perform a
custom prime.
4
Continuous Mononuclear Cell Collection (CMNC)
Tables 4-10 and 4-11 show the operating parameters to configure for a CMNC collection procedure.

Table 4-10: Parameters and setting options to configure for a CMNC collection procedure

Tab Parameter Description Setting Options

CMNC Run target: Whole blood Amount of the patient’s blood to be processed. Does not 100 to 50000
processed (mL) include AC. Default: 0
If you enter a value for this parameter, the system
automatically sets the targets for the run time and the
TBV processed to zero.

Run target: Run time (min) Time required to complete the run. 40 to 480
The run starts when the patient is connected and ends Default: 0
when the run targets have been attained. If you enter a
value for this parameter, the system automatically sets
the targets for the whole blood processed and the TBV
processed to zero.

Run target: TBV processed Number of the patient’s total blood volumes to be 1 to 10
processed. Default: 2
If you enter a value for this parameter, the system
automatically sets the targets for the whole blood
processed and the run time to zero.

Plasma collection: Plasma Volume of plasma to be collected into the plasma bag. 0 to 500
bag (mL) Default: 0

Plasma collection: Volume of plasma to be collected into the collection bag. 0 to 500
Collection bag (mL) Default: 0

Plasma collection Timing of the plasma collection. • Beginning of Run

• End of Run
Default: End of Run

Spectra Optia Apheresis System Operator’s Manual 55

Configuring the Spectra Optia System

Table 4-11: Parameters and setting options to configure for the use of AC during a CMNC procedure

Tab Parameter Description Setting Options

AC AC infusion Rate at which AC is infused to the patient. The 0.8 to 1.2
rate (mL/min/L TBV) configured rate represents the maximum rate at the Default: 0.8
start of the run.

Inlet:AC ratio (__:1) Ratio of the inlet pump flow rate to the AC pump flow 6 to 15
rate. The configured ratio represents the ratio at the Default: 12
start of the run.

Granulocyte (PMN) Collection

Table 4-12 shows the operating parameters to configure for a PMN collection procedure.

Table 4-12: Parameters and setting options to configure for an PMN collection procedure

Tab Parameter Description Setting Options

PMN Run target: Whole blood Amount of the patient’s blood to be processed. Does not 100 to 50000
processed (mL) include AC. If you enter a value for this parameter, the Default: 6000
system automatically sets the targets for the run time
and the TBV processed to zero.

Run target: Run time (min) Time required to complete the run. 40 to 480
The run starts when the patient is connected and ends Default: 0
when the run targets have been attained. If you enter a
value for this parameter, the system automatically sets
the targets for the whole blood processed and the TBV
processed to zero.

Run target: TBV processed Number of the patient’s total blood volumes to be 0.5 to 5
processed. Default: 0
If you enter a value for this parameter, the system
automatically sets the targets for the whole blood
processed and the run time to zero.

AC infusion Rate at which AC is infused to the patient. The 0.8 to 1.2

rate (mL/min/L TBV) configured rate represents the maximum rate at the Default: 0.8
start of the run.

Inlet:AC ratio (__:1) Ratio of the inlet pump flow rate to the AC pump flow 6 to 15
rate. The ratio configured represents the ratio at the Default:13
start of the run.

Plasma (mL) Volume of plasma to be collected into the plasma bag. 0 to 500
Default: 0

HES Indication that hydroxyethyl starch (HES) will be used for • Yes
the procedure. • No
The selection determines the default packing factor: Default: Yes
• Yes: Default packing factor is 1.6
• No: Default packing factor is 4.5
The selection also appears on the top left side of the
main run screen.

56 Spectra Optia Apheresis System Operator’s Manual

 Configuring the Spectra Optia System

White Blood Cell Depletion (WBCD)

Table 4-13 shows the operating parameters to configure for WBCD procedure.

Table 4-13: Parameters and setting options to configure for a WBCD procedure

Tab Parameter Description Setting Options

WBCD Run target: Whole blood Amount of the patient’s blood to be processed. Does not 100 to 50000
processed (mL) include AC. Default: 0
If you enter a value for this parameter, the system
automatically sets the targets for the run time and the
TBV processed to zero.

Run target: Run time (min) Time required to complete the run. The run starts when 40 to 480
the patient is connected and ends when the run targets Default: 0
have been attained.
If you enter a value for this parameter, the system
automatically sets the targets for the whole blood
processed and the TBV processed to zero.
4
Run target: TBV processed Number of the patient’s total blood volumes to be 0.5 to 5
processed. Default: 2
If you enter a value for this parameter, the system
automatically sets the targets for the whole blood
processed and the run time to zero.

AC infusion Rate at which AC is infused to the patient. The 0.8 to 1.2

rate (mL/min/L TBV) configured rate represents the maximum rate at the Default: 0.8
start of the run.

Inlet:AC ratio (__:1) Ratio of the inlet pump flow rate to the AC pump flow 6 to 15
rate. The ratio configured represents the ratio at the Default: 12
start of the run.

Custom replacement Percentage of citrate in the custom replacement fluid. 0 to 25

fluid (%) Default: 0

HES Indication that hydroxyethyl starch (HES) will be used for • Yes
the procedure. • No
The selection determines the default packing factor: Default: No
• Yes: Default packing factor is 1.6
• No: Default packing factor is 4.5
The selection also appears on the top left side of the
main run screen.

Spectra Optia Apheresis System Operator’s Manual 57

Configuring the Spectra Optia System

Platelet Depletion (PLTD)

Table 4-14 shows the operating parameters to configure for PLTD procedure.

Table 4-14: Parameters and setting options to configure for a PLTD procedure

Tab Parameter Description Setting Options

PLTD Run target: Whole blood Amount of the patient’s blood to be processed. Does not 100 to 50000
processed (mL) include AC. Default: 0
If you enter a value for this parameter, the system
automatically sets the targets for the run time and the
TBV processed to zero.

Run target: Run time (min) Time required to complete the run. The run starts when 40 to 480
the patient is connected and ends when the run targets Default: 0
have been attained.
If you enter a value for this parameter, the system
automatically sets the targets for the whole blood
processed and the TBV processed to zero.

Run target: TBV processed Number of the patient’s total blood volumes to be 0.5 to 5
processed. Default: 1.5
If you enter a value for this parameter, the system
automatically sets the targets for the whole blood
processed and the run time to zero.

AC infusion Rate at which AC is infused to the patient. 0.8 to 1.2

rate (mL/min/L TBV) The configured rate represents the maximum rate at the Default: 0.8
start of the run.

Inlet:AC ratio (__:1) Ratio of the inlet pump flow rate to the AC pump flow 6 to 15
rate. Default: 10
The ratio configured represents the ratio at the start of
the run.

Custom replacement Percentage of citrate in the custom replacement fluid. 0 to 25

fluid (%) Default: 0

Bone Marrow Processing (BMP)

Table 4-15 shows the operating parameters to configure for a BMP procedure.

Table 4-15: Parameters and setting options to configure for BMP procedure

Tab Parameter Description Setting Options

BMP Inlet flow rate (mL/min) Maximum flow rate at which the inlet pump pumps 20 to 142
bone marrow from the BMP bag into the tubing set Default:120
during the run.

Collect plasma Indication that plasma will be collected. • Yes

• No
Default: No

58 Spectra Optia Apheresis System Operator’s Manual

 Configuring the Spectra Optia System

Configuring the Use of a Blood Warmer

This section contains information about configuring operating parameters for the use of a blood warmer.
Parameters for configuring the use of a blood warmer can vary according to the procedure you are performing.
Table 4-16 shows all available parameters and setting options.

Table 4-16: Parameters and setting options to configure for using a blood warmer

Tab Parameter Description Setting Options

Blood Return line Indication that a blood warmer will be connected to the • Yes
Warmer return line. • No
You must prime the blood warmer tubing set before you Default: No
connect the patient.

Replace line Indication that a blood warmer will be connected to the • Yes
replace line during a procedure using an Exchange Set. • No
Default: No 4
Tubing set (mL) Volume of the blood warmer tubing set on the return 1 to 100
line. Default: 40
The system uses this information to adjust the
calculation for the extracorporeal volume, the minimum
volume required for a custom prime, and the volume of
saline required for rinseback.

Spectra Optia Apheresis System Operator’s Manual 59

Configuring the Spectra Optia System

60 Spectra Optia Apheresis System Operator’s Manual

 5
Preparing to Perform a Procedure

Spectra Optia Apheresis System Operator’s Manual 61

Preparing to Perform a Procedure

Supplies Required to Perform a Procedure

Assemble the supplies listed below before you begin a procedure. See the procedure-specific chapters of this manual
for the additional supplies required for each procedure.
• Spectra Optia Apheresis System
• Spectra Optia tubing set
Table 5-1 shows the tubing set required for each procedure.
• Standard or IDL filler
Table 5-1 shows the filler required for each procedure. See page 27 for more information about the fillers.
• 0.9% sodium chloride injection USP
• One of the following anticoagulant solutions:
• ACD-A (Anticoagulant Citrate Dextrose Solution A)
• Option for PMN and WBCD procedures: Solution of hydroxyethyl starch (HES) and 46.7% trisodium
citrate
For instructions on preparing the solution, see “Preparing an anticoagulant solution containing HES and
trisodium citrate” on page 162 or on page 178.
• If using peripheral access:
• Needle for the return site that is of sufficient gauge to accommodate the procedure pump flow rate
• Supplies for preparing the venipuncture site
• Blood pressure cuff
• If using a vascular access device:
• Supplies to disinfect, aspirate from, and connect to the device according to your standard operating
procedures
Optional supplies:
• Blood warmer and blood warmer tubing set, if using a blood warmer
• Spectra Optia® Apheresis System Collection Preference Tool
• Hemostats for clamping lines
• Supplies for collecting blood samples
• Apheresis procedure record

Table 5-1: Tubing set and filler required

Procedure Tubing Set Filler

TPE Exchange Set Standard

SPD Exchange Set Standard

RBCX Exchange Set Standard

MNC Collection Set Standard

CMNC IDL Set IDL

62 Spectra Optia Apheresis System Operator’s Manual

 Preparing to Perform a Procedure

Table 5-1: Tubing set and filler required (continued)

Procedure Tubing Set Filler

PMN IDL Set IDL

WBCD IDL Set IDL

PLTD IDL Set IDL

BMP IDL Set Standard

Spectra Optia Apheresis System Operator’s Manual 63

Preparing to Perform a Procedure

Selecting the Procedure

You must select the type of procedure you want to perform before you load the tubing set. Perform the following
steps to select a procedure:
1 Touch Select Procedure. The procedure selection screen appears.
2 Select the procedure you want to perform.
3 Touch Confirm. Once the system finishes loading the procedure software. a screen appears that displays the
filler and the tubing set required for the procedure.

Installing the Filler

Before you load the tubing set, verify that the correct filler is installed in the centrifuge. To remove and install a
filler, perform the following steps:

Removing the Filler

1 Open the centrifuge door.
2 Push the filler latch pin (Figure 5-1, number 1) toward the center of the centrifuge and raise the filler latch.

3 Push the filler locking pin (Figure 5-1, number 2) toward the center of the centrifuge. With the pin pushed
in, grasp the edge of the filler and lift up to raise the filler off the centrifuge.

1
2

Figure 5-1: Location of the filler latch pin (1) and the filler locking pin (2)

64 Spectra Optia Apheresis System Operator’s Manual

 Preparing to Perform a Procedure

Re-Installing the Filler

1 Align the two notches on the bottom of the filler with the two metal pins on the centrifuge as shown in
Figure 5-2, and firmly press the filler down until the filler locking pin is securely in place. You should hear a
click when the pin is in the correct position.

Figure 5-2: Notches on the filler aligned with the pins on the centrifuge

2 Verify that the filler is secure by pulling it upwards. If the filler is properly locked, it should remain firmly in
place.
5
3 Lower the filler latch.

Loading the Tubing Set

Follow the instructions below to unpack the tubing set, load the set on the system, and test the set. After you load
the set, the system performs a test to ensure that you have loaded the correct set for the procedure.
Caution: Before loading the tubing set, confirm that the filler that is installed is the correct filler for the
procedure. Using the incorrect filler will compromise the performance of the system and the outcome of the
procedure.

Caution: You may load the tubing set up to 24 hours before the procedure as long as you do not lower the
cassette or prime the set. Once you lower the cassette or prime the set, you must use the set during the same
work shift.

Note: Single-use tubing sets for the Spectra Optia system are considered applied parts because they make contact
with the patient. The tubing sets comply with the Class II Type BF electrical safety requirements of IEC 60601-1.

1 Verify that the tubing set has not expired by checking the expiration date on the cover of the package.
2 Document the lot number of the tubing set to use for future reference.
3 Touch Prepare Tubing Set. The screen appears instructing you to prepare the set.

Spectra Optia Apheresis System Operator’s Manual 65

Preparing to Perform a Procedure

Unpacking the Lines and the Bags

Put the tubing set package on top of the centrifuge cover with the package label upright and facing you, and
remove the cover from the package. Follow the instructions below according to the type of tubing set you are using.

Exchange Set
1 Take the line holder out of the package. The line holder holds the replace line (white clamps), the AC line
(orange), the saline line (green), and the extra remove line (yellow clamp). The remove bag with the attached
remove line is located inside the line holder.
2 Take out the remove bag and the extra remove line. Put the remove bag with attached lines on the right side
of the centrifuge cover.
3 Take out the replace line and put the line over the right side of the front panel.
4 Take out the AC line (orange) and the saline line (green) and hang the lines over the left side of the front
panel. Set the empty line holder aside.
5 Take the vent bag out of the package and hang the bag on the left side of the IV pole.
6 Take out the coiled inlet line (red clamps) and remove the paper tape from the coil. Hang the inlet
connection on the left end of the IV pole. Repeat this step with the return line (blue clamps).
7 Hang the remove bag on the IV pole.

Collection Set
1 Take the product bags and the vent bag out of the package and hang the bags from left to right on the IV pole
in the following order: vent bag, plasma bag, collection bag.
2 Take out the coiled inlet line (red clamps) and remove the paper tape from the coil. Hang the inlet
connection on the left end of the IV pole. Repeat this step with the return line (blue clamps).
3 Take out the AC line (orange) and the saline line (green) and hang the lines over the left side of the front
panel.

IDL Set
1 Take the product bags and the vent bag out of the package and hang the bags from left to right on the IV pole
in the following order: vent bag, plasma bag, collection bag.
2 Take out the replace line and put the line over the right side of the front panel between the two sides of the
IV pole.
3 Take out the coiled inlet line (red clamps) and remove the paper tape from the coil. Hang the inlet
connection on the left end of the IV pole. Repeat this step with the return line (blue clamps).
4 Take out the AC line (orange) and the saline line (green) and hang the lines over the left side of the front
panel.

66 Spectra Optia Apheresis System Operator’s Manual

 Preparing to Perform a Procedure

Snapping the Cassette into the Cassette Tray

1 Take the cassette out of the package and put the bottom of the cassette into the bottom edge of the cassette
tray (Figure 5-3).

2
Figure 5-3: Cassette snapped into the cassette tray

Ensure that there is nothing lodged behind the cassette or the tray that could interfere with the loading. 5
3 Press on the top corners of the cassette to snap the cassette into the tray.

Loading the Channel into the Centrifuge

1 Take the channel out of the package and put it on top of the centrifuge cover. Set the empty package aside.
2 Open the centrifuge door.
3 Locate the pin on the filler latch. Raise the latch by pushing the pin toward the center of the filler while
pulling the latch up.
4 Turn the centrifuge so that the loading port faces you.
5 Extend the lines between the cassette and the channel, and ensure that they are not twisted.

Spectra Optia Apheresis System Operator’s Manual 67

Preparing to Perform a Procedure

6 Pull the channel up through the loading port and then through the opening in the center of the filler. To
avoid damaging the chamber and the collect line when using a Collection Set, guide the chamber through
the loading port with one hand as you pull the channel through the loading port with the other hand
(Figure 5-4). Lower the filler latch and lock it in place.

Figure 5-4: Channel pulled through the loading port (Collection Set shown here)

7 Position the lower collar in the collar holder on the filler latch so that the inlet line (pink line) is not
obstructed by the other lines. Ensure that either the base of the pink line aligns with the space between the
two screws (Figure 5-5, number 1) or is adjacent to the indentation on the filler latch.
8 Grasp the centrifuge loop below the lower collar and gently pull the collar down until you hear the “click” of
the locking pin as it pops out and locks the collar in the collar holder. Ensure that the notch at the base of
the locking pin (Figure 5-5, number 2) is visible. If the collar is locked, you can see the notch.

Figure 5-5: Lower collar correctly positioned and locked with the notch on the locking pin visible

68 Spectra Optia Apheresis System Operator’s Manual

 Preparing to Perform a Procedure

9 Starting with the connector (Figure 5-6, number 1), insert the channel into the groove in the filler, finishing
with the inlet port (Figure 5-6, number 2). Run your finger over the groove and push down any section of
the channel that is not completely inserted in the groove. The channel must sit flush with the groove.

1 2

Figure 5-6: Channel pressed into the groove (Exchange Set shown here) 5
10 If you are using a Collection Set, put the chamber (Figure 5-7, number 3) into the chamber bracket. Ensure
that the chamber sits behind the clip at the opening of the bracket, so that the clip retains the chamber in the
bracket. Put the collect line to the chamber behind the lip of the optical reference (Figure 5-7, number 4), so
that the line does not block the optical reference.

Figure 5-7: Collect line correctly positioned behind the lip of the optical reference

Spectra Optia Apheresis System Operator’s Manual 69

Preparing to Perform a Procedure

Loading the Lower and Upper Bearings and the Upper Collar
1 Insert the narrow part of the lower bearing into the lower bearing holder (Figure 5-8) and the narrow part of
the upper bearing into the upper bearing holder (Figure 5-9). Ensure that the braided section of the loop is
not twisted.

Figure 5-8: Lower bearing inserted in the lower bearing Figure 5-9: Upper bearing inserted in the upper bearing holder
holder

2 Position the upper collar below the upper collar holder and insert the line into the holder (Figure 5-10). Pull
the line up to secure the upper collar in the holder (Figure 5-11).

Figure 5-10: Line inserted in the upper collar holder Figure 5-11: Upper collar secured in the upper collar holder

3 Spin the centrifuge clockwise to ensure that it rotates freely.

4 Close the centrifuge door.
5 Touch Load. The system lowers the cassette and performs several tests to verify that the tubing set and the
system components function properly.
6 Discard the empty tubing set package, according to your standard operating procedures.

70 Spectra Optia Apheresis System Operator’s Manual

 Preparing to Perform a Procedure

Priming the Tubing Set

Follow the instructions on the screen to prime the tubing set. The progress of the prime is displayed on the screen.
After the AC line is primed, the system sounds a tone to notify you to open the inlet saline line and the return saline
line in order for the prime to continue. Before the system primes the channel, it performs a test to verify that the
correct filler is installed.
The Exchange Set and the Collection Set are primed in 3 to 4 minutes. The IDL Set is primed in approximately
9 minutes. When the system finishes priming the set, it sounds a tone. The patient data screen appears.
Note: The AC line is not used during a BMP procedure.

Note: The menu buttons at the top of the screen are active so that you may enter or change the patient data or the
procedure data during the prime.

Spectra Optia Apheresis System Operator’s Manual 71

Preparing to Perform a Procedure

72 Spectra Optia Apheresis System Operator’s Manual

 6
Selecting Procedure Options

Spectra Optia Apheresis System Operator’s Manual 73

Selecting Procedure Options

Selecting Procedure Options

Procedure options are optional steps that you may choose to perform during a procedure. To select the options you
must first select a procedure. The available options vary by procedure and apply to the current procedure only. The
options are summarized in Table 6-1.
To select the procedure options, do the following:
1 Touch the Run menu button. The run tabs appear.
2 Touch the Options tab. The options screen appears.
3 Follow the instructions below to select the procedure options.
4 When you are finished selecting the options, touch Confirm.
5 Follow the instructions on the screen to resume the procedure.
Table 6-1: Procedure options

Procedure Option Procedure Description

Rinseback All procedures Allows you to specify whether the system should perform or skip rinseback at
• Yes the end of the run. During rinseback, the system pumps saline through the
• No tubing set and evacuates the fluid in the channel to return the remaining blood
components to the patient. If you perform a custom prime, the system will
automatically skip rinseback unless you specify otherwise. The default setting
for performing rinseback is Yes for most procedures. If you are performing a red
blood cell exchange procedure, or if you selected to perform a custom prime,
the default setting is No.

Custom prime • TPE Allows you to fill the tubing set with specified fluid (RBC, plasma, or albumin)
• Yes • SPD after you prime the set with saline and before you connect the patient.
• No • RBCX Performing a custom prime helps to maintain isovolemia when the patient has a
• MNC low RBC volume or a low total blood volume, such as a pediatric patient. After
• CMNC the custom prime is complete and the run is started, the fluid used is pumped
• PMN from the channel to the patient before the system establishes the interface.The
• WBCD default setting for performing a custom prime is No.
• PLTD

HES • PMN Allows you to indicate the use of hydroxyethyl starch (HES) during a procedure.
• Yes • WBCD The default setting is the configured setting.
• No

Saline rinse All procedures Allows you to rinse the tubing set with saline solution when you are concerned
• Yes about hypersensitivity reactions associated with residual ethylene oxide in the
• No tubing set, which is a result of sterilization. This option is available to select
before you connect the patient. The default setting for performing a saline rinse
is No.

Single Needle TPE Allows you to indicate the use of a single access to perform a procedure. The
• Yes default setting for the single-needle option is No.
• No

Collect plasma BMP Allows you to specify whether the system should collect plasma at the end of
• Yes the run. The system uses procedure data to determine the optimal plasma
• No volume to collect, but you may change the volume during the run. The default
setting to collect plasma is the configured setting.

74 Spectra Optia Apheresis System Operator’s Manual

 Selecting Procedure Options

Table 6-1: Procedure options (continued)

Procedure Option Procedure Description

Blood warmer • TPE Allows you to indicate the use of a blood warmer on the return line without
• Return line • SPD having to change the configured setting. You must also enter the volume of the
• Tubing set (mL) • RBCX blood warmer tubing set so that the system can adjust the volume of saline
• MNC required to perform rinseback. The default setting for using a blood warmer is
• CMNC the configured setting.
• PMN
• WBCD

Blood warmer • TPE Allows you to indicate the use of a blood warmer on the replace line without
• Replace line • SPD having to change the configured setting. The default setting for using a blood
• RBCX warmer is the configured setting.

Plasma collection CMNC Allows you to indicate when the configured volume of plasma should be
• Before the run starts: collected during the run. The selections change depending on whether the run
• Beginning of run has started. The default setting for plasma collection is End of Run.
• End of run
• After the run starts:
• Now
• End of run

Selecting Rinseback
Warning: Terumo BCT does not recommend performing rinseback during RBCX procedures. The data that the
system uses to predict the run targets does not include rinseback volume. If rinseback is performed, the run
targets may not be accurate.
6
The system considers the patient’s TBV and the fluid balance safety limit when determining the volume of fluid
that can be used to perform rinseback. There are four stages of rinseback. If the patient’s fluid balance has reached
the maximum limit for the procedure, the system might not complete all four stages. The stages are as follows:
• Stage 1: The system pumps the blood out of the channel for return to the patient. If you are using an
Exchange Set or a Collection Set, the system returns approximately 50 mL of volume to the patient. If you are
using an IDL Set, approximately 115 mL of volume is returned.
• Stages 2 through 4. During each stage, the system performs the following steps:
a. Pumps 20 mL of saline into the channel.
b. Restarts the centrifuge, spins the centrifuge to rinse the channel, and then stops the centrifuge.
c. Pumps the contents out of the channel for return to the patient.
If you intend to perform rinseback, confirm that the selection for rinseback is Yes. The system prompts you to
perform rinseback at the end of the run. If you do not want to perform rinseback, change your selection to No. If
you selected a custom prime, the default setting for rinseback is No. If you select No and decide later to perform
rinseback, perform the following steps:
1 When the run targets screen appears, touch the End Run menu button. The end run tabs appear.
2 Touch the Rinseback tab.
3 Follow the instructions on the screen to proceed with rinseback.

Spectra Optia Apheresis System Operator’s Manual 75

Selecting Procedure Options

Selecting and Performing a Custom Prime

The system prompts you to enter data for the custom prime after it primes the tubing set and before you connect
the patient. Two methods are available for selecting a custom prime:
• Select the custom prime option on the options screen. The custom prime option is available to select before
you connect the patient.
• Accept the system’s recommendation to perform a custom prime. The system makes the recommendation
based on the custom prime recommendation limit that was configured. If you change the patient data so that
the recommendation limit is no longer exceeded, the system will display an alert that a custom prime may no
longer be necessary.
If you perform a custom prime, you need the following supplies:
• Fluid for the custom prime
• Empty bag
• Filter or blood administration set (optional)
• Appropriate connectors to connect the inlet and return lines to the fluid and the empty bag

Note: If you perform a custom prime, the system does not perform the step to divert the saline used to prime the tubing
set. The saline is removed from the set during the custom prime.

Selecting the custom prime option

To select the custom prime option, touch the custom prime button until Yes appears on the button.

Accepting a custom prime recommendation

After you enter the patient data, the system displays a screen recommending that you consider performing a
custom prime. Perform the following steps:
1 Review the information on the screen, and confirm that it is correct. The screen also shows the recommended
fluid to use, the patient’s TBV and RBC volume that is in the tubing set, and what the system predicts the
patient’s Hct to be if a custom prime is not performed.

Warning: When performing a custom prime using red blood cells (RBC), ensure the unit contains a
sufficient number of RBC or RBC volume (RCV) to adequately fill the extracorporeal circuit of the tubing set.
An insufficient RCV may lead to an unintended decrease in patient hematocrit. The system will calculate the
necessary extracorporeal RCV based on the patient data entered (TBV and Hct), the tubing set and filler
used, if a blood/fluid warmer is used, and the type of procedure being performed.

Warning: Terumo BCT does not recommend the use of a diluted RBC unit to perform a custom prime. A
diluted unit may not contain a sufficient number of RBC or RBC volume (RCV) to compensate the patient for
the RCV required to adequately fill the extracorporeal circuit of the tubing set. If a diluted unit is used, the
patient may experience a decrease in hematocrit and may be unable to tolerate the procedure. The
attending physician should assess the patient’s condition and determine the appropriate RCV of the unit
used.

Note: To determine the number of RBC or RBC volume (RCV) in the unit you are using for the custom prime,
multiply the unit volume by the unit hematocrit. For example, a unit of 240 mL with a hematocrit of 60%
contains 144 mL of RCV (240 × 0.6 = 144).

2 To accept the recommendation, touch Yes. To decline the recommendation, touch No.

76 Spectra Optia Apheresis System Operator’s Manual

 Selecting Procedure Options

Entering data for the custom prime

If you select the custom prime option or accept a custom prime recommendation, the system prompts you to enter
data for the custom prime. Perform the following steps:
1 Choose one of the following fluid types to use for the custom prime by touching the corresponding button on
the screen:
• RBC

Note: To determine the number of RBC or RBC volume (RCV) in the unit you are using for the custom
prime, multiply the unit volume by the unit hematocrit. For example, a unit of 240 mL with a hematocrit of
60% contains 144 mL of RCV (240 × 0.6 = 144).

• Plasma
• Albumin
2 Enter the fluid data by touching the corresponding buttons on the screen:
• RBC unit Hct (%)
– This entry is available if you select RBC as the fluid type.
• Maximum inlet pump flow rate (mL/min)
– If you are using a filter, determine if the filter has a flow rate limit before you enter a maximum inlet
pump flow rate.
– Ensure that the access on the return line can accommodate the flow rate you entered.
• Volume (mL) of the custom prime fluid
6
– The patient will not receive the full benefit of the custom prime if the volume entered is less than
200 mL (Exchange Set or Collection Set) or 300 mL (IDL Set), plus the volume of any blood
warmer tubing on the return line.
3 Touch Confirm.

Starting the custom prime

1 Perform the steps that appear on the screen:
a. Connect the inlet line to the container of fluid to use for the custom prime. Connect a filter, if indicated.
b. Connect the return line to the empty bag.
c. Unclamp the inlet line and the return line.
2 Touch Start Custom Prime. The status of the custom prime appears on the screen.

Note: Monitor the progress of the custom prime. If the actual volume in the container of custom prime fluid
is less than the volume you entered on the screen, you may need to stop the custom prime before it is
complete to avoid drawing air into the tubing set.

3 When the custom prime is complete, the screen appears instructing you to connect the patient lines.

Spectra Optia Apheresis System Operator’s Manual 77

Selecting Procedure Options

Ending the custom prime before it is complete

1 Touch End Custom Prime. A screen appears on which you must confirm your decision to end the custom
prime.

Note: If you end the custom prime before the system has processed the recommended volume, an alarm
occurs reminding you that the patient will not receive the full benefit of the custom prime. Follow the
instructions on the screen to either resume or end the custom prime.

2 Touch End Custom Prime, and then touch Confirm.

Extending the custom prime

You can extend the custom prime by increasing the volume entered for the fluid to use for the custom prime. To
extend the custom prime, perform the following steps:
1 When the screen appears instructing you to connect the patient lines, touch the go back button. The screen
appears that instructs you to prime the inlet and return lines. Do not perform the instructions on the screen.
2 Touch Confirm. The screen appears that prompts you to enter the fluid data.
• If you decide not to extend the custom prime when you reach this screen, touch the Options tab. The
options screen appears. Change the custom prime button to No, and touch Confirm.
3 Touch the volume button and enter the sum of the original fluid volume plus the volume of the additional
fluid.
For example, if the volume that you first entered for the custom prime was 250 mL and you decide to extend
the custom prime by 30 mL, enter 280 mL.
4 Touch Confirm.
5 Touch Start Custom Prime.

Indicating the Use of HES

Touch the button for HES until the desired selection appears on the button. The change applies to the current
procedure only. To change the default setting, you must change the configured setting.
The selection determines the default packing factor for the procedure. If you select Yes, the default packing factor is
1.6. If you select No, the default packing factor is 4.5.

78 Spectra Optia Apheresis System Operator’s Manual

 Selecting Procedure Options

Selecting and Performing a Saline Rinse

The system prompts you to perform the saline rinse after it primes the tubing set and before you connect the
patient. If you perform a saline rinse, you need the following supplies:
• New container of saline that contains at least 250 mL.

Note: The system uses 250 mL of saline for a saline rinse. If you intend to perform a saline rinse more than
once, you need additional saline.

• Empty bag of sufficient volume to hold the saline that is used for the saline rinse.
• Appropriate connector to connect the return line to the empty bag.
The inlet pump flow rate during a saline rinse depends on the tubing set you use. Ensure that the access to the bag
on the return line can accommodate the flow rate. The inlet pump flow rates for the tubing sets are as follows:
• Exchange Set: 120 mL/min
• Collection Set: 90 mL/min
• IDL Set: 90 mL/min

Selecting the saline rinse option

To select the saline rinse option, touch the saline rinse button until Yes appears on the button. Resume the
procedure.

Starting the saline rinse

6
1 When the screen appears with the message “Prepare for saline rinse,” perform the steps that appear on the
screen:
a. Spike the new container of saline, and squeeze the drip chamber to ensure that saline drips into the
chamber.
b. Connect the empty bag to the return line.
2 Touch Continue.
3 Perform the steps that appear on the screen:
a. Wait 15 minutes to allow any residual ethylene oxide in the tubing set to diffuse into the saline.
b. Open the inlet saline line and the return saline line.
c. Unclamp the return line and flush the line to the access site with at least 50 mL of saline.
d. Close the return saline line.
4 Touch Start Saline Rinse. The status of the saline rinse appears on the screen.
5 To stop the saline rinse before it is complete, touch Cancel Saline Rinse. A screen appears on which you
must confirm your decision to cancel the saline rinse. Touch End Saline Rinse, and then touch Confirm.

Spectra Optia Apheresis System Operator’s Manual 79

Selecting Procedure Options

6 After the saline rinse is complete, perform the steps that appear on the screen:
• Close the inlet saline line.
• Clamp the return line.
7 Touch Continue. The screen instructing you to connect the patient lines appears.
8 If you intend to perform more than one saline rinse, proceed to the next section, “Repeating a saline rinse.”
Do not touch Confirm.

Repeating a saline rinse

You can perform a saline rinse as many times as necessary. To repeat a saline rinse, perform the following steps:
1 On the screen instructing you to connect the patient lines touch the go back button.
2 When the screen appears instructing you to clear the saline from the saline drip chamber and rehang the
container, touch Confirm.
3 Repeat the steps under “Starting the saline rinse” above.

Selecting and Confirming the Single-Needle Option

To use a single needle for a TPE procedure, you must first select and confirm the single-needle option. See
“Converting the Access to a Single Needle” on page 91 for instructions. You may change your selection for the
single-needle option before you prime the inlet line, the return line, and the single-needle connector. If you selected
to perform a saline rinse or a custom prime, you will be instructed to perform these steps before connecting the
single-needle connector.

Indicating Plasma Collection (BMP)

Touch the collect plasma button on the BMP options screen until the desired selection appears on the button. The
change applies to the current procedure only. To change the default setting, you must change the configured
setting.

Indicating the Use of a Blood Warmer

Follow the instructions below to indicate the use of a blood warmer during the procedure. You must prime the
blood warmer tubing set before you connect the patient. If you are using a blood warmer on the replace line, refer
to “Exchange Procedures: Using a Blood Warmer on the Replace Line” on page 267.

Exchange procedures
1 Select the line on the tubing set to which you want to connect the blood warmer. To use more than one blood
warmer, select both the return line and the replace line:
• To indicate a blood warmer on the return line, touch the return line button until Yes appears on the
button.
• To indicate a blood warmer on the replace line, touch the replace line button until Yes appears on the
button. Ensure that you connect the blood warmer to the replace line before you spike the replacement
fluid.
2 If you indicated a blood warmer on the return line, enter the volume of the blood warmer tubing set:
a. Touch the tubing set volume button. A data entry pad appears.
b. Enter the volume of the tubing set. The volume you entered appears on the button.

80 Spectra Optia Apheresis System Operator’s Manual

 Selecting Procedure Options

Collection and depletion procedures

1 Touch the return line button until Yes appears on the button.
2 Touch the tubing set volume button. A data entry pad appears.
3 Enter the volume of the blood warmer tubing set. The volume you entered appears on the button.

Indicating the Timing of Plasma Collection (CMNC)

Indicate your selection for when the system should collect plasma during a CMNC procedure by touching the
button for the desired option. The change applies to the current procedure only.

Spectra Optia Apheresis System Operator’s Manual 81

Selecting Procedure Options

82 Spectra Optia Apheresis System Operator’s Manual

 7
Therapeutic Plasma Exchange (TPE)
Procedures

Spectra Optia Apheresis System Operator’s Manual 83

Therapeutic Plasma Exchange (TPE) Procedures

Functional Description of a Therapeutic Plasma Exchange (TPE)

Procedure
During a TPE procedure, the system pumps the patient's blood into the tubing set and spins the centrifuge at the
speed required to target the optimal (default) packing factor of 20. The AIM system monitors the interface
position and adjusts the flow rate of the plasma pump to maintain the optimal interface position to remove the
plasma. When the AIM system determines that the buffy coat has reached a specific thickness in the connector, or
when an inlet volume equal to 0.25 of the patient's TBV has been processed, the system slows the plasma pump
and flushes the buffy coat through the RBC port and into the reservoir. The replace pump pumps replacement
fluid into the reservoir, where it combines with the RBC and the other cellular components for return to the
patient. The system manages the volume of plasma that is removed and fluid that is replaced according to the fluid
balance the operator selects.

TPE Procedures Using a Single Needle

During a TPE procedure using a single needle, the system performs therapeutic plasma exchange using a single
patient access. The run consists of two phases. During the first phase, the system pumps the patient’s blood into
the tubing set, separates and removes the plasma, and pumps replacement fluid and the RBC and the other cellular
components from the channel into the reservoir. When the high-level reservoir sensor detects fluid, indicating that
the reservoir is full, the first phase stops and the second phase begins. During the second phase, the system returns
the contents of the reservoir to the patient. When the low-level reservoir sensor no longer detects fluid, indicating
the reservoir is empty, the second phase stops and the first phase restarts. The system repeats this cycle until the run
ends.

Preparing to Perform a Procedure

Supplies
Assemble the supplies listed on page 62 before you begin a procedure. You will also need the following additional
supplies:
• Replacement fluid prescribed by the patient’s physician
• Spectra Optia® Single-Needle Connector, if performing a TPE procedure using a single needle
Optional supplies:
• Filters for the replacement fluid

Selecting the Procedure and Loading the Tubing Set

Follow the instructions starting on page 64 to select the procedure and load the tubing set. Before you load the
tubing set, verify that the set and the solutions you are using have not expired by checking the expiration date
printed on the packaging. Do not use an item if the current date is past the expiration date.

84 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange (TPE) Procedures

Navigating the TPE Procedure Screens

Menu Buttons and Tabs

Table 7-1 shows the menu buttons and tabs to use to navigate the screens during a TPE procedure. Menu buttons
and tabs are active depending on the current operating state. Touch a menu button to display the corresponding
tabs.

Table 7-1: Menu buttons and tabs on TPE procedure screens

Config Data Run End Run

System Patient data Exchange Status Rinseback

Report Fluid Operation status Disconnect

Procedure Alarm history Bolus Run targets

TPE Report Strobe

Blood warmer Run values

Options

Descriptions of Buttons, Icons, and Images

See Table 2-14 on page 36 for descriptions of the buttons, icons, and images that can appear on the screen during a
TPE procedure.

Spectra Optia Apheresis System Operator’s Manual 85

Therapeutic Plasma Exchange (TPE) Procedures

Entering and Changing Data During the Run

The Spectra Optia system requires that you enter specific data, such as patient data, to perform a TPE procedure.
The system also allows you to change numerical values for certain operating parameters during the run. Table 7-2
shows data entry ranges for the operating parameters according to the screen on which each data entry button
appears. To change or enter data, touch the button for the parameter that you want to change. A data entry pad
appears to enable you to enter a number. The data entry pad displays either the established range for the parameter
or the calculated range, if the range changes based on related data. Also, the range for Caution status is displayed in
yellow, if the data you enter could cause the system to operate in Caution status.

Table 7-2: Data entry ranges for TPE procedure parameters

Screen Parameter Range

Patient data Sex • Male
• Female

Height:
• ft • 1 to 8
• in • 0 to 11
• cm • 30 to 244

Weight:
• lb • 5 to 500
• kg • 2 to 227

Hct (%) 10 to 70

TBV (mL) 300 to 15000

Fluid data Replacement fluid • Plasma

• Saline/Albumin
• Custom

Fluid balance (mL or %) ± 25% of the patient’s TBV

(Caution status applies if the entry
exceeds ± 10% of the patient’s TBV.)

Options Rinseback • Yes

• No
Default:
• Yes if a custom prime is not
selected
• No if a custom prime is selected

Custom prime • Yes

• No
Default: No

Saline rinse • Yes

• No
Default: No

Single needle • Yes

• No
Default: No

86 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange (TPE) Procedures

Table 7-2: Data entry ranges for TPE procedure parameters (continued)

Screen Parameter Range

Blood warmer: • Yes
• Return line • No
• Replace line

Blood warmer: Tubing set volume (mL) 1 to 100

Custom prime Fluid type • RBC

• Plasma
• Albumin

RBC unit Hct (%) 25 to 80

Inlet flow rate (mL/min) 5 to 120

Volume (mL) 100 to 400

(Volume should be at least 200 mL
for the patient to receive the full
benefit.)

Run values AC infusion rate (mL/min/L TBV) 0.2 to 2.5

(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if the entered ratio
is not within the recommended range
of 6:1 to 15:1.)

Plasma removed (mL)

Run time (min)

Depends on the patient’s plasma
volume

40 to 480
7
Plasma volumes exchanged 0.5 to 4

Inlet flow rate (mL/min) 5 to 142

Replace volume: Target (mL) Depends on the patient’s plasma

volume

Main run Packing factor 4 to 20

Default: 20
(Packing factor can be changed only
during Semi-Automatic mode.)

Inlet flow rate (mL/min) 5 to 142

Replace volume (mL) Depends on the patient’s plasma

volume

AC infusion rate (mL/min/L TBV) 0.2 to 2.5

(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if entered ratio is
not within the recommended range of
6:1 to 15:1.)

Spectra Optia Apheresis System Operator’s Manual 87

Therapeutic Plasma Exchange (TPE) Procedures

Table 7-2: Data entry ranges for TPE procedure parameters (continued)

Screen Parameter Range

Exchange status Replacement fluid • Plasma
• Saline/Albumin
• Custom

Bolus Volume (mL) 10 to a volume that equals +25% of

the patient’s TBV

Flow rate (mL/min) 10 to 120

Run targets Plasma volumes exchanged 0.5 to 4

Run time (min) 40 to 480

Plasma removed (mL) Depends on the patient’s plasma

volume

Replacement fluid used (mL) Depends on the patient’s plasma

volume

Rinseback Return flow rate (mL/min) 2 to 100

Default: inlet flow rate that was in
use when the run ended or
100 mL/min, whichever is slower

88 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange (TPE) Procedures

Entering and Confirming Patient and Procedure Data

This section contains instructions for entering patient data, entering fluid data, and reviewing and confirming run
values. You can enter the data after you select the procedure and before you connect the patient. It is important that
the data you enter be as accurate and as current as possible.
Note: When you are required to enter numerical data, the system displays a data entry pad for entering the data. The
acceptable numerical range appears on the data entry pad.

Entering Patient Data

1 Touch the buttons on the screen to enter the following information:
• Sex
• Height
• Weight
• Hematocrit (Hct)
The Spectra Optia system uses the sex, height, and weight to calculate the patient’s TBV. See page 266 for the
formula the system uses to calculate this value. If you prefer not to use the TBV that the system calculated,
touch TBV and enter a different volume. The operator override icon ( ) will appear on the button.

Note: If the patient weighs less than 25 kg (approximately 55 lb), the system does not calculate a TBV. You
must calculate and enter the appropriate TBV for the patient.

2 Touch Confirm. The fluid data screen appears.

7
Entering Fluid Data
Perform the steps below to select the type of replacement fluid you are using and to enter the fluid balance.

Selecting the type of replacement fluid

1 Touch Fluid Type. A list of replacement fluid types appears.
2 Select one of the following replacement fluid types by touching the corresponding button on the screen:
• Plasma
– The system assumes that the plasma contains 15% citrate.
• Saline/Albumin
– The system assumes that the saline/albumin contains 4% citrate.
• Custom
– The system uses the citrate content that was entered on the TPE configuration screen. A data entry pad
appears to allow you to change the citrate content (%) of the fluid for the current procedure only.

Spectra Optia Apheresis System Operator’s Manual 89

Therapeutic Plasma Exchange (TPE) Procedures

Entering the fluid balance

Note: The fluid balance includes fluid that was administered and removed during the run and rinseback but does not
include fluid bolus volume.

1 To enter the fluid balance, choose one of the following options:

• To enter the fluid balance in mL, touch Volume and use the data entry pad to enter a negative or positive
volume. The system calculates and displays the corresponding percentage.
• To enter the fluid balance as a percentage, touch Percent and use the data entry pad to enter a percentage.
The system calculates and displays the corresponding volume.
2 Touch Confirm to save the fluid data. The run values screen appears.

Reviewing and Confirming the Run Values

1 Review the run values that appear on the screen and confirm that they are correct. The run targets for a TPE
procedure are listed below. A black frame appears around the button of the primary run target.
• Plasma volumes exchanged (mL)
• Run time (min)
• Plasma removed (mL)
• Replace volume: Target (mL)
If you change a value, the color of the value on the button changes from white to yellow. Values that were
affected by a change appear with a yellow arrow. The arrow points up or down to indicate an increase or
decrease in the value as a result of the change.

Note: Only the color of the last value you changed remains yellow. The values you previously changed revert to
white.

2 When you are finished reviewing the run values, touch Confirm.

90 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange (TPE) Procedures

Converting the Access to a Single Needle

You may select the single-needle option and convert the access to a single needle before or after you start the run.

Selecting and Confirming the Single-Needle Option

To use a single needle for the procedure, you must first select and confirm the single-needle option. Perform the
following steps to select and confirm the single-needle option:
1 Touch the Run menu button. The run tabs appear.
2 Touch the Options tab. The options screen appears.
3 Touch the button for the single-needle option until Yes appears on the button. A screen appears asking you
to confirm the conversion to a single-needle access.
4 Touch Convert Access to Single Needle.
5 Touch Confirm. The options screen reappears.
6 Review or select additional procedure options and then touch Confirm.

Note: If you select and confirm the single-needle option before you start the run, you may change your selection before
you prime the inlet line, the return line, and the single-needle connector. If you select and confirm the single-needle option
during the run, you cannot change your selection. You must complete the run using a single needle.

Connecting the Single-Needle Connector

Perform the following steps to connect the single-needle connector to the tubing set. Do not connect the
single-needle connector until you are instructed to do so.
Note: If you selected to perform a saline rinse or a custom prime, you will be instructed to perform these steps before you
connect the single-needle connector.
7
1 Select and confirm the single-needle option according to the instructions under “Selecting and Confirming
the Single-Needle Option” above. The single-needle icon ( ) appears on the main run screen and on the
exchange status screen to indicate that you have confirmed the option.
2 Follow the instructions on the screen to connect and prime the single-needle connector.

Spectra Optia Apheresis System Operator’s Manual 91

Therapeutic Plasma Exchange (TPE) Procedures

Priming the Inlet Line, the Return Line, and the Replace Line
Warning: When connecting a blood warmer tubing set to the return line, ensure that the tubing connection is
tight. Put the luer connection no higher than 20 in (50 cm) above the return access to prevent the possibility of air
entering the tubing.

Warning: If you are using a blood warmer on the return line, ensure that you completely prime the blood warmer
tubing set to remove all the air in the set before you connect the patient.

1 Follow the instructions on the screen to prime the inlet line and the return line. If you are using a blood
warmer on the replace line, follow the instructions under “Exchange Procedures: Using a Blood Warmer on
the Replace Line” on page 267 to connect and prime the blood warmer tubing set and to prime the replace
line. If you are not using a blood warmer or you are using a blood warmer on the return line, follow the
instructions on the screen.
2 Touch Confirm.
3 Follow the instructions on the screen to spike the replacement fluid container, to prime the replace line, and
to put the replace line into the replacement fluid detector.
4 Touch Continue. The screen appears with instructions for connecting the patient.

Connecting the Patient and Starting the Run

Warning: Before connecting the patient, check the inlet and return lines for air. If air is present in the lines,
remove the air before connecting the patient.

1 Follow the instructions on the screen to connect the patient and start the run.
2 Touch Start Run. The system begins drawing the patient’s blood into the tubing set. The main run screen
appears, and the system diverts approximately 40 mL of saline that was used to prime the tubing set into the
remove bag.

Note: If you performed a custom prime, the system does not perform the step to divert the saline. The saline was
removed from the set during the custom prime.

92 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange (TPE) Procedures

Monitoring the Run

The system displays information on the screens to help you monitor the progress of the run. To access the screens,
touch the Run menu button and then the tab for the screen you want to view. Be sure to verify that the volumes
displayed on the screens are consistent with the actual volumes in the fluid containers and in the bags.
See “Glossary of Terms” on page 278 for descriptions of the buttons on the screens.

Main Run Screen

The main run screen is the default run screen and displays or provides access to the information you most likely
need to monitor the run. If you want to return to the main run screen after viewing a different screen, touch the go
back button, the active menu button, or the tab for the current screen. There is no tab for the main run screen.

Algorithm control
The plasma of certain patients can cause extreme turbulence or platelet swirling to occur in the connector. If this
condition persists, the AIM system cannot effectively control the position of the interface. The system begins using
the entered hematocrit to calculate the plasma pump flow rate, and the algorithm control icon appears on the
screen in place of the interface image. After the interface position is stable for at least one minute, the AIM system
resumes control.

Exchange Status Screen

To access the exchange status screen, touch the Exchange Status tab. Use this screen to view information about the
current status of the run, including the patient’s fluid balance, the fluid administered, and the volumes that have
been exchanged and replaced during the run.

Replacement fluid
The type of replacement fluid currently in use appears on the button on this screen. Touch this button to change
the type of replacement fluid and then follow the instructions on the screens.
7

Spectra Optia Apheresis System Operator’s Manual 93

Therapeutic Plasma Exchange (TPE) Procedures

Monitoring the Patient

Managing Citrate Toxicity

If the patient experiences citrate toxicity, perform the following steps:
1 Touch the pause button to pause the pumps. An alarm occurs indicating that the procedure was paused and
the pumps were stopped.
2 Notify the attending physician of the patient’s condition according to your facility’s standard operating
procedures.
3 Touch the go back button to go to the run values screen, and decrease the AC infusion rate as desired.
4 Touch the active alarm button to return to the alarm screen, and then touch Continue. The run values
screen appears.
5 Review the run values and confirm that they are correct.
6 Touch Confirm to resume the procedure.
7 If decreasing the AC infusion rate does not alleviate the symptoms, touch the pause button to pause the
pumps again, and notify the attending physician.

Giving a Fluid Bolus

Perform the following steps to use the system to give the patient a fluid bolus:
1 Touch the Run menu button. The run tabs appear.
2 Touch the Bolus tab. The fluid bolus screen appears.
3 Follow the instructions on the screen to spike the saline container on the replace line. Confirm that the
replace line is not clamped.
4 Touch Volume and enter the volume (mL) of the bolus.
5 Touch Flow Rate and enter the flow rate (mL/min) for the bolus.

Note: If the fluid you use for the bolus is not saline, enter a flow rate that takes into account the percentage of
citrate in the fluid and that is in accordance with your local transfusion practices.

6 To begin the bolus, touch Start Bolus. The system delivers the bolus.
The screen displays the progress of the bolus. To cancel the bolus before delivery is complete, touch Cancel
Bolus.

7 When the bolus is complete, the system pauses. Touch Continue to resume the procedure.

Bolus volume and reported fluid balance

Be aware that the patient’s fluid balance displayed on the exchange status screen and on the procedure summary
screen does not include the volume of any bolus that was given to the patient during the procedure. The system
reports the total bolus volume in separate fields on the screens.

94 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange (TPE) Procedures

Optimizing the Run

Prediction for Removing a Substance From the Patient’s Plasma

Table 7-3 shows how the number of plasma volumes exchanged correlates to the removal of a hypothetical
substance from the patient’s plasma. The percentage that is removed is based on the assumption that there is no
equilibration with the extravascular compartment and that the patient’s plasma volume remains constant during the
procedure. Consider using this guideline to help you determine your procedure goals.

Table 7-3: Plasma exchange efficiency of a TPE procedure

Plasma Volumes Exchanged Percentage Removed

0.5 39

1.0 63

1.5 78

2.0 86

2.5 92

3.0 95
Source:
George W. Buffaloe, et al., “Technical Considerations,” Therapeutic Plasma Exchange Disease Compendium, 1983,
Dau P (ed.).

Handling Turbulence or Platelet Swirling in the Connector

If extreme turbulence or platelet swirling persists for more than 10 seconds, the system begins using the entered
7
hematocrit to calculate the plasma pump flow rate, and the algorithm control icon ( ) appears on the main run
screen in place of the interface image. Consider the following options when this condition occurs:
• Take no action. The AIM system automatically resumes control of the interface position after the position
stabilizes.
• Decrease the inlet pump flow rate to help reduce the turbulence. It could be necessary to decrease the flow rate
to 62 mL/min or less to achieve the optimal packing factor of 20.0.

Spectra Optia Apheresis System Operator’s Manual 95

Therapeutic Plasma Exchange (TPE) Procedures

Decreasing the Run Time After Converting the Access to a Single Needle
Converting the access to a single needle during the run causes an increase in the predicted run time for the
procedure. Consider the following alternatives for decreasing the predicted run time if a shorter run is necessary:
• Increase the inlet pump flow rate or increase the AC infusion rate.
Increasing these rates allows the system to process more blood in less time. Be aware that either option results
in a greater volume of AC delivered to the patient and increases the potential for the patient to experience a
citrate reaction.
• Increase the inlet:AC ratio.
This causes the inlet pump flow rate to increase. However, it decreases the system’s ability to manage
anticoagulation of the extracorporeal circuit and can result in clumping in the circuit. Monitor the run
carefully as you increase the inlet:AC ratio.
The increase in the run time can be more significant if you changed the inlet pump flow rate that the system had
established at the start of the run. After the conversion, the system resumes the run using the rate you entered
rather than using a rate that is optimal for a single access.

96 Spectra Optia Apheresis System Operator’s Manual

 8
Therapeutic Plasma Exchange with a
Secondary Plasma Device (TPE-SPD)
Procedures

Spectra Optia Apheresis System Operator’s Manual 97

Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Functional Description of a Therapeutic Plasma Exchange With a

Secondary Plasma Device (TPE-SPD) Procedure
During a TPE-SPD procedure, the system pumps the patient’s blood into the tubing set and spins the centrifuge at
the speed required to target the optimal (default) packing factor of 20. The AIM system monitors the interface
position and adjusts the flow rate of the plasma pump to maintain the optimal interface position for removing the
plasma. When the AIM system determines that the buffy coat has reached a specific thickness in the connector, or
when an inlet volume equal to 0.25 of the patient's TBV has been processed, the system slows the plasma pump
and flushes the buffy coat through the RBC port and into the reservoir.
The plasma pump pumps the plasma to the secondary plasma device. The treated plasma is then pumped into the
treated plasma bag. The replace pump pumps the contents of the treated plasma bag into the reservoir, where it
combines with the RBC and the cellular components from the channel for return to the patient. The system uses
the replace pump balance to manage the volume of plasma removed and the volume of plasma returned.

Preparing to Perform a Procedure

Supplies
Assemble the supplies listed on page 62 before you begin a procedure. You will also need the following additional
supplies:
• Secondary plasma device (plasma device), as prescribed

Warning: Before performing a therapeutic plasma exchange procedure with a secondary plasma device
(TPE-SPD procedure), carefully review the instructions for use provided by the manufacturer of the secondary
plasma device.

• Hemostats
• Extension tubing set to use to connect the plasma device to the Exchange Set
• Bag with a needle adapter to hold the treated plasma (treated plasma bag) and to attach to the outlet end of
the plasma device
Optional supplies:
• Bag to use for fluid waste diverted from the plasma device
• Connectors for connecting the treated plasma bag, the waste bag, or the tubing set to the plasma device. For
example:
• Two 3-way stopcocks or two Y-shaped connectors
• Male-to-male luer connector (optional)

Selecting the Procedure and Loading the Tubing Set

Follow the instructions starting on page 64 to select the procedure and load the tubing set. Before you load the
tubing set, verify that the set and the solutions you are using have not expired by checking the expiration date
printed on the packaging. Do not use an item if the current date is past the expiration date.

98 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Navigating the TPE-SPD Procedure Screens

Menu Buttons and Tabs

Table 8-1 shows the menu buttons and tabs to use to navigate the screens during a TPE-SPD procedure. Menu
buttons and tabs are active depending on the current operating state. Touch a menu button to display the
corresponding tabs.

Table 8-1: Menu buttons and tabs on TPE-SPD procedure screens

Config Data Run End Run

System Patient data Treatment status Rinseback

Procedure Plasma device Operation status Disconnect

Report Alarm history Bolus Run targets

SPD Report Strobe Treated plasma

Blood warmer Run values

Plasma device Options

Descriptions of Buttons, Icons, and Images

See Table 2-14 on page 36 for descriptions of the buttons, icons, and images that can appear on the screen during a
TPE-SPD procedure.

Spectra Optia Apheresis System Operator’s Manual 99

Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Entering and Changing Data During the Run

The Spectra Optia system requires that you enter specific data, such as patient data, to perform a TPE-SPD
procedure. The system also allows you to change numerical values for certain operating parameters during the run.
Table 8-2 shows data entry ranges for the operating parameters according to the screen on which each data entry
button appears. To change or enter data, touch the button for the parameter that you want to change. A data entry
pad appears to enable you to enter a number. The data entry pad displays either the established range for the
parameter or the calculated range, if the range changes based on related data. Also, the range for Caution status is
displayed in yellow, if the data you enter could cause the system to operate in Caution status.

Table 8-2: Data entry ranges for TPE-SPD procedure parameters

Screen Parameter Range

Patient data Sex • Male
• Female

Height:
• ft • 1 to 8
• in • 0 to 11
• cm • 30 to 244

Weight:
• lb • 5 to 500
• kg • 2 to 227

Hct (%) 10 to 70

TBV (mL) 300 to 15000

Plasma device Prime divert volume (mL) 0 to 500

(Volume cannot exceed 15% of the
patient’s TBV.)

Replace pump balance (%) 50 to 150

Saline prime • Yes

• No

Plasma flow rate (mL/min) 2 to 142

Options Rinseback • Yes

• No
Default:
• Yes if a custom prime is not
selected
• No if a custom prime is selected

Custom prime • Yes

• No
Default: No

Saline rinse • Yes

• No
Default: No

Blood warmer • Yes

• Return line • No
• Replace line

100 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Table 8-2: Data entry ranges for TPE-SPD procedure parameters (continued)

Screen Parameter Range

Blood warmer tubing set volume (mL) 1 to 100

Custom prime Fluid type • RBC

• Plasma
• Albumin

RBC unit Hct (%) 25 to 80

Inlet flow rate (mL/min) 5 to 120

Volume (mL) 100 to 400

(Volume should be at least 200 mL
for the patient to receive the full
benefit.)

Saline prime Volume (mL) 5 to 2000

Flow rate (mL/min) 1 to 100

Run values AC infusion rate (mL/min/L TBV) 0.2 to 2.5

(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if entered ratio is
not within the recommended range of
6:1 to 15:1.)

Plasma treated (mL) Depends on the patient’s plasma

volume.

Run time (min) 40 to 480

Plasma volumes treated 0.5 to 4

Inlet flow rate (mL/min)

Plasma flow rate (mL/min)

5 to 142

2 to 142
8
Main run Packing factor 4 to 20
Default: 20
(Packing factor can be changed only
during Semi-Automatic mode.)

Inlet flow rate (mL/min) 5 to 142

Plasma flow rate (mL/min) 2 to 142

Replace pump balance (%) 50 to 150

AC infusion rate (mL/min/L TBV) 0.2 to 2.5

(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if the entered ratio
is not within the recommended range
of 6:1 to 15:1.)

Spectra Optia Apheresis System Operator’s Manual 101

Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Table 8-2: Data entry ranges for TPE-SPD procedure parameters (continued)

Screen Parameter Range

Bolus Volume (mL) 10 to a volume that equals +25% of
the patient’s TBV

Flow rate (mL/min) 10 to 120

Run targets Plasma volumes treated 0.5 to 4

Run time (min) 40 to 480

Plasma treated (mL) Depends on the patient’s plasma

volume.

Treated plasma Volume (mL) 5 to 2000

Return flow rate (mL/min) 2 to 100

Plasma device rinse Volume (mL) 5 to 2000

Flow rate (mL/min) 1 to 100

Rinseback Return flow rate (mL/min) 2 to 100

Default: inlet flow rate that was in
use when the run ended or
100 mL/min, whichever is slower

102 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Entering and Confirming Patient and Procedure Data

This section contains instructions for entering patient data, entering fluid data, and reviewing and confirming run
values. You can enter the data after you select the procedure and before you connect the patient. It is important that
the data you enter be as accurate and as current as possible.
Note: When you are required to enter numerical data, the system displays a data entry pad for entering the data. The
acceptable numerical range appears on the data entry pad.

Entering Patient Data

1 Touch the buttons on the screen to enter the following information:
• Sex
• Height
• Weight
• Hematocrit (Hct)
The Spectra Optia system uses the sex, height, and weight to calculate the patient’s TBV. See page 266 for the
formula the system uses to calculate this value. If you prefer to override the TBV the system calculated, touch
TBV and enter a different volume. The operator override icon ( ) will appear on the button.

Note: If the patient weighs less than 25 kg (approximately 55 lb), the system does not calculate a TBV. You
must calculate and enter the appropriate TBV for the patient.

2 Touch Confirm. The data screen for the plasma device appears.

Reviewing and Confirming the Plasma Device Data

The default values that appear on the screen correspond to the values that were configured on the plasma device
configuration screen.
1 Review the values on the screen. Change them if needed so that they are correct for the current procedure.
8
2 Touch Confirm. The run values screen appears.

Spectra Optia Apheresis System Operator’s Manual 103

Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Reviewing and Confirming the Run Values

1 Review the run values that appear on the screen and confirm that they are correct. The run targets for a
TPE-SPD procedure are listed below. A black frame appears around the button of the primary run target.
• Plasma volumes treated
• Run time
• Plasma treated (mL)
If you change a value, the color of the value on the button changes from white to yellow. Values that were
affected by a change appear with a yellow arrow. The arrow points up or down to indicate an increase or
decrease in the value as a result of the change.

Note: Only the color of the last value you changed remains yellow. The values you previously changed revert to
white.

2 When you are finished reviewing the run values, touch Confirm.

104 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Connecting the Plasma Device Using an Extension Tubing Set

Follow the instructions in this section to use an extension tubing set to connect the plasma device to the Exchange
Set.

Setting Up and Priming the Extension Tubing Set

1 Follow the instructions on the screen to empty the saline drip chamber on the saline line.
2 Touch Confirm.
3 Follow the instructions on the screen to connect and prime the extension tubing set and to connect the
extension tubing set to the inlet end of the plasma device.
4 Touch Confirm.

Connecting the Treated Plasma Bag

If you intend to use the system to prime the plasma device with saline, follow the instructions under “Saline prime:
Yes.” If not, follow the instructions under “Saline prime: No.”
If you are performing a prime divert or you are using a blood warmer on the replace line, perform the following
steps before you connect the treated plasma bag:
• To perform a prime divert to remove any fluid in the plasma device, you must have entered a value for the
prime divert volume on the plasma device configuration screen or on the plasma device data screen. You must
also ensure that a waste bag or other appropriate container is connected to the outlet end of the plasma device
to hold the diverted fluid. After the prime divert is complete, the system pumps a volume into the treated
plasma bag that is equal to 50 mL or 5% of the patient’s TBV, whichever is less.
• If you are using a blood warmer on the replace line, follow the instructions “Exchange Procedures: Using a
Blood Warmer on the Replace Line” on page 267 before you connect the treated plasma bag. If you are not
using a blood warmer or are using a blood warmer on the return line, follow the instructions on the screen to
connect and prime the blood warmer tubing after you connect the treated plasma bag.

Saline prime: Yes

To use the Spectra Optia system to prime the plasma device, you must select Yes for a saline prime on the plasma
8
device configuration screen or on the plasma device data screen. You may prime the plasma device as many times as
necessary. If you ultimately decide not to perform the prime, touch Skip Prime.
Note: Monitor the volume in the saline container on the saline line. Saline from this container is also used for priming the
plasma device. If the container empties, air could be drawn into the tubing set.

1 Follow the instructions on the screen to connect a waste bag to the outlet end of the plasma device.
2 Touch Confirm.
3 Follow the instructions on the screen to spike the replace line into the saline container.
4 Touch Confirm. The screen appears instructing you to enter the data required for the prime and to prime the
plasma device.
5 Enter the volume of saline and the flow rate required for the prime.

Spectra Optia Apheresis System Operator’s Manual 105

Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

6 Touch Start Prime. The system starts priming the plasma device.
• To pause the prime, touch Pause Prime.
• To restart the prime, touch Start Prime.
The screen displays the progress of the prime.
• Current Prime indicates the volume of saline that has been processed for the current prime.
• Total Prime indicates the total volume of saline that was processed for priming the plasma device during
the current procedure.
7 After the volume for the prime has been processed, perform one of the following steps:
• To process additional volume, repeat steps 5 and 6.
• If you are finished priming the plasma device, touch Prime Complete.
8 Follow the instructions on the screen to clamp the replace line, spike the second replace line into the treated
plasma bag, unclamp the second replace line, and connect the treated plasma bag to the outlet end of the
plasma device.
9 Touch Confirm.

Saline prime: No
1 If you intend to perform a prime divert, follow the instructions on the screen to connect a waste bag to the
outlet end of the plasma device.
2 Touch Confirm.
3 Follow the instructions on the screen to spike the second replace line into the treated plasma bag, and to
connect the treated plasma bag to the outlet end of the plasma device.
4 Touch Confirm.

Priming the Inlet Line and the Return Line

Warning: When connecting a blood warmer tubing set to the return line, ensure that the tubing connection is
tight. Put the luer connection no higher than 20 in (50 cm) above the return access to prevent the possibility of air
entering the tubing.

Warning: If you are using a blood warmer on the return line, ensure that you completely prime the blood warmer
tubing set to remove all the air in the set before you connect the patient.

1 Follow the instructions on the screen to prime the inlet line, the return line, and the blood warmer tubing set,
if used.
2 Touch Confirm. The screen appears with instructions for connecting the patient and starting the run.

106 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Connecting the Patient and Starting the Run

Warning: Before connecting the patient, check the inlet and return lines for air. If air is present in the lines,
remove the air before connecting the patient.

1 Follow the instructions on the screen to connect the patient.

2 Touch Start Run. The system begins drawing the patient’s blood into the tubing set. The main run screen
appears, and the system diverts approximately 40 mL of saline that was used to prime the tubing set into the
plasma device. If you are performing a prime divert, the system begins pumping plasma into the plasma
device to divert the fluid that is in the plasma device into the waste bag.

Note: If you performed a custom prime, the system does not perform the step to divert the saline. The saline was
removed from the set during the custom prime.

Filling the Treated Plasma Bag

1 When the system is ready to fill the treated plasma bag with the initial volume of treated plasma, a tone
sounds. Follow the instructions on the screen to confirm that the treated plasma bag is empty and to ensure
that the appropriate lines are unclamped so that plasma will flow into the treated plasma bag.
2 Touch Confirm. The main run screen reappears. The system begins pumping treated plasma from the
plasma device into the treated plasma bag. The volume pumped into the bag is 50 mL or 5% of the patient’s
TBV, whichever is less. Once the volume has been pumped into the bag, the replace pump starts, and the
system begins returning treated plasma to the patient.
3 If you did not use the system to prime the plasma device, follow the instructions on the screen to perform
the following steps:
a. Squeeze the drip chamber on the line to the treated plasma bag to fill the chamber with treated plasma.
b. Touch Confirm. The main run screen reappears.
8

Spectra Optia Apheresis System Operator’s Manual 107

Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Monitoring the Run

The system displays information on the screens to help you monitor the progress of the run. To access the screens,
touch the Run menu button and then the tab for the screen you want to view. See “Glossary of Terms” on page 278
for descriptions of the buttons on the screens.

Main Run Screen

The main run screen is the default run screen and displays or provides access to the information you most likely
need to monitor the run. If you want to return to the main run screen after viewing a different screen, touch the go
back button, the active menu button, or the tab for the current screen. There is no tab for the main run screen.

Treatment Status Screen

To access the treatment status screen, touch the Treatment Status tab. Use this screen to view information about
the current status of the run, including the patient’s fluid balance, the cumulative volume of fluid boluses delivered,
the total volume of plasma treated (mL), and the plasma volumes treated.

108 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Monitoring the Patient

Managing Citrate Toxicity

If the patient experiences citrate toxicity, perform the following steps:
1 Touch the pause button to pause the pumps. An alarm occurs indicating that the procedure was paused and
the pumps were stopped.
2 Notify the attending physician of the patient’s condition according to your facility’s standard operating
procedures.
3 Touch the go back button to go to the run values screen, and decrease the AC infusion rate as desired.
4 Touch the active alarm button to return to the alarm screen, and then touch Continue. The run values
screen appears.
5 Review the run values and confirm that they are correct.
6 Touch Confirm to resume the procedure.
7 If decreasing the AC infusion rate does not alleviate the symptoms, touch the pause button to pause the
pumps again, and notify the attending physician.

Giving a Fluid Bolus

Perform the following steps to give the patient a fluid bolus:
1 Touch the Run menu button. The run tabs appear.
2 Touch the Bolus tab. The fluid bolus screen appears.
3 Follow the instructions on the screen to spike the saline container on the replace line. Confirm that the
replace line is not clamped.
4 Touch Volume and enter the volume (mL) of the bolus.
5 Touch Flow Rate and enter the flow rate (mL/min) for the bolus.

Note: If the fluid you use for the bolus is not saline, enter a flow rate that takes into account the percentage of
8
citrate in the fluid and that is in accordance with your local transfusion practices.

6 To begin the bolus, touch Start Bolus. The system delivers the bolus.
The screen displays the progress of the bolus. To cancel the bolus before delivery is complete, touch Cancel
Bolus.

7 When the bolus is complete, the system pauses. Touch Continue to resume the procedure.

Bolus volume and reported fluid balance

Be aware that the patient’s fluid balance displayed on the treatment status screen and on the procedure summary
screen does not include the volume of any bolus that was given to the patient during the procedure. The system
reports the total bolus volume in separate fields on the screens.

Spectra Optia Apheresis System Operator’s Manual 109

Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Optimizing the Run

Adjusting the Volume of Treated Plasma in the Treated Plasma Bag

Periodically monitor the volume in the treated plasma bag to ensure that an adequate volume is maintained during
the run. To increase or decrease the volume in the treated plasma bag, perform the following steps:
1 Go to the main run screen.
2 Ensure that the target flow rates and volumes are displayed. If they are not displayed, touch Current to
toggle to the target values.
3 Touch the button for the replace flow rate. A data entry pad appears allowing you to adjust the volume
currently in the bag or the volume maintained in the bag.

Adjusting the volume currently in the treated plasma bag

1 To adjust the volume currently in the treated plasma bag, perform one of the following steps:
• To add treated plasma to the bag, touch Fill. The replace pump pauses.
• To remove treated plasma from the bag, touch Drain. The AC, inlet, and plasma pumps pause.
Each time Fill or Drain is touched, the volume pumped into or out of the treated plasma bag is the lesser of
25 mL or 2.5% of the patient’s TBV.
To cancel the filling or the draining before the system pumps the entire volume, touch End.
2 When you finish adjusting the volume, touch Cancel to close the data entry pad.

Adjusting the volume maintained in the treated plasma bag

1 To adjust the volume maintained in the treated plasma bag, you must change the replace pump balance. Do
one of the following:
• To increase the volume maintained in the bag, touch the up arrow button until the desired replace pump
balance is displayed.
• To decrease the volume of treated plasma maintained in the bag, touch the down arrow button until the
desired replace pump balance is displayed.

Note: The replace pump balance decreases when you increase the volume to be maintained in the bag and
increases when you decrease the volume to be maintained in the bag.

2 When you finish adjusting the replace pump balance, touch Confirm.

110 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Managing a Positive Fluid Balance

The total volume of the AC used during a TPE-SPD procedure is returned to the patient with the treated plasma.
As a result, the patient’s fluid balance is always positive at the end of the run. Consider the following guidelines to
help decrease the volume if the additional volume is an issue for the patient:
• Increase the inlet:AC ratio to 15.0. Be aware that if the extracorporeal circuit is not adequately anticoagulated,
platelet clumping could occur. For more information about anticoagulation and addressing clumps or clots in
the circuit, see “Managing Anticoagulation of the Extracorporeal Circuit” on page 221.
• Do not rinse the contents remaining in the plasma device into the treated plasma bag at the end of the run.
• Do not return the contents of the treated plasma bag to the patient at the end of the run. Keep in mind that
doing this leaves the patient in a plasma-negative condition.

Returning the Contents of the Treated Plasma Bag to the Patient

Perform the following steps to return the contents of the treated plasma bag to the patient before rinseback. You
may only return the contents before rinseback if a run target was attained.
1 Ensure that the run targets screen is displayed. If the tabs are not displayed, touch the End Run menu button
to display the tabs.
2 Touch the Treated Plasma tab. The screen appears instructing you to return the treated plasma.
3 Follow the instructions on the screens. When the return is complete, the run targets screen re-appears.
Perform rinseback or disconnect the patient to complete the procedure.

Note: If you decide not to return the contents in the treated plasma bag to the patient, touch Skip Return to decline the
return.

Rinsing the Plasma Device and Performing Rinseback

The Spectra Optia system gives you the option to rinse the plasma in the plasma device into the treated plasma bag
before you perform rinseback. You may rinse the plasma device as many times as necessary. To rinse the plasma
device or to perform rinseback, touch Rinseback and follow the instructions on the screens. 8
Rinsing the plasma in the plasma device into the treated plasma bag
Before you begin the rinse, check the volume in the saline container on the saline line and confirm that it contains
enough volume to complete the rinse. Spike a new container, if necessary. Follow the instructions on the screen to
complete the rinse.
Note: If you decide not to rinse the plasma in the plasma device into the treated plasma bag, touch Skip Rinse to
decline the rinse.

Performing rinseback
When you are finished rinsing the plasma device, the screen that shows the status of rinseback appears, and
rinseback begins. To return the contents of the treated plasma bag to the patient during or after rinseback, follow
the instructions in “Returning the Contents of the Treated Plasma Bag to the Patient” on page 111.

Spectra Optia Apheresis System Operator’s Manual 111

Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

Managing a Prime Divert When the Patient Has a Low TBV

For patient safety, the Spectra Optia system does not allow you to enter a prime divert volume greater than 15% of
the patient’s TBV. Therefore, if the volume for the plasma device you are using exceeds the 15% limit, the system
will not divert the entire volume of fluid in the plasma device. Consider either manually priming the plasma device
with albumin or performing a manual prime divert.

Manually Priming the Plasma Device with Albumin

1 Before you connect the plasma device to the Exchange Set, use gravity to manually prime the plasma device
with albumin.
2 Touch the Data menu button. The data menu tabs appear.
3 Touch the Plasma Device tab. The plasma device screen appears.
4 On the plasma device screen, enter a value of 0.0 mL for the prime divert volume, and select No for a saline
prime.
5 Follow the instructions starting on page 105 to connect the plasma device to the Exchange Set, to prime the
inlet line and the return line, and to connect the patient and start the run. Since you are not priming the
plasma device with saline, be sure to follow the instructions under “Saline prime: No.”
6 After you touch Start Run, ensure that the albumin in the plasma device is flowing into the treated plasma
bag.

Performing a Manual Prime Divert

1 Connect the plasma device to the Exchange Set according to the instructions starting on page 105. If you did
not use the system to prime the plasma device, connect a waste bag to the outlet end of the plasma device.
2 Touch the Data menu button. The data menu tabs appear.
3 Touch the Plasma Device tab. The plasma device screen appears.
4 On the plasma device screen, enter a value of 0.0 mL for the prime divert volume.
5 When the screen appears with the instructions for spiking the second replace line into the treated plasma
bag, perform the following steps:
a. Spike the second replace line into the treated plasma bag.
b. Spike the replace line into a container of albumin. If you used the system to prime the plasma device,
remove the spike from the saline container and spike the line into the albumin container.
c. Unclamp the replace line and use the albumin to prime the line and the drip chamber on the second
replace line.
d. Clamp the second replace line before albumin flows into the treated plasma bag.
e. Clamp the line from the plasma device to the treated plasma bag.
f. Confirm that the line from the plasma device to the waste bag is unclamped.
g. Put the replace line into the replacement fluid detector.
h. Touch Confirm.
6 Follow the instructions starting on page 106 to prime the inlet line and the return line and to connect the
patient and start the run.
7 Once a volume of plasma that equals the volume of the plasma device has been processed, perform the
following steps:

112 Spectra Optia Apheresis System Operator’s Manual

 Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

a. Touch the pause button to pause the pumps. An alarm screen appears.
b. Clamp the line to the waste bag and unclamp the line to the treated plasma bag to allow the system to
begin filling the treated plasma bag.
c. Touch Continue to restart the pumps.
d. Once the system processes an addition 50 mL of plasma, clamp the replace line to the albumin container
and unclamp the second replace line to the treated plasma bag. The system begins returning the treated
plasma to the patient.

Spectra Optia Apheresis System Operator’s Manual 113

Therapeutic Plasma Exchange with a Secondary Plasma Device (TPE-SPD) Procedures

114 Spectra Optia Apheresis System Operator’s Manual

 9
Red Blood Cell Exchange (RBCX)
Procedures

Spectra Optia Apheresis System Operator’s Manual 115

Red Blood Cell Exchange (RBCX) Procedures

RBCX Procedure Types

The Spectra Optia system can be used to perform the following types of red blood cell exchange (RBCX)
procedures:
• Exchange
• Depletion/Exchange
• Depletion
During an exchange procedure, the system removes defective RBC from the patient and replaces them with healthy
donor RBC. During a depletion procedure, the system removes excess or defective RBC from the patient and
replaces them with desired replacement fluid. A depletion/exchange procedure consists of a depletion procedure
followed by an exchange procedure.

Functional Description of a Red Blood Cell Exchange (RBCX)

Procedure
During an RBCX procedure, the system pumps the patient's blood into the tubing set and spins the centrifuge at
the speed required to target the optimal (default) packing factor of 20. The plasma pump pumps the plasma into
the reservoir, while the RBC are passively pushed out of the connector and into the remove bag. The AIM system
monitors the intensity of the light near the top and bottom of the connector to detect any RBC spillover; however,
it does not monitor or control the interface position during an RBCX procedure. The replace pump pumps
replacement fluid into the reservoir where it combines with the plasma for return to the patient.
During an exchange procedure, RBC are removed from the channel until the target fraction of cells remaining
(FCR) or the target for replaced volume has been attained. During a depletion procedure, RBC are removed from
the channel until the target Hct (if performing a depletion procedure) or minimum Hct (if performing a
depletion/exchange procedure) has been attained.
The hematocrit of the blood in the RBC line exiting the centrifuge varies depending on the procedure type, the
run targets, and the hematocrit of the replacement RBC if an exchange procedure is performed.

116 Spectra Optia Apheresis System Operator’s Manual

 Red Blood Cell Exchange (RBCX) Procedures

Preparing to Perform a Procedure

Supplies
Assemble the supplies listed on page 62 before you begin a procedure. You will also need the following additional
supplies:
• Replacement fluid prescribed by the patient’s physician
Optional supplies:
• Filters for the replacement fluid

Selecting the Procedure and Loading the Tubing Set

Follow the instructions starting on page 64 to select the procedure and load the tubing set. Before you load the
tubing set, verify that the set and the solutions you are using have not expired by checking the expiration date
printed on the packaging. Do not use an item if the current date is past the expiration date.

Navigating the RBCX Procedure Screens

Menu Buttons and Tabs

Table 9-1 shows the menu buttons and tabs to use to navigate the screens during an RBCX procedure. Menu
buttons and tabs are active depending on the current operating state. Touch a menu button to display the
corresponding tabs.

Table 9-1: Menu buttons and tabs on RBCX procedure screens

Config Data Run End Run

System Patient data Exchange status Rinseback

Report Fluid Operation status Disconnect

Procedure Alarm history Bolus Run targets

RBCX

Blood warmer
Report Strobe

Run values
9
Options

Descriptions of Buttons, Icons, and Images

See Table 2-14 on page 36 for descriptions of the buttons, icons, and images that can appear on the screen during
an RBCX procedure.

Spectra Optia Apheresis System Operator’s Manual 117

Red Blood Cell Exchange (RBCX) Procedures

Entering and Changing Data During the Run

The Spectra Optia system requires that you enter specific data, such as patient data, to perform an RBCX
procedure. The system also allows you to change numerical values for certain operating parameters during the run.
Table 9-2 shows data entry ranges for the operating parameters, according to the screen on which each data entry
button appears. To change or enter data, touch the button for the parameter that you want to change. A data entry
pad appears to enable you to enter a number. The data entry pad displays either the established range for the
parameter or the calculated range, if the range changes based on related data. Also, the range for Caution status is
displayed in yellow, if the data you enter could cause the system to operate in Caution status.

Table 9-2: Data entry ranges for RBCX procedure parameters

Screen Parameter Range

Patient data Sex • Male
• Female

Height:
• ft • 1 to 8
• in • 0 to 11
• cm • 30 to 244

Weight:
• lb • 5 to 500
• kg • 2 to 227

Hct (%) 10 to 80

TBV (mL) 300 to 15000

Fluid data Exchange type • Exchange

• Depletion/Exchange
• Depletion
Default: Exchange

Depletion: Fluid type • Plasma

• Saline/Albumin
• Custom

Exchange: Fluid Hct (%) 10 to 80

Fluid balance (mL or %) ± 25% of the patient’s TBV

(Caution status applies if the entry
exceeds ± 5% of the patient’s TBV.)

Options Rinseback • Yes

• No
Default: No

Custom prime • Yes

• No
Default: No

Saline rinse • Yes

• No
Default: No

118 Spectra Optia Apheresis System Operator’s Manual

 Red Blood Cell Exchange (RBCX) Procedures

Table 9-2: Data entry ranges for RBCX procedure parameters (continued)

Screen Parameter Range

Blood warmer • Yes
• Return line • No
• Replace line

Blood warmer: Tubing set volume (mL) 1 to 100

Custom prime Fluid type • RBC

• Plasma
• Albumin

RBC unit Hct (%) 25 to 80

Inlet flow rate (mL/min) 5 to 120

Volume (mL) 100 to 400

Run values AC infusion rate (mL/min/L TBV) 0.2 to 2.5

(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if the entered ratio
is not within the recommended range
of 6:1 to 15:1.)

FCR (%) 1 to 99
• Starting defective RBC (%) • 10 to 100
• Target defective RBC (%) • 1 to 99 (Depends on the starting
defective RBC entered.)

Minimum Hct (%) 20 to current patient Hct

(Maximum Hct could be lower than
the current patient Hct if the patient
has a low TBV.)

Target Hct (%) 20 to 60 or current patient Hct

(Maximum Hct could be lower than

9
the current patient Hct if patient has
a low TBV.)

Replaced (mL): Exchange 10 to 10000

Inlet flow rate (mL/min) 5 to 142

Main run Inlet flow rate (mL/min) 5 to 142

Replace volume (mL) 10 to 10000

AC infusion rate (mL/min/L TBV) 0.2 to 2.5

(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if the entered ratio
is not within the recommended range
of 6:1 to 15:1.)

Exchange status Current patient Hct (%) 10 to 80

Spectra Optia Apheresis System Operator’s Manual 119

Red Blood Cell Exchange (RBCX) Procedures

Table 9-2: Data entry ranges for RBCX procedure parameters (continued)

Screen Parameter Range

Bolus Volume (mL) 10 to a volume that equals +25% of
the patient’s TBV

Flow rate (mL/min) 10 to 120

Run targets Target Hct (%) 20 to 60 or current patient Hct

(Maximum Hct could be lower than
the current patient Hct if the patient
has a low TBV.)

FCR (%) 1 to 99

Replaced (mL): Exchange 10 to 10000

Rinseback Return flow rate (mL/min) 2 to 100

Default: inlet flow rate that was in
use when the run ended or
100 mL/min, whichever is slower

120 Spectra Optia Apheresis System Operator’s Manual

 Red Blood Cell Exchange (RBCX) Procedures

Entering and Confirming Patient and Procedure Data

This section contains instructions for entering patient data, entering fluid data, and reviewing and confirming run
values. You can enter the data after you select the procedure and before you connect the patient. It is important that
the data you enter be as accurate and as current as possible.
Note: When you are required to enter numerical data, the system displays a data entry pad for entering the data. The
acceptable numerical range appears on the data entry pad.

Entering Patient Data

1 Touch the buttons on the screen to enter the following information:
• Sex
• Height
• Weight
• Hematocrit (Hct)
The Spectra Optia system uses the sex, height, and weight to calculate the patient’s TBV. See page 266 for the
formula the system uses to calculate this value. If you prefer not to use the TBV that the system calculated,
touch TBV and enter a different volume. The operator override icon ( ) will appear on the button.

Note: If the patient weighs less than 25 kg (approximately 55 lb), the system does not calculate a TBV. You
must calculate and enter the appropriate TBV for the patient.

2 Touch Confirm. The fluid data screen appears.

Selecting the Exchange Type and Entering the Fluid Data

The fluid data buttons are active or inactive according to the exchange type you select. Perform the steps below to
select the exchange type, to enter the replacement fluid data, and to enter the fluid balance desired for the patient at
the end of the procedure.

Selecting the exchange type

The default exchange type is Exchange and appears on the button for the exchange type when the screen appears.
To select a different exchange type, perform the following steps:
9
1 Touch Exchange. The following list of exchange types appears:
• Exchange
• Depletion/Exchange
• Depletion
2 Select the exchange type by touching the corresponding button on the screen.

Spectra Optia Apheresis System Operator’s Manual 121

Red Blood Cell Exchange (RBCX) Procedures

Entering the replacement fluid data

Depletion:
1 Touch Fluid Type. A list of replacement fluid types appears.
2 Select one of the following replacement fluid types by touching the corresponding button on the screen:
• Plasma
– The system assumes that the plasma contains 15% citrate.
• Saline/Albumin
– The system assumes that the saline/albumin contains 4% citrate.
• Custom
– The system uses the citrate content entered on the RBCX configuration screen. A data entry pad
appears to allow you to change the citrate content (%) of the fluid for the current procedure only.
Exchange:
1 Touch Fluid Hct. The data entry pad appears.
2 Enter the average Hct (%) of the replacement fluid for the exchange.
• The system assumes that the portion of the replacement fluid that is not RBC contains 19% citrate.

Note: The system uses data you enter, including the Hct of the replacement fluid, to determine when the target
Hct has been attained. It is important that you enter an accurate Hct for the replacement fluid.

Entering the fluid balance

Note: The fluid balance includes fluid that was administered and removed during the run and rinseback but does not
include fluid bolus volume.

1 To enter the fluid balance, choose one of the following options:

• To enter the fluid balance in mL, touch Volume and use the data entry pad to enter a negative or positive
volume. The system calculates and displays the corresponding percentage.
• To enter the fluid balance as a percentage, touch Percent and use the data entry pad to enter a percentage.
The system calculates and displays the corresponding volume.
2 Touch Confirm to save the fluid data. The run values screen appears.

122 Spectra Optia Apheresis System Operator’s Manual

 Red Blood Cell Exchange (RBCX) Procedures

Entering and Confirming Run Values

Enter the run targets listed below, according to the type of RBCX procedure you selected. Table 9-3 contains
descriptions of the run targets that appear on the run values screens. Then review the run values and make any
changes necessary to achieve your run targets. A black frame appears around the button of the primary run target.

Exchange procedures
• Target Hct (%)
• One of the following targets:
• Replaced: Exchange (mL)
• FCR (%)

Depletion/Exchange procedures
• Minimum Hct (%)
• Target Hct (%)
• One of the following targets:
• Replaced: Exchange (mL)
• FCR (%)

Depletion procedures
• Target Hct (%)

Table 9-3: Descriptions of run targets for RBCX procedures

Run Target Description

FCR (%) Fraction of cells remaining. Target percentage of starting defective RBC that will remain in
the patient’s blood at the end of the procedure. (Target defective RBC (%)/starting
defective RBC (%) = FCR.)
After you enter an FCR for an exchange procedure, the system calculates and displays the
volume of replacement fluid that is required to complete the procedure.

Note: You may enter the starting and target defective RBC instead of the FCR, and the
system will calculate and display the FCR. To do this, touch the button for FCR on the screen
and then touch FCR on the data entry pad. The blood drop icon (  ) appears on the data
9
entry pad to allow you to enter the values for defective RBC.

• Starting defective RBC (%) Percentage of defective RBC in the patient’s blood at the start of the procedure

• Target defective RBC (%) Percentage of defective RBC in the patient’s blood at the end of the procedure

Minimum Hct (%) Lowest patient Hct during the procedure

Target Hct (%) Desired patient Hct at the end of the procedure

Replaced (mL): Exchange Volume of replacement fluid that is required to complete the exchange procedure. If you
enter a volume here, the system calculates and displays the FCR.

Spectra Optia Apheresis System Operator’s Manual 123

Red Blood Cell Exchange (RBCX) Procedures

Perform the following steps to enter and confirm the run targets and run values:
1 Touch the button on the screen that corresponds to the target value you want to enter. The data entry pad
appears.
2 Enter the target value.
3 Review the run values that appear on the screen and confirm that they are correct. A black frame appears
around the button of the primary run target.

Note: During depletion/exchange procedures, the system displays the run time for the depletion in parentheses
above the total run time for the depletion/exchange.

If you change a value, the color of the value on the button changes from white to yellow. Values that were
affected by a change appear with a yellow arrow. The arrow points up or down to indicate an increase or
decrease in the value as a result of the change.

Note: Only the color of the last value you changed remains yellow. The values you previously changed revert to
white.

4 When you are finished entering and confirming the run targets and the run values, touch Confirm.

124 Spectra Optia Apheresis System Operator’s Manual

 Red Blood Cell Exchange (RBCX) Procedures

Priming the Inlet Line, the Return Line, and the Replace Line
Warning: When connecting a blood warmer tubing set to the return line, ensure that the tubing connection is
tight. Put the luer connection no higher than 20 in (50 cm) above the return access to prevent the possibility of air
entering the tubing.

Warning: If you are using a blood warmer on the return line, ensure that you completely prime the blood warmer
tubing set to remove all the air in the set before you connect the patient.

1 Follow the instructions on the screen to prime the inlet line and the return line. If you are using a blood
warmer on the replace line, follow the instructions under “Exchange Procedures: Using a Blood Warmer on
the Replace Line” on page 267 to connect and prime the blood warmer tubing set and to prime the replace
line. If you are not using a blood warmer or you are using a blood warmer on the return line, follow the
instructions on the screen.
2 Touch Confirm.
3 Follow the instructions on the screen to spike the replacement fluid container, to prime the replace line, and
to put the replace line into the replacement fluid detector.
4 Touch Continue. The screen appears with instructions for connecting the patient.

Connecting the Patient and Starting the Run

Warning: Before connecting the patient, check the inlet and return lines for air. If air is present in the lines,
remove the air before connecting the patient.

1 Follow the instructions on the screen to connect the patient and start the run.
2 Touch Start Run. The system begins drawing the patient’s blood into the tubing set. The main run screen
appears, and the system diverts approximately 40 mL of saline that was used to prime the tubing set into the
remove bag.

Note: If you performed a custom prime, the system does not perform the step to divert the saline. The saline was
removed from the set during the custom prime.

Spectra Optia Apheresis System Operator’s Manual 125

Red Blood Cell Exchange (RBCX) Procedures

Monitoring the Run

The system displays information on the screens to help you monitor the progress of the run. To access the screens,
touch the Run menu button and then the tab for the screen you want to view. Be sure to verify that the volumes
displayed on the screens are consistent with the actual volumes in the fluid containers and in the bags.
See “Glossary of Terms” on page 278 for descriptions of the buttons on the screens.

Main Run Screen

The main run screen is the default run screen and displays or provides access to the information you most likely
need to monitor the run. If you want to return to the main run screen after viewing a different screen, touch the go
back button, the active menu button, or the tab for the current screen. There is no tab for the main run screen.

Exchange Status Screen

To access the exchange status screen, touch the Exchange Status tab. Use this screen to view information about
the current status of the run, including the patient’s fluid balance, the fluids administered, the patient Hct, and the
volumes exchanged and replaced during the run.
If you are performing a depletion/exchange procedure, a yellow tick mark appears on the run time graph to
indicate when the depletion procedure will end and the exchange procedure will begin.

Replacement fluid
The type of replacement fluid currently in use appears on the button on this screen. Touch this button to change
the type of replacement fluid and then follow the instructions on the screens.

Patient Hct
The system uses the patient Hct and the replacement fluid Hct that was entered before the start of the run to
predict the current patient Hct displayed on the screen. The system does not take into account RBC that were
released from the spleen when predicting this value.

126 Spectra Optia Apheresis System Operator’s Manual

 Red Blood Cell Exchange (RBCX) Procedures

Monitoring the Patient

Managing Citrate Toxicity

If the patient experiences citrate toxicity, perform the following steps:
1 Touch the pause button to pause the pumps. An alarm occurs indicating that the procedure was paused and
the pumps were stopped.
2 Notify the attending physician of the patient’s condition according to your facility’s standard operating
procedures.
3 Touch the go back button to go to the run values screen, and decrease the AC infusion rate as desired.
4 Touch the active alarm button to return to the alarm screen, and then touch Continue. The run values
screen appears.
5 Review the run values and confirm that they are correct.
6 Touch Confirm to resume the procedure.
7 If decreasing the AC infusion rate does not alleviate the symptoms, touch the pause button to pause the
pumps again, and notify the attending physician.

Giving a Fluid Bolus

Perform the following steps to give the patient a fluid bolus:
1 Touch the Run menu button. The run tabs appear.
2 Touch the Bolus tab. The fluid bolus screen appears.
3 Follow the instructions on the screen to spike the saline container on the replace line. Confirm that the
replace line is not clamped.
4 Touch Volume and enter the volume (mL) of the bolus.
5 Touch Flow Rate and enter the flow rate (mL/min) for the bolus.

Note: If the fluid you use for the bolus is not saline, enter a flow rate that takes into account the percentage of
citrate in the fluid and that is in accordance with your local transfusion practices.

6 To begin the bolus, touch Start Bolus. The system delivers the bolus.
9
The screen displays the progress of the bolus. To cancel the bolus before delivery is complete, touch Cancel
Bolus.

7 When the bolus is complete, the system pauses. Touch Continue to resume the procedure.

Bolus volume and reported fluid balance

Be aware that the patient’s fluid balance displayed on the exchange status screen and on the procedure summary
screen does not include the volume of any bolus that was given to the patient during the procedure. The system
reports the total bolus volume in separate fields on the screens.

Spectra Optia Apheresis System Operator’s Manual 127

Red Blood Cell Exchange (RBCX) Procedures

Optimizing the Run

Impact of Patient Data and Procedure Data on the Procedure Outcome

It is essential to enter accurate data when performing an RBCX procedure. Small errors in the data entered can
result in large deviations in the expected outcome. The following patient data and procedure data can affect the
procedure outcome:
• Patient Hct
• Patient TBV
• Percentage of starting defective RBC
• Replacement fluid Hct
• Replacement fluid volume
• Patient fluid balance
If the patient’s laboratory values are not within the expected range after the procedure is completed, review the data
that was entered and verify that it was accurate. To review the data on the report screen, perform the following
steps:
1 Touch the Data menu button. The data tabs appear.
2 Touch the Report tab. The screen appears with a list of reports. The reports are identified by the procedure
date, start time, procedure type, and the patient’s TBV. The report for a procedure that was just completed is
labeled Current.
3 Touch the button that corresponds to the report you want to view. The report appears on the screen. For
instructions on printing a copy of the report, see “Printing Procedure Data Reports” on page 274.

Updating the Entered Patient Hct

Updating the entered hematocrit could be necessary under the following circumstances:
• The patient’s condition indicates a need to draw a blood sample and compare the laboratory value to what was
entered before the run was started.
• The AIM system detects that the RBC interface is too close to the top of the channel, and an alarm occurs.
If you need to update the entered Hct during the run, perform the following steps:
1 If the pumps are not paused, touch the pause button to pause the pumps. An alarm occurs because the
procedure was paused.
2 Measure the patient’s Hct according to your standard operating procedures.
3 Touch the Run menu button. The run tabs appear.
4 Touch the Exchange Status tab. The exchange status screen appears.
5 Touch the button for the patient Hct. The data entry pad appears.

128 Spectra Optia Apheresis System Operator’s Manual

 Red Blood Cell Exchange (RBCX) Procedures

6 Enter the current patient Hct. A screen appears to confirm the change to the Hct.
7 Follow the instructions on the screen to verify and confirm the change. The run values screen appears.
8 Review the run values.
9 Touch Confirm.
10 Return to the alarm screen and touch Continue to restart the pumps and resume the procedure.

Spectra Optia Apheresis System Operator’s Manual 129

Red Blood Cell Exchange (RBCX) Procedures

130 Spectra Optia Apheresis System Operator’s Manual

 10
Mononuclear Cell (MNC) Collection
Procedures

Spectra Optia Apheresis System Operator’s Manual 131

Mononuclear Cell (MNC) Collection Procedures

Functional Description of a Mononuclear Cell (MNC) Collection

Procedure
The Spectra Optia system cycles through a number of accumulation and collection phases during an MNC
collection procedure. The number of phases depends on the patient’s WBC count and the goals of the procedure.

Accumulation phase
During the accumulation phase, the system pumps the patient’s blood into the tubing set and spins the centrifuge
at the speed required to target the optimal (default) packing factor of 20. The AIM system adjusts the plasma pump
flow rate to control the concentration of cells that flow through the collect port (based on the collection
preference), and the collect pump pumps the MNC and platelets from the connector into the chamber. The
chamber fills with MNC and the platelets flow through the chamber and are returned to the patient.
The plasma pump also pumps plasma out of the channel and either into the reservoir, or into the plasma bag or the
collection bag if plasma collection is targeted. The red blood cells (RBC) are pushed out of the channel and into the
reservoir, where they combine with the plasma for return to the patient.

Collection phase
A collection phase occurs at the beginning of the second and all subsequent accumulation phases. The collection
phase begins once the system predicts that the chamber is at least 50% full of MNC, and the RBC detector detects
RBC in the collect line. When the phase begins, the system stops the plasma pump to lower the interface, stops the
collect pump, and decreases the centrifuge speed. It then restarts the collect pump and moves the collect valve into
the collect position. The collect pump pumps plasma through the chamber to flush the chamber contents into the
collection bag.
After the system flushes the chamber, it stops the collect pump and increases the centrifuge speed. It then restarts
the plasma pump and the collect pump to start the chase. During the chase, the system displaces the cells remaining
in the collect line between the chamber and the collect valve into the collection bag before it moves the collect valve
into the return position to end the collection phase.

Preparing to Perform a Procedure

Supplies
Assemble the supplies listed on page 62 before you begin a procedure.

Selecting the Procedure and Loading the Tubing Set

Follow the instructions starting on page 64 to select the procedure and load the tubing set. Before you load the
tubing set, verify that the set and the solutions you are using have not expired by checking the expiration date
printed on the packaging. Do not use an item if the current date is past the expiration date.

132 Spectra Optia Apheresis System Operator’s Manual

 Mononuclear Cell (MNC) Collection Procedures

Navigating the MNC Collection Procedure Screens

Menu Buttons and Tabs

Table 10-1 shows the menu buttons and tabs to use to navigate the screens during an MNC collection procedure.
Menu buttons and tabs are active depending on the current operating state. Touch a menu button to display the
corresponding tabs.

Table 10-1: Menu buttons and tabs on MNC collection procedure screens

Config Data Run End Run

System Patient data Fluid balance Rinseback

Procedure Alarm history Operation status Disconnect

Report Report Collection status Run targets

MNC Strobe Plasma

Blood warmer Run values

AC Options

Advanced control

Descriptions of Buttons, Icons, and Images

See Table 2-14 on page 36 for descriptions of the buttons, icons, and images that can appear on the screen during
an MNC collection procedure.

10

Spectra Optia Apheresis System Operator’s Manual 133

Mononuclear Cell (MNC) Collection Procedures

Entering and Changing Data During the Run

The Spectra Optia system requires that you enter specific data, such as patient data, to perform an MNC collection
procedure. The system also allows you to change numerical values for certain operating parameters during the run.
Table 10-2 shows data entry ranges for the operating parameters according to the screen on which the data entry
button appears. To change or enter data, touch the button for the parameter that you want to change. A data entry
pad appears to enable you to enter a number. The data entry pad displays either the established range for the
parameter or the calculated range, if the range changes based on related data. Also, the range for Caution status is
displayed in yellow, if the data you enter could cause the system to operate in Caution status.

Table 10-2: Data entry ranges for MNC collection procedure parameters

Screen Parameter Range

Patient data Sex • Male
• Female

Height
• ft • 1 to 8
• in • 0 to 11
• cm • 30 to 244

Weight
• lb • 5 to 500
• kg • 2 to 227

TBV (mL) 300 to 15000

Hct (%) 10 to 70

WBC (E3/µL) 1 to 200

Plt (E3/µL) 10 to 500

Options Rinseback • Yes

• No
Default:
• Yes if a custom prime is not
selected
• No if a custom prime is selected

Custom prime • Yes

• No
Default: No

Saline rinse • Yes

• No
Default: No

Blood warmer: Return line • Yes

• No

Blood warmer: Tubing set volume (mL) 1 to 100

Custom prime Fluid type • RBC

• Plasma
• Albumin

RBC unit Hct (%) 25 to 80

134 Spectra Optia Apheresis System Operator’s Manual

 Mononuclear Cell (MNC) Collection Procedures

Table 10-2: Data entry ranges for MNC collection procedure parameters (continued)

Screen Parameter Range

Inlet flow rate (mL/min) 5 to 120

Volume (mL) 100 to 400

(Volume should be at least 200 mL
for the patient to receive the full
benefit.)

Run values AC infusion rate (mL/min/L TBV) 0.2 to 2.5.

(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if the entered ratio
is not within the recommended range
of 6:1 to 15:1.)

Whole blood processed (mL) Patient’s TBV multiplied by 1 to 10

Run time (min) 40 to 480

TBV processed 1 to 10

Inlet flow rate (mL/min) 10 to 125

Plasma volume: Target (mL): Depends on the volume of plasma

collected into the collection bag.
(Total volume of plasma collected
cannot exceed 100% of the patient’s
total plasma volume, and cannot
cause the target or actual fluid
balance to be less than 75% of the
patient’s TBV.)

Collect flow rate (mL/min) 0.5 to 10

(Flow rate can be changed only when
the system is operating in
Semi-Automatic mode.)

Collect volume: Target (mL) Depends on the total volume of

• Volume (mL) plasma that was collected.
• Number of collection phases ( ) (Sum of the total plasma volume and
the collect volume cannot exceed
100% of the patient’s total plasma
volume, and the collect volume must
be less than or equal to the volume
of 50 collection phases.
10
Plasma volume in collection bag: Target (mL) Depends on the volume of plasma to
be collected into the plasma bag.
(Total volume of plasma collected
cannot exceed 100% of the patient’s
total plasma volume, and cannot
cause the target or actual fluid
balance to be less than 75% of the
patient’s TBV.)

Spectra Optia Apheresis System Operator’s Manual 135

Mononuclear Cell (MNC) Collection Procedures

Table 10-2: Data entry ranges for MNC collection procedure parameters (continued)

Screen Parameter Range

Main run Inlet flow rate (mL/min) 10 to 125

Collect flow rate (mL/min) 0.5 to 10

(Flow rate can be changed only when
operating in Semi-Automatic mode.)

AC infusion rate (mL/min/L TBV) 0.2 to 2.5

(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if the entered ratio
is not within the recommended range
of 6:1 to 15:1.)

Collection status Collection preference 20 to 80

Default: Depends on the patient’s
WBC and platelet counts that were
entered

Advanced control Control

• System (Default) • N/A
• Inlet volume (mL) • 250 to 5000. Default: 1000
• Operator • N/A
• RBC Detector • N/A

Chamber flush (mL) 6 to 100

Chamber chase (mL) 0 to 100

Run targets Plasma bag (mL): Target Depends on the volume of plasma to
be collected into the collection bag.
(Total volume of plasma collected
cannot exceed 100% of the patient’s
total plasma volume, and cannot
cause the target or actual fluid
balance to be less than 75% of the
patient’s TBV.)

Run time (min) 40 to 480

Whole blood processed (mL) Patient’s TBV multiplied by 1 to 10

TBV processed 1 to 10

Collection bag: Plasma (mL) Depends on the volume of plasma to

be collected into the plasma bag.
(Total volume of plasma collected
cannot exceed 100% of the patient’s
total plasma volume, and cannot
cause the target or actual fluid
balance to be less than 75% of the
patient’s TBV.)

136 Spectra Optia Apheresis System Operator’s Manual

 Mononuclear Cell (MNC) Collection Procedures

Table 10-2: Data entry ranges for MNC collection procedure parameters (continued)

Screen Parameter Range

Collection bag: Collect Depends on the total volume of
• Volume (mL) plasma to be collected.
• Number of collection phases ( ) (Sum of the total plasma volume and
the collect volume cannot exceed
100% of the patient’s total plasma
volume, and the collect volume must
be less than or equal to the volume
of 50 collection phases.

Rinseback Return flow rate (mL/min) 2 to 100

Default: inlet flow rate that was in
use when the run ended or
100 mL/min, whichever is slower

10

Spectra Optia Apheresis System Operator’s Manual 137

Mononuclear Cell (MNC) Collection Procedures

Entering and Confirming Patient and Procedure Data

This section contains instructions for entering patient data, and reviewing and confirming run values. You can
enter the data after you select the procedure and before you connect the patient. It is important that the data you
enter be as accurate and as current as possible.

Note: When you are required to enter numerical data, the system displays a data entry pad for entering the data. The
acceptable numerical range appears on the data entry pad.

Entering Patient Data

1 Touch the buttons on the screen to enter the following information:
• Sex
• Height
• Weight
• Hematocrit (Hct)
• White blood cell (WBC) count
• Platelet count
The Spectra Optia system uses the sex, height, and weight to calculate the patient’s TBV. See page 266 for the
formula the system uses to calculate this value. If you prefer not to use the TBV that the system calculated,
touch TBV and enter a different volume. The operator override icon ( ) will appear on the button.

Note: If the patient weighs less than 25 kg (approximately 55 lb), the system does not calculate a TBV. You
must calculate and enter the appropriate TBV for the patient.

2 Touch Confirm. The run values screen appears.

Reviewing and Confirming Run Values

1 Review the run values that appear on the screen and confirm that they are correct. The run targets for an
MNC collection procedure are listed below. A black frame appears around the button of the primary run
target.
• Whole blood processed (mL)
• TBV processed
• Run time (min)
• Collect volume: Target (mL)
The configured volumes for plasma collection into the plasma bag and plasma collection into the collection
bag appear on the buttons. The system attempts to collect the plasma during the early part of the run. It
collects the plasma volume into the plasma bag before it collects the plasma volume into the collection bag.

138 Spectra Optia Apheresis System Operator’s Manual

 Mononuclear Cell (MNC) Collection Procedures

If you change a value, the color of the value on the button changes from white to yellow. Values that were
affected by a change appear with a yellow arrow. The arrow points up or down to indicate an increase or
decrease in the value as a result of the change.

Note: Only the color of the last value you changed remains yellow. The values you previously changed revert to
white.

2 When you are finished reviewing the run values, touch Confirm.

Priming the Inlet Line and the Return Line

Warning: When connecting a blood warmer tubing set to the return line, ensure that the tubing connection is
tight. Put the luer connection no higher than 20 in (50 cm) above the return access to prevent the possibility of air
entering the tubing.

Warning: If you are using a blood warmer on the return line, ensure that you completely prime the blood warmer
tubing set to remove all the air in the set before you connect the patient.

1 Follow the instructions on the screen to prime the inlet line and the return line. If you are using a blood
warmer on the return line, follow the instructions on the screen to connect and prime the blood warmer
tubing set.
2 Touch Confirm. The screen appears with instructions for connecting the patient and starting the run.

Connecting the Patient and Starting the Run

Warning: Before connecting the patient, check the inlet and return lines for air. If air is present in the lines,
remove the air before connecting the patient.

1 Follow the instructions below and on the screen to connect the patient.
• If you are performing a peripheral venipuncture, see “Collection Set and IDL Set: Additional Instructions
for Use” on page 269 for instructions on using the needle protector.
• If you are performing a peripheral venipuncture and want to use the diversion bag on the inlet line, see
“Using the Diversion Bag to Collect a Sample From a Venipuncture” on page 269 for instructions.
2 Touch Start Run. The system begins drawing the patient’s blood into the tubing set. The main run screen
appears, and the system diverts approximately 40 mL of saline that was used to prime the tubing set into the
saline container.
10
Note: If you performed a custom prime, the system does not perform the step to divert the saline. The saline was
removed from the set during the custom prime.

Spectra Optia Apheresis System Operator’s Manual 139

Mononuclear Cell (MNC) Collection Procedures

Monitoring the Run

The system displays information on the screens to help you monitor the progress of the run. To access the screens,
touch the Run menu button and then the tab for the screen you want to view. Be sure to verify that the volumes
displayed on the screens are consistent with the actual volumes in the fluid containers and in the bags.
See “Glossary of Terms” on page 278 for descriptions of buttons that appear on the screens.

Main Run Screen

The main run screen is the default run screen and displays or provides access to the information you most likely
need to monitor the run. If you want to return to the main run screen after viewing a different screen, touch the go
back button, the active menu button, or the tab for the current screen. There is no tab for the main run screen.

Collection Status Screen

To access the collection status screen, touch the Collection Status tab. Use this screen to monitor the progress of
the accumulation phase and to adjust the collection preference, if necessary. You can also find information about
the current and previous collection and accumulation phases on this screen.

Collection preference
The collection preference is a reference number that the AIM system uses to determine the concentration of cells
that should flow through the collect port. The collection preference can affect the type of cells that fill the chamber
and how quickly the chamber fills.

AIM system and the concentration of cells flowing through the collect port
The AIM system cannot identify the type of cells that flow through the collect port; it can only control the
concentration of cells. It determines the concentration by evaluating how much light penetrates the contents in the
collect port as follows:
• High collection preference: More light can penetrate the contents. The concentration is low and the color in
the collect port looks light.
• Low collection preference: Less light can penetrate the contents. The concentration is high and the color in
the collect port looks dark.
The system then uses this information to adjust the plasma pump flow rate and achieve the specified collection
preference.

Collection preference and cell counts

The system uses the WBC count and the platelet count that you entered on the patient data screen to calculate the
collection preference for the run as follows:
• The higher the cell counts, the lower the collection preference.
• The lower the cell counts, the higher the collection preference
For information about optimizing the collection preference during the run, see “Optimizing the Collection
Preference” on page 144.

Trend graph
The trend graph shows the status of the current accumulation phase. It represents an area of the buffy coat that is in
the connector. The horizontal black line on the graph indicates the current collection preference. The green
diamonds indicate the concentration of cells flowing into the chamber as compared to the collection preference.

140 Spectra Optia Apheresis System Operator’s Manual

 Mononuclear Cell (MNC) Collection Procedures

If the system is unable to collect cells at the target collection preference, the green diamonds could appear above or
below the black line. As long as the diamonds appear in a controlled path within 20 units either above or below the
line, the run is progressing as intended.

Graph of inlet volume processed

The graph in the bottom right corner of the screen shows the inlet volume (mL) processed for the current and
previous six accumulation phases. The inlet volume processed icon ( ) appears to the left of the graph as an
indication. The row of numbers below the graph indicates the length of time in minutes of each accumulation
phase.
There are two rows of numbers above the graph:
• The top row displays the volume that was processed when the RBC detector detected cells in the collect line.
The RBC detected icon ( ) appears to the right of the row as an indication.
• The bottom row displays the volume that was processed before a collection phase was initiated.

10

Spectra Optia Apheresis System Operator’s Manual 141

Mononuclear Cell (MNC) Collection Procedures

Advanced Control Screen

To access the advanced control screen, touch the Advanced Control tab. Use this screen to make adjustments to the
run.

Flush chamber
To immediately change the position of the collect valve and flush the chamber, perform one of the following steps:
• To return the contents of the chamber to the patient, touch the button for return to patient and then touch
Apply. The collect pump pumps a volume of plasma equal to 1.5 multiplied by the flush volume through the
chamber to flush the contents of the chamber to the patient. If you return the contents of the chamber to the
patient, the system does not display the inlet volume that was processed before you initiated the return on the
graph on the collection status screen.
• To initiate a collection phase and flush the contents of the chamber into the collection bag, touch the button
for collect into bag and then touch Apply.

Clumping in connector
To address clumping in the connector, touch Decrease Inlet:AC Ratio. The system decreases the inlet:AC ratio to
8:1. After 100 mL of inlet volume has been processed, a screen appears with instructions for ensuring that the
clumping is resolved and for resuming the procedure. For additional information about anticoagulation in the
tubing set, see “Managing Anticoagulation of the Extracorporeal Circuit” on page 221.

Collection phase control

The collection phase control allows you to specify how collection phases are initiated. The selected control also
appears on the collection status screen. The following collection phase controls are available:
• System (default control): The system initiates a collection phase when the RBC detector detects RBC in the
collect line and the system predicts that the chamber is at least 50% full of target cells. The system uses an
algorithm to predict the number of target cells in the chamber.
• Inlet: The system initiates a collection phase after a specified inlet volume (mL) has been processed. When
you select this control, a data entry pad appears for you to enter the desired volume to be processed. The
volume that you enter appears on the button. When the Inlet control is selected, the test tube icon ( )
appears on the graph of the inlet volume processed on the collection status screen.
• Operator: This control allows the operator to initiate a collection phase when desired. To initiate a collection
phase, you must go to the advanced control screen and touch the collect into bag button. The system enters
Caution status when this control is selected. When the Operator control is selected, the operator override
icon ( ) appears on the graph of the inlet volume processed on the collection status screen.
• RBC Detector: The system initiates a collection phase when the RBC detector detects RBC in the collect line
and the system predicts that the chamber is at least 25% full of target cells. The system uses an algorithm to
predict the number of target cells in the chamber.

Chamber
The configured volumes for the chamber flush and the chamber chase appear on the buttons. You can adjust the
volumes at any time during the run. Any changes to the volumes take immediate effect and apply to the current
procedure only.

142 Spectra Optia Apheresis System Operator’s Manual

 Mononuclear Cell (MNC) Collection Procedures

Monitoring the Patient

Managing Citrate Toxicity

If the patient experiences citrate toxicity, perform the following steps:
1 Touch the pause button to pause the pumps. An alarm occurs indicating that the procedure was paused and
the pumps were stopped.
2 Notify the attending physician of the patient’s condition according to your facility’s standard operating
procedures.
3 Touch the go back button and go to the run values screen and decrease the AC infusion rate as desired.
4 Touch the active alarm button to return to the alarm screen, and then touch Continue. The run values
screen appears.
5 Review the run values and confirm that they are correct.
6 Touch Confirm to resume the procedure.
7 If decreasing the AC infusion rate does not alleviate the symptoms, touch the pause button to pause the
pumps again, and notify the attending physician.

10

Spectra Optia Apheresis System Operator’s Manual 143

Mononuclear Cell (MNC) Collection Procedures

Optimizing the Run

Optimizing the Collection Preference

The collection preference controls the concentration of cells that flow through the collect port. The system uses the
WBC count and the platelet count that you entered on the patient data screen to calculate the collection
preference. You can use the up and down arrows on the screen to increase or decrease the collection preference
during the run to accommodate the patient’s condition and to achieve your procedure goals. Consider the
following guidelines when adjusting the collection preference, keeping in mind that the patient’s WBC and platelet
counts affect the contents of the collection:
• Use a low collection preference to increase the concentration of cells in the collect port. The system adjusts the
plasma pump flow rate so that it collects more deeply in the buffy coat. This maximizes the yield of target cells
but could increase RBC contamination of the collected product.
• Use a high collection preference to decrease the concentration of cells in the collect port. The system adjusts
the plasma pump flow rate so that it collects more shallowly in the buffy coat. This helps to minimize RBC
contamination of the collected product but could result in a lower yield of target cells.

Minimizing Buffy Coat Accumulation

A buffy coat can accumulate in the connector for several reasons. To minimize accumulation of a buffy coat,
consider performing the following steps:
• Avoid pausing the pumps and conditions that cause the pumps to pause, such as alarm conditions. After the
pumps restart, it takes time for the collect pump to reach the target flow rate, which slows the collection of
cells from the connector.
• Decrease the collection preference. The interface might not be high enough to allow the system to collect the
buffy coat.
• Decrease the inlet pump flow rate until the buffy coat stops accumulating. If the inlet pump flow rate is too
fast, cells enter the channel faster than the collect pump can remove them, causing the accumulation. The
maximum flow rate for the collect pump during the accumulation phase is 3 mL/min.
• Confirm that the platelet count that was entered on the patient data screen is correct. If decreasing the
collection preference and the inlet pump flow rate did not reduce the accumulation and the collect pump flow
rate is less than 3 mL/min, increase the entered platelet count by 50. Do this only if you considered all other
options and you were still unable to reduce the buffy coat.

Decreasing the Run Time

Consider the following alternatives to decrease the predicted run time if a shorter run is necessary:
• Avoid pausing the pumps and conditions that cause the pumps to pause, such as alarm conditions. After the
pumps restart, it takes time for the pumps to reach the target flow rates again, which adds time to the run.
• Increase the inlet pump flow rate, or increase the AC infusion rate. Increasing these rates allows the system to
process more blood in less time. Be aware that either option results in faster delivery of AC to the patient,
which increases the potential for the patient to experience a citrate reaction.

144 Spectra Optia Apheresis System Operator’s Manual

 Mononuclear Cell (MNC) Collection Procedures

• Increase the inlet:AC ratio. This causes the inlet pump flow rate to increase. However, it decreases the system’s
ability to manage anticoagulation of the extracorporeal circuit and can result in clumping in the circuit.
Monitor the run carefully as you increase the inlet:AC ratio.
• Decrease the target run time. Make the run time the run target by entering the desired time on the run values
or run targets screen. This ensures that the run ends when required.

Transferring Plasma from the Plasma Bag into the Collection Bag
Caution: When transferring plasma from the plasma bag to the collection bag during an MNC collection procedure, you
must put the collection bag lower than the plasma bag as indicated in the instructions on the screen. Otherwise, cells in the
collection bag can flow into the plasma bag.

The system allows you to transfer plasma from the plasma bag into the collection bag during the run except during
a collection phase. To transfer plasma during the run, perform the following steps:
1 Touch the End Run menu button. The end run tabs appear.
2 Touch the Plasma tab.
3 Follow the instructions on the screen to put the collection bag lower than the plasma bag.
4 Touch Start Transfer. The plasma valve moves into the neutral position and the RBC valve moves into the
collect position.
5 Allow the plasma to flow from the plasma bag into the collection bag.
6 When the transfer is complete, touch Resume Run, or if the run targets have been attained and you want to
end the run, touch End Transfer. The plasma and RBC valves move back to the return position. The not
equal icon ( ) appears next to the plasma bag volume and the collection bag volume on the screens
indicating that the current volumes may be different from the displayed volumes.

Note: If you obtained a product sample before you transferred plasma into the collection bag, consider taking a new
sample. The additional volume you added to the collection bag could affect the cell concentration.

Transferring plasma when a collection phase is ready to start

If the chamber is full and a collection phase is ready to start, the system pauses the pumps and delays the collection
phase. To complete the transfer, follow the instructions under “Transferring Plasma from the Plasma Bag into the
Collection Bag” above, beginning with step 4. To cancel the transfer and allow the collection phase to occur, touch
the go back button.

10

Spectra Optia Apheresis System Operator’s Manual 145

Mononuclear Cell (MNC) Collection Procedures

Handling the Contents of a Partially Full Chamber

This section contains instructions for collecting or recovering the contents of a partially full chamber.

Resuming the Current Accumulation Phase

Unless the collect volume is the run target, the chamber could be partially full when a run target is attained. If the
chamber contains cells, the inlet volume that was processed for the current accumulation phase appears on the
screen. If you want to collect the contents in the chamber before you end the run, resume the current accumulation
phase to fill the chamber.
To resume the current accumulation phase, increase the collect volume to make it the run target. When the
chamber is full, the system initiates a collection phase. When the collection phase is complete, the run targets
screen reappears.

Collecting the Contents During Rinseback

If you need to end the run prematurely and want to collect the contents of the chamber during rinseback, perform
the following steps:
1 Touch the End Run menu button to display the menu tabs.
2 Touch the Rinseback tab. The screen with instructions to confirm your selection to perform rinseback
appears.
3 Touch Yes for collect into bag.
4 Touch Proceed to Rinseback and follow the instructions on the screens. The system initiates a collection
phase and then performs rinseback.

Recovering the Contents in the Chamber After Disconnecting the Patient

Consider the following options for recovering the contents in the chamber if you need to prematurely end the run
and disconnect the patient:

Recovering the contents in the chamber during rinseback.

1 Touch the End Run menu button to display the menu tabs.
2 Touch the Rinseback tab. The screen with instructions to confirm your selection to perform rinseback
appears.
3 Touch Yes for collect into bag.
4 Connect a bag to the return line.
5 Touch Proceed to Rinseback and follow the instructions on the screens. The system initiates a collection
phase and then performs rinseback.

Removing the chamber

If performing rinseback is not an option, you can still recover the cells by removing the chamber. To remove the
chamber, first clamp both lines to the chamber with a hemostat to ensure it does not leak. Then detach the
chamber from the set.

146 Spectra Optia Apheresis System Operator’s Manual

 11
Continuous Mononuclear Cell Collection (CMNC)
Procedures

Spectra Optia Apheresis System Operator’s Manual 147

Continuous Mononuclear Cell Collection (CMNC) Procedures

Functional Description of a Continuous Mononuclear Cell

Collection (CMNC) Procedure
During a CMNC procedure, the system pumps the patient’s blood into the tubing set and spins the centrifuge at
the speed required to target the optimal (default) packing factor of 4.5. The AIM system adjusts the flow rate of the
plasma pump to control the concentration of cells that flow through the collect port (based on the collection
preference). When the AIM system detects cells in the collect port, the system sounds a tone, the collect valve
moves into the collect position, and the collect pump pumps the mononuclear cells (MNC) into the collection bag.
The plasma pump pumps plasma out of the channel and either into the reservoir or into the plasma bag or the
collection bag, if plasma collection is targeted. The system always prioritizes collecting the MNC over collecting the
plasma. The red blood cells (RBC) are pushed out of the channel and into the reservoir, where they are combined
with the plasma for return to the patient.

Preparing to Perform a Procedure

Supplies
Assemble the supplies listed on page 62 before you begin a procedure.

Selecting the Procedure and Loading the Tubing Set

Follow the instructions starting on page 64 to select the procedure and load the tubing set. Before you load the
tubing set, verify that the set and the solutions you are using have not expired by checking the expiration date
printed on the packaging. Do not use an item if the current date is past the expiration date.

148 Spectra Optia Apheresis System Operator’s Manual

 Continuous Mononuclear Cell Collection (CMNC) Procedures

Navigating the CMNC Procedure Screens

Menu Buttons and Tabs

11
Table 11-1 shows the menu buttons and tabs to use to navigate the screens during a CMNC procedure. Menu
buttons and tabs are active depending on the current operating state. Touch a menu button to display the
corresponding tabs.

Table 11-1: Menu buttons and tabs on CMNC procedure screens

Config Data Run End Run

System Patient data Fluid balance Rinseback

Procedure Alarm history Operation status Disconnect

Report Report Collection status Run targets

CMNC Strobe

Blood warmer Run values

AC Options

Descriptions of Buttons, Icons, and Images

See Table 2-14 on page 36 for descriptions of the buttons, icons, and images that can appear on the screen during a
CMNC procedure.

Spectra Optia Apheresis System Operator’s Manual 149

Continuous Mononuclear Cell Collection (CMNC) Procedures

Entering and Changing Data During the Run

The Spectra Optia system requires that you enter specific data, such as patient data, to perform a CMNC
procedure. The system also allows you to change numerical values for certain operating parameters during the run.
Table 11-2 shows data entry ranges for the operating parameters according to the screen on which each data entry
button appears. To change or enter data, touch the button for the parameter that you want to change. A data entry
pad appears to enable you to enter a number. The data entry pad displays either the established range for the
parameter or the calculated range, if the range changes based on related data. Also, the range for Caution status is
displayed in yellow, if the data you enter could cause the system to operate in Caution status.

Table 11-2: Data entry ranges for CMNC procedure parameters

Screen Parameter Range

Patient data Sex • Male
• Female

Height:
• ft • 1 to 8
• in • 0 to 11
• cm • 30 to 244

Weight:
• lb • 5 to 500
• kg • 2 to 227

TBV (mL) 300 to 15000

Hct (%) 10 to 70

Options Rinseback • Yes

• No
Default:
• Yes if a custom prime is not
selected
• No if a custom prime is selected

Custom prime • Yes

• No
Default: No

Saline rinse • Yes

• No
Default: No

Blood warmer: Return line • Yes

• No

Blood warmer: Tubing set volume (mL) 1 to 100

Plasma collection • Now

• End of Run

Custom prime Fluid type • RBC

• Plasma
• Albumin

RBC unit Hct (%) 25 to 80

Inlet flow rate (mL/min) 5 to 70

150 Spectra Optia Apheresis System Operator’s Manual

 Continuous Mononuclear Cell Collection (CMNC) Procedures

Table 11-2: Data entry ranges for CMNC procedure parameters (continued)

Screen
Volume (mL)
Parameter
100 to 400
Range

(Volume should be at least 300 mL

11
for the patient to receive the full
benefit.)

Run values AC infusion rate (mL/min/L TBV) 0.2 to 2.5

(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if the entered ratio
is not within the recommended range
of 6:1 to 15:1.)

Whole blood processed (mL) Patient’s TBV multiplied by 1 to 10

Run time (min) 40 to 480

TBV processed 1 to 10

Inlet flow rate (mL/min) 5 to 142

Plasma volume: Target (mL) in plasma bag 0 to the patient’s plasma volume
minus the current collect volume and
the current volume of plasma in the
collection bag
(Sum of the total plasma volume and
the collect volume cannot exceed
100% of the patient’s total plasma
volume.)

Collect flow rate (mL/min) 0.5 to 10

Default:
• 1.0 if the inlet flow rate is equal to
or greater than 20
• Inlet flow rate multiplied by 0.05 if
the inlet flow rate is less than 20

Collect volume: Target (mL) 5 to the patient’s plasma volume

minus the current volume of plasma
in the plasma bag and in the
collection bag

Plasma in collection bag: Target (mL) 0 to the patient’s plasma volume

minus the current collect volume and
the current volume of plasma in the
plasma bag
(Sum of the total plasma volume and
the collect volume cannot exceed
100% of the patient’s total plasma
volume.)

Main run Packing factor 1 to 20

Default: 4.5

Inlet flow rate (mL/min) 5 to 142

Spectra Optia Apheresis System Operator’s Manual 151

Continuous Mononuclear Cell Collection (CMNC) Procedures

Table 11-2: Data entry ranges for CMNC procedure parameters (continued)

Screen Parameter Range

Collect flow rate (mL/min) 0.5 to 10

Collect volume (mL) 5 to the patient’s plasma volume

minus the current volume of plasma
in the plasma bag and in the
collection bag.

AC infusion rate (mL/min/L TBV) 0.2 to 2.5.

(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if the entered ratio
is not within the recommended range
of 6:1 to 15:1.)

Collection status Collection preference 10 to 90

Default: 50 after the interface is
established

Run targets Plasma bag (mL) 0 to the patient’s plasma volume

minus the current collect volume and
the current volume of plasma in the
collection bag
(Sum of the total plasma volume and
the collect volume cannot exceed
100% of the patient’s total plasma
volume.)

Run time (min) 40 to 480

Whole blood processed (mL) Patient’s TBV multiplied by 1 to 10

TBV processed 1 to 10

Collection bag: Plasma (mL) 0 to the patient’s plasma volume

minus the current collect volume and
the current volume of plasma in the
plasma bag
(Sum of the total plasma volume and
the collect volume cannot exceed
100% of the patient’s total plasma
volume.)

Collection bag: Collect (mL) 5 to patient’s plasma volume minus

the current volume of plasma in the
plasma bag and in the collection bag.

Rinseback Return flow rate (mL/min) 2 to 100

Default: inlet flow rate that was in
use when the run ended or
100 mL/min, whichever is slower

152 Spectra Optia Apheresis System Operator’s Manual

 Continuous Mononuclear Cell Collection (CMNC) Procedures

Entering and Confirming Patient and Procedure Data

This section contains instructions for entering patient data and reviewing and confirming run values. You can enter
the data after you select the procedure and before you connect the patient. It is important that the data you enter be
as accurate and as current as possible.
11
Note: When you are required to enter numerical data, the system displays a data entry pad for entering the data. The
acceptable numerical range appears on the data entry pad.

Entering Patient Data

1 Touch the buttons on the screen to enter the following information:
• Sex
• Height
• Weight
• Hematocrit (Hct)
The Spectra Optia system uses the sex, height, and weight to calculate the patient’s TBV. See page 266 for the
formula the system uses to calculate this value. If you prefer not to use the TBV that the system calculated,
touch TBV and enter a different volume. The operator override icon ( ) will appear on the button.

Note: If the patient weighs less than 25 kg (approximately 55 lb), the system does not calculate a TBV. You
must calculate and enter the appropriate TBV for the patient.

2 Touch Confirm. The run values screen appears.

Reviewing and Confirming the Run Values

1 Review the run values that appear on the screen and confirm that they are correct. The run targets for a
CMNC procedure are listed below. A black frame appears around the button of the primary run target.
• Whole blood processed (mL)
• TBV processed
• Run time (min)
• Collect volume: Target (mL)
If you change a value, the color of the value on the button changes from white to yellow. Values that were
affected by a change appear with a yellow arrow. The arrow points up or down to indicate an increase or
decrease in the value as a result of the change.

Note: Only the color of the last value you changed remains yellow. The values you previously changed revert to
white.

2 When you are finished reviewing the run values, touch Confirm.

Spectra Optia Apheresis System Operator’s Manual 153

Continuous Mononuclear Cell Collection (CMNC) Procedures

Collecting plasma
To collect the plasma, the system stops the collect pump, increases the centrifuge speed and decreases the inlet
pump flow rate to 60 mL/min, if necessary, to increase the packing factor to at least 14 and to reduce the number
of platelets flowing through the plasma port. Once the target packing factor is achieved, the system decreases the
plasma pump flow rate, which lowers the interface position. The system then increases the plasma pump flow rate
and once any remaining platelets have been cleared from the plasma line, the system moves the plasma valve into
the collect position and begins collecting plasma.
If you configured the procedure to collect plasma at the beginning of the run and you increase the target plasma
volume during the run, a screen appears with instructions for indicating whether the additional volume should be
collected immediately (now) or at the end of the run. Follow the instructions on the screen to indicate your
preference and resume the run.

Priority of collect volume and plasma volume

The system always prioritizes collection of the target collect volume over the target plasma volume when the plasma
collection is selected to occur at the end of the run. If you decrease a run target, make sure you thoroughly review
the values that have changed on the run values screen before you touch Confirm. If the decrease in the run target is
significant, the target plasma volume could be reduced to zero, and the collect volume could also decrease.

154 Spectra Optia Apheresis System Operator’s Manual

 Continuous Mononuclear Cell Collection (CMNC) Procedures

Priming the Inlet Line and the Return Line

Warning: When connecting a blood warmer tubing set to the return line, ensure that the tubing connection is
tight. Put the luer connection no higher than 20 in (50 cm) above the return access to prevent the possibility of air
entering the tubing.
11
Warning: If you are using a blood warmer on the return line, ensure that you completely prime the blood warmer
tubing set to remove all the air in the set before you connect the patient.

1 Follow the instructions on the screen to prime the inlet line and the return line. If you are using a blood
warmer on the return line, follow the instructions on the screen to connect and prime the blood warmer
tubing set.
2 Touch Confirm. The screen appears with instructions for connecting the patient and starting the run.

Connecting the Patient and Starting the Run

Warning: Before connecting the patient, check the inlet and return lines for air. If air is present in the lines,
remove the air before connecting the patient.

1 Follow the instructions below and on the screen to connect the patient.
• If you are performing a peripheral venipuncture, see “Collection Set and IDL Set: Additional Instructions
for Use” on page 269 for instructions on using the needle protector.
• If you are performing a peripheral venipuncture and want to use the diversion bag on the inlet line, see
“Using the Diversion Bag to Collect a Sample From a Venipuncture” on page 269 for instructions.
2 Touch Start Run. The system begins drawing the patient’s blood into the tubing set. The main run screen
appears, and the system diverts approximately 40 mL of saline that was used to prime the tubing set into the
saline container.

Note: If you performed a custom prime, the system does not perform the step to divert the saline. The saline was
removed from the set during the custom prime.

Spectra Optia Apheresis System Operator’s Manual 155

Continuous Mononuclear Cell Collection (CMNC) Procedures

Monitoring the Run

The system displays information on the screens to help you monitor the progress of the run. To access the screens,
touch the Run menu button and then the tab for the screen you want to view. Be sure to verify that the volumes
displayed on the screens are consistent with the actual volumes in the fluid containers and in the bags.
See “Glossary of Terms” on page 278 for descriptions of the buttons on the screens.

Main Run Screen

The main run screen is the default run screen and displays or provides access to the information you most likely
need to monitor the run. If you want to return to the main run screen after viewing a different screen, touch the go
back button, the active menu button, or the tab for the current screen. There is no tab for the main run screen.

Collection Status Screen

To access the collection status screen, touch the Collection Status tab. Use this screen to monitor the progress of
the run and to adjust the collection preference. You can also use this screen to change the position of the collect
valve to immediately direct the flow of cells from the collect line into the reservoir for return to the patient, if
necessary.

Collection preference
The collection preference is a reference number that the system uses to adjust the plasma pump flow rate, which
affects the concentration of cells that flow through the collect port. You can use the up and down arrows to change
the collection preference during the run to accommodate the conditions of the patient’s blood and achieve the
desired outcome of the procedure.
The default collection preference for a CMNC procedure is 50. While establishing the initial interface or while
re-establishing the interface after a pump pause or a centrifuge stop, the system targets a higher preference to avoid
collecting non-target cells before the interface is stable. The collection preference that the system targets depends
on whether or not you change the preference before the interface is established.
• If you do not change the collection preference, the system targets a collection preference of 60.
• If you change the collection preference, the system targets a collection preference that is about 10 points
higher than the number that you selected, but is not less than a preference of 20.
Once the interface is established, the system gradually decreases the collection preference either to the default or to
the number that you selected. For more information about optimizing the collection preference during the run, see
“Optimizing the Collection Preference” on page 158.

Trend graph
The trend graph represents an area of the buffy coat that is in the connector. The horizontal black line on the graph
indicates the current collection preference. The green diamonds indicate the concentration of cells flowing through
the collect port as compared to the collection preference.
If the system is unable to collect cells at the target collection preference, the green diamonds could appear above or
below the black line. As long as the diamonds appear in a controlled path within 20 units either above or below the
line, the run is progressing as intended.

Return to patient and collect into bag buttons

The position of the collect valve determines whether the system is directing the flow of cells in the collect line back
to the patient or into the collection bag. The system indicates the current position of the collect valve by showing
the corresponding button on this screen in a touched (lowered) position. You can manually change the position of
the collect valve at any time during the run.

156 Spectra Optia Apheresis System Operator’s Manual

 Continuous Mononuclear Cell Collection (CMNC) Procedures

• To direct the flow of cells from the collect line back to the patient, touch the return to patient button and then
touch Apply. The collect valve moves into the return position and the system begins pumping the cells into
the reservoir for return to the patient.

Note: If you touch the return to patient button, the system operates in Caution status because cells are not
being collected. The collect valve stays in the return position until you touch the collect into bag button.
11
• To direct the flow of cells in the collect line into the collection bag, touch the collect into bag button and then
touch Apply. The collect valve moves into the collect position, and the system begins pumping the cells into
the collection bag.

Monitoring the Patient

Managing Citrate Toxicity

If the patient experiences citrate toxicity, perform the following steps:
1 Touch the pause button to pause the pumps. An alarm occurs indicating that the procedure was paused and
the pumps were stopped.
2 Notify the attending physician of the patient’s condition according to your facility’s standard operating
procedures.
3 Touch the go back button to go to the run values screen, and decrease the AC infusion rate as desired.
4 Touch the active alarm button to return to the alarm screen, and then touch Continue. The run values
screen appears.
5 Review the run values and confirm that they are correct.
6 Touch Confirm to resume the procedure.
7 If decreasing the AC infusion rate does not alleviate the symptoms, touch the pause button to pause the
pumps again, and notify the attending physician.

Spectra Optia Apheresis System Operator’s Manual 157

Continuous Mononuclear Cell Collection (CMNC) Procedures

Optimizing the Run

Optimizing the Collection Preference

The collection preference controls the concentration of cells that flow through the collect port. You can use the up
and down arrows on the screen to increase or decrease the collection preference during the run to accommodate the
patient's condition and to achieve your procedure goals. Consider the following guidelines when adjusting the
collection preference, keeping in mind that the patient’s WBC and platelet counts affect the contents of the
collection:
• Use a low collection preference to increase the concentration of cells in the collect port. The system adjusts the
plasma pump flow rate so that it collects more deeply in the buffy coat. This maximizes the yield of target cells
but could increase RBC contamination of the collected product.
• Use a high collection preference to decrease the concentration of cells in the collect port. The system adjusts
the plasma pump flow rate so that it collects more shallowly in the buffy coat. This helps to minimize RBC
contamination of the collected product, but could result in a lower yield of target cells.

Monitoring the contents in the collect line and adjusting the color
Monitor the collect line where it exits the centrifuge below the cassette, and use the collection preference to adjust
the color of the contents in the line. To accurately evaluate the color, you should allow the collect pump to process
1 mL to 2 mL of volume before making an additional adjustment.
The Collection Preference Tool can help you evaluate which color is appropriate for the procedure. If the contents
in the line look either too light or too dark, consider making adjustments to the run according to the following
guidelines:
• Color is too light:
• Decrease the collection preference. This increases the concentration of cells that flow through the collect
port.
• Reset the collect pump flow rate to the default flow rate. When the collect pump flow rate is too slow, cells
can accumulate in the connector, making it difficult to collect cells that are deeper in the buffy coat.
• Color is too dark:
• Increase the collection preference. This decreases the concentration of cells that flow through the collect
port.

Minimizing Buffy Coat Accumulation

A buffy coat can accumulate in the connector for several reasons. To minimize accumulation of a buffy coat,
consider performing one of the following steps:
• Avoid pausing the pumps and conditions that cause the pumps to pause, such as alarm conditions. After the
pumps restart, it takes time for the collect pump flow rate to reach the target speed, which slows the collection
of cells from the connector.
• Increase the collect pump flow rate, especially if it is currently slower than the default flow rate established by
the system. Increase the flow rate in increments of 0.1 mL/min until the buffy coat stops accumulating.

Note: If the patient has a high WBC count, consider using a collect pump flow rate of 1.0 mL/min to 1.5 mL/min,
especially if you are using a high inlet flow rate.

158 Spectra Optia Apheresis System Operator’s Manual

 Continuous Mononuclear Cell Collection (CMNC) Procedures

• Decrease the collection preference. The interface may not be high enough to allow the system to collect the
buffy coat.

Collecting a Target Volume 11

If the procedure goal is a specific volume in the collection bag, consider changing the collect volume. This causes
the collect volume to become the run target. This target only includes the volume pumped by the collect pump.
The volume of any plasma collected is not included.

Decreasing the Run Time

Consider the following alternatives for decreasing the predicted run time if a shorter run is necessary:
• Avoid pausing the pumps and conditions that cause the pumps to pause, such as alarm conditions. After the
pumps restart, it takes time for the pumps to reach the target flow rates again, which adds time to the run.
• Increase the inlet pump flow rate or increase the AC infusion rate. Increasing these rates allows the system to
process more blood in less time. Be aware that either option results in a greater volume of AC delivered to the
patient and increases the potential for the patient to experience a citrate reaction.
• Increase the inlet:AC ratio. This causes the inlet pump flow rate to increase. However, it decreases the system’s
ability to manage anticoagulation of the extracorporeal circuit and can result in clumping in the circuit.
Monitor the run carefully as you increase the inlet:AC ratio.
• Decrease the target run time. Make the run time the run target by entering the desired time on the run values
or run targets screen. This ensures that the run ends when required.
If you decrease the run time and intend to collect plasma at the end of the run, make sure you review the
target plasma volume on the run values screen and confirm that it is still appropriate. The system prioritizes
collection of the target collect volume over the target plasma volume. This means that if you decrease the run
time, the system will decrease the target plasma volume. You can increase the target plasma volume if it is too
low, but be aware that the collect volume will decrease as a result.

Addressing Clumping in the Connector

Clumping can affect collection efficiency by interfering with the separation in the connector. The potential for
platelet clumping is difficult to predict since it does not always correlate with the patient’s platelet count. If you see
platelet clumping in the connector, perform the following steps:
1 Decrease the inlet:AC ratio to 8:1 until the clump disappears and until the system has processed at least
100 mL of inlet volume.
2 Check the connector for clumping and then perform one of the following steps:
• If the clumping is resolved, consider increasing the inlet:AC ratio to 10:1. Allow the system to process
500 mL to 1,000 mL of inlet volume before you consider increasing the ratio again. Do not increase the
ratio by more than 2.0 for every 500 mL to 1,000 mL of inlet volume processed.
• If the clumping persists, leave the inlet:AC ratio at 8:1 until the clumping disappears or for the remainder
of the run. Some clumps may become clots that are difficult to eliminate. Maintaining the ratio at 8:1 will
help minimize the impact on the collection efficiency.
For additional information about anticoagulation in the tubing set, see “Managing Anticoagulation of the
Extracorporeal Circuit” on page 221.

Spectra Optia Apheresis System Operator’s Manual 159

Continuous Mononuclear Cell Collection (CMNC) Procedures

160 Spectra Optia Apheresis System Operator’s Manual

 12
Granulocyte (PMN) Collection
Procedures

Spectra Optia Apheresis System Operator’s Manual 161

Granulocyte (PMN) Collection Procedures

Functional Description of a Granulocyte (PMN) Collection Procedure

During a PMN collection procedure, the system pumps the patient’s blood into the tubing set and spins the
centrifuge at the speed required to target the optimal (default) packing factor: 1.6, when HES is used, or 4.5, when
ACD-A is used. The AIM system adjusts the flow rate of the plasma pump to control the concentration of cells that
flow through the collect port (based on the collection preference). When the AIM system detects cells in the collect
port, the system sounds a tone, the collect valve moves into the collect position, and the collect pump pumps
granulocytes into the collection bag. The plasma pump pumps plasma out of the channel and either into the
reservoir or into the plasma bag, if plasma collection is targeted. The system always prioritizes collecting the PMN
over collecting the plasma. The red blood cells (RBC) are pushed out of the channel and into the reservoir, where
they combine with the plasma for return to the patient.

Preparing to Perform a Procedure

Supplies
Assemble the supplies listed on page 62 before you begin a procedure.

Anticoagulant Solutions for PMN Collection Procedures

You can use a solution that contains hydroxyethyl starch (HES) or ACD-A to perform a PMN collection procedure
on the Spectra Optia system.
Caution: If hydroxyethyl starch (HES) is not used during a PMN collection procedure, the collection efficiency
will be lower.

Using HES
HES is a sedimenting agent that causes RBC to separate more efficiently from granulocytes during a PMN
collection procedure. If you choose to use HES, you must select Yes for HES on the PMN configuration screen or
on the options screen. “HES: Yes” appears on the main run screen as a reminder of your selection. When using
HES, you must add trisodium citrate to the HES for use as the anticoagulant. The default packing factor when
HES is used is 1.6.

Preparing an anticoagulant solution containing HES and trisodium citrate

To prepare the correct anticoagulant solution, add 30 mL to 40 mL of 46.7% trisodium citrate solution to 500 mL
of HES. To prepare an anticoagulant solution with the same concentration as ACD-A, add 38 mL of trisodium
citrate solution to the HES.

Using ACD-A
If you choose to use ACD-A, you must select No for HES on the PMN configuration screen or on the options
screen. “HES: No” appears on the main run screen as a reminder of your selection. Also refer to “Optimizing a
PMN Collection Procedure When Using ACD-A” on page 173 for information about adjustments you can make
to optimize the run. The default packing factor when ACD-A is used is 4.5.

162 Spectra Optia Apheresis System Operator’s Manual

 Granulocyte (PMN) Collection Procedures

Selecting the Procedure and Loading the Tubing Set

Follow the instructions starting on page 64 to select the procedure and load the tubing set. Before you load the
tubing set, verify that the set and the solutions you are using have not expired by checking the expiration date
printed on the packaging. Do not use an item if the current date is past the expiration date.

12

Spectra Optia Apheresis System Operator’s Manual 163

Granulocyte (PMN) Collection Procedures

Navigating the PMN Collection Procedure Screens

Menu Buttons and Tabs

Table 12-1 shows the menu buttons and tabs to use to navigate the screens during a PMN collection procedure.
Menu buttons and tabs are active depending on the current operating state. Touch a menu button to display the
corresponding tabs.

Table 12-1: Menu buttons and tabs on PMN collection procedure screens

Config Data Run End Run

System Patient data Fluid balance Rinseback

Procedure Alarm history Operation status Disconnect

Report Report Collection status Run targets

PMN Strobe

Blood warmer Run values

Options

Descriptions of Buttons, Icons, and Images

See Table 2-14 on page 36 for descriptions of the buttons, icons, and images that can appear on the screen during a
PMN collection procedure.

164 Spectra Optia Apheresis System Operator’s Manual

 Granulocyte (PMN) Collection Procedures

Entering and Changing Data During the Run

The Spectra Optia system requires that you enter specific data, such as patient data, to perform a PMN collection
procedure. The system also allows you to change numerical values for certain operating parameters during the run.
Table 12-2 shows data entry ranges for the operating parameters according to the screen on which each data entry
button appears. To change or enter data, touch the button for the parameter that you want to change. A data entry
pad appears to enable you to enter a number. The data entry pad displays either the established range for the
parameter or the calculated range, if the range changes based on related data. Also, the range for Caution status is
displayed in yellow, if the data you enter could cause the system to operate in Caution status.
12
Table 12-2: Data entry ranges for PMN collection procedures

Screen Parameter Range

Patient data Sex • Male
• Female

Height:
• ft • 1 to 8
• in • 0 to 11
• cm • 30 to 244

Weight:
• lb • 5 to 500
• kg • 2 to 227

TBV (mL) 300 to 15000

Hct (%) 10 to 70

Options Rinseback • Yes

• No
Default:
• Yes if a custom prime is not
selected
• No if a custom prime is selected

Custom prime • Yes

• No
Default: No

HES • Yes
Selection determines the default packing factor. • No
• Yes: Default packing factor is 1.6
• No: Default packing factor is 4.5

Saline rinse • Yes

• No
Default: No

Blood warmer: Return line • Yes

• No

Blood warmer: Tubing set volume (mL) 1 to 100

Custom prime Fluid type • RBC

• Plasma
• Albumin

Spectra Optia Apheresis System Operator’s Manual 165

Granulocyte (PMN) Collection Procedures

Table 12-2: Data entry ranges for PMN collection procedures (continued)

Screen Parameter Range

RBC unit Hct (%) 25 to 80

Inlet flow rate (mL/min) 5 to 70

Volume (mL) 100 to 400

(Volume should be at least 300 mL
for the patient to receive the full
benefit.)

Run values AC infusion rate (mL/min/L TBV) 0.2 to 2.5

(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if the entered ratio
is not within the recommended range
of 6:1 to 15:1.)

Whole blood processed (mL) Patient’s TBV multiplied by 0.5 to 5

Run time (min) 40 to 480

TBV processed 0.5 to 5

Inlet flow rate (mL/min) 5 to 142

Plasma volume: Target (mL) in plasma bag 0 to the patient’s plasma volume
minus the current collect volume and
the current volume of plasma in the
collection bag
(Sum of the total plasma volume and
the collect volume cannot exceed
100% of the patient’s total plasma
volume.)

Collect flow rate (mL/min) 0.5 to 25

Default: inlet flow rate multiplied by
0.075

Collect volume: Target (mL) 5 to the patient’s plasma volume

minus the current volume of plasma
in the plasma bag and in the
collection bag

Main run Packing factor 1 to 20

• HES: Yes • Default: 1.6
• HES: No • Default: 4.5

Inlet flow rate (mL/min) 5 to 142

Collect flow rate (mL/min) 0.5 to 25

Collect volume (mL) 5 to the patient’s plasma volume

minus the current volume of plasma
in the plasma bag and in the
collection bag

166 Spectra Optia Apheresis System Operator’s Manual

 Granulocyte (PMN) Collection Procedures

Table 12-2: Data entry ranges for PMN collection procedures (continued)

Screen Parameter Range

AC infusion rate (mL/min/L TBV) 0.2 to 2.5
(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if the entered ratio
is not within the recommended range
12
of 6:1 to 15:1.)

Collection status Collection preference 10 to 90

Default: 60 after the interface is
established

Run targets Run time (min) 40 to 480

Whole blood processed (mL) Patient’s TBV multiplied by 0.5 to 5

TBV processed 0.5 to 5

Plasma bag (mL) 0 to the patient’s plasma volume

minus the current collect volume and
the current volume of plasma in the
collection bag
(Sum of the total plasma volume and
the collect volume cannot exceed
100% of the patient’s total plasma
volume.)

Collection bag (mL) 5 to the patient’s plasma volume

minus the current volume of plasma
in the plasma bag and in the
collection bag

Rinseback Return flow rate (mL/min) 2 to 100

Default: inlet flow rate that was in
use when the run ended or
100 mL/min, whichever is slower

Spectra Optia Apheresis System Operator’s Manual 167

Granulocyte (PMN) Collection Procedures

Entering and Confirming Patient and Procedure Data

This section contains instructions for entering patient data and reviewing and confirming run values. You can enter
the data after you select the procedure and before you connect the patient. It is important that the data you enter be
as accurate and as current as possible.

Note: When you are required to enter numerical data, the system displays a data entry pad for entering the data. The
acceptable numerical range appears on the data entry pad.

Entering Patient Data

1 Touch the buttons on the screen to enter the following information:
• Sex
• Height
• Weight
• Hematocrit (Hct)
The Spectra Optia system uses the sex, height, and weight to calculate the patient’s TBV. See page 266 for the
formula the system uses to calculate this value. If you prefer not to use the TBV that the system calculated,
touch TBV and enter a different volume. The operator override icon ( ) will appear on the button.

Note: If the patient weighs less than 25 kg (approximately 55 lb), the system does not calculate a TBV. You
must calculate and enter the appropriate TBV for the patient.

2 Touch Confirm. The run values screen appears.

Reviewing and Confirming the Run Values

1 Review the run values that appear on the screen and confirm that they are correct. The run targets for a PMN
procedure are listed below. A black frame appears around the button of the primary run target.
• Whole blood processed (mL)
• TBV processed
• Run time (min)
• Collect volume: Target (mL)
If you change a value, the color of the value on the button changes from white to yellow. Values that were
affected by a change appear with a yellow arrow. The arrow points up or down to indicate an increase or
decrease in the value as a result of the change.

Note: Only the color of the last value you changed remains yellow. The values you previously changed revert to
white.

2 When you are finished reviewing the run values, touch Confirm.

168 Spectra Optia Apheresis System Operator’s Manual

 Granulocyte (PMN) Collection Procedures

Collecting plasma
To collect the plasma, the system stops the collect pump, increases the centrifuge speed and decreases the inlet
pump flow rate to 60 mL/min, if necessary, to increase the packing factor to at least 14.0 and to reduce the number
of platelets flowing through the plasma port. Once the target packing factor is achieved, the system decreases the
plasma pump flow rate, which lowers the interface position. The system then increases the plasma pump flow rate
and once any remaining platelets have been cleared from the plasma line, the system moves the plasma valve into
the collect position and begins collecting plasma.

Priority of collect volume and plasma volume

12
The system always prioritizes collection of the target collect volume over the target plasma volume. If you decrease
a run target, make sure you thoroughly review the values that have changed on the run values screen before you
touch Confirm. If the decrease in the run target is significant, the target plasma volume could be reduced to zero,
and the collect volume could also decrease.

Spectra Optia Apheresis System Operator’s Manual 169

Granulocyte (PMN) Collection Procedures

Priming the Inlet Line and the Return Line

Warning: When connecting a blood warmer tubing set to the return line, ensure that the tubing connection is
tight. Put the luer connection no higher than 20 in (50 cm) above the return access to prevent the possibility of air
entering the tubing.

Warning: If you are using a blood warmer on the return line, ensure that you completely prime the blood warmer
tubing set to remove all the air in the set before you connect the patient.

1 Follow the instructions on the screen to prime the inlet line and the return line. If you are using a blood
warmer on the return line, follow the instructions on the screen to connect and prime the blood warmer
tubing set.
2 Touch Confirm. The screen appears with instructions for connecting the patient and starting the run.

Connecting the Patient and Starting the Run

Warning: Before connecting the patient, check the inlet and return lines for air. If air is present in the lines,
remove the air before connecting the patient.

1 Follow the instructions below and on the screen to connect the patient.
• If you are performing a peripheral venipuncture, see “Collection Set and IDL Set: Additional Instructions
for Use” on page 269 for instructions on using the needle protector.
• If you are performing a peripheral venipuncture and want to use the diversion bag on the inlet line, see
“Using the Diversion Bag to Collect a Sample From a Venipuncture” on page 269 for instructions.
2 Touch Start Run. The system begins drawing the patient’s blood into the tubing set. The main run screen
appears, and the system diverts approximately 40 mL of saline that was used to prime the tubing set into the
saline container.

Note: If you performed a custom prime, the system does not perform the step to divert the saline. The saline was
removed from the set during the custom prime.

170 Spectra Optia Apheresis System Operator’s Manual

 Granulocyte (PMN) Collection Procedures

Monitoring the Run

The system displays information on the screens to help you monitor the progress of the run. To access the screens,
touch the Run menu button and then the tab for the screen you want to view. Be sure to verify that the volumes
displayed on the screens are consistent with the actual volumes in the fluid containers and in the bags.
See “Glossary of Terms” on page 278 for descriptions of the buttons on the screens.

Main Run Screen

12
The main run screen is the default run screen and displays or provides access to the information you most likely
need to monitor the run. If you want to return to the main run screen after viewing a different screen, touch the go
back button, the active menu button, or the tab for the current screen. There is no tab for the main run screen.

Collection Status Screen

To access the collection status screen, touch the Collection Status tab. Use this screen to monitor the progress of
the run and to adjust the collection preference. You can also use this screen to change the position of the collect
valve to immediately direct the flow of cells in the collect line into the reservoir for return to the patient, if
necessary.

Collection preference
The collection preference is a reference number that the system uses to adjust the plasma pump flow rate, which
affects the concentration of cells that flow through the collect port. You can use the up and down arrows to change
the collection preference during the run to accommodate the conditions of the patient’s blood and achieve the
desired outcome of the procedure.
The default collection preference for a PMN collection procedure is 60. While establishing the initial interface or
while re-establishing the interface after a pump pause or a centrifuge stop, the system targets a higher preference to
avoid collecting non-target cells before the interface is stable. The collection preference that the system targets
depends on whether or not you change the preference before the interface is established.
• If you do not change the collection preference, the system targets a collection preference of 70.
• If you change the collection preference, the system targets a collection preference that is about 10 points
higher than the number that you selected, but is not less than a preference of 65.
Once the interface is established, the system gradually decreases the collection preference either to the default or to
the number that you selected. For more information about optimizing the collection preference during the run, see
“Optimizing the Collection Preference” on page 173.

Trend graph
The trend graph shows the status of the collection. It represents an area of the buffy coat that is in the connector.
The horizontal black line on the graph indicates the current collection preference. The green diamonds indicate the
concentration of cells flowing through the collect port as compared to the collection preference.
If the system is unable to collect cells at the target collection preference, the green diamonds could appear above or
below the black line. As long as the diamonds appear in a controlled path within 20 units either above or below the
line, the run is progressing as intended.

Return to patient and collect into bag buttons

The position of the collect valve determines whether the system is directing the flow of cells in the collect line back
to the patient or into the collection bag. The system indicates the current position of the collect valve by showing
the corresponding button on this screen in a touched (lowered) position. You may manually change the position of
the collect valve at any time during the run.

Spectra Optia Apheresis System Operator’s Manual 171

Granulocyte (PMN) Collection Procedures

• To direct the flow of cells from the collect line back to the patient, touch the return to patient button and then
touch Apply. The collect valve moves into the return position and the system begins pumping the cells into
the reservoir for return to the patient.

Note: If you touch the Return to Patient button, the system operates in Caution status because cells are not
being collected. The collect valve stays in the return position until you touch the Collect into Bag button.

• To direct the flow of cells in the collect line into the collection bag, touch the collect into bag button and then
touch Apply. The collect valve moves into the collect position and the system begins pumping the cells into
the collection bag.

Monitoring the Patient

Managing Citrate Toxicity

If the patient experiences citrate toxicity, perform the following steps:
1 Touch the pause button to pause the pumps. An alarm occurs indicating that the procedure was paused and
the pumps were stopped.
2 Notify the attending physician of the patient’s condition according to your facility’s standard operating
procedures.
3 Touch the go back button to go to the run values screen, and decrease the AC infusion rate as desired.
4 Touch the active alarm button to return to the alarm screen, and then touch Continue. The run values
screen appears.
5 Review the run values and confirm that they are correct.
6 Touch Confirm to resume the procedure.
7 If decreasing the AC infusion rate does not alleviate the symptoms, touch the pause button to pause the
pumps again, and notify the attending physician.

172 Spectra Optia Apheresis System Operator’s Manual

 Granulocyte (PMN) Collection Procedures

Optimizing the Run

Optimizing a PMN Collection Procedure When Using ACD-A

Caution: If hydroxyethyl starch (HES) is not used during a PMN collection procedure, the collection efficiency
will be lower.
12
If you choose to use ACD-A instead of HES during the procedure, confirm that No for HES is selected on the
PMN configuration screen or on the options screen. To optimize the collection when using ACD-A, consider
making one or more of the following adjustments to the run:
• Process more whole blood than the default of 6,000 mL. Be aware that doing this increases the run time and
the collect volume.
• Decrease the collection preference to collect more cells closer to the RBC interface. The color of the contents
in the collect line should appear slightly darker than the darkest color on the Collection Preference Tool.
• Increase the packing factor above the default of 4.5. Be aware that using a packing factor higher than the
default could result in an excess number of platelets collected. The system displays a warning screen with
instructions for monitoring the patient for platelet depletion and for resuming the procedure in Caution
status.
• Increase the collect pump flow rate above the default flow rate. This results in more cells collected and a larger
collect volume.

Optimizing the Collection Preference

The collection preference controls the concentration of cells that flow through the collect port. You can use the up
and down arrows on the screen to increase or decrease the collection preference during the run to accommodate the
patient's condition and to achieve your procedure goals. Consider the following guidelines when adjusting the
collection preference, keeping in mind that the patient's cell counts affect the contents of the collection:
• Use a low collection preference to increase the concentration of cells in the collect port. The system adjusts the
plasma pump flow rate so that it collects more deeply in the buffy coat. This maximizes the yield of target cells
but could increase RBC contamination of the collected product.
• Use a high collection preference to decrease the concentration of cells in the collect port. The system adjusts
the plasma pump flow rate so that it collects more shallowly in the buffy coat. This helps to minimize RBC
contamination of the collected product but could result in a lower yield of target cells.

Monitoring the contents in the collect line and adjusting the color
Monitor the collect line where it exits the centrifuge below the cassette, and use the collection preference to adjust
the color of the contents in the line. To accurately evaluate the color, you should allow the collect pump to process
1 mL to 2 mL of volume before making an additional adjustment.
The Collection Preference Tool can help you evaluate which color is appropriate for the procedure. If the contents
in the line look either too light or too dark, consider making adjustments to the run according to the following
guidelines:

Spectra Optia Apheresis System Operator’s Manual 173

Granulocyte (PMN) Collection Procedures

• Color is too light:

• Decrease the collection preference. This increases the concentration of cells that flow through the collect
port.
• Reset the collect pump flow rate to the default flow rate. When the collect pump flow rate is too slow, cells
can accumulate in the connector, making it difficult to collect cells that are deeper in the buffy coat.
• Color is too dark:
• Increase the collection preference. This decreases the concentration of cells that flow through the collect
port.

Minimizing Buffy Coat Accumulation

A buffy coat can accumulate in the connector for several reasons. To minimize accumulation of a buffy coat,
consider performing one of the following steps:
• Avoid pausing the pumps and conditions that cause the pumps to pause, such as alarm conditions. After the
pumps restart, it takes time for the collect pump flow rate to reach the target speed, which slows the collection
of cells from the connector.
• Increase the collect pump flow rate, especially if it is currently slower than the default flow rate established by
the system. Increase the flow rate in increments of 0.1 mL/min until the buffy coat stops accumulating.
• Decrease the collection preference. The interface may not be high enough to allow the system to collect the
buffy coat.

Targeting a Lower Collect Volume

If the predicted collect volume is more than desired or the procedure goal is a specific volume in the collection bag,
consider performing one of the following steps, keeping in mind that either step will decrease the collection
efficiency:
• Decrease the collect pump flow rate. This decreases the collect volume without affecting the inlet volume
processed. This also increases the concentration of cells in the connector, so you should monitor the connector
for buffy coat accumulation.
• Enter a target collect volume. The collect volume becomes the run target. The system processes less inlet
volume and therefore the run is shorter.

Decreasing the Run Time

Consider the following alternatives for decreasing the predicted run time if a shorter run is necessary:
• Avoid pausing the pumps and conditions that cause the pumps to pause, such as alarm conditions. After the
pumps restart, it takes time for the pumps to reach the target flow rates again, which adds time to the run.
• Increase the inlet pump flow rate or increase the AC infusion rate. Increasing these rates allows the system to
process more blood in less time. Be aware that either option results in a greater volume of AC delivered to the
patient and increases the potential for the patient to experience a citrate reaction.
• Increase the inlet:AC ratio. This causes the inlet pump flow rate to increase. However, it decreases how well
the system manages anticoagulation of the extracorporeal circuit and can result in clumping in the circuit.
Monitor the run carefully as you increase the inlet:AC ratio.
• Decrease the target run time. Make the run time the run target by entering the desired time on the run values
or run targets screen. This ensures that the run ends when required.

174 Spectra Optia Apheresis System Operator’s Manual

 Granulocyte (PMN) Collection Procedures

If you decrease the run time and intend to collect plasma at the end of the run, make sure you review the
target plasma volume on the run values screen and confirm that it is still appropriate. The system prioritizes
collection of the target collect volume over the target plasma volume. This means that if you decrease the run
time, the system will decrease the target plasma volume. You can increase the target plasma volume if it is too
low, but be aware that the collect volume will decrease as a result.

Addressing Clumping in the Connector

Clumping can affect collection efficiency by interfering with the separation in the connector. The potential for
12
platelet clumping is difficult to predict since it does not always correlate with the patient’s platelet count. If you see
platelet clumping in the connector, perform the following steps:
1 Decrease the inlet:AC ratio to 8:1 until the clump disappears and until the system has processed at least
100 mL of inlet volume.
2 Check the connector for clumping and then perform one of the following steps:
• If the clumping is resolved, consider increasing the inlet:AC ratio to 10:1. Allow the system to process
500 mL to 1,000 mL of inlet volume before you consider increasing the ratio again. Do not increase the
ratio by more than 2.0 for every 500 mL to 1,000 mL of inlet volume processed.
• If the clumping persists, leave the inlet:AC ratio at 8:1 until the clumping disappears or for the remainder
of the run. Some clumps may become clots that are difficult to eliminate. Maintaining the ratio at 8:1 will
help minimize the impact on the collection efficiency.
For additional information about anticoagulation in the tubing set, see “Managing Anticoagulation of the
Extracorporeal Circuit” on page 221.

Spectra Optia Apheresis System Operator’s Manual 175

Granulocyte (PMN) Collection Procedures

176 Spectra Optia Apheresis System Operator’s Manual

 13
White Blood Cell Depletion (WBCD) and
Platelet Depletion (PLTD) Procedures

Spectra Optia Apheresis System Operator’s Manual 177

White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

Functional Description of a White Blood Cell Depletion (WBCD) or a

Platelet Depletion (PLTD) Procedure
During a WBCD or a PLTD procedure, the system pumps the patient’s blood into the tubing set and spins the
centrifuge at the speed required to target the optimal (default) packing factor: 4.5 for a WBCD procedure using
ACD-A, and 20 for a PLTD procedure. The AIM system adjusts the flow rate of the plasma pump to control the
concentration of cells that flow through the collect port (based on the collection preference). When the AIM
system detects cells in the collect port, the system sounds a tone, the collect valve moves into the collect position,
and the collect pump pumps the cells into the collection bag. The plasma pump pumps plasma out of the channel
and into the reservoir. The red blood cells (RBC) are pushed out of the channel and into the reservoir, where they
combine with the plasma for return to the patient.
If the operator chooses to give replacement fluid during the run, the plasma valve periodically moves to the return
position to allow small volumes of replacement fluid to flow by gravity into the reservoir. In the reservoir, the
replacement fluid combines with the RBC and the plasma from the channel. The system manages the volume of
cells collected and fluid replaced according to the fluid balance the operator selects.

Preparing to Perform a Procedure

Supplies
Assemble the supplies listed on page 62 before you begin a procedure. You will also need the following additional
supplies:
• Replacement fluid prescribed by the patient’s physician

Note: Using a filter for the replacement fluid during a WBCD or a PLTD procedure is not recommended. A filter can
slow the flow of the replacement fluid into the reservoir and ultimately to the patient.

Anticoagulant Solutions for WBCD Procedures

You can use ACD-A or a solution that contains hydroxyethyl starch (HES) to perform a WBCD procedure on the
Spectra Optia system.

Using ACD-A
To indicate the use of ACD-A, you must select No for HES on the WBCD configuration screen or on the options
screen. “HES: No” appears on the main run screen as a reminder of your selection. The default packing factor when
ACD-A is used is 4.5.

Using HES
To indicate the use of HES, you must select Yes for HES on the WBCD configuration screen or on the options
screen. “HES: Yes” appears on the main run screen as a reminder of your selection.When using HES, you must add
trisodium citrate to the HES for use as the anticoagulant. The default packing factor when HES is used is 1.6.

Preparing an anticoagulant solution containing HES and trisodium citrate

To prepare the correct anticoagulant solution, add 30 mL to 40 mL of 46.7% trisodium citrate solution to 500 mL
of HES. To prepare an anticoagulant solution with the same concentration as ACD-A, add 38 mL of trisodium
citrate solution to the HES.

178 Spectra Optia Apheresis System Operator’s Manual

 White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

Selecting the Procedure and Loading the Tubing Set

Follow the instructions starting on page 64 to select the procedure and load the tubing set. Before you load the
tubing set, verify that the set and the solutions you are using have not expired by checking the expiration date
printed on the packaging. Do not use an item if the current date is past the expiration date.

13

Spectra Optia Apheresis System Operator’s Manual 179

White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

Navigating the WBCD and PLTD Procedure Screens

Menu Buttons and Tabs

Table 13-1 shows the menu buttons and tabs to use to navigate the screens during a WBCD or a PLTD procedure.
Menu buttons and tabs are active depending on the current operating state. Touch a menu button to display the
corresponding tabs.

Table 13-1: Menu buttons and tabs on WBCD and PLTD procedure screens

Config Data Run End Run

System Patient data Fluid balance Rinseback

Procedure Alarm history Operation status Disconnect

Report Report Collection status Run targets

WBCD or PLTD Strobe

Blood warmer Run values

Options

Descriptions of Buttons, Icons, and Images

See Table 2-14 on page 36 for descriptions of the buttons, icons, and images that can appear on the screen during a
WBCD or a PLTD procedure.

180 Spectra Optia Apheresis System Operator’s Manual

 White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

Entering and Changing Data During the Run

The Spectra Optia system requires that you enter specific data, such as patient data, to perform a WBCD or a
PLTD procedure. The system also allows you to change numerical values for certain operating parameters during
the run. Table 13-2 shows data entry ranges for the operating parameters according to the screen on which each
data entry button appears. To change or enter data, touch the button for the parameter that you want to change. A
data entry pad appears to enable you to enter a number. The data entry pad displays either the established range for
the parameter or the calculated range, if the range changes based on related data. Also, the range for Caution status
is displayed in yellow, if the data you enter could cause the system to operate in Caution status.

Table 13-2: Data entry ranges for WBCD and PLTD procedures

Screen Parameter Range 13

Patient data Sex • Male
• Female

Height:
• ft • 1 to 8
• in • 0 to 11
• cm • 30 to 244

Weight:
• lb • 5 to 500
• kg • 2 to 227

TBV (mL) 300 to 15000

Hct (%) 10 to 70

WBCD procedures: WBC (E3/µL) 1 to 1000

PLTD procedures: Plt (E3/µL) 10 to 7000

Options Rinseback • Yes

• No
• Yes if a custom prime is not
selected
• No if a custom prime is selected

Custom prime • Yes

• No
Default: No

HES • Yes
Selection determines the default packing factor. • No
• Yes: Default packing factor is 1.6
• No: Default packing factor is 4.5

Saline rinse • Yes

• No
Default: No

Blood warmer: Return line • Yes

• No

Blood warmer: Tubing set volume (mL) 1 to 100

Spectra Optia Apheresis System Operator’s Manual 181

White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

Table 13-2: Data entry ranges for WBCD and PLTD procedures (continued)

Screen Parameter Range

Custom prime Fluid type • RBC
• Plasma
• Albumin

RBC unit Hct (%) 25 to 80

Inlet flow rate (mL/min) 5 to 70

Volume (mL) 100 to 400

(Volume should be at least 300 mL
for the patient to receive the full
benefit.)

Run values AC infusion rate (mL/min/L TBV) 0.2 to 2.5

(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if the entered ratio
is not within the recommended range
of 6:1 to 15:1.)

Whole blood processed (mL) Patient’s TBV multiplied by 0.5 to 5

Run time (min) 40 to 480

TBV processed 0.5 to 5

Target fluid balance (mL or %) 70% to 125% of the patient’s TBV

(Caution status applies if the entry
exceeds ± 15% of the patient’s TBV.)

Replacement fluid:
• Fluid type • No fluid
• Plasma
• Saline/Albumin
• RBC
• Custom

• Average Hct of RBC (%) • 10 to 80

• Citrate content (%) of custom fluid • 0 to 25

• Volume (mL) 10 to patient’s TBV

Inlet flow rate (mL/min) 5 to 142

Collect flow rate (mL/min) 0.5 to 25

Default:
• WBCD: depends on the patient’s
WBC count
• PLTD: depends on the patient’s
platelet count

Collect volume: Target (mL) 5 to the patient’s plasma volume

182 Spectra Optia Apheresis System Operator’s Manual

 White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

Table 13-2: Data entry ranges for WBCD and PLTD procedures (continued)

Screen Parameter Range

Main run Packing factor: WBCD procedures 1 to 20
• HES: Yes • Default: 1.6
• HES: No • Default: 4.5

Packing factor: PLTD procedures 1 to 20

Default: 20

Inlet flow rate (mL/min) 5 to 142

Collect flow rate (mL/min)

Collect volume (mL)

0.5 to 25

5 to the patient’s plasma volume

13
AC infusion rate (mL/min/L TBV) 0.2 to 2.5
(Caution status applies if the entry
exceeds 1.2.)

Inlet:AC ratio (__:1) 2 to 50

(Warning appears if the entered ratio
is not within the recommended range
of 6:1 to 15:1.)

Collection status Collection preference 10 to 90

Default: 75 after the interface is
established

Run targets Run time (min) 40 to 480

Whole blood processed (mL) Patient’s TBV multiplied by 0.5 to 5

TBV processed 0.5 to 5

Collection bag (mL) 5 to the patient’s plasma volume

Rinseback Return flow rate (mL/min) 2 to 100

Default: inlet flow rate that was in
use when the run ended or
100 mL/min, whichever is slower

Spectra Optia Apheresis System Operator’s Manual 183

White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

Entering and Confirming Patient and Procedure Data

This section contains instructions for entering patient data and reviewing and confirming run values. You can enter
the data after you select the procedure and before you connect the patient. It is important that the data you enter be
as accurate and as current as possible.

Note: When you are required to enter numerical data, the system displays a data entry pad for entering the data. The
acceptable numerical range appears on the data entry pad.

Entering Patient Data

1 Touch the buttons on the screen to enter the following information:
• Sex
• Height
• Weight
• Hematocrit (Hct)
• WBCD procedures: WBC count
• PLTD procedures: Platelet count
The Spectra Optia system uses the sex, height, and weight to calculate the patient’s TBV. See page 266 for the
formula the system uses to calculate this value. If you prefer not to use the TBV that the system calculated,
touch TBV and enter a different volume. The operator override icon ( ) will appear on the button.

Note: If the patient weighs less than 25 kg (approximately 55 lb), the system does not calculate a TBV. You
must calculate and enter the appropriate TBV for the patient.

2 Touch Confirm. The run values screen appears.

Reviewing and Confirming the Run Values and the Fluid Data
1 Review the run values that appear on the screen and confirm that they are correct. The run targets for a
WBCD procedure or a PLTD procedure are listed below. A black frame appears around the button of the
primary run target.
• Whole blood processed (mL)
• TBV processed
• Run time (min)
• Collect volume: Target (mL)
If you change a value, the color of the value on the button changes from white to yellow. Values that were
affected by a change appear with a yellow arrow. The arrow points up or down to indicate an increase or
decrease in the value as a result of the change.

Note: Only the color of the last value you changed remains yellow. The values you previously changed revert to
white.

184 Spectra Optia Apheresis System Operator’s Manual

 White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

2 Review the target fluid balance and the replacement fluid data. To select replacement fluid to use during the
run and to change the target fluid balance, proceed to “Entering and changing the fluid data” below.

Note: You must use replacement fluid if the data you entered results in a target fluid balance of less than 70% of the
patient’s TBV.

3 When you are finished reviewing the run values and the fluid data, touch Confirm.

Entering and changing the fluid data

Follow the instructions below to select the replacement fluid, to enter the replacement fluid volume, and to change
the target fluid balance.

Entering the replacement fluid data

13
If you choose to give replacement fluid to the patient during the run, perform the following steps to select the type
of replacement fluid and to enter the volume:
1 Touch the button for the replacement fluid. A list of replacement fluid types appears.
2 Select one of the replacement fluid types listed below by touching the corresponding button on the screen.
The replacement fluid type you select and the applicable citrate content (%) or average hematocrit (%)
appear on the button:
• No Fluid (default)
• Plasma
– The system assumes that the plasma contains 15% citrate.
• Saline/Albumin
– The system assumes that the saline/albumin contains 4% citrate.
• RBC
– A data entry pad appears for you to enter the average hematocrit (%) of the fluid.
– The system assumes that the portion of the replacement fluid that is not RBC contains 19% citrate.
• Custom
– The system uses the citrate content that was entered on the WBCD or PLTD configuration screen. A
data entry pad appears to allow you to change the citrate content (%) of the fluid for the current
procedure only.
3 Touch the volume button. A data entry pad appears.
4 Enter the volume of the replacement fluid. The system calculates and displays the target fluid balance.

Spectra Optia Apheresis System Operator’s Manual 185

White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

Changing the target fluid balance

The system uses configuration settings and the patient data you entered to calculate the target fluid balance for the
patient at the end of the procedure. To change the target fluid balance, you must first select the type of replacement
fluid to use during the run. Perform the following steps to change the target fluid balance:
1 To enter the target fluid balance as a percentage, touch the percent (%) button. To enter it as a volume, touch
the volume (mL) button. A data entry pad appears.
2 Enter the new target fluid balance. The value you enter appears on the button. The system calculates and
displays the volume of replacement fluid required to achieve the target fluid balance.

Note: If you enter the target fluid balance as a percentage, the system calculates and displays the
corresponding volume on the volume button. The reverse applies if you enter the target fluid balance as a volume.

186 Spectra Optia Apheresis System Operator’s Manual

 White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

Priming the Inlet Line and the Return Line

Warning: When connecting a blood warmer tubing set to the return line, ensure that the tubing connection is
tight. Put the luer connection no higher than 20 in (50 cm) above the return access to prevent the possibility of air
entering the tubing.

Warning: If you are using a blood warmer on the return line, ensure that you completely prime the blood warmer
tubing set to remove all the air in the set before you connect the patient.

1 Follow the instructions on the screen to prime the inlet line and the return line. If you are using a blood
warmer on the return line, follow the instructions on the screen to connect and prime the blood warmer
tubing set.
13
2 Touch Confirm. The screen appears with instructions for connecting the patient and starting the run.

Positioning the IV Pole and the Replacement Fluid Container

If you are using replacement fluid during the run, confirm that the IV pole is raised to the highest level and hang
the replacement fluid container as high as possible on the pole, so that the fluid flows freely through the replace line
and into the reservoir.

Connecting the Patient and Starting the Run

Warning: Before connecting the patient, check the inlet and return lines for air. If air is present in the lines,
remove the air before connecting the patient.

1 Follow the instructions below and on the screen to connect the patient.
• If you are performing a peripheral venipuncture, see “Collection Set and IDL Set: Additional Instructions
for Use” on page 269 for instructions on using the needle protector.
• If you are performing a peripheral venipuncture and want to use the diversion bag on the inlet line, see
“Using the Diversion Bag to Collect a Sample From a Venipuncture” on page 269 for instructions.
2 Touch Start Run. The system begins drawing the patient’s blood into the tubing set. The main run screen
appears and the system diverts approximately 40 mL of saline that was used to prime the tubing set into the
saline container.

Note: If you performed a custom prime, the system does not perform the step to divert the saline. The saline was
removed from the set during the custom prime.

Spectra Optia Apheresis System Operator’s Manual 187

White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

Monitoring the Run

The system displays information on the screens to help you monitor the progress of the run. To access the screens,
touch the Run menu button and then the tab for the screen you want to view. Be sure to verify that the volumes
displayed on the screens are consistent with the actual volumes in the fluid containers and in the bags.
See “Glossary of Terms” on page 278 for descriptions of the buttons on the screens.

Main Run Screen

The main run screen is the default run screen and displays or provides access to the information you most likely
need to monitor the run. If you want to return to the main run screen after viewing a different screen, touch the go
back button, the active menu button, or the tab for the current screen. There is no tab for the main run screen.

Collection Status Screen

To access the collection status screen, touch the Collection Status tab. Use this screen to monitor the progress of
the run and to adjust the collection preference. You can also use this screen to change the position of the collect
valve to immediately direct the flow of cells in the collect line into the reservoir for return to the patient, if
necessary.

Collection preference
The collection preference is a reference number that the system uses to adjust the plasma pump flow rate, which
affects the concentration of cells that flow through the collect port. You can use the up and down arrows to change
the collection preference during the run to accommodate the conditions of the patient’s blood and achieve the
desired outcome of the procedure.
The default collection preference for WBCD and PLTD procedures is 75. While establishing the initial interface or
while re-establishing the interface after a pump pause or a centrifuge stop, the system targets a higher preference to
avoid collecting non-target cells before the interface is stable. The collection preference that the system targets
depends on whether or not you change the preference before the interface is established.
• If you do not change the collection preference, the system targets a collection preference of 85.
• If you change the collection preference, the system targets a collection preference that is about 10 points
higher than the number that you selected, but is not less than a preference of 65.
Once the interface is established, the system gradually decreases the collection preference either to the default or to
the number that you selected. For more information about optimizing the collection preference during the run, see
“Optimizing the Collection Preference” on page 190.

Trend graph
The trend graph represents an area of the buffy coat that is in the connector. The horizontal black line on the graph
indicates the current collection preference. The green diamonds indicate the concentration of cells flowing through
the collect port as compared to the collection preference.
If the system is unable to collect cells at the target collection preference, the green diamonds could appear above or
below the black line. As long as the diamonds appear in a controlled path within 20 units either above or below the
line, the run is progressing as intended.

Return to patient and collect into bag buttons

The position of the collect valve determines whether the system is directing the flow of cells from the collect line
back to the patient or into the collection bag. The system indicates the current position of the collect valve by
showing the corresponding button on this screen in a touched (lowered) position. You may manually change the
position of the collect valve at any time during the run.

188 Spectra Optia Apheresis System Operator’s Manual

 White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

• To direct the flow of cells from the collect line back to the patient, touch the return to patient button and then
touch Apply. The collect valve moves into the return position, and the system begins pumping the cells into
the reservoir for return to the patient.

Note: If you touch the return to patient button, the system operates in Caution status because cells are not
being collected. The collect valve stays in the return position until you touch the collect into bag button.

• To direct the flow of cells in the collect line into the collection bag, touch the collect into bag button and then
touch Apply. The collect valve moves into the collect position and the system begins pumping the cells into
the collection bag.

Monitoring the Patient

13
Managing Citrate Toxicity
If the patient experiences citrate toxicity, perform the following steps:
1 Touch the pause button to pause the pumps. An alarm occurs indicating that the procedure was paused and
the pumps were stopped.
2 Notify the attending physician of the patient’s condition according to your facility’s standard operating
procedures.
3 Touch the go back button to go to the main run screen, and decrease the AC infusion rate as desired.
4 Touch the active alarm button to return to the alarm screen, and then touch Continue. The run values
screen appears.
5 Review the run values and confirm that they are correct.
6 Touch Confirm to resume the procedure.
7 If decreasing the AC infusion rate does not alleviate the symptoms, touch the pause button to pause the
pumps again, and notify the attending physician.

Spectra Optia Apheresis System Operator’s Manual 189

White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

Optimizing the Run

Facilitating the Flow of Replacement Fluid

During WBCD and PLTD procedures, replacement fluid is delivered by gravity. The system does not pump the
fluid into the reservoir. To facilitate the flow of the replacement fluid, perform the following steps:
• Make sure that the IV pole from which the replacement fluid hangs is fully extended to maximize the effect of
gravity.
• Confirm that the frangible connector on the replace line is completely broken so that it does not obstruct the
fluid flow.
• Fill the drip chamber on the replace line so that it is nearly full to prevent the formation of bubbles in the line.
• Remove any air bubbles you see in the replace line.

Improving the flow of replacement fluid contained in bottles

Fluid contained in bottles might not flow as well by gravity as fluid contained in bags because bottles are not
vented. If the replacement fluid you are using is contained in a bottle, perform the following steps when spiking the
bottle to help improve the flow:
1 Squeeze and hold the drip chamber on the spike on the replace line.
2 Continue squeezing the drip chamber as you spike the bottle. Do not stop squeezing the drip chamber until
you invert the bottle and see that the spike is immersed in fluid.
3 Release the drip chamber. It should fill with fluid.

Optimizing the Collection Preference

The collection preference controls the concentration of cells that flow through the collect port. You can use the up
and down arrows on the screen to increase or decrease the collection preference during the run to accommodate the
patient's condition and to achieve your procedure goals. Consider the following guidelines when adjusting the
collection preference, keeping in mind that the patient's cell counts affect the contents of the collection:
• Use a low collection preference to increase the concentration of cells in the collect port. The system adjusts the
plasma pump flow rate so that it collects more deeply in the buffy coat. This maximizes the yield of target cells
but could increase RBC contamination of the collected product.
• Use a high collection preference to decrease the concentration of cells in the collect port. The system adjusts
the plasma pump flow rate so that it collects more shallowly in the buffy coat. This helps to minimize RBC
contamination of the collected product but could result in a lower yield of target cells.

190 Spectra Optia Apheresis System Operator’s Manual

 White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

Monitoring the contents in the collect line and adjusting the color
Monitor the collect line where it exits the centrifuge below the cassette, and use the collection preference to adjust
the color of the contents in the line. To accurately evaluate the color, you should allow the collect pump to process
1 mL to 2 mL of volume before making an additional adjustment.
The Collection Preference Tool can help you evaluate which color is appropriate for the procedure. If the contents
in the line look either too light or too dark, consider making adjustments to the run according to the following
guidelines:
• Color is too light:
• Decrease the collection preference. This increases the concentration of cells that flow through the collect
port.
• Verify that you have entered an accurate WBC count or platelet count.
13
• Reset the collect pump flow rate to the default flow rate. When the collect pump flow rate is too slow, cells
can accumulate in the connector, making it difficult to collect cells that are deeper in the buffy coat.
• Color is too dark:
• Increase the collection preference. This decreases the concentration of cells that flow through the collect
port.

Minimizing Buffy Coat Accumulation

A buffy coat can accumulate in the connector for several reasons. To minimize accumulation of a buffy coat,
consider performing one of the following steps:
• Avoid pausing the pumps and conditions that cause the pumps to pause, such as alarm conditions. After the
pumps restart, it takes time for the collect pump flow rate to reach the target speed, which slows the collection
of cells from the connector.
• Increase the collect pump flow rate, especially if it is currently slower than the default flow rate established by
the system. Increase the flow rate in increments of 0.1 mL/min until the buffy coat stops accumulating.
• Decrease the collection preference. The interface may not be high enough to allow the system to collect the
buffy coat.

Targeting a Lower Collect Volume

If the predicted collect volume is higher than desired or the procedure goal is a specific volume in the collection
bag, consider performing one of the following steps, keeping in mind that either step will decrease the collection
efficiency:
• Decrease the collect pump flow rate. This decreases the collect volume without affecting the inlet volume
processed. It also decreases the need for replacement fluid.
As a result, the concentration of cells in the connector could increase, so you should monitor the connector for
buffy coat accumulation. Consider waiting to decrease the collect pump flow rate until after one TBV has
been processed and the patient’s cell count could be lower.
• Enter a target collect volume. The collect volume becomes the run target. The system processes less inlet
volume and therefore the run is shorter.

Spectra Optia Apheresis System Operator’s Manual 191

White Blood Cell Depletion (WBCD) and Platelet Depletion (PLTD) Procedures

Addressing Clumping in the Connector

Clumping can affect collection efficiency by interfering with the separation in the connector. The potential for
platelet clumping is difficult to predict, since it does not always correlate with the patient’s platelet count. If you see
platelet clumping in the connector, perform the following steps:
1 Decrease the inlet:AC ratio to 8:1 until the clump disappears and until the system has processed at least
100 mL of inlet volume.
2 Check the connector for clumping and then perform one of the following steps:
• If the clumping is resolved, consider increasing the inlet:AC ratio to 10:1. Allow the system to process
500 mL to 1000 mL of inlet volume before you consider increasing the ratio again. Do not increase the
ratio by more than 2.0 for every 500 mL to 1,000 mL of inlet volume processed.
• If the clumping persists, leave the inlet:AC ratio at 8:1 until the clumping disappears or for the remainder
of the run. Some clumps may become clots that are difficult to eliminate. Maintaining the ratio at 8:1 will
help minimize the impact on the collection efficiency.
For additional information about anticoagulation in the tubing set, see “Managing Anticoagulation of the
Extracorporeal Circuit” on page 221.

192 Spectra Optia Apheresis System Operator’s Manual

 14
Bone Marrow Processing (BMP)
Procedures

Spectra Optia Apheresis System Operator’s Manual 193

Bone Marrow Processing (BMP) Procedures

Functional Description of a Bone Marrow Processing (BMP)

Procedure
The BMP procedure is intended for bone marrow processing for the purpose of hematopoietic reconstitution.
During a BMP procedure, the system pumps bone marrow from the bone marrow processing (BMP) bag into the
tubing set channel and spins the centrifuge at the speed required to target the optimal (default) packing factor of
20. The AIM system adjusts the flow rate of the plasma pump to control the concentration of cells that flow
through the collect port (based on the collection preference). The BMP bag must contain at least 125 mL of RBC
for the system to establish an interface that is high enough to collect cells. When the AIM system detects cells in the
collect port, the system sounds a tone, the collect valve moves into the collect position, and the collect pump
pumps the cells into the collection bag. The plasma pump pumps plasma out of the channel and either into the
reservoir or into the plasma bag, if plasma collection is targeted. The red blood cells (RBC) are pushed out of the
channel and into the reservoir where they combine with the plasma for return to the BMP bag for additional
processing.

Preparing to Perform a Procedure

Supplies
Assemble the supplies listed on page 62 before you begin a procedure. You will also need the following additional
supplies:
• Spectra Optia® BMP Accessory Set
Optional supplies:
• Blood administration set with a male luer connector and the appropriate size filter for filtering clots, bone
chips, and debris from the bone marrow
• Sterile tubing welder with the appropriate replacement wafers

Filtering the Bone Marrow

Filter the bone marrow according to your facility’s standard operating procedure. The bone marrow must be filtered
to remove fat, bone particles, and cellular debris before it is processed. The 200-micron filter on the administration
line in the BMP Accessory Set may be used for additional filtration, if desired.

Adding ACD-A to the Bone Marrow

The bone marrow must be adequately anticoagulated before processing to prevent clumping in the tubing set. The
recommended ratio of bone marrow to ACD-A is 10:1. Perform the following steps to calculate the necessary
volume of ACD-A and to add it to the bone marrow:
1 Determine the tare weight of the bag containing the bone marrow.
2 Weigh the bag of bone marrow (BM bag).
3 Calculate the bone marrow (BM) volume:
BM bag weight – bag tare weight-
------------------------------------------------------------------------------- = BM volume (mL)
1.058

194 Spectra Optia Apheresis System Operator’s Manual

 Bone Marrow Processing (BMP) Procedures

4 Calculate the volume of ACD-A to add to the BM bag:

BM volume (mL)-
----------------------------------------- = ACD-A (mL)
10

5 Add the ACD-A volume from step 4 to the BM bag and mix the contents of the bag thoroughly.
6 Calculate the total BM volume (BMV) to enter on the BM data screen during the procedure:
BM volume (mL) + ACD-A (mL) = BMV (mL)

7 Measure the hematocrit (Hct) of the bone marrow in the BM bag. This is the Hct you enter on the BM data
screen during the procedure.

Transferring the Bone Marrow Into the BMP Accessory Set

Perform the following steps to transfer the bone marrow from the BM bag into the BMP Accessory Set:
1
2
Verify that the accessory set has not expired by checking the expiration date on the cover of the package.
Open the package containing the accessory set and unpack the contents.
14
3 Unfold the BMP bag and lay it on a flat surface.
4 Clamp the following lines of the accessory set:
• Inlet line (red clamp)
• Sample bulb assembly (white clamp)
• Lines to both spikes (white clamps) on the administration line
• Both lines (white clamps) of the luer connector assembly
• Return line (blue clamp)
5 Connect the BM bag to the administration line using one of the following two methods:
• Spike the BM bag using one of the spikes on the administration line. The 200–micron filter on the line to
the spike provides additional filtration.
• Connect the BM bag to the luer connector assembly on the administration line. If the bone marrow
requires filtration, use a blood administration set with the appropriate size filter to connect the bag to the
luer connector.
6 Unclamp the line to the spike or on the line of the luer connector assembly on the administration line.
7 Hang or hold the BM bag above the BMP bag and transfer the bone marrow.
8 Seal the administration line below the luer connector on the inlet line (Figure 14-1). You must seal the line
below the connector, or you will not be able to connect the BMP bag to the inlet line of the tubing set.

Spectra Optia Apheresis System Operator’s Manual 195

Bone Marrow Processing (BMP) Procedures

9 Remove the administration line and the BM bag. Discard the line and the bag according to your facility’s
standard operating procedure.

Figure 14-1: Correct location to seal the administration line on the BMP Accessory Set

Selecting the Procedure

Follow the instructions on page 64 to select the procedure.

Preparing the Tubing Set for Plasma Collection When Using an IDL Set With Catalog
Number 10300
If you configured the system to collect plasma and you are using an IDL Set with the catalog number 10300, a
screen appears before you load the tubing set instructing you to prepare the tubing set for plasma collection.
Unpack the tubing set, and then either spike the plasma bag on the replace line of the tubing set or use a sterile
tubing welder to connect the plasma bag to the replace line. Using a sterile tubing welder to connect the plasma bag
helps to maintain a functionally closed system.

Spiking the plasma bag on the replace line

Seal or clamp the plasma bag line, and then follow the instructions on the screen.

Using a sterile tubing welder to connect the plasma bag to the replace line
Connect the plasma bag line to the replace line between the frangible connector and the cassette of the tubing set.
Follow the manufacturer’s instructions for using the sterile tubing welder.

Loading and Priming the Tubing Set

Verify that the tubing set and the saline solution you are using have not expired by checking the expiration date
printed on the packaging. Do not use an item if the current date is past the expiration date. Then follow the
instructions starting on page 65 to load and prime the tubing set.
The AC line is not used during a BMP procedure. After you load the tubing set, follow the instructions on the
screen to seal the AC line. This AC line should be sealed to prevent air from entering the set.

196 Spectra Optia Apheresis System Operator’s Manual

 Bone Marrow Processing (BMP) Procedures

Navigating the BMP Procedure Screens

Menu Buttons and Tabs

Table 14-1 shows the menu buttons and tabs to use to navigate the screens during a BMP procedure. Menu buttons
and tabs are active depending on the current operating state. Touch a menu button to display the corresponding
tabs.

Table 14-1: Menu buttons and tabs on BMP procedure screens

Config Data Run End Run

System BM data Operation status Rinseback

Procedure Alarm history Collection status Disconnect

Report

BMP
Report Strobe

Run values
Run targets
14
Options

Descriptions of Buttons, Icons, and Images

See Table 2-14 on page 36 for descriptions of the buttons, icons, and images that can appear on the screen during a
BMP procedure.

Spectra Optia Apheresis System Operator’s Manual 197

Bone Marrow Processing (BMP) Procedures

Entering and Changing Data During the Run

The Spectra Optia system requires that you enter specific data, such as BM data, to perform a BMP procedure. The
system also allows you to change numerical values for certain operating parameters during the run. Table 14-2
shows data entry ranges for the operating parameters according to the screen on which each data entry button
appears. To change or enter data, touch the button for the parameter that you want to change. A data entry pad
appears to enable you to enter a number. The data entry pad displays either the established range for the parameter
or the calculated range, if the range changes based on related data. Also, the range for Caution status is displayed in
yellow, if the data you enter could cause the system to operate in Caution status.

Table 14-2: Data entry ranges for BMP procedures

Screen Parameter Range

BM data BMV (mL) 300 to 3000

Hct (%) 10 to 50

Options Rinseback • Yes

• No
Default: Yes

Saline rinse • Yes

• No
Default: No

Collect plasma • Yes

• No

Run values BM processed (mL) BMV multiplied by 4 to 10

Default: BMV multiplied by the
number of BM cycles.
(Minimum volume depends on the
volume of RBC in the BMP bag.)

BM cycles 4 to 10
(Minimum number of cycles depends
on the volume of RBC in the BMP
bag.)

Inlet flow rate (mL/min) 20 to 142

Plasma volume (mL): Target 0 to 500

Collect flow rate (mL/min) 1 to 5

Default: inlet pump flow rate
multiplied by 0.0167

Collect volume (mL): Target Up to 500

Main run Packing factor 1 to 20

Default: 20

Inlet flow rate (mL/min) 20 to 142

Collection status Collection preference 10 to 90

Default: 50 after the interface is
established

198 Spectra Optia Apheresis System Operator’s Manual

 Bone Marrow Processing (BMP) Procedures

Table 14-2: Data entry ranges for BMP procedures (continued)

Screen Parameter Range

Run targets BM processed (mL) BMV multiplied by 4 to 10
(Minimum volume depends on the
volume of RBC in the BMP bag.
Default is the BMV multiplied by the
number of BM cycles.)

BM cycles 4 to 10
(Minimum number of cycles depends
on the volume of RBC in the BMP
bag.)

Collection bag (mL) Up to 500

Rinseback
Plasma bag (mL)

Return flow rate (mL/min)

0 to 500

2 to 100
Default: inlet flow rate that was in
14
use when the run ended or
100 mL/min, whichever is slower

Spectra Optia Apheresis System Operator’s Manual 199

Bone Marrow Processing (BMP) Procedures

Entering and Confirming Bone Marrow (BM) and Procedure Data

This section contains instructions for entering the BM data and reviewing and confirming the run values. You can
enter the data after you select the procedure and before you connect the BMP bag. It is important that the data you
enter be as accurate as possible.

Note: When you are required to enter numerical data, the system displays a data entry pad for entering the data. The
acceptable numerical range appears on the data entry pad.

Entering BM Data
1 Touch the buttons on the screen to enter the following information:
• BMV (mL)
• Hematocrit (Hct)
The BMP bag must contain at least 125 mL of RBC. The tubing set channel must contain enough RBC for
the system to establish an interface that is high enough for cells to be pumped into the collect line. If the bag
contains less than 125 mL, the system displays instructions for either increasing the RBC volume or
discontinuing the procedure.
2 Touch Confirm. The run values screen appears.

Reviewing and Confirming the Run Values

1 Review the run values that appear on the screen and confirm that they are correct. The run targets for a BMP
procedure are listed below. A black frame appears around the button of the primary run target.
• BM processed (mL)
• BM cycles
• Collect volume: Target (mL)
If you configured the system to collect plasma, the default volume of plasma appears on the button for the
target volume. The default target volume is equal to the collect volume.
If you change a value, the color of the value on the button changes from white to yellow. Values that were
affected by a change appear with a yellow arrow. The arrow points up or down to indicate an increase or
decrease in the value as a result of the change.

Note: Only the color of the last value you changed remains yellow. The values you previously changed revert to
white.

2 When you are finished reviewing the run values, touch Confirm.

200 Spectra Optia Apheresis System Operator’s Manual

 Bone Marrow Processing (BMP) Procedures

Preparing to Start the Run

Follow the instructions below and on the screens to connect the BMP bag to the tubing set and to prime the inlet
line.

Connecting the BMP Bag to the Tubing Set

1 Lay the BMP bag lower than the saline container.
2 Connect the inlet and return lines on the BMP bag to the inlet and return lines on the tubing set using one
of the following two methods:
• Use the luer connectors on the inlet and return lines to connect the BMP bag to the tubing set. Verify that
the luer connections are secure and that the connections do not leak.
• Use a sterile tubing welder to connect the BMP bag to the tubing set. Follow the manufacturer’s
instructions for using the sterile tubing welder. Using a sterile tubing welder to connect the BMP bag helps
to maintain a functionally closed system. 14
3 Touch Confirm.

Priming the Inlet Line

1 Unclamp the inlet line and prime the line. Be sure to prime the inlet line through the port on the BMP bag.
Be careful not to add more saline than is necessary to the BMP bag to prime the inlet line.
2 Close the inlet saline line only.
3 Touch Confirm.

Starting the Run

1 Follow the instructions on the screen to hang the BMP bag and ensure that it is not creased. Be sure to hang
the BMP bag on the back hooks of the IV pole, and use each eyelet on the bag and one eyelet per hook.
Remove any creases in the BMP bag so that the cells can circulate freely in the bag.

Note: You must hang the BMP bag on the back hooks of the IV pole. The front hooks cannot properly
accommodate the bag.

2 Touch Start Run. The system begins drawing the bone marrow into the tubing set. The main run screen
appears, and the system diverts approximately 40 mL of saline used to prime the tubing set into the saline
container.

Mixing the Contents of the BMP Bag During the Run

Mixing the contents of the BMP bag helps incorporate the saline coming into the bag from the return line and
prevents the cellular components from settling in areas of the bag. Gently mix the contents several times during
each BM cycle. When mixing, leave the bag hanging on the IV pole and avoid drawing air into the inlet line.

Spectra Optia Apheresis System Operator’s Manual 201

Bone Marrow Processing (BMP) Procedures

Monitoring the Run

The system displays information on the screens to help you monitor the progress of the run. To access the screens,
touch the Run menu button and then the tab for the screen you want to view. Be sure to verify that the volumes
displayed on the screens are consistent with the actual volumes in the fluid containers and in the bags.
See “Glossary of Terms” on page 278 for descriptions of the buttons on the screens.

Main Run Screen

The main run screen is the default run screen and displays or provides access to the information you most likely
need to monitor the run. If you want to return to the main run screen after viewing a different screen, touch the go
back button, the active menu button, or the tab for the current screen. There is no tab for the main run screen.

Collection Status Screen

To access the collection status screen, touch the Collection Status tab. Use this screen to monitor the progress of
the run and to adjust the collection preference. You can also use this screen to change the position of the collect
valve to immediately direct the flow of cells in the collect line into the reservoir for return to the BMP bag, if
necessary.

Collection preference
The collection preference is a reference number that the system uses to adjust the plasma pump flow rate, which
affects the concentration of cells that flow through the collect port. You can use the up and down arrows to change
the collection preference during the run to accommodate the conditions of the bone marrow and achieve the
desired outcome of the procedure.
The default collection preference for a BMP procedure is 50. While establishing the initial interface or while
re-establishing the interface after a pump pause or a centrifuge stop, the system targets a higher preference to avoid
collecting non-target cells before the interface is stable. The collection preference that the system targets depends
on whether or not you change the preference before the interface is established.
• If you do not change the collection preference, the system targets a collection preference of 70.
• If you change the collection preference, the system targets a collection preference that is about 10 points
higher than the number that you selected, but is not less than a preference of 70.
Once the interface is established, the system gradually decreases the collection preference either to the default or to
the number that you selected. For more information about optimizing the collection preference during the run, see
“Optimizing the Collection Preference” on page 204.

Trend graph
The trend graph represents an area of the buffy coat that is in the connector. The horizontal black line on the graph
indicates the current collection preference. The green diamonds indicate the concentration of cells flowing through
the collect port as compared to the collection preference.
If the system is unable to collect cells at the target collection preference, the green diamonds could appear above or
below the black line. As long as the diamonds appear in a controlled path within 20 units either above or below the
line, the run is progressing as intended.

202 Spectra Optia Apheresis System Operator’s Manual

 Bone Marrow Processing (BMP) Procedures

Return to BMP bag and collect into bag buttons

The position of the collect valve determines whether the system is directing the flow of cells in the collect line back
to the BMP bag or into the collection bag. The system indicates the current position of the collect valve by showing
the corresponding button on this screen in a touched (lowered) position. You may manually change the position of
the collect valve at any time during the run.
• To direct the flow of cells in the collect line back to the BMP bag, touch the return to BMP bag button and
then touch Apply. The collect valve moves into the return position, and the system begins pumping the cells
into the reservoir for return to the BMP bag.

Note: If you touch the return to BMP bag button, the system operates in Caution status because cells are not
being collected. The collect valve stays in the return position until you touch the collect into bag button.

• To direct the flow of cells in the collect line into the collection bag, touch the collect into bag button and then
touch Apply. The collect valve moves into the collect position and the system begins pumping the cells into
the collection bag. 14

Spectra Optia Apheresis System Operator’s Manual 203

Bone Marrow Processing (BMP) Procedures

Optimizing the Run

Optimizing the Collection Preference

The collection preference controls the concentration of cells that flow through the collect port. You can increase or
decrease the collection preference during the run to accommodate the condition of the bone marrow and to achieve
your procedure goals. Consider the following guidelines when changing the collection preference:
• Decrease the collection preference to collect as many target cells as possible. This may result in greater RBC
contamination of the collected product.
• Increase the collection preference to minimize RBC contamination of the collected product. This may result
in a lower yield of target cells.

Monitoring the contents in the collect line and adjusting the color
Monitor the collect line where it exits the centrifuge below the cassette, and use the collection preference to adjust
the color of the contents in the line.
The Collection Preference Tool can help you evaluate which color is appropriate for the procedure. If the contents
in the line look either too light or too dark, consider changing the collection preference according to the following
guidelines:
• If the color is too light, decrease the collection preference. This increases the concentration of cells that flow
through the collect port.
• If the color is too dark, increase the collection preference. This decreases the concentration of cells that flow
through the collect port.

Addressing Clumping in the Connector

Clumping can affect collection efficiency by interfering with the separation in the connector. Clumping and the
formation of clots can occur during a BMP procedure if the bone marrow was not adequately anticoagulated using
ACD-A. If you see clumping in the connector, verify that the appropriate amount of ACD-A was added to the BM
bag. If the clumping persists, consider adding ACD-A to the BMP bag.

Reducing the Concentration of Platelets in the Collection Bag

Decreasing the packing factor reduces the volume of platelets flowing into the collection bag. If the concentration
of platelets in the collection bag is higher than desired, consider decreasing the packing factor to 4.5 to help reduce
the concentration.

204 Spectra Optia Apheresis System Operator’s Manual

 Bone Marrow Processing (BMP) Procedures

Changing the Target Plasma Volume

The system collects the target plasma volume after the other run targets have been attained. The plasma valve
moves into the collect position, and the system pumps plasma into the plasma bag. A message appears on the
message bar indicating that the plasma collection is in process. When the plasma collection is complete, the plasma
valve moves into the return position.
If you decide to collect plasma and you did not previously configure the procedure for plasma collection or select
the option to collect plasma, perform the following steps:
1 Touch the target button for the plasma bag, and enter the desired volume. The screen appears instructing you
to prepare the tubing set for plasma collection.
2 If you are using an IDL Set with catalog number 10300, spike the plasma bag to the tubing set, or connect
the plasma bag according to the instructions under “Using a sterile tubing welder to connect the plasma bag
to the replace line” on page 196. The run values screen appears.
3 Touch Confirm. The run targets screen appears and the system collects that target plasma volume.

Concentrating the RBC in the BMP Bag

14
To concentrate the RBC in the BMP bag, remove as much plasma as possible from the BMP bag. Follow the
instructions under “Changing the Target Plasma Volume” above and enter the maximum volume of plasma
available to collect. The maximum volume is displayed in the volume range on the data entry pad. This volume is
based on the volume of plasma required to maintain a maximum Hct of 65% in the BMP bag.

Spectra Optia Apheresis System Operator’s Manual 205

Bone Marrow Processing (BMP) Procedures

206 Spectra Optia Apheresis System Operator’s Manual

 15
Ending the Run and
Completing the Procedure

Spectra Optia Apheresis System Operator’s Manual 207

Ending the Run and Completing the Procedure

Ending the Run Before a Run Target is Attained

Warning: Terumo BCT does not recommend performing rinseback during RBCX procedures. The data that the
system uses to predict the run targets does not include rinseback volume. If rinseback is performed, the run
targets may not be accurate.

If you decide to end the run before a run target is attained, perform the following steps:
1 Touch the End Run menu button.
2 Choose one of the following options:
• To perform rinseback, touch the Rinseback tab.
• To skip rinseback, touch the Disconnect tab.
3 Follow the instructions on the screens to complete the procedure and disconnect the patient.

Ending the Run After a Run Target is Attained

The run targets screen appears and the system sounds a tone when one or more run targets have been attained. The
screen displays the target and current values of the run targets. The volume of AC in the product bags is also
displayed on the screens of the collection procedures. A yellow frame around a current value indicates that the run
target was attained. Review the run targets and decide to end or extend the run.

Ending the Run

Perform the following steps to end the run:
1 Touch Rinseback and follow the instructions on the screen to confirm your selection.
• If you are not performing rinseback, touch Disconnect and follow the instructions on the screen to
confirm your selection.
• If you decide not to perform rinseback, follow the instructions to skip rinseback under “Ending the Run
Before a Run Target is Attained” above.
2 Follow the instructions on the screen to clamp the inlet line.
3 Touch Continue. The system tests the pressure in the inlet line.
4 Follow the instructions on the screen to open the inlet saline line and to clamp and then seal the lines to the
product bags. See “Sealing the lines using the Seal Safe System” on page 210 for instructions on using the
Seal Safe system.
Caution: When performing a collection procedure using the Collection Set or the IDL Set, seal the collect line above the T-
shaped connector to the plasma line as shown in the illustration below. If you seal the collect line below the connector, the cells
in the collection bag could flow back into the tubing set when the system raises the cassette.

208 Spectra Optia Apheresis System Operator’s Manual

 Ending the Run and Completing the Procedure

5 Touch Continue. The screen that shows the status of rinseback appears.
6 When rinseback is complete, follow the instructions under “Completing the Procedure” to disconnect the
patient and complete the procedure.

Extending the Run

Perform the following steps to extend the run:
1 Touch the button for the run target that you want to increase, and enter a new value for the target on the data
entry pad. The run values screen appears.
2 Review the run values.
3 Touch Confirm. The system resumes the run. When the new run target is attained, the run targets screen
reappears.
4 Follow the instructions on the screens to disconnect the patient and complete the procedure.

15

Spectra Optia Apheresis System Operator’s Manual 209

Ending the Run and Completing the Procedure

Completing the Procedure

Disconnecting the Patient and Sealing the Lines

Follow the instructions on the screen to disconnect the patient or the BMP bag, seal the lines to the fluid
containers and the bags, and raise the cassette. See “Sealing the lines using the Seal Safe System” below for
instructions on using the Seal Safe system. The system confirms that the saline lines are closed and the inlet and
return lines are clamped. The system then raises the cassette. The procedure summary screen appears.

Sealing the lines using the Seal Safe System

Warning: Ensure that the sealer head and the tubing are free of moisture and debris before using the Seal Safe
system.

Warning: Do not seal the tubing within 8 cm (3 in) of the needle, or you may cause a burn at the needle entry
point.

Warning: Do not place your fingers within 2.5 cm (1 in) of the Seal Safe system’s sealing jaw, or you may
receive a radio frequency (RF) burn.

Caution: Use the Seal Safe system only on tubing distributed by Terumo BCT. The Seal Safe system may not
perform as expected on other tubing.

Perform the following steps to seal the lines to the fluid containers and the bags using the Seal Safe system:
1 Hold the sealer head in the palm of your hand with your fingers on the plastic cover of the lever, so that the
jaws open facing upward and you can see the indicator light on the head (Figure 15-1).

Figure 15-1: Hold the sealer head with jaws open facing upward

210 Spectra Optia Apheresis System Operator’s Manual

 Ending the Run and Completing the Procedure

2 Place the tubing into the jaw of the head and squeeze the lever until the jaw is completely closed and the
indicator light illuminates (Figure 15-2).

Figure 15-2: Hold the jaw closed until the indicator light illuminates

3 After the indicator light goes off, hold the jaw closed for one second, and then release the lever.
4 Remove the tubing and inspect the integrity of the seal.
5 Put the sealer head back into the holder on the Spectra Optia system.

15

Spectra Optia Apheresis System Operator’s Manual 211

Ending the Run and Completing the Procedure

Reviewing the Data on the Procedure Summary Screens

The procedure summary contains important data about the procedure. The screens appear at the end of the
procedure after you raise the cassette. The data displayed varies by procedure. Table 15-1 contains descriptions of
the data that may appear on the screens.

Table 15-1: Data on the procedure summary screens

Data Description
AC in collection bag Total volume (mL) of AC from the AC container that is in the collection bag

AC in plasma bag Total volume (mL) of AC from the AC container that is in the plasma bag

AC in remove bag Total volume (mL) of AC from the AC container that is in the remove bag

AC to patient Total volume (mL) of AC from the AC container that the patient received

AC used Total volume (mL) of AC that was used during the run

AC used for prime Total volume (mL) of AC from the AC container that was used for priming the tubing set

Bolus Total volume (mL) of fluid that was delivered to the patient for a bolus

Blood removed Total volume (mL) of blood that is in the remove bag

BM cycles Total number of times that the system processed the bone marrow volume (BMV)

BM processed Total volume (mL) of bone marrow that the inlet pump processed during the run

Collect Total volume (mL) of cells and AC that the collect pump processed into the collection bag

Collection bag Combined volume (mL) of cells, AC, and plasma that are in the collection bag

Custom prime Total volume (mL) of fluid that was used for the custom prime

End time Time the system completed the run or rinseback, if rinseback was performed

FCR Percentage (%) of starting defective cells remaining in the patient’s blood at the end of the run

Fluid balance Patient fluid balance (mL or %) at the end of the run. This does not include any bolus volume.

Inlet processed Total volume (mL) of fluid, including whole blood and AC, that the inlet pump processed

Plasma bag The total volume (mL) of plasma that is in the plasma bag. This includes AC.

Plasma in collection bag Total volume (mL) of plasma that the plasma pump processed into the collection bag. This
includes AC.

Plasma removed Total volume (mL) of plasma that is in the remove bag

Plasma treated Total volume (mL) of the patient’s plasma that was treated

Plasma volumes exchanged Total number of the patient’s plasma volumes that were exchanged

Plasma volumes treated Total number of the patient’s plasma volumes that were treated

Remove bag Total volume (mL) of saline, AC, and blood in the remove bag

Replaced:Depletion Total volume (mL) of replacement fluid used during the depletion

Replaced:Exchange Total volume (mL) of replacement fluid used during the exchange

Replacement used Total volume (mL) of fluid that the replace pump processed. This does not include any bolus
volume.

212 Spectra Optia Apheresis System Operator’s Manual

 Ending the Run and Completing the Procedure

Table 15-1: Data on the procedure summary screens (continued)

Data Description
Rinseback Total volume (mL) of fluid that the return pump processed during rinseback. This does not
include any bolus volume delivered during rinseback.

Run time Total time (min) that was taken to process inlet volume before the run targets were attained.
This does not include the time to complete rinseback or the time when the inlet pump was
paused.

Saline diverted Total volume (mL) of saline used to prime the tubing set that was diverted to the saline
container after the run started

Saline rinse Total volume (mL) of saline that was used for the saline rinse

Saline to patient due to air Total volume (mL) of saline delivered to the patient due to the system removing air from the
removal return line

Start time Time when the operator touched Start Run

Target Hct Target Hct (%) for the patient at the end of the run

TBV processed

Tubing set
Total number of patient TBV that were processed

Difference between the volume (mL) of fluid in the tubing set at the start of the run and the
volume in the set at the start of rinseback, or at the end of the run if rinseback is not
15
performed. A negative value indicates that there is fluid volume in the set.

Volume removed Total volume (mL) of fluid that the plasma pump processed

Volume replaced Total volume (mL) of fluid that the replace pump processed. This does not include any bolus
volume or the volume of a saline prime

Whole blood processed Total volume (mL) of the patient’s blood that the inlet pump processed during the run.

Starting a New Procedure

Touch New Procedure on page 2 of the procedure summary. The system resets so that you can select your next
procedure.

Spectra Optia Apheresis System Operator’s Manual 213

Ending the Run and Completing the Procedure

Removing the Tubing Set

Note: If you do not perform rinseback, the channel of the tubing set will be full of fluid when you unload the set. After you
raise the cassette, empty the channel by putting the cassette and the bags at a level below the channel, allowing the fluid in
the channel to drain into the vent bag.

Once you finish the procedure and raise the cassette, perform the following steps to remove the tubing set:
1 Open the centrifuge door.
2 Remove the upper collar from the collar holder by grasping the lines above and below the collar and pulling
the lines downward.
3 Remove the upper and lower bearings from the bearing holders.
4 If you are using a Collection Set, remove the chamber from the bracket.
5 Gently pull the channel from the filler.
6 Push in the locking pin on the centrifuge collar holder, and remove the collar from the holder by grasping
the tubes above the collar and pulling upward.
7 Push the filler latch pin toward the center of the centrifuge, and raise the filler latch.
8 Fold the channel in half, and pull the channel through the loading port and out of the centrifuge chamber.
9 Lower the filler latch.
10 Close the centrifuge door.
11 Remove the lines from the fluid detectors.
12 Remove any bags from the IV pole.
13 Press the latch on the upper right corner of the cassette tray, and lift the cassette from the tray.
14 Discard the tubing set, according to your standard operating procedures.

214 Spectra Optia Apheresis System Operator’s Manual

 16
Troubleshooting

Spectra Optia Apheresis System Operator’s Manual 215

Troubleshooting

Troubleshooting Alarms
The Spectra Optia system has independent control and safety systems that constantly monitor the performance of
the system. If either system detects an operation error or a potentially unsafe operating condition, the system
sounds an alarm and illuminates the warning lights on the monitor. The warning lights remain constant if the
control system detected the error, and flash if the safety system detected the error.
The operator plays an essential role in the safe operation of the system. If an alarm occurs, it is crucial for the
operator to consider all possible causes for the alarm and thoroughly read the instructions that appear on the screen
to resolve the alarm. It is the operator’s responsibility to determine if it is safe to continue the procedure, and to
follow the appropriate instructions.

Navigating the Alarm Screens

The system displays information about the alarm and troubleshooting instructions on the screen. Figure 16-1
shows an example of an active alarm screen, which appears if an alarm occurs. Figure 16-2 shows an example of an
alarm action screen, which shows the steps to perform to resolve the condition causing the alarm. Tables 16-1
and 16-2 contain descriptions of the different areas of the screens.

1
2

5
3

Figure 16-1: Example of an active alarm screen

Table 16-1: Description of an active alarm screen

Area Description
1 Alarm name States the name of the alarm that occurred.

2 Alarm explanation Provides a brief explanation of the condition that caused the alarm.

3 Possible causes Lists the possible causes of the alarm in order of most likely (top) to least likely
(bottom). Each possible cause is an active button that you can touch to display the
action steps you should perform to resolve the condition causing the alarm.

4 Scroll button Indicates that additional possible causes for the alarm condition exist. Touch the button
to view the additional causes.

5 Action buttons Displays buttons of available actions that you can touch to help resolve the condition.
For details, read the action steps for the possible cause before you touch an action
button.

216 Spectra Optia Apheresis System Operator’s Manual

 Troubleshooting

1
2

3
4

Figure 16-2: Example of an alarm action screen

Table 16-2: Description of an alarm action screen

Area Description
1 Alarm name States the name of the alarm that occurred.

2
3
Alarm explanation

Possible cause
Provides a brief explanation of the condition that caused the alarm.

Shows the possible cause of the alarm, which was selected from the list on an active
16
alarm screen.

4 Action steps Shows the action steps to perform to resolve the condition causing the alarm.

If an alarm occurs, perform the following steps:

Note: If you want to temporarily silence the alarm tone, touch the mute button at the bottom of the screen.

1 Read the alarm name and the alarm explanation.

2 Read the list of possible causes for the alarm, and identify the most probable cause for the alarm.
3 Touch the button for the cause that you identified. The alarm action screen appears.
4 Follow the steps on the screen to resolve the condition causing the alarm.
5 If the actions for the cause you identified do not resolve the condition, repeat steps 2 through 4 until you
resolve the condition. To view previous or subsequent alarm action screens, touch the scroll buttons. To
return to the active alarm screen, touch the go back button.

Note: Most alarm conditions can be resolved by reading the possible causes for the alarm and following the
instructions on the alarm actions screens. It is not necessary to contact a service representative unless instructed.

Spectra Optia Apheresis System Operator’s Manual 217

Troubleshooting

Troubleshooting Multiple Alarms

To view a list of active alarms, do the following:
1 Touch the active alarm button at the bottom of the screen. The screen of active alarms appears with a list of
active alarms.
2 Touch the button of the alarm that you want to troubleshoot.
3 To exit the screen, touch the go back button.

Note: You must resolve all conditions causing alarms before you can resume the procedure. The active alarm button
appears at the bottom of the screen if there are additional conditions to resolve. Some conditions may resolve
themselves when you troubleshoot other conditions, and as a result will disappear from the list of active alarms.

Viewing Alarm History

1 Touch the Data menu button. The data tabs appear.
2 Touch the Alarm History tab. The alarm history screen appears with a list of alarms that have occurred,
including the time the alarm occurred.
3 To exit the screen, touch the go back button.

Muting the Alarm Tone

You may silence the alarm tone for 2 minutes by touching the mute button on the lower left corner of the screen.
The system sounds a reminder tone every minute thereafter to remind you that there is an active alarm. If a new
alarm occurs, the system restores the alarm tone.

218 Spectra Optia Apheresis System Operator’s Manual

 Troubleshooting

Using Semi-Automatic Mode

Note: Semi-Automatic mode is not available during an RBCX procedure.

When the system is operating in Semi-Automatic mode, the AIM system does not control the position of the
interface. The system controls the interface position using the entered hematocrit and other procedure values.
There are two reasons to enter Semi-Automatic mode:
• You may choose to enter Semi-Automatic mode with the AIM system enabled if certain procedure conditions
occur.
• You may be required to disable the AIM system and enter Semi-Automatic mode to resume the procedure if
certain alarm conditions occur.

Entering Semi-Automatic Mode With the AIM System Enabled

• Exchange procedures: You may choose to enter Semi-Automatic mode because the AIM system did not
correctly identify the position of the interface due to a patient condition. The AIM system continues to
monitor the interface position although it does not control it. Since the AIM system remains enabled, you
may return to Automatic mode at any time.
• Collection and depletion procedures: You may choose to enter Semi-Automatic mode to control the
concentration of cells that flow through the collect port. The AIM system monitors the interface position but
it does not control the position. The system displays the image of the collect port on the main run screen and
the collection status screen. It also displays the status of the collection on the trend graph on the collection
16
status screen, but does not display the collection preference. Since the AIM system remains enabled, you may
return to Automatic mode at any time.
Perform the following steps to enter Semi-Automatic mode with the AIM system enabled:
1 Touch the Run menu button. The run tabs appear.
2 Touch the Operation Status tab. The operation status screen appears.
3 Touch Proceed to Semi-Automatic Mode.
4 Touch Confirm.
To return to Automatic mode, perform the following steps:
1 Touch the Run menu button. The run tabs appear.
2 Touch the Operation Status tab. The operation status screen appears.
3 Touch Proceed to Automatic Mode.
4 Touch Confirm.
5 If you are performing an exchange procedure, continue to monitor the interface position to ensure that it
does not drift from the intended position.

Entering Semi-Automatic Mode With the AIM System Disabled

When the AIM system is disabled, it does not monitor or control the interface position. During collection and
depletion procedures, the system does not display the image of the collect port on the main run screen or on the
collection status screen. It also does not display the collection preference on the trend graph on the collection status
screen. A button to disable the AIM system appears on the alarm screen. Once you disable the AIM system, you
must complete the procedure in Semi-Automatic mode.

Spectra Optia Apheresis System Operator’s Manual 219

Troubleshooting

Resuming the Procedure in Semi-Automatic Mode

Once you have entered Semi-Automatic mode, follow the instructions below to resume the procedure.

Exchange procedures
1 Look through the viewport to view the interface position. The interface position should appear low and the
RBC layer should be thin.
To adjust the interface position, go to the patient data screen and change the entered Hct. If the position
seems too high, increase the Hct by 3 percentage points. You may do this up to three times for a total increase
of 9 percentage points.
2 Monitor the interface position and adjust the position again, if necessary.

MNC collection procedures

1 Go to the collection status screen.
2 Look through the view port to view the concentration of cells flowing through the collect port. Once the
interface is in the correct position, you should see swirls of cells flowing through the collect port. If the AIM
system is enabled, the image of the collect port on the screen should also show the swirls.
3 Ensure the concentration of cells flowing through the collect port is correct. To adjust the concentration of
cells, touch the up or down arrow button one time to adjust the plasma pump flow rate:
• To decrease the concentration of cells, touch the up arrow button.
• To increase the concentration of cells, touch the down arrow button.
4 View the collect port again and re-evaluate the concentration of the cells. If the concentration needs further
adjustment, touch the up or down arrow button again.
5 If the collection phase control is System, allow the system to initiate a collection phase when the RBC
detector detects target cells in the collect line.
6 Continue to monitor the concentration of cells flowing through the collect port, and adjust the
concentration again, if necessary.

CMNC, PMN collection, and depletion procedures

1 Go to the collection status screen.
2 Look through the view port to view the concentration of cells flowing through the collect port. Once the
interface is in the correct position, you should see swirls of cells flowing through the collect port. If the AIM
system is enabled, the image of the collect port on the screen should also show the swirls.
3 Examine the collect line where it exits the centrifuge to ensure the color in the line is correct. To adjust the
color, touch the up or down arrow button one time to adjust the plasma pump flow rate:
• If the color is too light, decrease the collection preference by touching the down arrow button. This
increases the concentration of cells that flow through the collect port.
• If the color is too dark, increase the collection preference by touching the up arrow button. This decreases
the concentration of cells that flow through the collect port.
4 Examine the collect line again and re-evaluate the color. If the color needs further adjustment, touch the up
or down arrow button again.
5 Continue to monitor the collect line and adjust the color again, if necessary.

220 Spectra Optia Apheresis System Operator’s Manual

 Troubleshooting

Managing Anticoagulation of the Extracorporeal Circuit

Caution: Terumo BCT has validated the system's performance when the extracorporeal circuit is properly
anticoagulated using ACD-A, and recommends using ACD-A to anticoagulate the circuit.

Proper anticoagulation of the system's extracorporeal circuit ensures that the flow of blood and fluid through the
circuit is not obstructed during the procedure. Terumo BCT recommends that you use an inlet:AC ratio up to 15:1
when using ACD-A. The system’s default inlet:AC ratio depends on the procedure selected. You may need to use a
different ratio, however, for a patient with a unique hematologic condition. If the circuit is not adequately
anticoagulated, platelet aggregates or clots may form, and eventually cause an obstruction in one or more of the
following areas:
• Filter at the bottom of the reservoir
• Collect port (Collection Set, IDL Set)
• Tubing set connector, which can result in an unstable interface
To eliminate the aggregates or clots, decrease the inlet:AC ratio. If an alarm occurs indicating a possible obstruction,
follow the instructions on the alarm action screen, and monitor the system for the rest of the procedure. If you do
not eliminate the obstruction, the system may require that you discontinue the procedure.

Handling Fluid Leaks

The fluid leak detector is a strip of moisture-sensitive material running down the back wall and floor of the
centrifuge chamber. If it detects moisture inside the centrifuge chamber, or if it is not functioning correctly, an
16
alarm occurs.
1 If you do not see signs of blood or moisture, wipe the surface and along the ridges of the detector with an
alcohol wipe, using a gentle, side-to-side motion.
2 Dry the detector using a gauze pad or a soft, lint-free cloth.
3 If you see a fine spray of blood or moisture on the inside walls of the centrifuge chamber, a small leak exists.
Do one of the following to discontinue the procedure:
• If the patient is not connected and the cassette is lowered, touch Unload and unload the tubing set.
• If the patient is connected and the procedure is in progress, go to the main run screen and touch the End
Run menu button to display the menu tabs. Then choose one of the following options:

– If rinseback is an option, consider completing stage 1 of rinseback. Touch the Rinseback tab and
follow the instructions on the screen to perform rinseback. During stage 1, the centrifuge does not
spin. After the system starts pumping saline into the tubing set and spinning the centrifuge to
complete stages 2 through 4, the alarm could recur. If the alarm recurs, touch the Disconnect tab
and follow the instructions on the screen to disconnect the patient and end the procedure.
– If rinseback is not an option, touch the Disconnect tab, and follow the instructions on the screen to
disconnect the patient and end the procedure.
4 Follow the instructions in Chapter 17, “Maintaining the Spectra Optia System,” to disinfect the centrifuge
chamber. If you are unable to adequately perform the disinfection, contact your Terumo BCT representative
for assistance.

Spectra Optia Apheresis System Operator’s Manual 221

Troubleshooting

Resuming a Procedure After a System Reset

The system resets itself under the following conditions:
• Power to the system fails and is then restored.
• You touch Reset, according to instructions on an alarm screen.
• An alarm condition causes the system to reset itself.
• You turn the system off and then on again.
After the reset, the system performs a series of tests to ensure that it is safe to resume the procedure. A screen
appears with instructions for how to proceed after the reset. Do the following:
1 Follow the instructions on the screen to resume the procedure at the point before the reset occurred. You may
also choose to discontinue the procedure.
• If the reset occurred during a run and you chose to continue the procedure, a screen appears asking you to
ensure that both saline lines are closed. Follow the instructions on the screen to confirm that the lines are
closed.
• If an alarm was active when the reset occurred, the action buttons that appear on the screen will be the
same as the buttons that were available on the alarm screen. If the alarm condition still exists after you
complete the instructions on the screen, the alarm will recur.
2 Verify that the system restored the patient and procedure data you entered before the reset occurred. The
system restores the data only if the tubing set cassette was in the lowered position when the reset occurred.
• If the reset occurred before you started a custom prime, the system does not restore the custom prime data.
Go to the screen that instructs you to enter the custom prime data and re-enter the data.
3 Verify that you completed the task that appeared on the screen before the reset occurred. Depending on
when the reset occurred, you may need to repeat a sequence of steps.
• If the reset occurred during administration of a fluid bolus, the system discontinued the bolus. Go to the
exchange status screen to view the volume that the system administered.

Note: If power to the device has been off for more than 8 hours, the system might not allow you to resume the
procedure.

222 Spectra Optia Apheresis System Operator’s Manual

 Troubleshooting

Performing a Manual Rinseback

Important: You should read and understand these instructions before you attempt to perform a manual
rinseback.
If you are not able to complete a procedure due to an alarm condition, a power interruption, or a system
malfunction, you may choose to perform a manual rinseback. Perform the following steps to complete a manual
rinseback.

Clamping and Sealing the Lines

1 Clamp the inlet and return lines.
2 Close the saline lines.
3 Disconnect the inlet line from the patient.
4 Seal the AC line.
5 Seal the following lines according to the type of tubing set you are using:
• Exchange Set: remove line, replace line
• Collection Set: collect line to the collection bag, plasma line to the plasma bag
• IDL Set: collect line to the collection bag, plasma line to the plasma bag, replace line

Note: Ensure that you do not seal the line to the vent bag. If you seal the line, you will not be able to resume
the manual rinseback.
16
6 Turn off the Spectra Optia system.

Draining the Channel

1 Open the centrifuge door. If the door does not open, follow the instructions on page 226 to manually open
the door.
2 Remove the channel from the filler and hang it on the IV pole with the inlet line at the highest point, so that
the fluid in the channel drains into the cassette reservoir.
3 If you are using an Exchange Set, ensure that the RBC valve is in the return position (Figure 16-3), or the
fluid will not drain.

Figure 16-3: RBC valve in the return position (Exchange Set shown here)

Spectra Optia Apheresis System Operator’s Manual 223

Troubleshooting

Returning the Fluid to the Patient

1 Remove the rotor from the return pump:
a. Push in the rotor and turn it to the left to unlock.
b. Pull the rotor off the pump.
2 Use a hemostat to clamp the RBC line directly below the cassette (Figure 16-4).

Note: Do not seal the RBC line instead of clamping it. If you seal the line, the tubing set could leak when you
raise the cassette to unload the set.

Figure 16-4: Where to clamp the RBC line (Exchange Set shown here)

3 Unclamp the return line (Figure 16-5).

Figure 16-5: Return line unclamped

4 Gently squeeze the vent bag to push the fluid from the reservoir to the patient. This should take several
minutes to complete. Do not try to expedite this process by applying more pressure to the bag.

Warning: Do not apply excess pressure to the vent bag when pushing fluid from the reservoir to the
patient during a manual rinseback or you could damage the red blood cells that you are returning to the
patient.

5 When the level of fluid in the reservoir drops to the level of the reservoir filter (Figure 16-6), clamp the
return line and stop squeezing the vent bag. .

Warning: Do not continue to squeeze the vent bag after the fluid in the reservoir reaches the level of the
reservoir filter during a manual rinseback. If you continue to squeeze the bag, you could deliver air to the
patient.

224 Spectra Optia Apheresis System Operator’s Manual

 Troubleshooting

Figure 16-6: Level of fluid in the reservoir at the level of the reservoir filter (Exchange Set shown here)

6 Disconnect the patient.

7 Remove the hemostat from the RBC line. Ensure that you do this before you raise the cassette in step 9, or
the return pressure sensor will leak.
8 Replace the rotor on the return pump:
a. Pull the tubing out of the pump housing and down toward the cassette.
b. While holding the return pump tubing in the position described in step a., push the rotor back in the

9
housing.
If the system functions, perform the following steps: 16
a. Turn on the system.
b. Touch Disconnect to discontinue the procedure.
c. Touch Unload to raise the cassette.
d. Unload the tubing set.
10 If the system does not function, manually raise the cassette according to the instructions on page 226, and
then unload the tubing set.

Spectra Optia Apheresis System Operator’s Manual 225

Troubleshooting

Manual Method for Opening the Centrifuge Door and Raising the
Cassette
If the power to the system is interrupted when the centrifuge is spinning, or the system does not function correctly,
the pumps stop and the centrifuge door may not open. To unload the tubing set, you need to manually open the
centrifuge door and raise the cassette.

Manually Opening the Centrifuge Door

1 Confirm that the system is turned off. Unplug the system from the power source.
2 Remove the cap from the centrifuge door lock-release hole, which is located near the top-right corner of the
centrifuge door.
3 Insert the centrifuge door key or a long, thin, metal rod into the lock-release hole (Figure 16-7). Push in the
key until you hear a click.

Note: Do not use a cotton swab, stick, or other breakable object to manually open the centrifuge door, as it
may break and jam the door.

Figure 16-7: Centrifuge door key in the lock-release hole

4 Remove the key.

5 Squeeze the centrifuge door handle and gently lower the door. Replace the cap into the lock-release hole.

Manually Raising the Cassette

If a system malfunction occurs and you must turn off the Spectra Optia system, you can manually raise the cassette
to remove the tubing set. To raise the cassette and open the valves, perform the following steps:
Warning: Do not touch Unload to unload the tubing from the pumps or remove the tubing set when a patient is
connected to the Spectra Optia system, or the patient may receive surplus fluids through the inlet and return lines.

1 Confirm that the patient is disconnected.

2 Seal or clamp the lines to the fluid containers.
3 Unplug the system from the power source.

226 Spectra Optia Apheresis System Operator’s Manual

 Troubleshooting

4 Turn each valve to the neutral position using a flat-blade screwdriver (Figure 16-8).

Figure 16-8: Valves turned to the neutral position

5 Remove each pump rotor from the pumps:

a. Push in the rotor and turn it to the left.

6
b. Pull the rotor off the pump.
Insert the screwdriver into the small hole in the vent on the back of the system (Figure 16-9) until you
engage the slotted end of the pin attached to the back of the cassette tray. You may need to angle the
16
screwdriver to locate the pin.

Figure 16-9: Screwdriver inserted in the hole in the back of the system

7 Turn the screwdriver counterclockwise until it no longer turns, and the cassette tray is in the fully raised
position.
8 Follow the instructions on page 214 to remove the tubing set from the system.

Spectra Optia Apheresis System Operator’s Manual 227

Troubleshooting

228 Spectra Optia Apheresis System Operator’s Manual

 17
Maintaining the Spectra Optia System

Spectra Optia Apheresis System Operator’s Manual 229

Maintaining the Spectra Optia System

Cleaning and Disinfecting the Spectra Optia System

This section contains instructions for cleaning and disinfecting the Spectra Optia system. Follow the instructions
for cleaning the system to remove dirt and other substances that could impair the function of the system. Follow
the instructions for disinfecting the system to eliminate potentially infectious substances. Always confirm that the
system is clean and undamaged before use.
Warning: Turn off the system before cleaning or disinfecting to prevent possible electrical shock or damage to
the equipment.

Warning: When cleaning and disinfecting equipment surfaces that might have been exposed to blood, take
adequate precautions to prevent possible exposure to and transmission of infectious diseases.

Compatible Cleaning Solutions

Caution: Clean the Spectra Optia system using a mild, non-abrasive cleaning solution or a mild detergent.
Industry standard practice defines mild cleaning solution and mild detergent as a solution or detergent that is safe
on skin and on washable surfaces, such as dishwashing liquid. Use of a solution that is not compatible with the
materials on the system may damage the material or operating characteristics of the system.

The cleaning solutions listed below are compatible for use on the Spectra Optia system. Use the solution specified
in the instructions when cleaning.
• Mild detergent
• 70% isopropyl alcohol
• Water

Compatible Disinfecting Solutions

Caution: Disinfect the Spectra Optia system using a disinfecting solution that is compatible for use on the
system. Use of a disinfecting solution that is not compatible could damage the material or operating characteristics
of the system.

The disinfecting solutions listed below are compatible for use on the Spectra Optia system.
• 0.63% sodium hypochlorite
• 70% isopropyl alcohol
• 0.50% ammonium chloride
If the disinfecting solution used by your facility contains an active ingredient that is not on this list, test the
solution before use by applying it to an inconspicuous area on the system to confirm that is does not damage or
discolor the system.

230 Spectra Optia Apheresis System Operator’s Manual

 Maintaining the Spectra Optia System

Application of Cleaning and Disinfecting Solutions

Caution: Use only a gauze pad, a lint-free cloth, or a wipe when cleaning or disinfecting the touch screen, the
covers on the AIM system lights in the centrifuge, and the aperture plate on the filler. Use of an abrasive brush,
scrub material, or a sharp object can damage the surface of the components.

The materials listed below are recommended for use alone or in conjunction with a compatible cleaning or
disinfecting solution. Avoid using abrasive material, which could damage the function of the components and the
appearance of the system.
• Gauze pad
• Soft lint-free cloth
• Cotton swab
• Commercial or industrial wipe that is pre-moistened with a compatible solution from the lists above.

Frequency of Cleaning and Disinfecting

Some of the system components require more frequent cleaning than other components. See “Cleaning Schedule
for the Spectra Optia System”on page 239 for the recommended frequency of cleaning. Disinfect the system when
it is exposed to an infectious substance or according to your standard operating procedures.

17

Spectra Optia Apheresis System Operator’s Manual 231

Maintaining the Spectra Optia System

Cleaning and Disinfecting the System Components

This section contains instructions for cleaning and disinfecting the components that can come in contact with dirt
and infectious material. Use the solutions and materials described under “Cleaning and Disinfecting the
Spectra Optia System” when performing these activities. The operator is responsible for cleaning and disinfecting
these components.

Surface of the System

Exterior surfaces
Wipe the exterior surfaces of the Spectra Optia system using a mild detergent or a disinfecting solution.

Touch screen
Caution: To avoid damaging the touch screen, do not douse the touch screen with fluid or leave fluid on the
screen after cleaning or disinfecting the screen. Always dry the screen with a gauze pad or a clean cloth after
exposing it to fluid.

1 Wipe the touch screen, using a mild detergent or a disinfecting solution.

2 Dry the touch screen, using a gauze pad or a soft, lint-free cloth.

Components on the Front Panel

Fluid spilled on the components on the front panel could interfere with the system operation even if it is not
visible. For the location of the components, see “Front Panel” on page 23.

Sensors and detectors

1 The sensors are easier to access if the cassette tray is in the lowered position. Perform the following steps to
lower the cassette tray:
a. Turn on the system.
b. Touch Select Procedure. The procedure selection screen appears.
c. Select any procedure and touch Confirm.
d. When the screen that instructs you to load a tubing set appears, do not load a tubing set.
e. Touch Load. The system lowers the cassette tray.
f. Turn off the system.
2 Wipe the sensors and the detectors, using water or a disinfecting solution.
3 After disinfecting, wipe the sensors and the detectors again, using water to remove any residue left by the
disinfecting solution.

Valves
Wipe the surfaces of the valves, using mild detergent or a disinfecting solution.

232 Spectra Optia Apheresis System Operator’s Manual

 Maintaining the Spectra Optia System

Pump housings and pump rotors

1 Remove each pump rotor from the housing as follows:
a. Push in the rotor and turn it to the left (Figure 17-1).
b. Pull the rotor out of the housing.

Figure 17-1: Removing the rotor from the pump housing

2 Wipe the housing and the rotor, using mild detergent or a disinfecting solution.

Note: If necessary, you can rinse the pump rotors with water or mild detergent before disinfection to loosen
any residue left by a spill.

3 Wipe the rotor again using water to remove any residue left by the detergent or solution.
4 Allow the rotor to air-dry before replacing it in the housing.
5 Align the rotor with the housing. Ensure that the metal bar in the housing aligns with the corresponding slot
in the rotor. Push in the rotor and turn it to the right to lock the rotor in place. If you do not properly install
the rotor, an alarm will occur the next time you load a tubing set. 17
Note: Ensure that you install the rotor with the black dot in the housing for the replace/collect pump.

Components in the Centrifuge Chamber

Dirt or residue on the components in the centrifuge chamber can affect the performance of the components or the
performance of the AIM system. For the location of the fluid leak detector and the AIM system lights, see
“Centrifuge Chamber” on page 26. For the location of the aperture plate and the optical reference, see “Filler” on
page 27.

Fluid leak detector

1 Wipe the surface and along the ridges of the detector, using a mild detergent or disinfecting solution and a
gentle, side-to-side motion. Be careful not to damage the ridges of the detector.
2 Wipe the detector again using water to remove any residue left by the solution.
3 Dry the detector, using a gauze pad or a soft, lint-free cloth.

Spectra Optia Apheresis System Operator’s Manual 233

Maintaining the Spectra Optia System

Covers on the AIM system lights

Caution: Use only a gauze pad, a lint-free cloth, or a wipe when cleaning or disinfecting the touch screen, the
covers on the AIM system lights in the centrifuge, and the aperture plate on the filler. Use of an abrasive brush,
scrub material, or a sharp object can damage the surface of the components.

1 Wipe the covers, using water or a disinfecting solution.

2 After disinfecting, wipe the covers again using water to remove any residue that was left by the disinfecting
solution.
3 Dry the covers, using a gauze pad or a soft, lint-free cloth.

Filler
1 Follow the instructions on page 64 to remove the filler from the centrifuge.
2 Wipe the filler, using a mild detergent or a disinfecting solution. Use a cotton swab to clean the groove of
the filler and a dry cotton swab or alcohol pad to remove excess fluid.

Note: If necessary, you can rinse the filler with water or mild detergent before disinfection to loosen any
residue left by a spill.

3 Wipe the surfaces of the aperture plate, using water to remove any residue that was left by the cleaning
solution or disinfecting solution.
4 Dry the aperture plate, using a gauze pad or a soft, lint-free cloth.
5 Allow the remaining surfaces of the filler to air-dry completely.
6 Follow the instructions on page 65 to re-install the filler on the centrifuge.

Seal Safe System: Jaw Cavity

Examine the sealer head after each procedure. If you see dirt or fluid in the jaw cavity, follow the instructions below
to remove the residue. It is important that the jaw cavity be kept clean. Residue left in the cavity can impair the
performance of the device.
Warning: Disconnect the sealer head from the RF cable before cleaning to avoid receiving a serious radio
frequency (RF) burn during the cleaning process.

1 Disconnect the sealer head from the RF cable.

2 Remove and discard the splash guard, if used.

234 Spectra Optia Apheresis System Operator’s Manual

 Maintaining the Spectra Optia System

3 Clean the jaw cavity, using a cotton swab dampened with alcohol. Do not use other cleaning or disinfecting
solutions to clean the cavity (Figure 17-2).

Figure 17-2: Cleaning the jaw cavity with a cotton swab

4 Clean all areas outside the jaw cavity. Squeeze the lever to expose areas outside of the cavity, and clean those
areas.
5 Dry all parts of the jaw and jaw cavity, using a cotton swab.

Seal Safe System: Sealer Head

Follow the instructions below to clean the sealer head and to replace the splash guard. You must disassemble the
sealer head to clean it.

Disassembling of the sealer head

1 Disconnect the sealer head from the RF cable.
2
3
Remove and discard the splash guard, if used.
Hold the sealer head in a vertical position with the jaw end pointing upward, and use your thumb to depress
17
the jaw to the closed position. Do not squeeze the lever. For additional leverage, place the bottom of the
sealer head on a padded surface (Figure 17-3).

Figure 17-3: Depressing the jaw to the closed position

Spectra Optia Apheresis System Operator’s Manual 235

Maintaining the Spectra Optia System

4 Remove the lever by slightly releasing the jaw and pulling the lever down and back (Figure 17-4).

Figure 17-4: Removing the lever

5 Remove the jaw by pulling it up and sideways (Figure 17-5).

Figure 17-5: Removing the jaw

Cleaning the sealer head

1 Wipe the components with alcohol applied to a cotton swab. Do not use other cleaning or disinfecting
solutions to clean the components.
2 Dry the components using a cotton swab, a gauze pad, or a soft, lint-free cloth.

236 Spectra Optia Apheresis System Operator’s Manual

 Maintaining the Spectra Optia System

Reassembling the sealer head

1 Ensure that the spring is in place in the head.
2 Locate the grooves on both sides of the head. Align the jaw with the grooves and slide it down the sealer head
until it touches the spring (Figure 17-6). Ensure that the spring fits into the indentation in the jaw.

Figure 17-6: Aligning the jaw with the grooves

3 Use your thumb to slightly depress the jaw. Ensure that the spring stays in place.
4 Replace the lever by tipping it at a 45° angle and positioning the lever pivots behind and below the pivot
slots (Figure 17-7).

17

Figure 17-7: Replacing the lever

5 Push down the lever to engage the lever pivots while simultaneously depressing the jaw with your thumb.
6 Release your thumb. The lever should fully engage and secure the jaw on the sealer head.
7 Squeeze the lever to ensure that the head mechanically functions. If the jaw does not completely close, check
the position of the spring.
8 Attach a new splash guard, if required, according to the instructions “Attaching a new splash guard” below.
9 Reconnect the RF cable to the sealer head and put the sealer head back into the holder.

Spectra Optia Apheresis System Operator’s Manual 237

Maintaining the Spectra Optia System

Attaching a new splash guard

Perform the following steps to attach a new splash guard after cleaning the sealer head or as necessary:
1 Disconnect the RF cable from the sealer head if it is still connected.
2 Prepare a new splash guard:
a. Remove the perforated inset from one side of the splash guard (Figure 17-8).
b. Fold the other inset inward at a 90° angle to form a clip (Figure 17-8).

Figure 17-8: Inset folded to form a clip

c. Fold the sides of the splash guard inward at the perforations (Figure 17-9).

Figure 17-9: Splash guard folded at the perforations

3 Align the splash guard with the lever assembly on the sealer head.
4 Attach the splash guard and use the clip to lock it in place (Figure 17-10).

Figure 17-10: Attaching the splash guard and locking it in place

5 Reconnect the RF cable to the sealer head and put the sealer head back into the holder.

238 Spectra Optia Apheresis System Operator’s Manual

 Maintaining the Spectra Optia System

Cleaning Schedule for the Spectra Optia System

Table 17-1 shows the summarized instructions and suggested frequency for cleaning the Spectra Optia system. The
schedule can change, depending on how often the system is used. Use this schedule in conjunction with the
detailed instructions in this chapter to clean the system.
Table 17-1: Suggested cleaning schedule for the Spectra Optia system

Frequency
Component After Each Procedure Weekly Monthly
System surface • Use mild detergent.
• Allow to air-dry.

Touch screen • Use mild detergent.

• Dry with a gauze pad.

Front panel: sensors • Use water only.

• Allow to air-dry.

Front panel: detectors • Use water only.

• Allow to air-dry.

Front panel: valves • Use mild detergent.

• Allow to air-dry.

Front panel: pumps • Use mild detergent.

• Allow to air-dry.

Centrifuge chamber: filler • Use mild detergent.

surface • Allow to air-dry.

Centrifuge chamber:
filler aperture plate and optical
• Use water only.
• Allow to air-dry.
17
reference

Centrifuge chamber: fluid leak • Use mild detergent.

detector • Dry with a gauze pad.

Centrifuge chamber: covers on • Use water only.

AIM system lights • Dry with a gauze pad.

Seal Safe system: jaw cavity As needed:

• Use 70% isopropyl alcohol.
• Dry with a cotton swab.

Seal Safe system: sealer head • Use 70% isopropyl alcohol.

• Dry with a cotton swab.
• Replace the splash guard.

Spectra Optia Apheresis System Operator’s Manual 239

Maintaining the Spectra Optia System

Performing Preventive Maintenance

To prolong equipment life and to ensure maximum performance of the Spectra Optia system, a qualified service
technician should calibrate the system and perform preventive maintenance every 6 months, with a compliance
window of ± 30 days from the scheduled date of the maintenance. Contact your Terumo BCT representative for
more information.

240 Spectra Optia Apheresis System Operator’s Manual

 18
Spectra Optia System Specifications

Spectra Optia Apheresis System Operator’s Manual 241

Spectra Optia System Specifications

Spectra Optia System Specifications

General System Specifications

Electrical

Table 18-1: Electrical power and safety

Characteristics Performance Conditions

Electrical power rating 100 V AC to 240 V AC Where a circuit breaker provides excess
50/60 Hz, 1050 VA current protection

Ethernet port Port is electrically isolated. • Location where a device can be connected
to the system to print reports or to collect
and transmit data to Terumo BCT
• Location where service personnel can
connect to the system to download
procedure information to a computer when a
patient is not connected

Safety certifications Meets the requirements of EN 60601-1 and CE Marking

EN 61010-2-20

Device is certified by CSA International in CSA Certification to applicable U.S. and

accordance with applicable U.S. and Canadian Canadian standards
standards. For applicable standards for the
product, see Table 18-36 on page 261.

Meets the requirements of category IP21 of

IEC 60529

Environmental

Table 18-2: Environmental: Spectra Optia device

Characteristics Performance Conditions

Ambient operating 15.5 °C to 27.7 °C (60 °F to 82 °F)
temperature

Ambient operating 8% to 80% Relative humidity (RH), non-condensing

humidity

Cleaning • Surface of the device can be cleaned and Device is not damaged by cleaning and
disinfected disinfecting with the compatible cleaning
• Pump rotors can be removed for cleaning solutions and disinfecting solutions, according
and disinfection to the instructions described in Chapter 17 of
• Channel leaks are contained within the this manual.
centrifuge chamber
• Centrifuge chamber can be cleaned and
disinfected

Access by foreign material Device is protected against access by foreign

objects and falling water.

242 Spectra Optia Apheresis System Operator’s Manual

 Spectra Optia System Specifications

Table 18-2: Environmental: Spectra Optia device (continued)

Characteristics Performance Conditions

Restrictions Device is not for use in an explosive
atmosphere.

Shipping temperature −29 °C to 60 °C (−20 °F to 140 °F)

Shipping humidity 8% to 90% Relative humidity (RH), non-condensing

Storage temperature 0 °C to 60 °C (32 °F to 140 °F)

Storage humidity 8% to 80% Relative humidity (RH), non-condensing

Table 18-3: Environmental: Seal Safe system

Characteristics Performance Conditions

Ambient operating temperature 15.5 °C to 27.7 °C (60 °F to 82 °F)
(sealer head with RF cable)

Ambient operating humidity 8% to 80% Relative humidity (RH), non-condensing

Cleaning Components can be cleaned and disinfected. Device is not damaged by cleaning and
disinfecting with the compatible cleaning
solutions and disinfecting solutions, according
to the instructions described in Chapter 17 of
this manual.

Fluid spillage The unit is safe to use if fluid is spilled on the

sealer head or on the RF cable.

Table 18-4: Environmental: Tubing sets

Characteristics Performance Conditions

Storage temperature • Long term storage range: 0 °C to 35 °C
(32 °F to 95 °F)
• Permitted excursions:
18
• −29 °C to 0 °C (−20 °F to 32 °F) for up to
72 hours
• 35 °C to 50 °C (95 °F to 122 °F) for up to
6 weeks

Storage humidity • 0% to 75% Relative humidity (RH), non-condensing

• Permitted excursions: Up to 85% RH ± 5%
for up to 72 hours

Physical

Table 18-5: Physical: Spectra Optia system

Characteristics Performance Conditions

Floor space required 0.43 m2 (4.6 ft2) Applies to a floor slope of less than 5°

Minimum clearance 30 cm (11.8 in) around the perimeter of the

device

Spectra Optia Apheresis System Operator’s Manual 243

Spectra Optia System Specifications

Table 18-5: Physical: Spectra Optia system (continued)

Characteristics Performance Conditions

Height • 106.4 cm (41.9 in) (without the IV pole)
• 162.1 cm (63.8 in) (with the IV pole)

Width 52.7 cm (20.75 in)

Depth 81.3 cm (32.0 in)

Weight Up to 97 kg (213 lb) without accessories

System weight plus Safe Working 102 kg (225 lb) Safe Working Load is the maximum external
Load load that includes tubing set, accessories, and
solutions.

Table 18-6: Physical: Seal Safe system

Characteristics Performance Conditions

Physical dimensions (sealer head Diameter: 2.5 cm (1 in)
with RF cable) Relaxed length: Approximately 1.1 m (3.7 ft)

Weight External parts: 0.4 kg (0.9 lb)

Sound pressure level

Table 18-7: Sound pressure level during system operation

Characteristics Performance Conditions

Average sound pressure level 68 dB(A) SPL to 70 dB(A) SPL Normal operating conditions
during the run state

Table 18-8: Sound pressure level of alarm tone

Characteristics Performance Conditions

Sound pressure level • Low setting: 62 dB(A) SPL
• High setting: 75 dB(A) SPL

244 Spectra Optia Apheresis System Operator’s Manual

 Spectra Optia System Specifications

System Components
Centrifuge
Table 18-9: Centrifuge speed and g-force

Characteristics Performance Conditions

Centrifuge speed • Standard filler: up to 3,000 rpm
• IDL filler: 550 to 2,500 rpm

Maximum g-force in the channel 1,200 g Device is operating at maximum speed.

Pumps

Table 18-10: Pump flow rates

Characteristics Performance Conditions

AC pump Up to 12 mL/min When a patient is connected

Inlet pump • MNC collection procedures: Up to 125 mL/min

• All other procedures: Up to 142 mL/min

Plasma pump • MNC collection procedures: Up to 125 mL/min Operator can enter a pump flow rate
• All other procedures: Up to 142 mL/min from within this range during the
procedure.

Collect pump • MNC collection procedures: 0.5 mL/min to Operator can enter a pump flow rate
10 mL/min from within this range during the
• During accumulation phase: Up to 3 mL/min procedure.
• During collection phase: Up to 7 mL/min

• CMNC procedures: 0.5 mL/min to 10 mL/min

• PMN collection, WBCD, PLTD procedures:
0.5 mL/min to 25 mL/min

• BMP procedures: 1 mL/min to 5 mL/min 18

Replace pump • TPE, TPE-SPD, RBCX procedures: Up to 150 mL/min • Normal operating conditions
• During administration of a bolus: 10 to 120 mL/min • Operator can enter a pump flow rate
from within this range for the
administration of a bolus.

Return pump • All procedures: Up to 295 mL/min • Normal operating conditions

• During rinseback: 2 mL/min to 100 mL/min • Operator can enter a pump flow rate
from within this range for rinseback.

Spectra Optia Apheresis System Operator’s Manual 245

Spectra Optia System Specifications

Table 18-11: Pump volume accuracy

Characteristics Performance Conditions

Fluid balance accuracy • TPE, TPE-SPD, RBCX procedures: ± 8% of • Normal operating conditions
commanded balance • No line restrictions
• MNC collection, CMNC, PMN collection, • Pump accuracy can be affected by the
WBCD, PLTD procedures: ± 8% up to 2 TBV temperature and viscosity of the fluids.
processed

Fluid replaced accuracy WBCD, PLTD procedures: ± 10% or 100 mL up • Applies if replacement fluid is administered
to 2 TBV processed during the procedure
• Normal operating conditions
• No line restrictions
• Volume accuracy can be affected by the
temperature and viscosity of the fluids.

Volume accuracy of all pumps ± 6% or 20 mL of displayed value, whichever • Normal operating conditions
is greater • No line restrictions
• Pump accuracy can be affected by the
temperature and viscosity of the fluids.

Sensors and detectors

Table 18-12: AC and replacement fluid detectors

Characteristics Performance Conditions

Time to alarm Alarm is generated less than 2 seconds either
after the detector senses the absence of fluid
or when the line is removed from the detector
after fluid is sensed.

Table 18-13: Centrifuge pressure sensor

Characteristics Performance Conditions

Operating range 400 mmHg to 2,000 mmHg

Alarm point 1,350 mmHg Accuracy ± 10%

Table 18-14: Fluid leak detector

Characteristics Performance Conditions

Detection sensitivity • Fluid leaks are detected when moisture Normal operating conditions
reaches the wall or bottom of the chamber.
• Detector is capable of detecting a drop of
0.5 mL of fluid in the centrifuge.

Table 18-15: Inlet and return pressure sensors

Characteristics Performance Conditions

Operating range –300 mmHg to +500 mmHg

246 Spectra Optia Apheresis System Operator’s Manual

 Spectra Optia System Specifications

Table 18-15: Inlet and return pressure sensors (continued)

Characteristics Performance Conditions

Default alarm point • Inlet pressure sensor:
–250 mmHg ± 30 mmHg
• Return pressure sensor:
+400 mmHg ± 37 mmHg

Pressure accuracy ± 6% of the sensor reading or ± 20 mmHg,

whichever is greater

Table 18-16: RBC detector

Characteristics Performance Conditions

RBC detection level > 1.5% hematocrit • TPE procedures: System automatically
diverts fluid away from the remove bag
when it detects RBC.
• MNC collection procedures: System initiates
a collection phase when it detects RBC
exiting the chamber.

Table 18-17: Low-level and high-level reservoir sensors

Characteristics Performance Conditions

Pump stroke volume between • 49 mL ± 9 mL Level sensor requires a load force of > 5 lb
sensors • Sensors detect foam as air. (2.3 kg) each (> 10 lb [4.5 kg] total).

Alarm occurrence When fluid is not detected at the low-level System performs a duplicate (redundant)
sensor, the system stops the pumps before air safety check. If condition is not resolved after
enters the line. a specific number of tries, operator must
disconnect patient.

Table 18-18: Return line air detector

Characteristics Performance Conditions

18
Alarm occurrence Alarm is generated if the system calculates Normal operating conditions
that the patient might have more than 1 mL of
air in circulation.

Monitor and touch screen

Table 18-19: Monitor and touch screen

Characteristics Performance Conditions

Monitor with graphical user • Monitor holds a touch screen that provides a Screen is touched to cause a change in
interface (GUI) touch screen tactile operator interface. resistance.
• Monitor has a speaker for sounding
procedure and alarm tones, alarm lights,
and two external dedicated buttons with
icons (stop button and pause button).

Size Measures 26.7 cm (10.5 in) diagonally

Spectra Optia Apheresis System Operator’s Manual 247

Spectra Optia System Specifications

Table 18-19: Monitor and touch screen (continued)

Characteristics Performance Conditions

Screen type • Color, liquid crystal display (LCD)
• Monitor holds backlight bulbs, which a
service representative can replace when
necessary.

System Software
Safety system
Table 18-20: Safety system

Characteristics Performance Conditions

Alarms Audible alarm (mutable), steady red lights, • Lights flash if a safety system alarm occurs.
flashing red lights, and an alarm screen. • Lights are constant if a control system alarm
occurs.

Safety No single point of failure causes injury to the

patient or the operator.

Alarms
Table 18-21: Basic safety and performance requirements

Characteristics Performance Conditions

Priority assignment Conditions causing alarms are considered low
priority according to guidance provided by
IEC 60601-1-8, which indicates that the
operator must be made aware of the condition
causing the alarm so that appropriate action
can be taken.

Table 18-22: AC infusion rate alarm

Characteristics Performance Conditions

Detection method Detection cycle: AC infusion rate is too high.
1. The return pump stops. The cycle starts.
The system pumps a small amount of air
into the reservoir.
2. The return pumps starts. The low-level
reservoir sensor detects air.
3. The return pump stops. The cycle ends and
the next cycle starts.

248 Spectra Optia Apheresis System Operator’s Manual

 Spectra Optia System Specifications

Table 18-23: AC pump flow rate alarms

Characteristics Performance Conditions

Detection method • AC pump speed is too fast. • AC pump speed is greater than 120 rpm.
The pump stopped within two revolutions.

• AC is flowing directly to the patient. • AC pump flow rate is greater than the inlet
pump flow rate for more than 0.4 mL net AC
pumped to the patient.

• Inlet:AC ratio is too low. • System calculated an inlet:AC ratio that is

greater than 20% below the
operator-specified value for 2 mL of inlet
volume.

• Inlet:AC ratio is too high. • System calculated inlet:AC ratio that is 20%
above the operator-specified value for 10 mL
of inlet volume.

Delay time Less than 5 cycles of occlusion

Table 18-24: Inlet:AC ratio alarms

Characteristics Performance Conditions

Detection method • AC ratio is greater than 20% below the • AC ratio is too low.
configured value.

• AC ratio is greater than 20% above the • AC ratio is too high.

configured value.

Delay time Alarm occurs when either of the above

conditions is met during the run until
rinseback starts.

18

Spectra Optia Apheresis System Operator’s Manual 249

Spectra Optia System Specifications

Extracorporeal Volume (ECV)

Note: Under normal operating conditions, the ECV does not exceed the typical ECV shown in Table 18-25. Under
certain infrequent alarm conditions, the ECV may momentarily increase to the maximum ECV unless the patient’s TBV is
less than 750 mL. If the patient’s TBV is less than 750 mL, the ECV does not exceed the typical ECV under any
condition.

Table 18-25: ECV by procedure

Maximum ECV
Procedure Tubing Set Filler Typical ECV (mL)
(mL)
TPE:
• Dual-needle access • Exchange • Standard • 141 • 185
• Single-needle access • Exchange • Standard • 185 • 185

RBCX Exchange Standard 141 185

TPE-SPD Exchange Standard 141* 185*

MNC collection Collection Standard 147 191

CMNC IDL IDL 253 297

PMN collection IDL IDL 253 297

WBCD IDL IDL 253 297

PLTD IDL IDL 253 297

*ECV shown does not include the volume of the secondary plasma device used during the procedure.

Tubing Set and Accessory Set Components

Note: Single-use tubing sets for the Spectra Optia system are considered applied parts because they make contact
with the patient. The tubing sets comply with the Class II Type BF electrical safety requirements of IEC 60601-1.

Table 18-26: Tubing set and accessory set components

Characteristics Performance Conditions

Remove bag volume 6L Bag is a component of the Exchange Set.

Collection bag volume 940 mL Bag is a component of the Collection Set and
the IDL Set.

Plasma bag volume • Liquid: 1,000 mL • Bag is a component of the Collection Set, the
• Frozen: 600 mL IDL Set, and the BMP Accessory Set.
• Volume shown is the maximum target
volume.

BMP bag volume 3L Bag is a component of the BMP Accessory Set.

250 Spectra Optia Apheresis System Operator’s Manual

 Spectra Optia System Specifications

Table 18-26: Tubing set and accessory set components (continued)

Characteristics Performance Conditions

Reservoir volume • Between the high- and low-level sensors: Reservoir prevents more than 0.5 mL of air
49 mL from entering the return line.
• Entire reservoir: 56 mL

Sterile barrier filter Collection Set and IDL Set: Filter is on the AC line and on the saline line.
• 0.2 microns.
• Helps to maintain a functionally closed
system.

Reservoir filter Prevents particles (200 microns or larger) from

entering the return line exiting the reservoir.

Inlet line trap Traps large particles.

AC check valve Prevents the free flow of AC through the tubing

set.

Administration line filter on BMP 200 microns. Can be used for additional Filter is used for additional filtration of bone
Accessory Set filtration of bone marrow. marrow, if desired.

RBC residual volume • When rinseback is performed (average Normal operating conditions
volume):
• Exchange Set: 10 mL
• Collection Set: 10 mL
• IDL Set: 17 mL
• When rinseback is not performed: Equal to
the ECV of the tubing set multiplied by the
patient’s Hct

Channel life • Exchange Set: 6 hours Normal operating conditions

• Collection Set: 8 hours
• IDL Set: 8 hours

18

Spectra Optia Apheresis System Operator’s Manual 251

Spectra Optia System Specifications

Electromagnetic Compatibility (EMC)

The Spectra Optia system complies with either the 60601-1-2 (4th Ed.) emission limits described in Tables 18-27
through 18-29, or the 60601-1-2 (3rd Ed.) emission limits described in the Tables 18-30 through 18-35.
Operators should ensure that the system is used in an environment that complies with these specifications. If you
are unsure which set of EMC information applies to your Spectra Optia system, contact your Terumo BCT
representative.

60601-1-2 (4th Ed.) EMC information

Note: The EMISSIONS characteristics of this equipment make it suitable for use in industrial areas and hospitals
(CISPR 11 class A). If it is used in a residential environment (for which CISPR 11 class B is normally required) this
equipment might not offer adequate protection to radio-frequency communication services. The user might need to
take mitigation measures, such as relocating or re-orienting the equipment.

Table 18-27: Emissions tests 60601-1-2 (4th Ed.)

Emissions Test Compliance Electromagnetic Environment–Guidance

Conducted and radiated Group 1 The system uses high frequencies only for internal function
radio frequency (RF) (e.g., computer timing signals and internal communication).
emissions The RF emissions meet the requirements of standard
CISPR 11 CISPR 11. Therefore, RF emissions are very low and are not
likely to interfere with nearby electronic equipment.

Conducted and radiated RF Group 2 The Spectra Optia system emits RF for the Seal Safe
emissions Class A system, so the Seal Safe can perform its intended function.
CISPR 11 The RF is only emitted when sealing tubing. Nearby
electronic equipment may be affected.

Harmonic distortion Class A Not applicable

IEC 61000-3-2

Voltage fluctuations and Complies

flicker emissions
IEC 61000-3-3

Table 18-28: Immunity tests and test levels 60601-1-2 (4th Ed.)

Immunity Test Test Level IEC 60601

Electrostatic ± 8 kV contact
discharge (ESD) ± 15 kV air
IEC 61000-4-2

Radiated RF EM 3 V/m
fields 80 MHz to 2.7 GHz
IEC 61000-4-3 80% AM at 1 kHz

For proximity fields See immunity test levels and test frequencies in Table 18-29
from RF wireless
communications
equipment
IEC 61000-4-3

Electrical fast ± 2 kV for power supply lines

transients/bursts ± 1 kV for input and output lines
IEC 61000-4-4 100 kHz repetition frequency

252 Spectra Optia Apheresis System Operator’s Manual

 Spectra Optia System Specifications

Table 18-28: Immunity tests and test levels 60601-1-2 (4th Ed.) (continued)

Immunity Test Test Level IEC 60601

Surges ± 1 kV line(s) to line(s)
IEC 61000-4-5 ± 2 kV line(s) to earth

Conducted 3V
disturbances induced 0.15 MHz to 80 MHz
by RF fields 6 V in ISM bands between 0.15 MHz and 80 MHz
IEC 61000-4-6 80% AM at 1 kHz

Power frequency 30 A/m

magnetic fields
IEC 61000-4-8

Voltage dips 0% U45; 0.5 cycle

IEC 61000-4-11 At phase angles 0°, 45°, 90°, 135°, 180°, 225°, 270°, and 315°
UT 100 V and 230 V

0% UT; 1 cycle
70% UT; 25 cycles
Single phase: at 0°
UT 100 V and 230 V

Voltage interruptions 0% UT; 250 cycles

IEC 61000-4-11 UT 100 V and 230 V
Note: UT is the voltage of the main alternating-current power supply before use of the test level.
Electromagnetic environment–guidance for IEC 61000-4-11
If the user of the Spectra Optia system is aware of frequent power interruptions at his or her facility and requires continued operation during
mains power interruptions, it is recommended that the Spectra Optia system be powered from a suitably rated uninterruptible power supply.

Table 18-29: Test specification for ENCLOSURE PORT IMMUNITY to RF wireless comm. equip. 60601-1-2 (4th Ed.)

Test IMMUNITY
frequency
(MHz)
Band (MHz) Service Modulation
Maximum
power (W)
Distance
(m)
TEST LEVEL
(V/m) 18
385 380 to 390 TETRA 400 Pulse modulation 18 Hz 1.8 0.3 27

450 430 to 470 GMRS 460 FM ± 5 kHz 2 0.3 28

FRS 460 deviation 1
kHz sine

710
704 to 787 LTE Band 13, 17 Pulse modulation 0.2 0.3 9
745
217 Hz
780

810 GSM 800/900 2

800 to 960 TETRA 800 Pulse modulation 0.3 28
870 iDEN 820 b) 18 Hz
930 CDMA 850
LTE Band 5

Spectra Optia Apheresis System Operator’s Manual 253

Spectra Optia System Specifications

Table 18-29: Test specification for ENCLOSURE PORT IMMUNITY to RF wireless comm. equip. 60601-1-2 (4th Ed.) (continued)

Test IMMUNITY
Maximum Distance
frequency Band (MHz) Service Modulation TEST LEVEL
power (W) (m)
(MHz) (V/m)
1.720 GSM 1800
1.700 to 1.990 CDMA 1900 Pulse modulation 2 0.3 28
1.845 GSM 1900 b) 217 Hz
1.970 DECT; LTE Band 1,
2, 3, 25; UMTS

2.450 2.500 to 2.570 Bluetooth Pulse modulation 2 0.3 28

WLAN 802.11 b/g/n b) 217 Hz
RFID 2450
LTE Band 7

5.240
5.100 to 5.800 WLAN 802.11 a/n Pulse modulation 0.2 0.3 9
5.500
b) 217 Hz
5.785

254 Spectra Optia Apheresis System Operator’s Manual

 Spectra Optia System Specifications

60601-1-2 (3rd Ed.) EMC information

Emissions guidance

Note: The term “emissions” refers to the effects that the system can have on other devices in its vicinity.

Table 18-30: EMC emissions guidance 60601-1-2 (3rd Ed.)

Emission Test Compliance Electromagnetic Environment

Radio frequency (RF) Group 1 System uses high frequencies only for internal function
emissions CISPR 11 (e.g., computer timing signals and internal communication).
Device meets RF emissions requirements of standard
CISPR 11. Therefore, RF emissions are very low and are not
likely to interfere with nearby electronic equipment.

RF emissions Group 2 Seal Safe system emits RF when sealing tubing. Nearby
CISPR 11 electronic equipment not compliant with standard
IEC 60601-1-2 or standard CISPR 24 may be affected.

RF emissions Class A System is suitable for use in all establishments other than
CISPR 11 residential and establishments directly connected to the
public low-voltage power supply network that supplies
power to buildings used for residential purposes.

Harmonic emissions Class A

IEC 61000-3-2

Voltage fluctuations and Complies

flicker emissions
IEC 61000-3-3

Electromagnetic immunity

Note: The term “immunity” refers to the system’s ability to operate correctly in the presence of electromagnetic
disturbances. 18
Table 18-31: Electromagnetic immunity 60601-1-2 (3rd Ed.)

Immunity Test Test Level IEC 60601 Compliance Level Electromagnetic Environment
Electrostatic ± 6 kV contact ± 6 kV contact
discharge ± 8 kV air ± 8 kV air
IEC 61000-4-2

Electrical fast ± 2 kV for power supply ± 2 kV for power supply Quality of the main power supply should be
transient/burst lines lines that of a typical blood center or a hospital
IEC 61000-4-4 ± 1 kV for input and output ± 1 kV for input and output environment.
lines lines

Surge IEC 61000-4-5 ± 1 kV line to line ± 1 kV line to line Quality of the main power supply should be
± 2 kV line to earth ± 2 kV line to earth that of a typical blood center or a hospital
environment.

Spectra Optia Apheresis System Operator’s Manual 255

Spectra Optia System Specifications

Table 18-31: Electromagnetic immunity 60601-1-2 (3rd Ed.) (continued)

Immunity Test Test Level IEC 60601 Compliance Level Electromagnetic Environment
Voltage dips, short Class A Refer to Table 18-32.
interruptions, and
voltage variations on
power supply input
lines IEC 61000-4-11

Power frequency 3 A/m 3 A/m Magnetic fields of power frequency should be

(50/60 hertz (Hz)) at levels characteristic of a typical location in
magnetic field a typical blood center or hospital environment.
IEC 61000-4-8

256 Spectra Optia Apheresis System Operator’s Manual

 Spectra Optia System Specifications

Table 18-32: Voltage variations 60601-1-2 (3rd Ed.)

Test Level
Immunity Test Compliance Levels Electromagnetic Environment
IEC 60601-1-2
100 V 230 V

Voltage dips, short < 5% UT < 5% UT < 5% UT • Quality of the main power supply
interruptions, and (> 95% dip in UT) for (> 95% dip in UT) for (> 95% dip in UT) for should be that of a typical blood
voltage variations on 0.5 cycles 0.5 cycles 0.5 cycles center or a hospital environment.
power supply input • Interruptions of the main power
lines < 40% UT < 70% UT < 40% UT supply at voltages of 100 or less
IEC 61000-4-11 (> 60% dip in UT) for (> 30% dip in UT) for (> 60% dip in UT) for will cause the system to restart
5 cycles 2 cycles 5 cycles and the procedure to resume as
permitted by IEC 61000-4-11.
< 70% UT < 85% UT < 70% UT • If power interruptions are
frequent, the use of a suitably
(> 30% dip in UT) for (> 15% dip in UT) for (> 30% dip in UT) for
rated uninterruptible power supply
25 cycles 25 cycles 25 cycles
is recommended.
< 5% UT < 5% UT < 5% UT
(> 95% dip in UT) for (> 95% dip in UT) for (> 95% dip in UT) for
5 seconds 5 seconds 5 seconds

Note: UT is the voltage of the main alternating-current power supply before use of the test level.

18

Spectra Optia Apheresis System Operator’s Manual 257

Spectra Optia System Specifications

Guidance and manufacturer’s declaration

Note: These guidelines may not apply in all situations. Electromagnetic propagation is affected by absorption and
reflection from structures, objects, and people.

Table 18-33: Electromagnetic immunity (table 1 of 2) 60601-1-2 (3rd Ed.)

Test Level Electromagnetic Environment:

Immunity Test Compliance Level
IEC 60601-1-2 Recommended Separation Distance
Portable and mobile RF communications
equipment should be used no closer to any
part of the system, including cords, than the
recommended separation distance calculated
from the equation applicable to the frequency
of the transmitter.

Conducted RF 3 Vrms 3V d = 1.2 P

IEC 61000-4-6 150 kHz to 80 MHz
For calculations based on this equation, see
Table 18-35.

Radiated RF 3 V/m 3 V/m d = 1.2 P

IEC 61000-4-3 80 MHz to 2.5 GHz
80 MHz to 800 MHz

For calculations based on this equation, see

Table 18-35.

Note: At 80 MHz and 800 MHz, the separation distance for the higher frequency range applies.

258 Spectra Optia Apheresis System Operator’s Manual

 Spectra Optia System Specifications

Table 18-34: Electromagnetic immunity (table 2 of 2) 60601-1-2 (3rd Ed.)

Test Level Electromagnetic Environment: Recommended

Immunity Test Compliance Level
IEC 60601-1-2 Separation Distance

d = 2.3 P
800 MHz to 2.5 GHz

Where P is the maximum output power rating of the

transmitter in watts, according to the transmitter
manufacturer, and d is the recommended separation
distance in meters (m).

For calculations based on this equation, see Table 18-35.

Field strengths from fixed RF transmitters, as determined by

an electromagnetic site survey,a should be less than the
compliance level in each frequency range.b

Interference may occur in the vicinity of equipment marked

with the following symbol:

Note: At 80 MHz and 800 MHz, the separation distance for the higher frequency range applies.

a Field strengths from fixed transmitters—such as base stations for radio telephones (cellular and cordless) and land mobile radios, amateur
radios, AM and FM radio broadcasts, and TV broadcasts—cannot be theoretically predicted with accuracy. To assess the impact of fixed RF
transmitters on the electromagnetic environment, consider performing an electromagnetic site survey. If the measured field strength in the
location in which the system is used exceeds the applicable RF compliance level, the system should be observed to confirm normal operation. If
abnormal performance is observed, it may be necessary to reorient or relocate the system.

bOver the frequency range 150

kHz to 80 MHz, field strengths should be less than 3 V/m. 18

Spectra Optia Apheresis System Operator’s Manual 259

Spectra Optia System Specifications

The Spectra Optia system is intended for use in an electromagnetic environment in which radiated RF
disturbances are controlled. According to immunity test data, it is unlikely that commonly used communication
devices such as cell phones or other wireless-equipped devices meeting 802.11g/n standards will adversely affect the
Spectra Optia system. However, if electromagnetic interference is noticed, or higher-powered devices such as
two-way radios are to be used in the vicinity of the Spectra Optia system, the user can help prevent interference by
maintaining a minimum distance between portable and mobile RF communications equipment (transmitters) and
the Spectra Optia system. Refer to Table 18-35 for recommended separation distances according to the frequency
and maximum output power specified by the manufacturer of the communications device.

Table 18-35: Recommended separation distances between portable and mobile RF communications devices and the Spectra Optia
system 60601-1-2 (3rd Ed.)

Maximum Output Power Rating

Separation Distance (m) According to Frequency of Transmitter
(W) of Transmitter
150 kHz to 80 MHz 80 MHz to 800 MHz 800 MHz to 2.5 GHz

d = 1.2 P d = 1.2 P d = 2.3 P

0.01 0.12 0.12 0.23

0.1 0.38 0.38 0.73

1 1.2 1.2 2.3

10 3.8 3.8 7.3

100 12 12 23
Note: For transmitters rated at a maximum output power not listed in the table, the recommended separation distance d in meters can be
estimated using the equation applicable to the frequency of the transmitter, where P is the maximum output power rating of the transmitter in
watts, according to the transmitter manufacturer.

Note: At 80 MHz and 800 MHz, the separation distance for the higher frequency range applies.

260 Spectra Optia Apheresis System Operator’s Manual

 Spectra Optia System Specifications

Symbols and Certifications

The symbols shown in Table 18-36 can appear on the Spectra Optia system, as applicable.
Table 18-36: Spectra Optia system symbols and certifications

Symbol Definition
Indicates that the product was manufactured in accordance with Annex II of the European Council
Directive 93/42/EEC, as amended.

Indicates that the device is certified by CSA International in accordance with applicable U.S. and
Canadian standards for conformance with the requirements of CAN/CSA-C22.2 No. 601-1-M90,
CAN/CSA-C22.2 No. 1010.2.20-94, and UL 60601-1, as well as the applicable respective
amendments to these standards.

Indicates that the device is classified as Type BF per safety standard EN 60601-1. This classification
is based on the degree of protection against electrical shock, as defined in that standard.

Indicates that the device is protected against access by solid objects and falling water, as defined in
IP21
standard IEC 60529.

Indicates that the device requires an alternating supply current.

Indicates a protective conductor terminal. The symbol is located near the chassis’ grounding
locations.

Indicates a protective earth ground. The symbol is located near the chassis’ main grounding location
and at other protective ground points.
18
Indicates that the main power is turned on.

Indicates that the main power is turned off.

Indicates that the equipment is subject to directive 2012/19/EU concerning waste electrical and
electronic equipment (WEEE) and must be disposed of accordingly.

Indicates a non-pyrogenic fluid pathway.

Spectra Optia Apheresis System Operator’s Manual 261

Spectra Optia System Specifications

Table 18-36: Spectra Optia system symbols and certifications (continued)

Symbol Definition
Indicates a medical device that is intended for one use or for use on a single patient during a single
procedure.

Indicates the medical device manufacturer.

Indicates the date when the medical device was manufactured (or sterilization date, if the product is
sterile).

Indicates the Authorized representative in the European Community.

Indicates the product quantity when the quantity is placed in the square.

Indicates the manufacturer’s batch code so that the batch or lot can be identified.

Indicates the date after which the medical device is not to be used.

Indicates the presence of a sterile fluid path. The method of sterilization is ethylene oxide (EO).

Indicates that the use of the product is by prescription only.

Indicates the manufacturer’s catalog number so that the medical device can be identified.

Indicates that the user should consult the instructions for use.

Indicates a medical device that needs protection from light sources.

262 Spectra Optia Apheresis System Operator’s Manual

 Spectra Optia System Specifications

Table 18-36: Spectra Optia system symbols and certifications (continued)

Symbol Definition
Indicates a medical device that needs to be protected from moisture.

Indicates that the product packaging complies with European Directive 94/62/EC for packaging and
packaging waste.

Indicates that the product is made from high-density polyethylene.

Indicates that the product contains phthalates, specifically Di(2-ethylhexyl) phthalate (DEHP).

Indicates a medical device that is not to be resterilized.

Indicates the range of temperatures to which the device can be safely exposed.

Indicates the range of humidity to which the device can be safely exposed.

Indicates the correct upright position of the transport package.

18
Indicates that the contents of the transport package are fragile; therefore, it shall be handled with
care.

Indicates that stacking of the transport package is not allowed and no load should be placed on the
transport package.

Spectra Optia Apheresis System Operator’s Manual 263

Spectra Optia System Specifications

264 Spectra Optia Apheresis System Operator’s Manual

 A
Supplementary Information

Spectra Optia Apheresis System Operator’s Manual 265

Supplementary Information

Formula for Calculating Total Blood Volume (TBV)

Table A-1: Formula for calculating TBV (mL) using data in metric and English units

Metric
Female 183 + [356 × height3 (meters)] + [33.1 × weight (kg)]

Male 604 + [367 × height3 (meters)] + [32.2 × weight (kg)]

English
Female 183 + [0.005835 × height3 (inches)] + [15 × weight (lb)]

Male 604 + [0.006012 × height3 (inches)] + [14.6 × weight (lb)]

Sources:
Allen TH, et. al., “Prediction of Blood Volume and Adiposity in Man From Body Weight and Cube of Height.”
Metabolism, 1956; 5, no. 3: 328-345.
Nadler SB, et al., “Prediction of Blood Volume in Normal Human Adults.” Surgery, 1962; 52, no. 2:
224-232.

TPE Procedures: Plasma and Platelet Removal Efficiency

Table A-2: Plasma and platelet removal efficiency for TPE procedures using the Spectra Optia system

Measure Result (%)

Plasma removal efficiency 87.0 (mean)

Platelet removal efficiency 1.0 (median)

Source:
Tormey CA, et al., “Improved Plasma Removal Efficiency for Therapeutic Plasma Exchange Using a New Apheresis
Platform.” Transfusion, 2010; 50: 471-477.

266 Spectra Optia Apheresis System Operator’s Manual

 Supplementary Information

Exchange Procedures: Using a Blood Warmer on the Replace Line

Note: If you are performing a TPE-SPD procedure and used the system to prime the plasma device, the saline
container on the replace line must contain a volume equal to or greater than the volume of the blood warmer tubing set
in order to completely prime the tubing set.

1 Load the blood warmer tubing set onto the blood warmer. Be sure to leave enough tubing on each end of the
set to allow connection to the replace line.
2 Clamp one end of the blood warmer tubing set.
3 Clamp both replace lines.
4 Unscrew the luer connector on the replace line.
5 Connect the female end of the luer connector on the blood warmer tubing set to the male end of the luer
connector on the replace line.
6 Spike the replacement fluid container with the replace line and squeeze the drip chamber.
7 Unclamp both replace lines to prime the lines and fill the drip chamber on the second replace line.
8 Reclamp the second replace line.
9 Unclamp the blood warmer tubing set and prime the tubing set.
10 Reclamp the blood warmer tubing set.
11 Connect the male end of the luer connector on the blood warmer tubing set to the female end of the luer
connector on the replace line.
12 Put the replace line into the replacement fluid detector so that the luer connector is below the fluid detector
and the manifold is above the fluid detector. The luer connector must be positioned below the replacement
fluid detector.

Note: Ensure that you put the luer connector below the replacement fluid detector. If the blood warmer tubing set is
not positioned below the fluid detector and the tubing fills with air during the procedure, you must disconnect the blood
warmer tubing set at the luer connector and manually reprime the set. If you do not reprime the set, the vent bag could
overfill with air.

13 Unclamp the blood warmer tubing set.

14 Touch Continue.
A

Spectra Optia Apheresis System Operator’s Manual 267

Supplementary Information

Tubing Sets: Using the Needleless Injection Ports

The needleless injection ports on the Spectra Optia system tubing sets are intended to allow you to infuse fluid or
medication or to draw samples without the use of a needle. Use a syringe or extension tubing set that has a male
luer connector to connect to the port.
To use the needleless injection port, perform the following steps:
1 Swab the surface of the needleless injection port according to your standard operating procedure (SOP). Let
the port air-dry.

Note: Testing on the needleless injection port included swabbing the surface of the port with 70% isopropyl
alcohol for 25 to 30 seconds and allowing it to air-dry for 1 minute.

2 Using aseptic technique, carefully connect the syringe or the extension tubing set to the port by pushing the
syringe or other luer connector straight into the port using a clockwise, twisting motion. Do not try to
connect to the port at an angle or to pry open the slit in the port. Once the connection is made, ensure that
it is secure.
3 To disconnect from the port, twist the syringe or connector counterclockwise. The port completely closes
after each use and therefore does not require a separate injection port cap.
4 Flush the port after each use according to your SOP.

268 Spectra Optia Apheresis System Operator’s Manual

 Supplementary Information

Collection Set and IDL Set: Additional Instructions for Use

Using the Needle Protector on the Inlet Needle of the Collection Set and the IDL Set
The inlet needle on the Collection Set and the IDL Set has a needle protector to protect you from accidental injury
when you remove the needle. Follow the instructions below to correctly insert and remove the inlet needle.

Inserting the inlet needle

1 Prepare the venipuncture site according to your standard operating procedure.
2 Position the needle protector away from the wings of the needle so it does not interfere with the
venipuncture.
3 Grasp the wings, remove the tip protector from the needle, and perform the venipuncture.
4 Secure the needle tubing, according to your standard operating procedure.

Removing the inlet needle

1 Release the needle tubing, according to your standard operating procedure.
2 Prepare the dressing and place it over the venipuncture site, according to your standard operating procedure.
3 Ensure that the finger hook on the needle protector points up. Slide the needle protector forward into
position under the wings of the needle.
4 Place the index finger of one hand inside the finger hook. While maintaining appropriate pressure on the
venipuncture site, pull the tubing with the other hand so that the needle slides into the needle protector.
5 Continue pulling the tubing until you hear a “click,” indicating that the needle protector is locked in place.
Once the needle is locked in the needle protector, release the finger hook while maintaining pressure on the
venipuncture site.
6 Dispose of the needle, according to your standard operating procedure.

Using the Diversion Bag to Collect a Sample From a Venipuncture

To use the diversion bag on the inlet line, perform the following steps:
1
2
3
Perform the venipuncture with the inlet needle.
Unclamp the inlet line.
Unclamp the line to the diversion bag.
A
4 Allow the desired volume of blood to flow into the diversion bag.
5 Clamp and then seal the line to the diversion bag. You may also remove the bag.

Spectra Optia Apheresis System Operator’s Manual 269

Supplementary Information

Adding Anticoagulant to the Collection Bag

Perform the following steps to add the appropriate anticoagulant to the collection bag:
1 Clamp the line above the tubing containing the frangible connector on the accessory line of the collection bag.
2 Completely break the frangible connector by bending the tubing back and forth.
3 Using aseptic technique, remove the cap from the luer connector below the sterile barrier filter, and attach a
syringe containing the desired amount of anticoagulant to the connector.
4 Unclamp the line above the frangible connector.
5 Slowly inject the anticoagulant through the sterile barrier filter into the collection bag.
6 Clamp the line above the frangible connector.
7 Remove the syringe from the luer connector.

Note: To prevent fluid from flowing from the collection bag towards the luer connector, do not remove the syringe
from the luer connector before you clamp the line above the frangible connector.

8 To ensure that you delivered all of the anticoagulant in the syringe into the collection bag, perform the
following steps:
a. Attach a syringe containing at least 2.3 mL of saline to the luer connector. (The volume of the accessory
line and sterile barrier filter is approximately 2.3 mL.)
b. Unclamp the line above the frangible connector.
c. Slowly inject the saline through the sterile barrier filter to flush the anticoagulant from the filter into the
collection bag.
d. Clamp the line above the frangible connector.
e. Remove the syringe from the luer connector.

270 Spectra Optia Apheresis System Operator’s Manual

 Supplementary Information

Using the Sample Bulbs to Obtain a Product Sample

This section contains instructions for using a sample bulb on the collection bag to obtain a product sample, and
options for removing a sample from a bulb.

Obtaining a Product Sample

To obtain a product sample using the sample bulbs on the collection bag, perform the following steps:
1 Ensure that the line between the collection bag and the manifold on the sample bulb assembly is clamped.
2 Clamp one of the lines between the manifold and the sample bulb.
3 Gently mix the product in the bag to ensure that you obtain a representative sample.
4 Unclamp the line between the collection bag and the manifold on the sample bulb assembly.
5 Gently squeeze the sample bulb attached to the line that is not clamped to withdraw the desired amount of
the sample.
6 To express any excess sample back into the collection bag, perform the following steps:
a. Invert the sample bulb, and hold it above the fluid level of the collection bag.
b. Gently squeeze the sample bulb to express the excess sample into the bag.
7 To use the residual air in the sample bulb to clear the fluid from the line between the collection bag and the
sample bulb, perform the following steps:
a. Hold the sample bulb upright and below the collection bag.
b. Gently squeeze the sample bulb. The residual air in the bulb pushes the product from the line into the
collection bag.
c. While maintaining pressure on the sample bulb, clamp the line between the manifold and the sample bulb.
8 Before you remove the sample bulb containing the product sample, permanently seal the line between the
clamp below the manifold and the sample bulb.
9 Disconnect the sample bulb at the seal on the line.

Removing a Product Sample From the Sample Bulb

Below are three options for removing a sample from a sample bulb. Select one of these options or follow your own
process or standard operating procedure to remove the sample.
Option 1: Convert the sample bulb to a test tube to remove the sample
A
To convert the sample bulb to a test tube to remove the sample, cut off the top of the sample bulb at the dotted line
on the bulb. The bulb accommodates stoppers suitable for use with 12 mm × 75 mm test tubes.
Option 2: Pour the product sample into a test tube or other container
To pour the sample into a test tube or other container, cut the line below the seal, and gently squeeze the sample
bulb to express the sample into the container.
Option 3: Aspirate the sample from the sample bulb using a needle or a needleless adapter with an attached syringe
To aspirate the sample from the bulb, perform the following steps:
1 Insert a needle or a needleless adapter with an attached syringe into the sampling port.
2 Invert the sample bulb.
3 Slowly aspirate the product sample into the syringe. A small amount of product may remain in the sampling
port.

Spectra Optia Apheresis System Operator’s Manual 271

Supplementary Information

4 Remove the needle or the needleless adapter from the sampling port.
5 Transfer the sample to a test tube or other container.
6 Discard the sample bulb.

272 Spectra Optia Apheresis System Operator’s Manual

 Supplementary Information

Calculating the Volume of the Collected Product

To calculate the volume of the collected product after a collection procedure, divide the weight of the collected
product by the specific gravity of the cells. Follow the steps below to determine the weight of the collected product
and perform the calculation.

Determining the Weight of the Collected Product

Note: The scales used to weigh the collected product should be routinely calibrated before use. Tare weight should be re-
established following any manufacturing change to the bag or internal procedure revision.

To determine the weight of the collected product, you must subtract the weight of the tare bag from the weight of
the collection bag after the procedure is completed.

Preparing a tare bag and establishing a tare weight

1 Seal an empty collection bag at the tubing location stated in your facility’s standard operating procedure
(SOP). Ensure that the bag contains any tubing, label, clamp, or other component that is on the bag when a
collected product is weighed at your facility.
2 Weigh the tare bag and record the weight. Ensure that all tubing, labels, clamps, and other components are
on the scale when you weigh the bag.
3 Mark the tare bag with the tare weight, the date used to establish the weight, and the product for which it
can be used. Retain this bag for your reference to verify that the tare weight you are using represents the
current bag configuration.

Determining the weight of the collected product

Determine the weight of the collected product using one of the following methods:
Method 1:
1 Put the tare bag on the scale. Ensure that all tubing, labels and other components are also on the scale.
2 Set the weight on the scale to zero.
3 Remove the tare bag from the scale.
4 Put the collection bag containing the collected product on the scale, and weigh the bag according to your
facility’s SOP. The weight shown on the scale is the weight of the collected product.
A
Method 2:
1 Weigh the collection bag containing the collected product according to your facility’s SOP.
2 Subtract the tare weight you recorded for the tare bag from the weight of the collection bag. The result is the
weight of the collected product.

Calculating the Volume of the Collected Product

Terumo BCT uses 1.03 as the specific gravity for calculating the volume. To determine the volume, use the
following formula:
Weight of collected product ÷ 1.03 = Volume of collected product

Spectra Optia Apheresis System Operator’s Manual 273

Supplementary Information

Printing Procedure Data Reports

The Spectra Optia system stores procedure data reports for up to one hundred procedures. Perform the steps below
to connect a printer or a computer to the Spectra Optia system and to print a copy of a report.

Connecting a Printer to the Spectra Optia System

Ensure that the printer meets the following requirements before connecting it to the system:
• Printer must be network compatible. The system cannot communicate with Universal Serial Bus (USB) or
parallel printers.
• Printer must be compatible with Adobe® PostScript® 3™ page description language. The system does not
communicate properly with printers that are only compatible with earlier versions of the language.
• Printer must have a configurable Internet Protocol (IP) address. The address you assign to the printer must
begin with 172.21 to correspond with the system’s address.
• Printer must be able to use transmission control protocol (TCP) port number 9100 for Local Area Network
(LAN) printing.
• Ethernet cable used to connect the printer to the system must be a crossover cable.

Note: If you are connecting the system to the printer via a network device, such as a router or a switch, use a
standard Ethernet cable.

Perform the following steps to connect your Spectra Optia system to a printer:
1 Connect one end of the crossover cable to the printer and the other end of the cable to the Ethernet port on
the Spectra Optia system. The Ethernet port is located on the bottom right side of the back of the system next
to the connection for the power cord.
2 Configure the parameters and options on the report configuration screen to use a printer to print a copy of
the report. See Table 4-3 on page 51 for descriptions of the parameters and options.
3 Touch Test on the connection button to verify the connection between the system and the printer.
For additional information about connecting a printer to the Spectra Optia system, contact your Terumo BCT
service representative.

274 Spectra Optia Apheresis System Operator’s Manual

 Supplementary Information

Connecting a Computer to the System

Ensure that the computer meets the following requirements before connecting it to the system:
• Computer must have the following applications installed:
• File Transfer Protocol (FTP) server software
• Software used to convert PostScript files to Portable Document Format (PDF) files
• Ethernet cable used to connect the computer to the system must be a crossover cable.

Note: If you are connecting the system to the printer via a network device, such as a router or a switch, use a
standard Ethernet cable.

Perform the following steps to connect your Spectra Optia system to a computer:
1 Connect one end of the cross-over cable to the computer, and the other end of the cable to the Ethernet port
on the Spectra Optia system. The Ethernet port is located on the bottom right side of the back of the system
next to the connection for the power cord.
2 Configure the parameters and options on the report configuration screen to use a computer to print a copy
of the report. See Table 4-3 on page 51 for descriptions of the parameters and options.
3 Touch Test on the connection button to verify the connection between the system and the computer.
For additional information about connecting a computer to the Spectra Optia system, contact your local
Terumo BCT service representative.

Printing a Report
Perform the following steps to deliver the report to either a printer or a computer for printing:
1 Touch the Data menu button. The data tabs appear.
2 Touch the Report tab. The screen appears with a list of reports in order of the most recent procedure to the
least recent procedure. The reports are identified by the procedure date, start time, procedure type, and
patient’s TBV. To view additional reports, touch the scroll bar.

Note: The button on the screen for the report for a procedure that was just completed is labeled Current.

3 Touch the button that corresponds to the report that you want to print. The report appears on the screen.
A
4 Touch the button at the top left side of the report to deliver a copy of the report to the device specified on
the report configuration screen as follows:
• If you selected a printer, Print appears on the button.
• If you selected a computer, Print to File appears on the button.
• If you did not select a device and intend only to view the report, No Device appears on the button.

Spectra Optia Apheresis System Operator’s Manual 275

Supplementary Information

276 Spectra Optia Apheresis System Operator’s Manual

 B
Glossary of Terms

Spectra Optia Apheresis System Operator’s Manual 277

Glossary of Terms

Glossary of Terms
A Abbreviation for ampere.
AC Abbreviation for anticoagulant.
AC infusion rate Rate in mL/min/L TBV at which anticoagulant is infused to the patient
during the run.
ACD-A Anticoagulant used during apheresis procedures. ACD-A stands for
Anticoagulant Citrate Dextrose Solution A.
Administration line Component of the BMP Accessory Set used to transfer bone marrow
from the transfer bag (BM bag) into the accessory set.
AIM Abbreviation for automated interface management.
AIM system Optical detection system used by the Spectra Optia system to monitor
and control the position of the interface in the channel.
Albumin Plasma protein that helps to maintain fluid balance and to control the
viscosity of plasma.
Allogeneic Describes a blood transfusion or transplantation in which the donor and
the recipient are different but of the same species.
Alloimmunization Transfusion complication whereby a recipient develops antibodies toward
antigens from a donated blood product.
A/m Abbreviation for ampere per meter.
Anticoagulant Agent used to prevent the formation of blood clots.
Antigen Foreign substance capable of stimulating an immune response when
introduced into the body.
Apheresis Blood component separation procedure in which whole blood is drawn
from a patient or donor, and passed through a device that separates the
blood into components. Particular components are either removed or
collected, and the remaining components are returned.
Autologous Describes a blood transfusion or transplantation in which the donor and
the recipient are the same.
Bearing Hard plastic component of the centrifuge loop of the tubing set that
connects the loop to the centrifuge arm and to the entrance of the
centrifuge loading port.
Blood component In apheresis, the RBC, WBC, platelets, and plasma.
Blood warmer Device used to increase the temperature of fluid or blood delivered or
returned to a patient.
BM Abbreviation for bone marrow.
BM bag Bag containing source bone marrow before the bone marrow is
transferred into the BMP bag to perform a BMP procedure.

278 Spectra Optia Apheresis System Operator’s Manual

 Glossary of Terms

BMP bag Component of the BMP Accessory Set that holds the bone marrow
during a BMP procedure.
BMP procedure Apheresis procedure used to collect MNC from source bone marrow.
Bolus Dose of fluid given to a patient intended to mitigate hypovolemia.
Bone marrow Spongy tissue inside some bones that contains stem cells.
Buffy coat Fraction of blood after centrifugation that contains most of the white
blood cells and platelets.
Cassette Component of the tubing set that snaps onto the front panel of the
system and directs the flow of fluid through the set.
Catheter Tube that can be inserted into a vessel to allow the flow of blood or
injection of fluid.
Centrifugation Process that uses centrifugal force to separate a mixture.
Centrifuge loop Component of the tubing set. The group of lines that are loaded into the
centrifuge.
Channel Component of the tubing set used to separate a patient’s blood into
cellular components.
Chamber (Collection Set) Component of the Collection Set used for the secondary separation of
platelets and target cells.
Circulatory overload Elevation in blood pressure caused by an increase in blood volume.
CISPR Abbreviation for International Special Committee on Radio Interference,
a subcommittee of the IEC.
Citrate Salt or ester of citric acid that is used as an anticoagulant because it binds
calcium ion.
Citrate toxicity Condition that could occur in certain patients as a result of infusion of
ACD-A during an apheresis procedure. Mild forms of this condition are
generally recognized by peripheral paresthesia, tingling sensations in the
extremities, and/or restlessness. Severe forms of this condition can result
in significant cardiac dysfunction.
Clotting Result of activated platelets releasing chemicals that stimulate clotting
factors, causing the blood to coagulate.
Clumping Result of activated platelets sticking together during an apheresis
procedure.
B
CMNC Abbreviation for continuous mononuclear cell collection.
CMNC procedure Apheresis procedure used to collect MNC from a patient.
Collar Six-sided plastic component of the centrifuge loop of the tubing set that
secures the end of the loop in the centrifuge.
Collect line Component of the Collection Set and the IDL Set used to carry collected
blood components to the collection bag.

Spectra Optia Apheresis System Operator’s Manual 279

Glossary of Terms

Collection bag Component of the Collection Set and the IDL Set used to hold collected
blood components for collection or depletion purposes.
Connector Component of the tubing set that secures the lines where the separated
components exit the channel. It may also facilitate separation.
Custom prime Process of filling the tubing set with specified fluid after priming the set
with saline and before starting the run. Useful when treating a patient
with a low RBC volume or low TBV to maintain isovolemia.
dB Abbreviation for decibel.
Default Setting or value that is preset by the manufacturer and used by the system
in the absence of a selection made by the operator.
Diversion bag Component of the Collection Set and the IDL Set used to capture a skin
plug after performing a peripheral venipuncture or to collect a blood
sample.
ECV Abbreviation for extracorporeal volume.
ERCV Abbreviation for extracorporeal red blood cell volume.
Electrolyte Mineral in blood and body fluids essential to the function of muscle
action and other body processes.
Electromagnetic compatibility Branch of electrical sciences that studies the unintentional generation,
propagation, and reception of electromagnetic energy with reference to
electromagnetic interference (EMI) that such energy may induce.
Electromagnetic compatibility ensures that, when used as intended,
electronic and electrical equipment works correctly when subjected to
certain amounts of EMI and does not emit EMI that could interfere with
other equipment.
EMC Abbreviation for electromagnetic compatibility.
Erythrocyte Term for a red blood cell.
Erythrocytapheresis Apheresis procedure used to separate RBC from a patient’s blood.
Ethylene oxide Chemical compound that is used to sterilize medical products and
devices.
EO Abbreviation for ethylene oxide.
Extracorporeal circuit Tubing that carries the blood when the blood is outside of the patient’s
body. This includes the Spectra Optia system tubing set and the tubing
set of any other device connected to the set.
Extracorporeal volume Volume of the patient’s blood that is outside of the body during an
apheresis procedure.
Extracorporeal red blood cell Number of the patient’s red blood cells that are outside of the body
volume during an apheresis procedure.
FCR Abbreviation for fraction of cells remaining.
Four-lumen tubing Lines that comprise the centrifuge loop of the tubing set.

280 Spectra Optia Apheresis System Operator’s Manual

 Glossary of Terms

Fluid shift Change in the patient’s intravascular volume during an apheresis

procedure as blood is drawn, one or more components are retained, and
the remaining components are returned, with or without replacement
fluid.
Fraction of cells remaining Desired percentage of starting defective RBC remaining in the patient’s
blood at the end of a RBC exchange procedure.
Functionally closed system Blood collection system that uses sterile barrier filters to prevent bacteria
from entering the system.
G-CSF Abbreviation for granulocyte-colony stimulating factor.
Gear train Component of the centrifuge chamber that consists of a series of rotating
gears that keep the filler and the centrifuge arm spinning at the proper
speed.
GHz Abbreviation for gigahertz.
Graft-versus-host disease Condition that occurs when cells from a transplanted organ or tissue
attack the cells or tissue of the transplant recipient.
Granulocyte Type of WBC.
Granulocyte-colony stimulating Protein that can be given to a patient to stimulate the bone marrow to
factor produce WBC.
GVHD Abbreviation for graft-versus-host disease.
Hct Abbreviation for hematocrit.
Hematoma Localized collection of blood in an organ, space, or tissue due to a break
in the wall of a blood vessel.
Hgb Abbreviation for hemoglobin.
Hemolysis Disruption of the RBC membrane, causing the release of hemoglobin.
Hemostat Instrument used to compress a bleeding vessel or to stop the flow of fluid
through a tube.
HES Abbreviation for hydroxyethyl starch.
Hydroxyethyl starch Volume expander that can be used during PMN collection procedures
and WBCD procedures and that causes the RBC to form rouleaux,

Hz
facilitating collection of WBC.
Abbreviation for hertz. B
Inlet:AC ratio Ratio of the inlet pump flow rate to the AC pump flow rate, expressed as
parts of inlet volume to one part of anticoagulant.
Inlet access Refers to the patient access from which whole blood is drawn.
Inlet flow rate Speed at which blood is drawn from the patient.
Inlet line Line on the tubing set used to carry anticoagulated blood from the
patient to the channel.
Inlet pressure Force per unit of area on the blood flow as it is drawn from the patient.

Spectra Optia Apheresis System Operator’s Manual 281

Glossary of Terms

Interface Area where the cellular components of blood meet the plasma in the
connector.
IEC Abbreviation for International Electrotechnical Commission, an
international standards organization for electrical, electronic, and related
technologies.
IP (Internet Protocol) address Numerical identifier for a computer or a device on a network that enables
communication among the devices on the network.
IV Abbreviation for intravenous.
kV Abbreviation for kilovolt.
Leukapheresis Apheresis procedure used to separate WBC from a patient’s blood.
Leukemia Cancer of the blood-forming cells in the bone marrow.
Lymphocyte Type of WBC.
Malaria Disease caused by a parasite and usually transmitted through a mosquito
bite, which infects the RBC.
Manifold Component of the tubing set. A connector with multiple ports used to
join a line with one or more other lines. It may also include an injection
port.
Manual rinseback Process whereby the operator, not the system, performs rinseback, in case
of a power or system failure.
MHz Abbreviation for megahertz.
mmHg Abbreviation for millimeters of mercury.
MNC Abbreviation for mononuclear cell or mononuclear cells.
MNC collection procedure Apheresis procedure used to collect MNC from a patient.
Mononuclear cell Type of WBC.
Obstruction Object or a condition that restricts the flow of fluid through the tubing
set.
Packed RBC Preparation of RBC with most of the plasma removed.
Packing factor Relationship between the inlet flow rate and the centrifuge speed that
indicates the degree of separation of the blood components during an
apheresis procedure.
Paresthesia Tingling sensation around the mouth that is a symptom of citrate toxicity
or hypocalcemia.
Patient access Refers to the device used to gain entry to a patient’s venous system.
Peripheral blood Blood in a vein or artery.
Peripheral blood stem cell Stem cell that circulates in the peripheral blood.
Plasma Fluid portion of the blood that transports proteins and enzymes through
the body.

282 Spectra Optia Apheresis System Operator’s Manual

 Glossary of Terms

Plasma bag Bag on the tubing set that holds collected plasma. This bag is on the
Collection Set and in the BMP Accessory Set.
Plasma device Short form for secondary plasma device.
Plasma line Line on the tubing set used to carry concurrently collected plasma to the
plasma bag. This line is on the Collection Set and on the IDL Set.
Plasmapheresis Apheresis procedure used to separate plasma from a patient’s blood.
Platelet Small cell fragment that aids in blood coagulation by helping to repair
damage to walls of blood vessels.
PLTD procedure Apheresis procedure used to collect excess platelets from a patient.
PLTD Abbreviation for platelet depletion.
PMN Abbreviation for granulocyte or granulocytes.
PMN collection procedure Apheresis procedure used to collect granulocytes from a donor.
Port number Numerical identifier used for the transmission of data between devices in
a network.
Primary run target Specific value that has been configured or entered on the run values
screen and that when attained, causes the system to end the run. A black
frame appears around the button of the primary run target to distinguish
it from other run targets.
Prime Process of pumping saline through the tubing set to prepare the set for the
run.
Procedure Series of steps performed to accomplish apheresis on the Spectra Optia
system. A procedure starts when the procedure is selected and ends when
the patient is disconnected.
Radio frequency Frequency in which radio waves are transmitted.
RBC Abbreviation for red blood cell or red blood cells.
RBCX Abbreviation for red blood cell exchange.
RCV Abbreviation for red blood cell volume.
Red blood cell Formed element of the blood responsible for delivering oxygen from the
lungs to the tissues and helping to return carbon dioxide from the tissues
to the lungs.
Red blood cell depletion procedure Type of red blood cell exchange procedure in which excess or defective
B
RBC are removed from a patient and replaced with desired replacement
fluid.
Red blood cell depletion/exchange Type of red blood cell exchange procedure that consists of a depletion
procedure procedure followed by an exchange procedure.
Red blood cell exchange procedure Apheresis procedure used to remove defective RBC from a patient and
replace them with healthy donor RBC.
Red blood cell volume Number of red blood cells in a specific unit or circulating in the patient’s
blood.

Spectra Optia Apheresis System Operator’s Manual 283

Glossary of Terms

Remove bag Bag on the tubing set that holds the removed blood components. This
bag is only on the Exchange Set.
Remove line Line on the Exchange Set used to carry removed blood components from
the channel to the remove bag.
Replace line Line on the tubing set used to carry replacement fluid from the
replacement fluid container to the reservoir. This line is on the Exchange
Set and on the IDL Set.
Replacement fluid Fluid given to the patient during an exchange procedure to replace the
blood components removed.
Reservoir Component of the tubing set cassette that contains the fluid to be
returned to the patient.
Reservoir filter 200-micron filter located at the exit of the reservoir used to filter the fluid
returned to the patient.
Return access Refers to the patient access through which blood components and fluids
are returned.
Return flow rate Speed at which blood is returned to the patient.
Return line Line that carries fluid from the reservoir to the patient.
Return pressure Force per unit of area on the blood flow as it is returned to the patient.
RF Abbreviation for radio frequency.
Rinseback Process that clears the channel of remaining cells and returns them to the
patient after the run.
rpm Abbreviation for revolutions per minute.
Run State during a procedure when apheresis is performed. The run starts
when the patient is connected and ends when a run target is attained.
Run target One or more values that appear on the run values screen and on the run
targets screen that should be attained when the run ends. The system
predicts these values based on the primary run target.
Saline Sterile 0.9% sodium chloride and water solution used to prime the tubing
set and to perform an apheresis procedure.
Saline rinse Process that rinses the tubing set with saline before the run to clear the set
of any residual ethylene oxide, a by-product of sterilization.
Secondary plasma device Device used to treat the separated plasma before it is returned to the
patient.
Sickle cell disease Inherited blood disorder that affects the hemoglobin in RBC.
Single-needle access Single patient access for both the inlet access and the return access.
Spillover Condition when some RBC from the channel have entered the plasma
line.
SPD Abbreviation for the procedure on the Spectra Optia system that is
performed with a secondary plasma device.

284 Spectra Optia Apheresis System Operator’s Manual

 Glossary of Terms

SPL Abbreviation for sound pressure level.

Stem cell Non-specialized cell capable of renewing itself through cell division or of
being induced to become a tissue-specific or organ-specific cell.
System reset Process that occurs when the system restarts itself after a power
interruption or under certain alarm conditions.
TBV Abbreviation for total blood volume.
Therapeutic apheresis Apheresis procedure used to remove a pathological blood component in
order to treat a patient.
TPE Abbreviation for therapeutic plasma exchange.
TPE procedure Apheresis procedure used to remove plasma from a patient and replace it
with new plasma or a compatible replacement fluid.
Total blood volume Entire volume of the patient’s circulating blood, including the plasma and
the cellular components.
Treated plasma bag Bag that holds the treated plasma before it is returned to the patient
during a TPE procedure using an SPD.
Uticaria Temporary skin condition caused by allergic reaction and characterized by
a rash and severe itching.
V Abbreviation for volt.
V AC Abbreviation for volts of alternating current.
Vascular access device Type of catheter used to access to the central venous system of a patient.
Vent bag Bag on the tubing set that holds air that has been displaced from the
system.
V/m Abbreviation for volts per meter.
W Abbreviation for watt.
WBC Abbreviation for white blood cell or white blood cells.
White blood cell Cellular component of the immune system that protects all cells and
tissues against foreign organisms and matter.
WBCD Abbreviation for white blood cell depletion.
WBCD procedure Apheresis procedure used to collect excess white blood cells from a
patient.
B

Spectra Optia Apheresis System Operator’s Manual 285

Glossary of Terms

286 Spectra Optia Apheresis System Operator’s Manual

 Index

A alarm mute button 36

muting 218
abbreviations, procedure 20
sound pressure level 244
AC (mL) procedure summary data
screen descriptions 216
in collection bag 212
troubleshooting 216
in plasma bag 212
multiple alarms 218
in remove bag 212
volume, configuring 49
to patient 212
warning lights on monitor 216, 248
used (during the run) 212
algorithm control 93
used for prime 212
algorithm control icon 37
AC configuration 55, 56
anticoagulant
AC container configuration 50
ACD-A 16
AC fluid detector 24
using during a PMN collection procedure 173
AC infusion rate
HES solution 16, 162
citrate toxicity, managing 94, 109, 127, 143, 157,
preparing 162
172, 189
anticoagulant (AC) pump 23
configuring 52, 53, 55, 56, 57, 58
anticoagulant solution
data entry range 87, 101, 119, 135, 151, 166, 182
HES solution 178
AC pump 23
preparing 178
accessory bracket 21
anticoagulant, adding to collection bag 270
accessory set
anticoagulation of the extra corporeal circuit 221
warnings for use 8
arrow buttons
accumulation phase 132
left and right arrows 37
ACD-A
arrow buttons, up and down 38
citrate toxicity 16
Automatic mode 29
contents of 16
recommended ratio to bone marrow 194
using during a PMN collection procedure 173 B
volume to add to bone marrow 194 bar code reader 24
AIM system biohazardous waste disposal 18
collection preference 140 blood drop icon 37
description of 29 blood removed procedure summary data 212
lights 26 blood warmer
cleaning 234 bracket 21
alarm limit configuration configuring
inlet pressure 50 replace line 59
plasma pressure 53 return line 59
return pressure 50 tubing set volume 59
alarm mute button 36 indicating use of 80
alarm volume configuration 49 on replace line 105
alarms option, description of 75
active alarm button 36 options screen 119
alarm history screen 218 Blood warmer icon 38
alarm tone BM cycles procedure summary data 212

Spectra Optia Apheresis System Operator’s Manual 287

Index

BM data fluids used during procedures 14

data entry range procedure
BMV 198 collection 11
Hct 198 general 11
entering 200 Seal Safe system 14
RBC volume required 200 service 10
BM processed procedure summary data 212 system 9
BMP accessory set tubing set
administration line, sealing 195 Collection Set 13
bone marrow, transferring into set 195 Exchange Set 13
BMP bag general 12
correctly hanging 201 IDL Set 13
mixing contents in bag 201 centrifuge arm 26
BMP procedure configuration 58 centrifuge chamber components
BMV data entry range 198 AIM system lights 26
bolus, fluid centrifuge arm 26
administration of 94, 109, 127 filler 26
data entry range 88, 102, 120 fluid leak detector 26
procedure summary data (mL) 212 gear shroud 26
volume reported 94, 109, 127 loading port 26
bracket, accessory 21 lower bearing holder 26
buffy coat, minimizing accumulation of 144, 158, 174, 191 strobe lights 26
buttons upper bearing holder 26
active button 35 upper collar holder 26
inactive button 35 centrifuge door 21
menu manually opening 226
BMP procedure 197 centrifuge loop, loading into centrifuge 67
CMNC procedure 149 centrifuge pressure sensor 24
MNC collection procedure 133 centrifuge speed, maximum 245
PLTD procedure 180 certifications, definitions of 261
PMN collection procedure 164 chamber bracket (standard filler) 27
RBCX procedure 117 chamber chase
TPE procedure 85 adjusting 142
TPE-SPD procedure 99 configuring 54
WBCD procedure 180 chamber flush
monitor adjusting 142
pause 36 configuring 54
stop 36 chamber, handling if partially full 146
screen channel, loading into centrifuge 67
active alarm 36 check mark icon 37
alarm mute 36 circuit breaker 22
clock 36 citrate toxicity management 94, 109, 127, 143, 157, 172,
go back 36 189
left and right arrows 37 cleaning
left and right scroll 37 Seal Safe system 234
up and down arrow 38 cleaning, system
up and down scroll 36 centrifuge chamber 233
cleaning solutions 230
C frequency 239
front panel 232
cassette
materials to use 231
manually raising 226
surface 232
snapping into tray 67
touch screen 232
cassette tray 21
clock button 36
Caution status 32
clumping in connector
cautions for use 9
BMP procedure 194, 204
definition of 2
CMNC procedure 159

288 Spectra Optia Apheresis System Operator’s Manual

 Index

Decrease Inlet AC Ratio button 142 procedure-specific parameters 52

depletion procedures 192 BMP 58
PMN procedure 175 CMNC collection 55
CMNC procedure configuration 55 MNC collection 54
collect (mL) procedure summary data 212 PLTD 58
collect into bag button 142, 156, 171, 188, 203 PMN collection 56
collect line, adjusting color in RBCX 53
BMP procedure 204 TPE 52
CMNC procedure 158 TPE-SPD 52
PMN collection procedure 173 WBCD 57
collect plasma (BMP) connection test configuration for printer 51
configuring 58 connector, clumping in see clumping in connector
description of 74 consumables required see supplies required
selecting 80 contraindications for use statement 3
collect port conventions used in manual 2
decreasing cell concentration in 144, 158, 173, 190, cord holder 22
204 cord, power 22
image 37 custom prime
increasing cell concentration in 144, 158, 173, 190, data entry range 87, 101, 119, 134, 150, 165, 182
204 data, entering 77
collect pressure sensor 24 description of 74
collect pump 23 ending before prime is complete 78
collect valve 24 extending 78
collect valve position performing 76
collect 142, 156, 171, 188 procedure summary data (mL) 212
return 142, 156, 171, 188 reactions to 18
collect volume recommendation
lowering target 174, 191 accepting or declining 76
priority over plasma collection 154, 169 configuring 50
specifying target 159 selecting 76
collected product starting 77
calculating volume of 273 supplies required 76
weighing 273 volume recommended 77
collection bag custom replacement fluid configuration 52, 53, 57, 58
establishing tare weight 273
procedure summary data (mL) 212 D
collection phase
data entry pad 34
controls 142
data entry range
description of 132
BMP procedure 198
collection preference
CMNC procedure 150
cell counts used to calculate 140
MNC collection procedure 134
data entry range 136, 152, 167, 183, 198
PLTD procedure 181
description of 140, 156, 171, 188, 202
PMN collection procedure 165
graphic 39
RBCX procedure 118
high preference, using 144, 158, 173, 190, 204
TPE procedure 86
low preference, using 144, 158, 173, 190, 204
TPE-SPD procedure 100
trend graph 140, 156, 171, 188, 202
WBCD procedure 181
collection procedure cautions for use 11
data, fluid see fluid data
collection procedure warnings for use 7
data, patient see patient data
Collection Set cautions for use 13
date configuration
components, system 21
current date 49
computer connection 275
format 49
configuration
decimal configuration 49
procedure-independent parameters 49
Decrease Inlet AC Ratio button 142
procedure 50
depletion procedure cautions for use 11
report 51
depletion procedure warnings for use 7
system 49

Spectra Optia Apheresis System Operator’s Manual 289

Index

detectors filtration before processing 194

air, return line 24 fluid balance
fluid data entry range 86, 118
AC 24 entering 122
replacement 24 limits by procedure 33
RBC 24 managing, TPE-SPD procedure 111
device configuration for printing 51 procedure summary data 212
disconnecting patient 210 fluid data
disinfection, system data entry range
centrifuge chamber 233 depletion procedures 182
disinfecting solutions 230 RBCX procedure 118
front panel 232 TPE procedure 86
materials to use 231 entering 121
surface 232 fluid balance
touch screen 232 entering 122
diversion bag, using 269 fluid detectors
do not connect patient icon 37 AC 24
replacement 24
E fluid leak detector 26
fluid leaks, troubleshooting 221
electrical warnings for use 4
fluids used during procedures
end run summary screen see procedure summary screen 212
cautions for use 14
end time procedure summary data 212
fluid types
Ethernet port 22
ACD-A 16
exchange procedure warnings for use 7
HES 16
Exchange Set cautions for use 13
replacement fluid 16
exchange type, RBCX
saline solution 16
description of 116
warnings for use 8
selecting 121
flush chamber 142
extension tubing set
initiating a collection phase 142
priming 105
returning contents to patient 142
extracorporeal circuit, anticoagulation of 221
fraction of cells remaining see FCR
extracorporeal volume 250
front panel 21
front panel components
F detectors
FCR AC fluid 24
data entry range 119, 120 RBC 24
description of 123 replacement fluid 24
procedure summary data 212 return line air 24
filler 26 pumps
channel loading 67 AC 23
cleaning 234 collect pump 23
disinfecting 234 inlet 23
IDL 27 plasma 23
installation 64 replace 23
removal 64 return 23
standard 27 sensors
filler components bar code reader 24
centrifuge collar holder 27 centrifuge pressure 24
chamber bracket (standard filler) 27 collect pressure 24
groove 27 inlet pressure 24
latch 27 plasma pressure 24
locking pin 68 pressure, return 24
optical reference 27 reservoir, high-level 24
filler required for each procedure 62 reservoir, low-level 24
filtration of bone marrow valves
additional filtration 194 collect 24

290 Spectra Optia Apheresis System Operator’s Manual

 Index

plasma 24 infectious waste disposal 18

RBC 24 injection port, using 268
remove 24 injection site, using 268
functional description of procedure see procedure description inlet AC ratio
clumping in connector, resolving 159, 175, 192
G configuring 52, 53, 55, 56, 57, 58
data entry range 87, 101, 119, 135, 151, 166, 182
gear shroud 26
Decrease Inlet AC Ratio button 142
go back button 36
ramping, configuring 55
granulocyte collection see PMN collection 56
Inlet collection phase control 142
graph of inlet volume processed 141
inlet pressure alarm limit configuration 50
graphics, screen
inlet pressure sensor 24
collection preference 39
inlet processed (mL) procedure summary data 212
interface graphic 37
inlet pump 23
groove, filler 27
inlet pump flow rate
configuring 58
H during saline rinse
handle wheels 22 Collection Set 79
hash mark icon 38 Exchange Set 79
Hct of bone marrow in BM bag, measuring 195 IDL Set 79
Hct of bone marrow, data entry range 198 inlet volume processed
Hct of patient graph of 141
data entry range 86, 100, 118, 134, 150, 165, 181 icon 38
updating 128 Inlet collection phase control 142
height of patient procedure summary data 212
configuring unit of measure 50 installation, system
data entry range 86, 100, 118, 134, 150, 165, 181 setting up the system 42
hematocrit see Hct turning the system on and off 43
HES intended use statement 3
anticoagulant solution, preparing 162, 178 interface graphic 37
configuring 57 interface, user see screen
description of 16, 74 IP address configuration 51
indicating use of 78 IV pole 21
high-level reservoir sensor 24 IV pole release button 22
humidity, device shipping and storage 243
hydroxyethyl starch see HES 16, 57 L
hypervolemia limits, procedure 33
hypovolemia limits, procedure 33 language configuration 49
leak detector see fluid leak detector 26
leaks see fluid leaks
I lights
icons, screen AIM system 26
algorithm control 37 strobe 26
blood drop 37 lines, sealing 210
check mark 37 loading port 26
do not connect patient 37 loading the tubing set
hash mark 38 see tubing set 65
inlet volume processed 38 lower bearing holder 26
not equal 38 low-level reservoir sensor 24
operator override 38
RBC detected 38 M
Semi-Automatic mode 37
single-needle 37 maintenance, preventive 240
test tube 38 MNC collection procedure configuration 54
IDL Set cautions for use 13 modes of operation see operating modes
images, screen monitor 21
collect port image 37 moving the system see transport, system
mute button, alarm 36

Spectra Optia Apheresis System Operator’s Manual 291

Index

N CMNC procedure 151

MNC collection procedure 132
needle protector, using 269
PLTD procedure 183
needleless injection port, using 268
PMN collection procedure 166
non-infectious waste disposal 18
TPE procedure 87
not equal icon 38
TPE-SPD procedure 101
note, definition of 2
WBCD procedure 183
description of 30
O paper size configuration 51
operating modes 29 patient data
Automatic mode 29 affect on procedure outcome 128
Semi-Automatic mode 29 data entry range
Operator collection phase control 142 Hct 86, 100, 118, 134, 150, 165, 181
operator override icon 38 height 86, 100, 118, 134, 150, 165, 181
optical reference 27 platelet count 181
options, procedure platelet count patient 134
blood warmer TBV 86, 100, 118, 134, 150, 165, 181
description of 75 WBC count 134, 181
indicating use of 80 weight 86, 100, 118, 134, 150, 165, 181
collect plasma entering 89, 103, 121, 138, 153, 168
description of 74 patient reactions to procedures 17
selecting 80 patient, disconnecting 210
custom prime pause button 36
data, entering 77 plasma (mL) procedure summary data
description of 74 in collection bag 212
ending before prime is complete 78 plasma bag 212
extending 78 plasma bag, treated see treated plasma bag
performing 76 plasma collection
recommendation, accepting or declining 76 BMP procedure using tubing set 10300 196
selecting 76 CMNC procedure 154
starting 77 collect volume priority 154, 169
supplies required 76 PMN collection procedure 169
volume recommended 77 volume collected, changing after attaining run target 205
HES plasma collection into collection bag
description of 74 configuring
indicating use of 78 plasma collection into plasma bag
plasma collection configuring 56
description of 75 plasma collection option (CMNC) 75, 81
indicating timing of 81 plasma collection, configuring
rinseback into collection bag 55
description of 74 into plasma bag 55
selecting 75, 76 timing of (CMNC) 55
saline rinse plasma device
description of 74 connecting 105
performing 79 prime divert, performing 105
repeating 80 rinsing 111
selecting 79 saline prime, configuring 53
starting 79 saline prime, performing 105, 106
single needle plasma device configuration 53
description of 74 plasma device data, changing 103
selecting 80 plasma device, data entry range 100
plasma exchange efficiency 95
P plasma flow rate, configuring 53
packing factor plasma pressure alarm limit, configuring 53
default plasma pressure sensor 24
BMP procedure 198 plasma pump 23
plasma removal efficiency, TPE procedure 266

292 Spectra Optia Apheresis System Operator’s Manual

 Index

plasma removed procedure summary data 212 TPE, single needle 84

plasma treated procedure summary data TPE-SPD 98
plasma treated (mL) 212 WBCD 178
plasma volumes treated 212 procedure options see options, procedure
plasma valve 24 procedure screen description 34
plasma volumes exchanged procedure summary data 212 procedure selection 64
plasma volumes exchanged, configuring 52 procedure states 30
plasma volumes treated, configuring 52 color scheme 35
plasma, transferring into collection bag 145 procedure summary screen 212
platelet count of patient, data entry range 134, 181 procedure warnings
platelet depletion procedure see PLTD procedure 58 collection 7
platelet removal efficiency, TPE procedure 266 depletion 7
platelet swirling in connector exchange 7
algorithm control 93 procedural, general 4
handling 95 pump accuracy 246
platelets in collection bag, reducing volume of 204 pump flow rates 245
PLTD procedure configuration 58 pumps
PMN collection procedure configuration 56 AC 23
pole, IV 21 collect 23
port number configuration for printer 51 inlet 23
power cord 22 plasma 23
power cord holder 22 replace pump 23
power failure return 23
cassette, manually raising 226
centrifuge door, manually opening 226 R
resuming a procedure 222
RBC contamination, minimizing 144, 158, 173, 190
power interruption see power failure
RBC detected icon 38
power switch 21
RBC detector 24
pressure sensor accuracy, inlet and return 247
collection phase control 142
pressure sensors
RBC detector detection level 247
centrifuge 24
RBC in BMP bag
collect 24
concentrating 205
inlet 24
maximum Hct in bag 205
plasma 24
volume required 200
return 24
RBC valve 24
preventive maintenance 240
RBC volume, calculating 76, 77
prime divert (TPE-SPD) 105
RBC, residual volume of 251
configuring volume 53
RBCX procedure configuration 53
patient with low TBV 112
RCV, calculating 76, 77
performing 106
reactions to fluid used for custom prime 18
prime, custom see custom prime
reactions to procedures 17
prime, tubing set 71
remove bag (mL) procedure summary data 212
printer connection 274
remove valve 24
procedure abbreviations 20
replace pump 23
procedure cautions
replace pump balance
collection 11
adjusting 110
depletion 11
configuring 53
general 11
replaced (mL) depletion procedure summary data 212
procedure configuration 50
replaced (mL) exchange (RBCX) 123
procedure description
replaced (mL) exchange procedure summary data 212
BMP 194
replacement fluid
CMNC 148
custom
MNC collection 132
citrate percent, configuring 52
PLTD 178
percent citrate, configuring 53, 57, 58
PMN collection 162
flow rate, improving
RBCX 116
during depletion procedures 190
TPE 84

Spectra Optia Apheresis System Operator’s Manual 293

Index

from a bottle 190 decreasing

purpose of 16 CMNC procedure 159
replacement fluid detector 24 MNC collection procedure 144
replacement used (mL) procedure summary data 212 PMN collection procedure 174
report configuration 51 TPE procedure, single needle 96
report type configuration 51 run time (min) procedure summary data 213
report update interval configuration 51 run values
reports, printing 275 changing 90, 104, 123, 138, 153, 168, 184, 200
computer, connecting 275 data entry range
printer, connecting 274 AC infusion rate 87, 101, 119, 135, 151, 166,
reports, reviewing 128 182
reservoir sensors BMP procedure 198
high-level 24 CMNC procedure 151
low-level 24 inlet AC ratio 87, 101, 119, 135, 151, 166, 182
reset of system during a procedure 222 MNC collection procedure 135
return line air detector 24, 247 PLTD procedure 182
return pressure alarm limit configuration 50 PMN collection procedure 166
return pressure sensor 24 RBCX procedure 119
return pump 23 TPE procedure 87, 101
return to BMP bag button 203 WBCD procedure 182
return to patient button 142, 156, 171, 188 run, ending
rinseback before target is attained 208
description of 74 rinseback, performing
performing manual 223
manual 223 using system 208
using system 208 run, extending 209
plasma device, rinsing 111 if chamber is partially full 146
selecting 75, 76 treated plasma bag, returning contents of 111
rinseback (mL) procedure summary data 213
RLAD see return line air detector 24 S
run summary see procedure summary screen 212
saline (mL) to patient due to air removal 213
run targets
saline diverted (mL) procedure summary data 213
collect volume
saline prime
lowering 174, 191
configuring 53
collect volume, specifying 159
data entry range 101
data entry range
declining 106
BMP procedure 199
skipping 106
CMNC procedure 152
supplies required 79
MNC collection procedure 136
saline prime (TPE-SPD)
PLTD procedure 183
performing 105
PMN collection procedure 167
skipping 105
RBCX procedure 120
saline rinse
TPE procedure 88
description of 74
TPE-SPD procedure 102
inlet pump flow rate
WBCD procedure 183
Collection Set 79
list of
Exchange Set 79
BMP procedure 200
IDL Set 79
CMNC procedure 153
performing 79
MNC collection procedure 138
procedure summary data (mL) 213
PLTD procedure 184
repeating 80
PMN collection procedure 168
selecting 79
RBCX procedure 123
starting 79
TPE procedure 90
saline solution 16
TPE-SPD procedure 104
sample bulbs, using 271
WBCD procedure 184
sample, obtaining
run time
diversion bag, using 269
configuring 55, 56, 57, 58

294 Spectra Optia Apheresis System Operator’s Manual

 Index

sample bulbs, using 271 start time procedure summary data 213
screen buttons see buttons 35 starting defective RBC
screen color scheme 35 data entry range 119
screen description, alarm 216 description of 123
screen description, procedure 34 stop button 36
scroll buttons storage humidity, device 243
left and right 37 storage temperature, device 243
up and down 36 strobe lights 26
Seal Safe system 21 supplies required
cautions for use 14 all procedures 62
cleaning BMP procedure 194
jaw cavity 234 CMNC procedure 148
sealer head 235 custom prime 76
lines, sealing 210 MNC collection procedure 132
sealer head PLTD procedure 178
disassembling 235 PMN collection procedure 162
reassembling 237 RBCX procedure 117
splash guard, replacing 238 saline prime 79
warnings for use 8 TPE procedure 84
secondary plasma device see plasma device TPE-SPD procedure 98
selecting the procedure 64 WBCD procedure 178
Semi-Automatic mode icon 37 switch, power 21
Semi-Automatic mode, using 29 symbols, definitions of 261
AIM system disabled 219 symptoms of patient reactions to procedures 17
AIM system enabled 219 system cautions for use 9
CMNC procedure 220 System collection phase control 142
depletion procedures 220 system configuration 49
MNC collection procedure 220 system warnings for use 3
PMN collection procedure 220
sensors T
bar code reader 24
tabs, menu
pressure
BMP procedure 197
centrifuge 24
CMNC procedure 149
collect 24
MNC collection procedure 133
inlet 24
PLTD procedure 180
plasma 24
PMN collection procedure 164
return 24
RBCX procedure 117
reservoir
TPE procedure 85
high-level 24
TPE-SPD procedure 99
low-level 24
WBCD procedure 180
serial number, system 22
tare weight of collection bag, establishing 273
service cautions for use 10
target defective RBC
service information 15
data entry range 119
service warnings for use 4
description of 123
shipping humidity, device 243
Target Hct procedure summary data 213
shipping temperature, device 243
TBV of patient
single needle, TPE procedure
calculating, formula for 266
converting to 91
data entry range 86, 100, 118, 134, 150, 165, 181
decreasing run time 96
overriding system calculation 89, 121, 138, 153, 168,
description of 74, 84
184
selecting 80
TBV processed procedure summary data 213
single-needle icon 37
TBV processed, configuring 54, 55, 56, 57, 58
software verification configuration 49
temperature, device shipping and storage 243
SPD see TPE-SPD 52
test tube icon 38
Spectra Optia® Apheresis System Collection Preference Tool
time configuration
Collection Preference Tool 62
current time 49
splash guard, replacing 238

Spectra Optia Apheresis System Operator’s Manual 295

Index

format 49 upper collar holder 26

touch screen see screen
TPE procedure configuration 52 V
TPE using a single needle see single needle, TPE procedure
valves
TPE-SPD procedure configuration 52
collect valve 24
transport, system
plasma 24
in a vehicle 45
RBC 24
preparing for transport 44
remove valve 24
treated plasma bag
view port 21
adjusting volume in 110
volume removed (mL) procedure summary data 213
connecting 105
volume replaced (mL) procedure summary data 213
initial volume pumped into bag 107
returning contents of 111
trisodium citrate 162, 178 W
troubleshooting warnings for use 3
alarms 216 accessory set 8
alarm history screen 218 definition of 2
multiple alarms 218 electrical 4
anticoagulation of the extracorporeal circuit 221 fluids used during procedures 8
cassette, manually raising 226 general procedural 4
centrifuge door, manually opening 226 procedure
fluid leaks 221 collection 7
manual rinseback 223 depletion 7
tubing set exchange 7
anticoagulation of 221 Seal Safe system 8
bag volumes 250 service 4
cautions for use 12 system 3
Collection Set 13 tubing set, general 8
Exchange Set 13 waste disposal 18
IDL Set 13 WBC count of patient, data entry range 134, 181
channel life 251 WBCD procedure configuration 57
injection port, using 268 weight of patient
loading 65 configuring unit of measure 50
bearings, upper and lower 70 data entry range 86, 100, 118, 134, 150, 165, 181
cassette 67 wheel pedal 22
channel 67 wheels, system 22
lower collar 68 pedal 22
upper collar 70 system handle 22
priming 71 white blood cell depletion procedure see WBCD procedure 57
procedure summary data 213 whole blood processed procedure summary data 213
RBC, residual volume in 251 whole blood processed, configuring 54, 55, 56, 57, 58
removing 214
reservoir volume 250 Y
unloading 214 yield of target cells, maximizing 144, 158, 173, 190
unpacking lines and bags
Collection Set 66
Exchange Set 66
IDL Set 66
warnings for use 8
tubing set required for each procedure 62
turbulence in connector
algorithm control 93
handling 95

U
upper bearing holder 26

296 Spectra Optia Apheresis System Operator’s Manual

Attach addenda here
Operator’s Manual

Spectra Optia® Apheresis System

Terumo BCT, Inc. Terumo BCT Asia Pte. Ltd.

10811 West Collins Avenue 89 Science Park Drive
Lakewood, Colorado 80215-4440 #04-25 (Lobby B)
USA The Rutherford
Singapore 118261
USA Phone: 1.877.339.4228
Phone: +1.303.231.4357 Phone: +65.6715.3778
Fax: +1.303.542.5215 Fax: +65.6774.1419

Terumo BCT Europe N.V. Terumo BCT Latin America S.A.

Europe, Middle East and Africa La Pampa 1517–12th Floor
Ikaroslaan 41 C1428DZE
1930 Zaventem Buenos Aires
Belgien Argentina

Phone: +32.2.715.05.90 Phone: +54.11.5530.5200

Fax: +32.2.721.07.70 Fax: +54.11.5530.5201

Terumo BCT Japan, Inc.

Tokyo Opera City Tower 49F
3-20-2, Nishi-Shinjuku,
Shinjuku-ku, Tokyo, 163-1450,
Japan

Phone: +81.3.6743.7890
Fax: +81.3.6743.9800

TERUMOBCT.COM

©2021 Terumo BCT, Inc. Part No.1000004965 Reorder No. 703261003